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ABSTRACT 
Human embryonic stem cells (hESCs) are thought to have enormous potential for use 
in regenerative medicine, whilst simultaneously allowing us insights into human 
embryonic development, disease modelling and drug discovery. Differentiation to 
mesodermal lineages, such as cardiomyocytes and blood, may allow for improved 
treatment of cardiac and haematopoietic diseases. hESC-derived immune cell types 
may also allow the circumnavigation of the immune barrier. This thesis aims to test 
the hypothesis that formation of hESC derivatives is regulated by the same 
mechanisms and ontology as in vivo embryo development. Therefore, by identifying 
and facilitating the mechanisms of mesoderm induction, hESC differentiation can be 
optimised to maximise the production of mesoderm, and, ultimately, mesoderm 
derivatives. 
Using a Xenopus laevis animal cap model with simultaneous treatment with activin B 
or fgf4, together with tall, Im02 and gatal mRNA, resulted in substantial increases 
in mesodermal, haemangioblast and erythropoietic cell markers. One of the most 
successful methods for hESC differentiation is by the formation of human embryoid 
bodies (hEBs). To reduce first the number of variables in current mass culture 
protocols for hEB formation, such as hEB size, a forced aggregation system was 
established that produced homogeneous hEBs from defined numbers of cells. This 
system was then optimised to enhance production beating cardiomyocytes by varying 
the number ofhESCs used for hEB formation and also the number of days in culture. 
This system was assessed in four hESC lines and demonstrated' ubstantial inter-line 
variability in cardiomyocyte production (1.6± 1.0% to 9.5±0.9°0). Differentiation was 
also perfonned using chemically defined media (CDM) with the addition of actiyin 
A and FGF2 and resulted in 23.6±3.6% of hESs producing beating cardiomyocytcs. 
In addition immunohistochemistry was performed to assess the relationship of cells 
expressing markers for mesoderm, pluripotency, ectoderm, and endoderm to 
establish a standard spatial and temporal map ofhEB differentiation. 
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Abbreviation Description 
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AKTI V-akt murine thymoma viral oncogene homolog 1 
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BMPR Bone morphogenetic protein receptor 
I 
BMT Bone marrow transplant 
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Sal-like 4 (Drosophila) 
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Note on gene nomenclature 
Due to the lack of clarity regarding gene nomenclature across publications and 
databases (Fundel and Zimmer, 2006), this thesis uses the recommended notation 
provided by the respective genome nomenclature committees for each organism. 
Human gene and protein names and symbols follow current Human Genome 
Nomenclature Committee guidelines (http://www.gene.ucl.ac.uklnomenclature/).To 
summarise, gene symbols are italicised with all letters in uppercase. Proteins 
designations are the same as the gene symbol, but not italicised with all letters in 
uppercase. mRNA and cDNA use the gene symbol and formatting conventions. 
Mouse gene and protein names and symbols follow current Mouse Genome 
Nomenclature Committee guidelines 
(http://www.informatics.jax.org/mgihome/nome!!L). To summarise, gene symbols are 
italicised with first letter uppercase and the remaining letters in lower case. Proteins 
designations are the same as the gene symbol, but not italicised with all letters in 
uppercase. mRNA and cDNA use the gene symbol and formatting conventions. 
Xenopus gene and protein names and symbols are in the process of being converted 
to HGNC nomenclature 
(http://xlaevis.cpsc.ucalgary.ca/gene/static/geneNomenclature.jsp) as shown in the 
Xenbase Gene database (http://xlaevis.cpsc.ucalgary.ca/gene/gene.do).To 
summarise, gene symbols are not italicised with all letters in lowercase. Proteins 
designations are the same as the gene symbol, but not italicised and all letters in 
uppercase. mRNA and cDNA use the gene symbol and fonnatting conventions. 
Names and symbols of Xenopus genes and proteins not yet in the Xenbase Gene 
database follow nomenclature most frequently used in the literature. 
1 INTRODUCTION 
1.1 THE POTENTIAL OF HUMAN EMBRYONIC STEM CELLS 
Human embryonic stem cells (hESCs) could potentially usher in a new era of cellular 
regeneration of diseased organs and tissues rather than chronic support with drug 
therapies (Passier and Mummery, 2003). hESCs can also be used in the field of 
developmental biology, providing us with novel models for the study of human 
embryonic and foetal development, including disorders of development such as birth 
defects or embryonal tumours (Dvash and Benvenisty, 2004). Using hESCs to access 
human embryonic gene expression ontogeny will also provide us with new tools for 
the investigation of growth and differentiation factors, which can be used to 
differentiate hESCs into cell types for use in disease modelling and drug discovery 
(Ben-Nun and Benvenisty, 2006). 
1.1.1 Stem cell potency 
A stem cell, by definition, is a cell that can proliferate by a process of self-renewal 
whilst maintaining the ability to give rise more committed descendents (Reya et aI., 
2001). In the embryo, cells of the morula have the potential to generate an entire 
organism and its associated extra-embryonic tissues, termed totipotency (reviewed 
by Rippon and Bishop, 2004). Subsequently, cellular differentiation results in the 
formation of the blastocyst which consists of the outer trophectoderm, which will 
fonTI the trophoblast component of the placenta, and the inner cell mass (leM), 
which will develop into the embryo proper and the chorioallantois. The cells of the 
ICM are described as pluripotent, detined as the ability to form all of the tissues of 
the developing embryo (Smith, 2005). 
1.1.2 Foetal and adult stem cells 
Once embryonic and foetal development is complete it is thought that many, if not 
most, tissues of the human body maintain adult stem cells within their population. 
These adult stem cells have been proposed to be essential and perhaps the only cells 
important for lifelong tissue regeneration (Weissman, 2005). Such stem cells are able 
to self-renew and differentiate into multiple organ specific cell types, termed 
multi potency (Lakshmipathy and Verfaillie, 2005). 
The use of adult stem cells in clinical therapies has existed since 1968 in the form of 
a bone marrow transplant (BMT) for patients that suffer from congenital blood or 
immune disorders or have had their own bone marrow damaged by cancer treatment. 
Haematopoietic stem cells (HSCs) that are transplanted during a BMT are 
responsible for repairing the patient's capacity to manufacture healthy blood and 
Immune cells (Weissman, 2000). However, In many cases, such as 
neurodegenerative disorders and type I diabetes, the prospect of transplantation of 
adult cells is still very poor since they are far less mitotically active than foetal cells 
and the ability to self-renewal is reserved for a rare population of stem cells 
(Weissman, 2005). 
1.1.2.1 Adult stem cell plasticity 
Traditionally organ-specific adult stem cells have been thought to be stringently 
restricted to making differentiated cell types of the tissue in which they reside 
(Anderson et al., 2001) and they take on new roles in an orchestrated, unidirectional 
and irreversible manner (Lemischka, 2001). However, experiments have been 
performed that have challenged the system of lineage-restriction in organ specific 
stem cells (Serafini and Verfail1ie, 2006). These experiments hayc been interpreted 
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as evidence that stem cells from some adult sources, under certain 
microenvironmental conditions, seem to have that is a wider capacity for renewal, 
termed 'plasticity' (Lakshmipathy and Verfaillie, 2005). 
Whilst the underlying mechanism of the apparent plasticity of adult stem cells is still 
in debate, it is thought that there are four main possibilities (reviewed by 
Lakshmipathy and Verfaillie, 2005, Martin-Rendon and Watt, 2003) assuming that 
results are based on sustained, robust multilineage engraftment and not morphology 
or the expression of lineage-specific antibodies. Firstly, that the reports are based on 
infusion of non-pure populations that contain multiple stem cell types. Secondly, the 
maintenance of more multipotent cells, with higher lineage potential, within a tissue 
is another option or even the possibility that the entire concept of organ-specific stem 
cells is wrong and they are essentially pluripotent (Anderson et al., 2001). A third 
explanation is cell fusion, particularly where stem cells of one lineage are cultured in 
the microenvironment of another cell type (Ying et al., 2002, Terada et al., 2002, 
reviewed by Wurmser and Gage, 2002). The final explanation for plasticity, the only 
one representing true plasticity, is de-differentiation and subsequent re-
differentiation, transdetermination or even trans differentiation (Martin-Rendon and 
Watt, 2003), perhaps by genomic reprogramming possibly due to the in vitro culture. 
While clearly useful for some applications such as BMT, autologous adult stem cells 
are generally difficult to proliferate in culture for extended periods of time and 
maintain in an . undifferentiated' state due to an inability to recreate their stem cell 
niche (Verfaillie et aI., 2002). Adult stem cells are also very rare and generally found 
as tissue-resident cells as well as in the blood and bone marrow, and the prospects of 
extraction, amplification and transplantation to good manufacturing practice 
standards on a per patient basis are daunting (Skottman et aI., 2006). 
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1.1.2.2 Mouse and human embryonic carcinoma and PGC derived cells 
The first pluripotent cell lines to be established were embryonic carcinoma (EC) cell 
lines derived from mouse and human germ cell tumours (Stevens and Little, 1954, 
reviewed by Chambers and Smith, 2004). These cells can be continuously expanded 
in culture and differentiated into cells of the three germ layers. Mouse EC cells can 
also be injected into mouse blastocysts and contribute to all of the normal tissues of 
chimeric mice generated (Illmensee and Mintz, 1976). EC cells being of cancer 
origin and frequently aneuploid, are not suitable for clinical applications. Similarly, 
mouse and human embryonic germ cells, which are derived from primordial germ 
cells (PGCs), are classed a pluripotent and can contribute to all cell lineages in 
chimeric mice, although they have lower plating efficiencies than ECs (Matsui et al., 
1991, Resnick et al., 1992, Shamblott et al., 1998). 
1.1.3 Embryonic stem cells 
The definition of an embryonic stem cell (ESC) was established in primates by 
Thomson et al. (1998) as (i) derivation from the preimplantation or periimplantation 
embryo, (ii) prolonged undifferentiated proliferation, and (iii) stable developmental 
potential to form derivatives of all three embryonic germ layers even after prolonged 
culture. 
Mouse embryonic stem cells (mESCs) were first isolated from day 2.5 post-
fertilisation murine blastocysts using techniques based on experience gained from the 
culture of EC cells (Martin, 1981, Evans and Kaufinan, 1981). Only more recently 
have ESCs from primates bE-en derived (rhesus monkey (Thomson ef al.. 1995). 
common manlloset (Thomson ef al., 1996), and cynomolgus monkey (Suemori ef al .. 
2001)). along with hESCs in 1998 (Thomson ef al., 1998). Similar to ECs. \\"hcn 
injected into mouse blastocysts, mESCs can for chimeras and contribute to all 
observable tissues and the genn line (Bradley et ai., 1984). This ability has lead to 
the creation of numerous knock-in and knock-out transgenic mice for the 
investigation of gene expression and regulation in vivo. 
mESC were initially established on and maintained by co-culture with mitotically 
inactivated mouse embryonic fibroblast (MEF) feeders. The absence MEFs or MEF 
conditioned medium results in spontaneous, random differentiation, with 
heterogeneous populations of differentiated cells appearing throughout the mESC 
colonies (Martin, 1981, Evans and Kaufman, 1981). Studies identified the cytokine 
LIF (leukaemia inhibitory factor, Smith and Hooper, 1987, Gearing et aI., 1987) as 
one of the feeder cell-derived molecules that plays a pivotal role in the self-renewal 
of these cells whilst also inhibiting their differentiation. On gelatine coated plates, in 
the presence of foetal bovine serum (FBS), recombinant LIF can replace the feeder 
cell function and maintain the growth of undifferentiated mESCs (Smith et aI., 1988, 
Williams et aI., 1988). Although in serum free culture, LIF alone is not able to 
prevent mESCs from differentiating, the addition of BMP4 (bone morphogenetic 
protein 4) allows undifferentiated mESC growth (Ying et aI., 2003). The 
combination of these discoveries allows mESC to be grown with defined factors in 
the absence of serum or feeders. 
1.1.4 Signalling pathways involved in maintaining mESC pluripotency 
LIF acts by binding to the heterodimeric LIF receptor (LIFR) which consists of two 
transmembrane proteins, LIFR itself and IL6ST (illterleukin 6 signal transducer, 
previously known as gp 130). LIFR activates JAK 1 (Janus kinase 1) mediated ST AT3 
(signal transducer and activator of transcription 3) protein activation (Niwa (!f al.. 
1998. Burdon (!f al.. 1999a). A study using a chimeric ST A T3 molecule activated by 
estradiol suggests that ST A T3 signalling alone may be sufficient to block 
differentiation (Matsuda et aI., 1999). The role of the LIF 1ST A T3 in maintaining 
pluripotency is thought to be only facultative in vivo (Nichols et aI., 2001) as Lij-I-
(Stewart et aI., 1992) and Stat3-1- (Takeda et aI., 1997) mouse embryos can succeed 
beyond gastrulation. The successful function of LIF 1ST A T3 signalling In 
maintaining mESC pluripotency is thought to be a recapitulation of process of 
diapause. This process occurs naturally when lactating females conceive causing the 
arrest of embryo development at the late blastocyst stage and the prevention of 
implantation (Nichols et aI., 2001). The binding of LIF to its receptor also initiates 
signalling pathways that are antagonistic to self-renewal such as the differentiation 
promoting extra-cellular signal-related kinase mitogen-activated protein kinase (ERK 
MAPK) pathway, (Burdon et aI., 1999b). The balance between these antagonistic 
pathways plays an important role in regulating self-renewal and determining the fate 
of undifferentiated mESCs (Burdon et aI., 1999a). 
The effect of BMP4 on mESC self-renewal involves induction of Idl (inhibitor of 
DNA binding 1) expression through SMAD 1/5/8 (mothers against decapentaplegic 
homolog 1, 5 and 8, Ying et al., 2003) and inhibition of the ERK MAPK pathway 
and the p38 MAPK (response to stress) pathway (Burdon et aI., 1999b, Qi et aI., 
2004). A role for phosphoinositide 3-kinases (PI3K) signalling in enhancing mESC 
survival and cell cycle progression has also emerged (Burdon et aI., 2002). 
The maintenance of pluripotency also requires interactions between transcription 
factors. Three 'core' pluripotency factors have been identified: POU5Fl (POU class 
5 homeobox I, previously known as OCT4), which is essential for pluripotency both 
in \'itro and in \'ivo (Nichols ct al.. 1998); SOX2 (SRY (sex detennining region Y)-
box 2), which is a transcriptional partner for POU5F 1 (A \'ilion ct aI., 2003, Rodda et 
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at., 2005); and NANOG (Nanog homeobox), which promotes self-renewal and 
alleviates the requirement for LIF (Mitsui et at., 2003, Chambers et aI. , 2003) , 
although is not essential for maintaining the pluripotent state (Chambers et at., 2007). 
These three transcription factors interact in feedback regulatory circuits (Boyer et aI. , 
2005, Loh et at., 2006) and together are thought to act as master regulators of 
pluripotency (Gokhale and Andrews, 2008). In addition to POU5Fl , SOX2 and 
NANOG, evidence also points to the involvement of a number of other transcription 
factors in the control of pluripotency (Wang et al., 2006, Zhou et al., 2007, Kim et 
al., 2008). An overview of the factors that control mESC pluripotency is shown in 
Figure 1-1. 
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Figure 1-1: Signalling pathways regulating mESC pluripotency 
LIF signalling (through the JAKliSTAT3) and BMP4 signalling (through SMAD1I5 and ID1) 
maintain pluripotency, however, when added individually, BMP4 and LIF induce 
mesodermallendodennal and neuroectodem1al differentiation of mESC cultures respectively (Ying e/ 
al., 2003 , Rao, 2004). POU5F 1, SOX2, and NANOG act in concert to promote pluripotency. LIF can 
also signal the ERK MAPK pathway that can induce differentiation. Diagram adapted from Hys lop ef 
al., (2005b) . 
1.1.5 Human embryonic stem cells 
hESCs have been derived from fresh or fro zen, blastocyst stage embryo gencrated 
through a sisted reproduction procedure , fertili ed either by ill )'irro fCliili ation 
(lVF) or intracytopl a mic pcrm inj cction p eS !). The c embryos arc donated ror 
.3 1 
research with infonned consent after being selected for disposal either because they 
are excess to patients needs or because they are of insufficient quality for embryo 
transfer (Mitalipova et al., 2003). Alternatively embryos can be created in vitro, with 
infonned consent, specifically for the purpose of deriving hESCs lines (Lanzendorf 
et al., 2001) although in most countries this is considered ethically inappropriate. 
Other methods of producing hESCs such as parthenogenesis as perfonned with non-
human primates (Cibelli et al., 2002, Vrana et al., 2003) have recently proven 
feasible in humans (Revazova et aI., 2007, Kim et al., 2007a). 
As with mESCs, the derivation process for hESCs involves culturing embryos to the 
blastocyst stage and isolating the rCM. hESC lines have also been derived from 
morula stage embryos (Strelchenko et aI., 2004). The cell population is then 
expanded on feeder cells and serially passaged to fonn a hESC line. Most cell lines 
are derived from between d6 and d8 blastocysts which provide approximately 30 and 
50 rCM cells respectively (Stojkovic et aI., 2004b). Under the appropriate conditions, 
hESCs are able to self-renew and maintain undifferentiated phenotype over extended 
periods of time, possibly indefinitely. hESCs express high levels of telomerase 
(Thomson et aI., 1998), a ribonuclearprotein that adds telomere repeats to 
chromosome ends, thereby maintaining their length, which is highly correlated with 
immortality in human cell lines (Kim et at., 1994). 
The very first study that describes the separation of human rCM cells and their 
continued culture, although only for two passages, was perfonned in 1994 by 
manually isolating the ICM (Bongso et aI., 1994). This method was superseded, \\ith 
few exceptions (Amit and Itskovitz-Eldor. 2002), by immunosurgery (Thomson et 
aI., 1998, Solter and Knowles. 1975). a process in which the zona pellucida is first 
rl'l11o\'C'd by digestion with pronase followed by se\ccti\'C'ly rcmo\'al of the 
trophectoderm layer of the blastocyst using specific antibodies such as rabbit anti-
human whole serum (Reubinoff et al., 2000). This method resulted in the first 
successful derivation of hESCs by Thomson et at. (1998) with the HI, H7, H9, H 13 
and H14lines. These cells were grown on MEFs in a medium containing FBS. These 
lines have formed the basis of the vast majority of hESCs experiments that have been 
performed to date (Goh et at., 2005, Allegrucci et al., 2005). Derivations of hESCs 
all result in the isolation of a pluripotent population from several ICM cells. The cell 
line H9 was the first to undergo single cell cloning (Amit et al., 2000) to form two 
clonal lines H9.1 and H9.2, demonstrating that individual hESCs are in fact 
pluripotent. Similar experiments have since been performed with the HI, H 13, 13 and 
16 lines (Amit and Itskovitz-Eldor, 2002). It has also been demonstrated that zygotes 
with chromosomal abnormalities can be used as a source for derivation of hESCs 
(Suss-Toby et al., 2004) and hESCs can be derived from single blastomeres 
(Klimanskaya et al., 2006). 
Numerous hESCs lines have now been established (Table 1-1) using a variety of 
media, feeders and enzymatic (collagenase/trypsin), non enzymatic (cell dissociation 
buffer) or mechanical passage methods (reviewed by Allegrucci and Young, 2007). 
Table 1-1: Main hESC lines derived to da te 
~ ~ IIna Reference 
H1 , H7, H9, H13, H14 (Thomson et al., 1998) 
HES-1 to 4 (Reubinoff et al., 2000, Richards et al., 2002) 
ES-76, ES-78-1 , ES-78-2 (Lanzendorf et al., 2001) 
1-3, 1-4, 1-6, 1-9 (Amit and Itskovitz-Eldor, 2002, Suss-Toby et al., 2004) 
BG01 to 4 (Mitalipova et al. , 2003) 
Miz-hES (Park et al., 2003, Lee et al., 2005) 
WT3 (Pickering et al. , 2003) 
HS181 (Hovatta et aI. , 2003) 
HSF-1, HSF-6 (Abeyta et aI. , 2004) 
Royan H1, H2, H6 (Baharvand et al., 2004, Baharvand et al., 2006a) 
Maria Biotech MB (Park et al., 2004b) 
Sahlgrenska 1 to 3 (Heins et al., 2004) 
hES-NCL 1 (Stojkovic et al., 2004a) 
HUES-1to17 (Cowan et al., 2004) 
ACT-14 (Klimanskaya et al., 2005) 
SNUhES1 to 3 (Oh et aI. , 2005) 
UCSF-1 (Genbacev et al., 2005) 
HS293, HS306 (Inzunza et al., 2005) 
VAL-1, VAL-2 (Simon et al. , 2005) 
PKU1 , PKU2 (Hong-mei and Gui-an, 2006) 
H15, H16 (Ludwig et al., 2006b) 
ReliCell hES1 (Mandai etal. , 2006) 
MA01 , MA09 (Klimanskaya et al., 2006) 
VUB01 to 5 (Mateizel et al., 2006) 
NOTT1 , NOTT2 (Burridge et al., 2007) 
NTU1 to 3 (Chen et al., 2007) 
1.1.6 Surface markers of hESCs and mESCs 
hESC lines derived from different laboratories show similar expression profiles of 
surface markers including: 1) the globoseries glycolipid stage specific embryonic 
antigens, SSEA3 and SSEA4; 2) the keratan sulphate antigens, TRA-I-60, TRA- 1-
8 1, GCTM2 and GCTM343 and 3) the liver alkaline phosphatase antigens, TRA-2-
49 and T RA-2-54 (Adewumi et aI., 2007) . Mouse rCM and mESCs also expre 
SSEA 1 but do not express SSEA3 , SSEA4, 1 RA-I-60 or TRA-J -81 (Carpcntcr ('{ 
aI. , 2003). Desp ite these differences, 19 1 proteins ha\'e been detected as cx-prc cd in 
both m ESCs and hESCs but not in their ditlerentiatcd dcrinlti\'Cs (Van Hoof C{ 01.. 
2006). 
1.1.7 Maintaining hESC pluripotency 
1.1.7.1 Serum and serum replacement 
The first hESCs lines were originally derived in medium containing FBS (Thomson 
et al., 1998). FBS is serum harvested from bovine foetuses and consists of a complex 
mix of proteins of unknown composition that exhibits substantial batch variation. 
FBS can contain compounds both beneficial and detrimental to hESC culture (Amit 
et al., 2000). The use of FBS raises the concern of the introduction of viruses, prions 
or xenobiotic pathogens from cow to human (Cobo et aI., 2005). 
Knockout® Serum Replacement (KSR) from Invitrogen (Price et aI., 1998) and 
VitroLife (Chen et al., 2007) has been used in an attempt to remove the FBS from 
hESC experiments, although these still contains animal proteins. Evidence exists that 
HI hESCs lines can incorporate immunogenic nonhuman sialic acid, N-
glycolylneuraminic (Neu5Gc), from the mouse feeder layer and/or KSR they are 
cultured with (Martin et aI., 2005). Many humans have circulating antibodies to 
Neu5Gc, though not necessarily at a high titre (Cerdan et al., 2006), which could 
result in complement mediated cell death of cells bearing this molecule (Nguyen et 
aI., 2005). The use of xenogenic FBS or KSR in these culture media makes them 
unsuitable for transplantation therapy and a substitute needs to be found such as a 
serum/serum replacement containing only human proteins or serum-free media 
fonnulations. Human serum is used in human IVF procedures (Wang and Sun, 
2005), therefore exposure to human materials maybe possible. Human serum has 
been demonstrated to be able to replace FBS in hESC culture ~ R i c h a r d s s ef aI., 2002). 
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1.1.7.2 Murine and human feeders 
The fibroblast feeder layer remains the most poorly defined component of the hESC 
culture (Amit et al., 2000). These fibroblasts secrete multiple growth factors, 
including fibroblast growth factors (FGFs), transforming growth factor ~ ~ (TGFB 1), 
activin A, WNTs and antagonists of BMP signalling (Levenstein et ai., 2006). 
Therapeutic treatment using cell lines which have been cultured on these nonhuman 
cells may not be possible. Human marrow stromal cells (Cheng et ai., 2003), foreskin 
cells (Hovatta et al., 2003, Choo et ai., 2004), uterine endometrial cells (Lee et al., 
2005) and foetal muscle and skin cells derived from aborted foetuses (Richards et al., 
2003), and fibroblasts derived from the hESCs themselves (Wang et ai., 2005d) have 
all been tested for their potential to support undifferentiated growth. With the 
addition of human serum, human feeders have demonstrated the capacity to support 
undifferentiated growth in a completely xeno-free system (Richards et ai., 2002). 
1.1.7.3 Artificial matrices for feeder-free culture 
The presence of feeders both slows passaging and complicates studies of hESC 
undifferentiated growth; therefore attempts have been made to use alternative 
matrices for feeder-free culture. It has been demonstrated that hESCs can be cultured 
in a feeder-free environment using KSR containing MEF conditioned medium on a 
basement membrane matrix called Matrigel. This matrix was shown to be equal or 
superior to laminin, fibronectin or collagen IV matrices (Xu et ai., 2001). Matrige1 is 
derived from mouse Engelbreth Holm-swarm sarcoma, a tumour rich in extra-
cellular matrix proteins. Its major component is laminin, followed by collagen IV, 
hepm"an sulfate proteoglycans, and entactin (Xu et ai., 2001). Using MatIige1 with 
MEF-conditioned medium the hESCs have no direct contact with the MEFs so any 
fceder cell contact-related factors which may be aiding hESCs pluripotcncy can be 
eliminated. However, Matrigel is still produced from animal products. To avoid this, 
human 1aminin has also been used as a matrix (Stojkovic et aI., 2005). Recently a 
entirely synthetic semi-interpenetrating polymer network, a polymer hydrogel, has 
been used as artificial matrix for support of HSF-6, but this was only demonstrated to 
support growth for up to 5 days (Li et aI., 2006b). Progress in avoiding the use of 
using FBS and MEF-conditioned medium to maintain undifferentiated hESCs has 
been made by combining KSR containing medium with high concentrations of FGF2 
(100 ng mrl) without conditioning the medium with growth on Matrigel (Levenstein 
et al., 2006). 
1.1.7.4 Chemically defined media 
Further progress has been made using Matrige1 along with semi-chemically defined 
medium, avoiding the use of FBS or KSR. As well as improving the potential for 
clinical use, more defined media greatly simplifies studies of developmental 
mechanisms. Some of the more successful media have included Iscove's Modified 
Dulbecco's Medium/F-12 Nutrient Mixture (IMDM/F-12) supplemented with activin 
A or NODAL and FGF2 (Vallier et aI., 2005), Dulbecco's Modified Eagle's 
Medium/F-12 Nutrient Mixture (DMEM/F-12) supplemented with N2/B27 and high 
concentrations of FGF2 (Liu et aI., 2006b, Yao et aI., 2006), HESCO (hESC 
cocktail) supplemented with WNT3A and FGF2 (Lu et aI., 2006), or TeSR 1 or 
modified TesRl supplemented with FGF2 (Ludwig et aI., 2006a, Ludwig et aI., 
2006b). None of these media can be classed as full chemically defined as they each 
are supplemented with bovine serum albumin (BSA). Ultimately, development of a 
fully defined culture system suitable for supporting hESC derivation, gnn\,th and 
ditferentiation without feeders, serum or serum replacement (human or otherwise) 
and using a medium of a known protein composition will al1o\\' us to minimise the 
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variability that affects the reproducibility and robustness of hESC culture and allow 
the initiation of differentiation in a fully controlled manner. 
1.1.8 Signalling pathways involved in maintaining hESC pluripotency 
Unlike mESCs, which can be maintained in a undifferentiated state by LIF, the 
addition of LIF does not sustain the culture of hESCs in the absence of feeder layers 
(Thomson et al., 1998) and it is not fundamental to hESC pluripotency (Humphrey et 
aI., 2004, Daheron et al., 2004), despite the expression of both LIF and LIFR in 
hESCs (Aghajanova et al. , 2006). The signalling pathways involved in maintaining 
hESC pluripotency have been well characterised and are reviewed below and shown 
in Figure 1-2. 
FGF2 ---+ PI3K1AKT ---+ Prolif"ralion 
LEFTY1I2---i NODAL activin A TGFB1 I----NOG 
Mesoderm 
Endoderm 
ERK MAPK 
________ ~ ~ - - - - - - - - Neuroectoderm 
Trophectoderm 
Primitive endoderm 
Figure 1-2: Signalling pathways regulating hESC pluripotency 
TGFB lIactivin AJNODAL pathwa y ac tiva tion and BMP pathway repression by OG (noggin) are 
required to maintain hESC pluripotency whilst FGF2 signa lling through PI3 KJA KT is required to 
maintain ce llular proliferati on . Diagra m adapted from Hyslop (' / (1 / .. (2005b). 
1.1.B.1 FGF signalling 
Although it remai ns unclear what direct rol e FGF signalling ha on hESCs. the 
requ iremcnt for FGF2 to maintain pluripotency in the absence of feeders (Vallier Cf 
aI. , 2005 . AU c/ (I I. . 2005 b) and the presence of FGF2 . FGFJ I. FGFJ:; a ~ ~ \\ell tl" 
FGF receptor 1 (FGFRl), FGFR2, FGFR3 and FGFR4 transcripts in hESCs indicates 
that FGF signalling is active in undifferentiated hESCs (Sato et aI., 2003, Sperger et 
aI., 2003, Dvash et at., 2004, Ginis et aI., 2004, Rao et aI., 2004, Dvorak and Hampl, 
2005). Of the 22 members of the FGF family, FGF2 has the most well defined role in 
contributing to hESC pluripotency (Xu et aI., 2005a, Xu et aI., 2005b). FGF2 
signalling is initiated by the binding of FGF2, along with the co-ligand heparan 
sulphate, to any of the four FGFRs. The resulting dimerisation results in the 
phosphorylation of the docking protein FRS2 (fibroblast growth factor receptor 
substrate 2), followed by the recruitment of several GRB2 (growth factor receptor-
bound protein 2) molecules. Activated GRB2 molecules then recruit the nucleotide 
exchange factor SOS 1 (son of sevenless homolog 1, Dvorak and Hampl, 2005). The 
formation of the FRS2-GRB2-S0S complex results in activation of the ERK MAPK 
and PI3KJanaplastic lymphoma kinase (AKT) pathways that are suggested to have 
roles in self-renewal/differentiation and cell proliferation, respectively, in hESCs 
(Kang et aI., 2005, Armstrong et aI., 2006, Li et aI., 2007). In addition, FGF2 has 
been demonstrated to up-regulate activin A, TGFB 1, and BMP4 in hESCs (Greber et 
aI., 2007). 
1.1.8.2 BMP signalling 
BMPs are members of the T G F ~ ~ superfamily. Of the 20 BMPs, the roles of BMP2 
and BMP4 have been most intensely studied in hESCs. The four BMP receptors, 
activin receptor 1 (ACYRl), BMP receptor lA (BMPRIA), BMPRIB and BMPR2 
can fonn a variety of dimer combinations at the cell surface, each generating 
difTerent signalling effects and responses (Stewart et aI., 2006). The canonical BMP 
signalling pathway is initiated by the binding of BMP to a heterodimer of BMPR 1 A 
and BMPR:2 (Ying ct at., :2003). This leads to activation of SMAD 1, S\1AD5 and 
SMAD8, which fonns a heteromeric complex with SMAD4 (Miyazawa et af.. 2002). 
This complex then binds to SMAD responsive elements in IDI promoters and 
activates transcription (Ruzinova and Benezra, 2003). 
In hESCs, the undifferentiated state is characterised by low levels of phosphorylated 
SMAD 1/5/8 suggesting that suppression of BMP signalling is necessary for the 
maintenance ofpluripotency (James et af., 2005, Xu et al., 2005b). In addition, BMP 
antagonists such as NOG (noggin), have been demonstrated to aid the maintenance 
of pluripotency in hESCs (Xu et af., 2005b, Wang et af., 2005a), although it is 
suggested that some level of BMP signalling may be required to maintain the 
undifferentiated state (Xu et af., 2005b). BMP signalling also promotes 
differentiation to extra-embryonic lineages (Xu et al., 2002b, Pera et af., 2004) whilst 
NOG can promote differentiation to neuroectodenn (Pera et af., 2004). 
1.1.8.3 TGFB1, activin A and NODAL signalling 
TGFB1, NODAL and activin A fonn disulphide-linked homodimers (in the case of 
activin A fonned from two inhibin ~ A A (INHBA) subunits) that all function through a 
similar mechanism by binding a type II receptor (ACVR2 or ACVR2B) which 
recruits and trans-phosphorylates a type I receptor (ACVR1, ACVRI B, ACVR 1 C or 
TGFBR 1, Ebner et af., 1993). The type I receptor then recruits and phosphorylates 
SMAD2 and SMAD3 (Lebrun et af., 1999). SMAD3 then translocates to the nucleus 
and interacts with SMAD4 through multimerisation, resulting in their modulation as 
transcription factor complexes responsible for the expression of a large variety of 
genes (Chen et af., 2002). Non-SMAD pathways, such as the ERK, p38 and JNK 
MAPK and PI3K1 AKT pathways, have also been associated with TGFB l,acti\'in 
A/NODAL signal transduction (reviewed by Chen ef af., 2006b). Binding of 
NODAl, to the type II receptor requires the co-receptor TDGF I (tcratocarcinoma-
40 
derived growth factor 1, previously known as Cripto, Gritsman et al., 1999) and is 
inhibited by LEFTY1 and LEFTY2 (left-right determination factor 1 and 2) and 
CER1 (Cerberus 1, Schier and Shen, 2000). TDGFI also acts as an inhibitor of 
activin A along with FST (follistatin) and FSTL3 (follistatin-like 3, Chen et aI., 
2006b). 
In hESCs, SMAD2 and SMAD3 have been shown to be necessary in maintaining the 
undifferentiated state, although these are not necessary for maintaining mESCs 
pluripotency (James et aI., 2005). Individually, TGFBI (Amit et aI., 2004) or activin 
A (Beattie et aI., 2005) can maintain the pluripotent state, although proliferation is 
reduced. The combination of activin A or TGFB 1 and FGF2 can maintain 
pluripotency and proliferation (Amit et al., 2004, Vallier et aI., 2005). Additionally, 
it has been demonstrated that activin A regulates FGF, WNT and BMP pathways in 
hESCs (Xiao et al., 2006). NODAL initiates the expression of NODAL antagonists 
LEFTY1 and LEFTY2 which are suggested to have a role in mesoderm induction 
(Dvash et al., 2006). NODAL also prevents differentiation along the neuroectoderm 
pathway (Vallier et al., 2004a) and can bind extra-cellular BMP leading to inhibition 
of the effects mediated by both NODAL and BMP (Yeo and Whitman, 2001). 
1.1.9 Maintenance of karyotype 
Karyotypic stability is an important consideration when hESCs for developmental 
studies. The first report of karyotypic abnormality in hESCs was observed in the H9 
cell line after 7 months of culture (Amit et aI., 2000). This was followed by reports 
of the use of feeder fl ee systems promoting genomic instability of hESCs after 
prolonged in 1'ifro culture, such as aneuploidy (Carpenter cf at., 2004). gain of 
chromosome 17q and 12 when using KSR (Draper cl aI., 2004) and aberrant X 
chromosome expression (Inzunza ct (//.. 200-+). In addition, attempts to adapt the 
-+1 
HS 181 cell line to grow without an extra-cellular matrix resulted in a karyotype 
change to 47,XX,del(7)(ql1.2),+i(12)(pl0) along with decreased pluripotency (Imreh 
et al., 2006). 
1.1.10 Differences between hESC lines and transcriptome profiles 
The transcriptome profile ofhESCs has been studied using a wide variety of methods 
to attempt to identify potential markers and regulators of self-renewal and 
differentiation. The use of hierarchical clustering of microarray data has been used in 
the past to identify if adult and embryonic stem cells have a common . sternness' 
molecular profile (Ramalho-Santos et aI., 2002, Ivanova et aI., 2002). A number of 
groups have used microarrays to asses the gene expression profiles of 
undifferentiated hESC lines (Boyer et al., 2005, Enver et aI., 2005, Skottman et aI., 
2005, Golan-Mashiach et aI., 2005, Rao et aI., 2004, Bhattacharya et aI., 2004, 
Abeyta et aI., 2004, Carpenter et aI., 2004, Zeng et aI., 2004b, Sperger et aI., 2003). 
Along with microarrays, properties ofhESCs have also been compared by RT-PCR, 
quantitative real-time PCR (Noaksson et aI., 2005), in situ hybridisation (ltskovitz-
Eldor et aI., 2000), expressed sequence tag scan (Brandenberger et aI., 2004b), serial 
analysis of gene expression (Richards et aI., 2004) and massively parallel signature 
sequencing (Wei et aI., 2005, Brandenberger et aI., 2004a, Miura et at., 2004). 
Although data produced by microarray studies is of constantly improving quality, a 
concern is the apparent little agreement between different studies. Meta-analysis of 
the data from microarray studies only manages to achieve the resolution to suggest 
that markers present in hESCs but absent in other cell populations exist and one 
review of three independent studies found the expression of just 7 genes commonly 
agreed to be signiticant (Suarez-Farinas ct a/., 2005). This problem has undennined 
contidcnce in microalTay tcchnology (Marshall. 2004. t\llegrucci and Young. 2007). 
To compare hESCs lines in a rigorous manner requires them to be cultured under 
identical culture conditions (Denning et al., 2006), when studied in this manner 
substantial differences in growth efficiency, cloning efficiency and stable 
transfection rates have been noted (Richards et aI., 2002, Ware et aI., 2006). These 
differences between lines have been suggested to be due to the legacy of inherited 
epigenetic effects from early culture conditions (Allegrucci et aI., 2007). 
1.1.11 Legal and ethical issues of hESC research 
The legal position of different countries on hESC research varies across the globe 
depending on religious, moral, historical or socio-economic grounds (McLaren, 
2001). The main ethical issue surrounding hESC research involves the determination 
of when does the embryo become a human being and if the blastocyst stage human 
embryo classifies as 'life', is a basic human rights being disrespected by destroying 
the embryo (Tsai, 2005). The creation ofhESC lines, which is generally from surplus 
human embryos created during an IVF course, is more frequently seen as acceptable 
as these embryos would normally be disposed as they are either not longer required 
or not capable of forming an embryo. (Lo et aI., 2005). The creation of human 
embryos explicitly for the derivation of hESCs, or through therapeutic cloning 
methods such as somatic cell nuclear transfer (SCNT), is currently allowed in only a 
very limited number of countries (Daley et at., 2007). 
1.1.12 Applications of human embryonic stem cells 
1.1.12.1 Use as a model for early hllmall development 
As a result of their ability to differentiate into many ditTerent cell types, hESCs open 
up exciting new opp01iunities to model human embryonic development and study the 
mechanisms underlying lineage specification ill )'itro (D\'ash and Benvenisty, 200-l). 
Early human development is relatively inaccessible to experimental analysis due to 
logistical and moral considerations, and the majority of current information on the 
development of human embryos has been obtained from sectioning terminated 
foetuses (Daley, 2002). Since hESCs can recapitulate embryogenesis by expressing 
developmentally regulated genes and by activating signalling pathways as they occur 
in vivo, they can be used to analyse the effect of specific mutations on particular 
developmental events (Dvash et al., 2006). 
1.1.12.2 Drug discovery and toxicology screening 
Functional assays are used at various stages of drug development such as target 
identification and validation, library screening for early hits and leads, and for 
pharmacological analysis of lead optimisation and drug candidate selection (Friel et 
al., 2005). Many drug discovery programs have failed because targets validated in 
animal models prove to be of less significance in humans (Pouton and Haynes, 
2005). The ability of hESCs to differentiate to a variety of adult cells types provides 
a platform to improve cell culture models used for drug discovery and development 
by replacing animal- or tumour-derived cell lines or lines immortalised by genetic 
modification (Pouton and Haynes, 2005). 
1.1.12.3 Cellular model for human disorders 
Human genetic disorders are caused by gain of or loss of function mutations. Gain of 
function mutations can be modelled in hESC-derived cells by introducing a gene 
harbouring at mutation using techniques such as transfection. However. most 
inhelited genetic defects involvc loss of function mutations which can be introduced 
into hESCs using techniques such as homologous recombination, lentidral 
transfection or RNA interference (Ben-Nun and Benvenisty, 2006). Additionalh'. 
hESC lines can be created using techniques such as SCNT using somatic cells from 
patients with the disease of interest (Alberio et aI., 2006) or by deriving hESCs from 
embryos diagnosed with the disease of interest by preimplantation genetic diagnosis 
(Pickering et at., 2005). 
1.1.12.4 Source of cells for cell therapy and regenerative medicine 
Diseases caused by the loss of a specialised organ-specific cell type, such as 
Parkinson's disease in which dopamine producing neuronal cells are destroyed 
(Lerou and Daley, 2005) or heart disease due to a loss of function of cardiomyocytes 
(Nir et at., 2003), are prime candidates for hESC-derived cell therapy (Ringe et at., 
2002). Other diseases, such as those caused by self-reactivity of the immune system 
including: multiple sclerosis, rheumatoid arthritis, lupus, type 1 diabetes and 
inflammatory bowel disease (Weissman, 2005) may also be potential candidates for 
treatment with hESC-derived HSCs. 
1.1.13 Overcoming tissue incompatibility in hESC-derived transplants 
Transplantation of heterologous hESC-derived cells or tissues could potentially raise 
the same possibility for graft rejection that currently hampers traditional solid-organ 
transplantation (Drukker and Benvenisty, 2004), although it has been demonstrated 
that hESCs and hESC-derived cells do possess some immune-privileged properties 
(Li et aI., 2004b) .. The transplantation of HSCs, derived from hESCs, into foetal 
sheep has been shown lead to successful, albeit with only low level and limited. 
engraftment (Narayan et aI., 2006). It has been suggested that cells derived from 
HSCs, the precursor of blood and the immune system, may be able to induce donor-
specific tolerance by mixed haematopoietic chimerism (Bradley et at.. 2002, Sykes. 
:2001). This raises the hope that transfer of hESC -deriycd HSCs into a patient could 
lead to the stable long-tenn coexistence of multilineage haematopoietic cells of both 
the patient and the hESC line (Kaufman et a/., 2001). This could then lead to 
immunological tolerance to the alloantigens expressed by any other cell types 
derived from the same hESC line (Priddle et a/., 2006). 
Another route to evading the immune system, which would avoid the potential 
ethical concerns of hESCs, has recently been demonstrated by the production of 
induced pluripotency (iPS) cells. This system involved the reprogramming of mouse 
fibroblasts by retroviral introduction of Pou5fl, Sox2, Myc and Klf4 and selection for 
Fbxol5 expression to produce cells of mESC-like character (Takahashi and 
Yamanaka, 2006). This process has been further enhanced by selection for Nanog 
expression (Okita et a/., 2007, Wernig et a/., 2007, Maherali et a/., 2007). If this 
work could be repeated using human fibroblasts it would potentially provide a route 
for providing patient specific pluripotent stem cells (Yamanaka, 2007). 
1.2 APPROACHES TO DIRECTED HUMAN EMBRYONIC STEM CELL 
DIFFERENTIATION 
When removed from the factors that maintain pluripotency, hESCs spontaneously 
differentiate through symmetric cell division (Zwaka and Thomson, 2005), lose their 
near-homogenous phenotype, begin to differentiate and then fonn basic primitive 
structures in a chaotic manner (Thomson et aI., 1998, Itskovitz-Eldor et aI., 2000). 
Theoretically, hESCs are capable of differentiating to all of the 200 or more somatic 
and genn cell types in the adult human body (Reubinoff et aI., 2000). Culture 
conditions and protocols have been developed to improve upon this random 
differentiation and numerous tenninal cell types have been derived as shown in 
Table 1-2. 
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Table 1-2: Cell types produced by in vitro differentiation of hESCs 
:.;.. ;a:.:..-: ~ ~ hESC line I f ~ ~ ' ' Reference I ... ,," ~ ~ . ~ ; , - " "
Endoderm 
insulin producing cells H9, H9.2, H13, 16 (Assady et al., 2001 , Segev et al., 2004, Jiang et 
al., 2007) 
hepatocyte-like cells H1 , H9, Sahlgrenska 1 
(Rambhatla et a/., 2003, Lavon et a/. , 2004 , 
Shirahashi et al., 2004, Baharvand et al., 2006b, 
Soderdahl et a/. , 2007) 
pancreatic cells H9 (Lavon et al., 2006) 
lung alveolar epithelium H9.2 (Wang et al., 2007a) 
Mesoderm 
(Kaufman et al., 2001 , Chadwick et al., 2003 , 
Cerdan et al., 2004, Lu et al., 2004, Zhan et al., 
2004, Tian et al., 2004 , Wang et al., 2004, Wang 
H1 , H9, HES2, HSF6, et al., 2005b, Vodyanik et a/. , 2005, Wang et al., 
haematopoietic cel ls BG01 , BG02, BG03, 2005c, Menendez et al. , 2004, Zambidis et a/., 
SNUhES3 2005, Ng et a/. , 2005b, Kim et al., 2005, Qiu et al., 
2005, Woll et al., 2005, Bowles et al., 2006 , 
Slukvin et a/. , 2006, Anderson et a/. , 2006, Chang 
et al., 2006, Vodyanik et al., 2006, Galic et a/., 
2006, Srivastava et a/. , 2007) 
(Wang et al., 2004, Levenberg et al., 2002 , 
vascular endothelial cells H1, H9, H9.2, H13, 16 Gerecht-Nir et a/. , 2003, Gerecht-N ir et al., 2004c, 
Gerecht-Nir et al., 2005, Wang et a/. , 2007b) 
(Kehat et al., 2001 , Xu et al., 2002a , Mummery et 
H1 , H7, H9, H9.1, H9.2, al., 2002, Kehat et al., 2002 , Mummery et al., 
cardiomyocytes H14, HES-2, HUES-7, 2003, He et al., 2003, Snir et al., 2003, Satin et NOTT1 , NOTT2, BG01 , a/. , 2004, Kehateta/. , 2004 , Reppel eta/. , 2004 , 
ReliCel11 Xue et al., 2005, Huber et al., 2007 , Pal and 
Khanna , 2007, Burridge et al., 2007) 
osteoblasts H1 , H9, TNG15 (Sottile et al., 2003, Bielby et al., 2004, Lerou and Daley, 2005) 
germ cells H9, HSF1, HSF6 (Clark et al., 2004) 
mesenchymal stem cells HUES9, H1 , H9 (Barberi et al., 2005, Lian et al., 2007) 
adipocytes H9 (Xiong et al., 2005) 
skeletal myoblasts H9 (Barberi et al. , 2005) 
Ectoderm 
(Reubinoff et aI. , 2001 , Sch uldiner et aI. , 2001 , 
neurons/ neural H1 , H7, H9, H9.2, HES- Carpenter et aI. , 2001 , Zhang et al., 2001 , Schulz 
progenitors 1, HES-2, HES-3 BG01 , et aI. , 2003, Pera et al., 2004, Ben-Hur et al., BG02 2004, Nasonkin and Koliatsos , 2006, Johnson et 
al., 2007, Pankratz et aI. , 2007, Nat et al., 2007) 
H1 , H9, HES-3, BG01 , (Schulz et al., 2004 , Perrier et al., 2004 , Zeng et 
dopaminergic neurons BG02, BG03, MB03, al., 2004a, Park et al., 2004a, Buytaert-Hoefen et 
HSF-1, SNU-hES-3, M al. , 2004) 
motorneurons H1 , H9 (Li et al., 2005) 
oligodendrocytes H7 (Nistor et al., 2005) 
kerati nocytes H9 (Green et al., 2003) 
retinal H1 , H7, H9 (Klimanskaya et al., 2004 , Ahmad et al., 2007) 
Extra-embryonic 
trophoblast H1 , H7 , H9, H14 (Xu et a/. , 2002b, Geraml-Nainl et aI , 2004) 
yolk sac visceral HES-2 (Conley et al . 2004a) 
endoderm 
-
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A variety of different techniques have been applied to direct the differentiation of 
hESCs and the main approaches are reviewed below. 
1.2.1 Co-culture 
To direct differentiation to a particular lineage, co-culture systems using stromal cell 
types characteristic of the same lineage or 'niche' location have been used. For blood 
differentiation, co-culture of undifferentiated hESCs with the murine bone marrow 
cell lines, S 17 and OP9, or the yolk sac endothelial line, C 166, have proven 
successful (Kaufman et ai., 2001, Vodyanik et ai., 2005). For cardiomyocyte 
differentiation, mouse visceral-endoderm-like END-2 cells have proven successful 
(Mummery et al., 2002). This type of experiment, although useful to prove the 
possibility of deriving a cell type, allow us only limited insights into the regulators of 
differentiation to a particular lineage (Weitzer, 2006). 
1.2.2 Monolayer and adherent colony differentiation 
Several lineages have been formed when hESC colonies have been plated as 
monolayers on Matrigel-, fibronectin- or gelatine-coated plates. Neuroectoderm 
formation has been reported using NOG to block BMP signalling (Gerrard et ai., 
2005, Nasonkin and Koliatsos, 2006), smooth muscle cells formation has been 
reported using all-trans retinoic acid (Huang et ai., 2006), oseteogenic cell and 
mesenchymal stem cells formation has been reported using enzymatic dissociation of 
partially differentiated aggregates in dexamethasone, ascorbic acid-2-phosphate and 
p-glycerolphosphate (Karp et aI., 2006, Olivier et at., 2006); chondrocyte formation 
has been reported using BMP2 (Toh ct al., 2007), and endothelial cell formation has 
been reported without supplementation (Wang et aI., 2007b). Successful 
haematopoietic differentiation in monolayer cultures has been achicnxi in primate 
ESCs using OP9 (bone-marrow derived stromal cells) conditioned medium (Zhang et 
af., 2006). However, adherence of dissected mESC colonies to gelatinised surfaces 
produced almost no haematopoietic colony forming units (Nishikawa et af., 1998, 
Dang et af., 2002). The potential for monolayer-based directed differentiation of 
hESCs colonies to neural, definitive endoderm/pancreatic and early cardiac muscle 
cells in CDM supplemented with growth factors has also been reported (Yao et at., 
2006). As yet the differentiation of hESCs as true monolayers (i.e. allowing single 
cell hESCs to attach to a matrix rather than colonies of hESCs, which would 
facilitate scale-up to clinically relevant levels) has not been described. 
1.2.3 Three-dimensional differentiation on polymer scaffolds 
Polymer scaffolds are an ideal system for inducing three-dimensional tissue 
formation as they can be tailored to modulate cell attachment, growth and 
differentiation, by varying scaffold polymer and fabrication technique, and can be 
biodegradable (Zoldan and Levenberg, 2006). hESCs have been differentiated on 
polymeric scaffolds coated with Matrigel or fibronectin supplemented with growth 
factors and were observed to form structures of neural tissues, cartilage and liver as 
well as a network of blood vessels (Levenberg et af., 2003). 
1.2.4 Genetic modification 
Delivery of defined factors to promote directed differentiation can be problematic. 
Genetic modification can be used to direct hESC differentiation by over-expression 
or ablation of regulatory genes (reviewed by Drukker and Benvenisty, 2004, Yates 
and Daley, 2006). In order to monitor differentiation, tissue specific promoters can 
drive a visible marker gene product such as green fluorescent protein (GFP), or a 
selectable marker, such as an antibiotic resistance gene (Eigcs ct al.. 2001). Cell 
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sorting can be used to select relevant cells if the desired cell type expresses a unique 
pattern of cell surface antigens, such as CD34+ CD38- for the isolation of 
haematopoietic progenitors (Kaufinan et aI., 2001). 
In hESCs various methods for ectopic gene expression have been explored so far 
(reviewed by Wobus and Boheler, 2005, Menendez et aI., 2005). These include 
transient or stable transfection (Eiges et aI., 2001, Lakshmipathy et aI., 2004, Vallier 
et al., 2004b), stable lentiviral transduction (Ma et aI., 2003, Gropp et aI., 2003, 
Smith-Arica et al., 2003), retroviral-based vector transduction (Menendez et al., 
2004, Wang et al., 2005c), and conditional gene expression using an inducible 
recombinase (Nolden et aI., 2006, Vallier et aI., 2007). Loss-of-function studies 
using small interfering (siRNAs) have been shown to be effective at knocking down 
gene expression (Hay et al., 2004, Matin et aI., 2004, Vallier et at., 2004b, Zaehres et 
aI., 2005, Hyslop et aI., 2005a). Homologous recombination, which allows for gene 
targeting, has also been reported in hESCs (Zwaka and Thomson, 2003, Urbach et 
aI., 2004). 
1.2.5 Embryoid bodies 
Thus far the most widely used strategy for successful directed in vitro differentiation 
of hESCs has employed an initial aggregation step to form human embryoid bodies 
(hEBs) that promote germ layer formation before specialised cell types. Embryoid 
bodies (EBs) are 3-D, sphelical multi-cellular aggregates that differentiate in a 
spontaneous manner (reviewed by Weitzer, 2006). Mouse EBs (mEBs) can, to a 
limited extent, recapitulate early post implantation embryonic development and 
mimic the ontogeny of gene expression patterns that appear during embryogenesis 
(Doetschman ct aI., 1985, Keller, 1995). The tirst ill ,'itro studies \\'CIT perfom1cd in 
the 1970's on EBs generated from teratoma and teratocarcinoma cells (Lc\'ine c{ aI., 
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1974, Martin et aI., 1977). In the 1980's mEBs fonned from mESCs (Evans and 
Kaufman, 1981, Martin, 1981) demonstrated the capacity of ESCs to fonn all three 
genn layers. After the initial isolation of hESCs (Thomson et aI., 1998) hEBs were 
quickly demonstrated to have a potential comparable to mESs (ltskovitz-Eldor et aI., 
2000, Schuldiner et al., 2000). 
1.2.6 Gastrulation-like development in mouse embryoid bodies 
Gastrulation-like processes are known to take place in mEBs (reviewed by Weitzer, 
2006), but the regulation of genn layer specification remains poorly understood 
(reviewed by Murray and Edgar, 2004, Spagnoli and Hemmati-Brivanlou, 2006). 
The early stages of mEB development have been best characterised in mESs fonned 
in suspension cultures and can be separated into seven distinct stages; (1) 
aggregation, (2) primitive endodenn fonnation, (3) basement membrane assembly 
(4) primitive ectodenn epithelium fonnation, (5) cavitation, (6) visceral and parietal 
endodenn fonnation and (7) genn layer induction. These stages are summarised in 
Figure 1-3. 
A B c D 
Figure 1-3: Diagrammatic representation of ea rl y m EB differentiation 
!\) d I , CO l I I med ia ted m ESC compacti on (b lue ce ll s). B) d2-4 , primiti ve endodernl fonnation on the exterior of the mEB (red cells) . C) d3-5, basement m embra ne assemb ly 
(grcy). D) d4-5, primit ive ec todernl epithe lium forma ti on and programmed ce ll death of epiblast-like cell s no t in contac t with basement membrane. E) d5-6 , co ntinu ed 
JCH' loPIllCllt of primit ive ec todernl epithe lium , viscera l ec toderm deve lopment and of cavi tation comple ti on. F) d7 , mEB attachment to a plate or co llagen matrix (b lack line) 
via primiti ve e nd ode rm (red ce ll s undernea th the centre of the mEB) which spreads away from the mEB to fornl parie tal endodernl (green ce lls) . Vi sceral endodernl fo rm s 
l'pll hc li a l cy,-, ts o n top (I I' the ce ntra l ce ll mass o f the m EBs (red cells above centre of m EB) . G) Primitive ectoderm epi the lium (blue cells) differenti a te to mesoderma l cc ll s 
(ycll(m ) a nd definitive endode rm (purp le). T he culture medium substitutes for the blastocoe l, and the central cyst (ins ide primitive ectoderm epithelium ) is ana logous to th e 
pr()- (llll nl o ti c ea \ 'it y in the e mbryo (di agram adapted fro m Weitzer, 2006, Li el aI , 2003 , Rodda el 01., 2002). 
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1.2.6.1 Aggregation 
On d 1 following suspension mESCs form an irregularly shaped aggregate of cells 
that are morphologically indistinguishable from one another (reviewed by Murray 
and Edgar, 2004). An essential factor in this process is CDHI (E-cadherin). Cdhr/-
mESCs fail to aggregate or undergo differentiation (Larue et aI., 1994). CDHI 
stimulates the phosphorylation of the multiple docking protein, GAB 1 (Shinohara et 
ai., 2001), thereby regulating FGFI activation of the anti-apoptotic PI3K1AKT 
pathway (Lamothe et aI., 2004) and preventing cell death. In addition, CDH1-
dependent mESC aggregation may be a prerequisite for the restriction of FGF 
signalling to the outer cells of the developing mEB and primitive endoderm 
formation discussed below. 
1.2.6.2 Primitive endoderm formation 
After d 1 mEBs begin to expand then, at d2-4, bubbles of cells can be seen on the 
surface of the mEB (Li et ai., 2002, Murray and Edgar, 2000). These outer cells form 
a monolayer that covers the entire surface of the mES (Bader et aI., 2001, Ikeda et 
aI., 1999), which then elongate (Murray and Edgar, 2001 b) to form hypoblast-like, 
extra-embryonic primitive endoderm (Smyth et aI., 1999), see Figure 1-3B. Primitive 
endoderm is characterised by the expression of Afp (a-fetoprotein, Abe et aI., 1996), 
Dolichos bioflorus agglutinin (Bader et aI., 2001), Nrtf] (COUP-TF1, Murray and 
Edgar, 2001 b) and KRT8 (cytokeratin 8), recognised by TROMA-l antibody, and an 
absence of expression of the pluripotency markers P01l5f] (Mountford et al.. 1998) 
and Nanog (Hamazaki ct at., 1004). 
Primitive endodell11 ditTerentiation is dependent on FGF signalling, as demonstrated 
by the targeted disruption of Fgf4 (Wilder ct at.. 1997). FGF4 is expressed in the 
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ICM and contributes to the maintenance of the endodenn (Goldin and Papaioannou, 
2003). The majority of FGF dependent signals go through FRS2, a docking protein 
(Lax et a!., 2002), that communicates with the adaptor molecule GRB2 (Cheng et a!., 
1998). Previously it was thought that FGF4 signalled endodenn induction through 
the ERK MAPK pathway, activation of which has been shown to induce endodenn 
differentiation in F9 embryonal carcinoma cells (Verheijen et a!., 1999). However, 
while Fgf4-1- (Feldman et al., 1995) or GrbT1- (Cheng et al., 1998) mouse embryos 
die with defective endodenn fonnation, FrsT1- embryos survive until advanced 
gastrulation (Hadari et al., 2001). Subsequent analysis of signal transduction in 
mEBs formed from mESCs with a dominant negative Fgf2r mutation which 
aggregate but do not fonn primitive endodenn (Chen et a!., 2000, Li et a!., 2001a) 
revealed that PI3KJAKT pathway rather than ERK MAPK signalling is affected by 
FGF activity (Chen et a!., 2000, Li et a!., 2001b). Downstream of this FGF4, GRB2, 
PI3KJAKT cascade are GATA6 and GATA4 (Li et a!., 2004a). mESCs can be 
induced directly to an endodermal-like phenotype by forced Gata4 or Gata6 
expression (Fujikura et a!., 2002). Gata4-1- embryos die between E8.0 and E9.0 
during heart morphogenesis (Kuo et a!., 1997, Molkentin et aI., 1997) whereas 
Gata6-1- embryos die at E5.5-7.5 because of defects in visceral endodenn fonnation 
(Morrisey et a!., 1998). Ectopic Gata6 expression can induce Gata4 expression and 
loss of Gata6 expression results in the loss of Gata4, whereas loss of Gata4 results in 
the up-regulation of Gata6 (Kuo et aI., 1997, Morrisey et al.. 1998). Taken together 
these results suggests that Gata6 is upstream of Gata4 and behaves as the master 
gene for endodenn regulation (Fujikura et al.. 2002). GAT A4/GATA6 up-regulate 
the expression of the transcliption factors N r ~ { J J and N r ~ f 2 2 (COUP-TF2. MUlTay and 
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Edgar, 2001b) which in tum induce laminin 1 subunit expression, such as Lame} and 
Lamb} (Li et al., 2004a). 
Initially it was perceived that this primitive endodermal cell fate is determined by 
intercellular interactions resulting from the cell's position on the surface of the 
aggregate, rather than from heterogeneous cells that migrate to the surface (Becker et 
al., 1992, Mountford et aI., 1998). In F9 human embryonal carcinoma cell-derived 
EBs, the primitive endoderm cells on the EB surface have been suggested to provide 
a barrier that prevents factors in the medium from modulating differentiation of 
internal cells (Miki, 1999). Recently it was demonstrated that the ICM ofE3.5 mouse 
embryo is already heterogeneous, with NANOG and GAT A6 expressed in a . salt and 
pepper' pattern. This expression pattern was shown not to be based on blastomere 
history or position the ICM (Chazaud et al., 2006). 
1.2.6.3 Basement membrane assembly and primitive ectoderm epithelium 
formation 
Once formed, this outer layer of primitive endodermal cells expresses large amounts 
of basement membrane components, largely consisting of laminins (reviewed by Li 
et aI., 2003). Contact with the basement membrane induces undifferentiated mESCs 
in the centre of the mEB to become epiblast-like (Li et aI., 2004a, Murray and Edgar, 
2000), see Figure 1-3C. This is associated with up-regulation of Fgf5 (Haub and 
Goldfarb, 1991) and down-regulation of Bmp4 (Coucouvanis and Martin, 1995). 
although no obvious morphological changes occur (Rathjen et aI., 1999). Once the 
basement membrane ;s fonned epiblast-like cells that are contact become pobrised to 
fonn primitive ectodennal epithelium (Coucouvanis and Mm1in. 1995, Ikeda et al., 
1999), see Figure 1-30. This is suggested to be in response to B\1P and IH H 
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signalling from the primitive endoderm (Coucouvanis and Martin, 1999, Maye et af.. 
2000). 
1.2.6.4 Cavitation 
The combination of primitive endoderm, basement membrane and columnar epiblast 
epithelium initiates programmed cell death (PCD) in the majority of remaining 
epiblast cells that are not in contact with the basement membrane. This promotes 
cavitation at the centre of the mEB (Li et af., 2004a, reviewed by Murray and Edgar, 
2004). mEBs formed from mESC lines with double knockout of Lamcl, that encodes 
the laminin y1 subunit, do not form a basement membrane or columnar ectodermal 
epithelium and do not cavitate (Smyth et af., 1999, Murray and Edgar, 2000, Murray 
and Edgar, 2001c). Apoptosis and autophagy are the two dominant methods ofPCD. 
In mEBs two autophagy related genes, Atg5 and Beclinl, are essential for cavitation 
(Qu et al., 2007). 
1.2.6.5 Visceral and parietal endoderm formation 
Simultaneously to cavitation the outer surface primitive endoderm differentiates to 
visceral endoderm (see Figure 1-3F). This has a characteristic columnar epithelial 
morphology and expresses markers such as Hnf4a (Hepatic nuclear factor 4, alpha), 
Foxa2, Soxl7, Alp, Evxl, Ttr (transthyretin) and Krt8 (Coucouvanis and Martin, 
1999, Dufort et af., 1998, Spyropoulos and Capecchi, 1994, Conley et af., 2007). 
BMP4 has been implicated in cavitation and visceral endoderm formation and 
inhibition of BMP signalling using a dominant negative Bmprl b prevents H l ~ f 4 a a
expression, cavitation and visceral endoderm formation. Using mEBs formed from a 
Bmp4-- mESC line that do not cayitate, it has been demonstrated that media 
supplementation with of anyone of BMP2, BMP-+ or BMP7 can rescue lb!(/a 
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expression, cavitation and visceral endoderm formation (Coucouvanis and Martin, 
1999). Indian hedgehog (IHH) signalling also has a role in visceral endoderm 
formation, since the IHH signalling can be inhibited downstream of the signalling 
receptor by stimulating PKA activity with cAMP and forskolin (Maye et aI., 2000). 
Thus promotes the outer primitive endoderm to form parietal endoderm instead of 
visceral endoderm. 
If transferred onto tissue culture plates, the basement membrane allows mEB 
attachment and the surface of the tissue culture plate fulfils a role similar to 
Reichert's membrane (Weitzer, 2006). The remaining primitive endoderm in contact 
with the dish is induced to from a spreading sheet of parietal endoderm (Grabel and 
Casanova, 1986) which migrates away from the mEB and then undergoes an 
epithelial to mesenchymal transition (Bader et al., 2001). This is characterised by 
denoted by the up-regulation of Plat (tissue plasminogen activator or t-PA, Bader et 
aI., 2001) and KRT19 (cytokeratin 19), recognised by TROMA-3 antibody (Sauer et 
aI., 1998, Murray and Edgar, 200 1 c), and down-regulation of Alp (Stary et aI., 2005). 
After attachment, visceral endoderm is maintained as an epithelial bubble on top of 
the cell mass (Bader et aI., 2001, Murray and Edgar, 2001a). 
1.2.6.6 Definitive germ layer formation 
Once mEBs have attached to culture plates the primitive ectoderm epithelium inside 
the ring of visceral and parietal endoderm begins to undergo differentiation towards 
the three definitive germ layers, endodenn, mesoderm and ectoderm see (Figure 
1-3G). mEBs genn layer formation is suggested invol\'e recapitulatil)l1 of some of the 
signalling pathways expelienced in l'h'o and mESs are thought to express most if not 
all of the growth factors, signal mediators and transcliption factors necessary for the 
regulation of embryogenesis in l'il'O (\Vcitzer. 2006). In mESs the parietal cndodenn 
has been shown to influence the primitive ectoderm epithelium to differentiate 
towards mesodermal lineages, as demonstrated by the detection of a proliferating 
horseshoe shaped area of mesoderm, that expresses T, inside the ring of parietal 
endoderm which goes onto form erythrocytes and cardiomyocytes (Bader et aI., 
2001). 
1.2.6.7 Chaotic differentiation in mEBs due to lack ofpolarity 
The chaotic nature of germ layer differentiation in mEB is most likely due to the lack 
of polarity and related asymmetry of gene expression (Weitzer, 2006). The lack of 
polarity is due to a combination of mEB cell aggregation, rather than embryo-type 
clonal differentiation, and the lack of trophoblast and subsequent extra-embryonic 
ectoderm. Polarity has yet to be studied in free floating EBs (Weitzer, 2006). 
1.2.7 Primitive endoderm formation and cavitation in human and primate 
embryoid bodies 
Similar processes to those that occur in mEBs, including radial differentiation, 
apoptosis, central cavitation and expression of primitive endoderm associated 
markers have been reported in hEBs. 
Ikskovitz-Eldor et ai., (2000) described H9 hEBs as composed of densely packed 
cells at d3 before becoming cavitated at d4, accumulating fluid and becoming cystic 
at d 14 (with between 20-90% of hEBs cystic at d20). Conley et ai., (2007) described 
HES-2 hEBs as containing fluid-filled cysts from d7 onwards and observed the 
presence of apoptotic cells at d3. 5 and 7. Cavity formation in hEBs was suggested to 
be less extensive as than in mEBs (Conley ct aI., 2007). Apoptosis in hESs also 
occurs before the fon11ation of a visceral endoden11 layer, suggesting that the dsceral 
cndodcnn may not be required for the initiation of cavitation in the hES system 
(Conley et ai., 2007). In addition, in FES22 and FES30 hESCs, only limited 
proportions ofhEBs formed cavities at d7 (Mikkola et aI., 2006). 
The presence of primitive endoderm has been described in HES-2 hEBs by the 
detection of AFP, KRT8, and GATA6 expression throughout d3 and d5 (Conley et 
ai., 2007). At d7 expression of these markers, as well as TTR, was detected in a thin 
layer of cells at the hEB periphery, suggesting differentiation of primitive endoderm 
to visceral endoderm (Conley et ai., 2007). Primitive endoderm marker expression in 
an outer epithelial layer has also been described in d8 HI hEBs by the detection of 
KRT8 (Gerami-Naini et ai., 2004) and in dI3 HSF6 hEBs by the detection of AFP 
(Poon et aI., 2006). 
hEBs formed from H9 or HSF6 hESCs differentiated in CDM without additional 
growth factors grew as homogenous spheres with no apparent tissue organisation at 
dIO and neuroectoderm-like differentiation at dII-dI4 (Vallier et aI., 2004a). In 
contrast, when using the same culture conditions, the transgenic over-expression of 
NODAL induced 75-95% of hEBs to form three distinct cell layers at d 10. AFP was 
expressed in the outside layer and POU5FI was expressed in the inner layers, 
although no definitive germ layer differentiation was detected (Vallier et aI., 2004a). 
Comparison of these properties between lines and differentiation methods has not 
been made. 
1.2.8 Differences between human and mouse development and their 
implications for EB formation and differentiation 
There are significant differences between mouse and human development that may 
be reflected in EB differentiation. In humans, the first 10 days of embryonic 
differentiation are almost exclusiH.'ly devoted to the fonnation of the c\:tra-
60 
embryonic membranes whereas the mouse has already reached midgestation by this 
point (Dvash and Benvenisty, 2004). This suggests that in vitro hEB differentiation 
will be substantially slower than mEB differentiation. Also of particular relevance to 
hEB differentiation are the differences in the arrangement of the germ layers. Human 
embryos form a planar bilaminar disc, whereas mouse embryos form a more compact 
egg cylinder that undergoes germ layer-inversion (Eakin and Behringer, 2004). It has 
been suggested that mouse gastrulation, which is substantially more three-
dimensional than human gastrulation may have unique features compared to 
gastrulation in other mammals (Tam and Behringer, 1997, Beddington and 
Robertson, 1998). Also in the human embryo, extra-embryonic mesoderm is thought 
to be derived from the extra-embryonic endoderm before the appearance of the 
primitive streak (Bianchi et at., 1993). 
Although mEBs only partially mimic the formation process of the embryo, striking 
patterning processes have been reported in common marmoset EBs with the 
formation of chaotic structures resembling yolk sac, amnion and embryonic disc with 
a primitive streak-like structure (Thomson et ai., 1996). These complex structures 
were not reported in rhesus monkey EBs (Thomson et at., 1995), although the 
formation of a bilaminar disc in colonies with the lower layer undergoing a 
epithelial-mesenchymal transition was observed (Behr et at., 2005). 
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1.3 MAMMALIAN GASTRULATION 
To differentiate hESCs to mesoderm by mimicking in vivo ontology, an in-depth 
knowledge of the process of gastrulation is required. Very little data on germ layer 
induction and the signalling pathways involved human gastrulation are available, and 
only recently has it been possible to perform large scale gene expression studies on 
the human blastocyst (Adjaye et aI., 2005). In contrast, the mouse embryo is a well 
studied example of mammalian gastrulation and the processes involved are now well 
understood (reviewed by Tam and Loebel, 2007). 
1.3.1 Lineage choice in the mouse embryo 
At the morula stage, when the mouse embryo consists of a ball of about 16 cells, the 
outer cells express Cdx2 and develop epithelial characteristics (Strumpf et af., 2005), 
these cells become the trophectoderm. This trophectoderm forms numerous extra-
embryonic tissues in later in development including the extra-embryonic ectoderm 
and the ectoplacental cone (Downs and Davies, 1993). The inner cells of the embryo 
form the ICM which gives rise to all embryonic and some extra-embryonic tissues 
(Smith, 2005). 
At around E4.0 to E4.25 the outer layer of the ICM facing the blastocoelic cavity 
ditTerentiates to from the primitive endoderm which contributes cells to form the 
parietal endoderm. These cells migrate over the blastocoelic surface and, together 
with the trophoblast will, later in differentiation, form the parietal yolk sac which 
secretes a basement membrane to form Reichert's membrane (Salamat ef a/., 1995). 
At ES.O the ICM forms epiblast which maintains expression of genes that are 
charactetistic of plUlipotent cells such as P O l l ~ f J . . Sox.J, Nanog and Sall.f. At the 
same time, the polar trophectodenn cells differentiate to extra-embryonic eetodenn 
and remaining primitive endoderm differentiates to form visceral endoderm which 
surrounds the embryo and will eventually provide contribute to the visceral 
endoderm lining of the extra-embryonic yolk sac (Lawson and Pedersen, 1987). 
At ES.S the remaining polar trophectoderm forms the ectoplacental cone and the 
familiar 'egg cylinder' shape is formed. The egg cylinder consists of the extra-
embryonic ectoderm formed from the trophectoderm surrounded by extra-embryonic 
visceral endoderm at the proximal end (top) of the egg cylinder and the embryo 
proper at the distal end (bottom) as shown in Figure 1-4A. The embryo proper 
acquires the shape of a cup made of two layers, an outer layer of visceral endoderm 
and an inner layer of epiblast. Both the extra-embryonic ectoderm and epiblast 
surround the proamniotic cavity (Tam and Behringer, 1997). At this time-point the 
proximal-distal patterning of the epiblast occurs (Beddington and Robertson, 1999, 
Lu et al., 2001). At E.6.0, anterior-posterior patterning of the embryo occurs (Perea-
Gomez et aI., 2004), as shown in Figure 1-4B. At E6.S, gastrulation commences with 
the formation of the primitive streak on the posterior side of the embryo. The epiblast 
cells then undergo an epithelial to mesenchymal transition, ingress via 
morphogenetic cell movements and migrate along the outer surface towards the 
anterior pole to form mesoderm and endoderm (Figure 1-4C). At E7.S mesodermal 
cell types become patterned to their respective fates and endoderm and the node are 
formed (Figure l-4D). These two tissues and the ectoderm, the descendents of 
epiblast cells that do not pass through the primitive streak, constitute the three 
primary genTI layers that contain progenitors of all embryonic tissues as well as the 
extra-embryonic mesodenTI of the yolk sac, the allantois and the amnion (Tam and 
Behringer, 1997, Loebe1 et a/., 2003, Tam and LoebeL 2007, Ang and Constam. 
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2004). A diagram of the relationships between cell types in mouse development is 
provided in Figure 1-5. 
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Figure 1-5: Relationships between cell lineages during mouse development 
1.3.2 Signalling in gastrulation 
To generate the plimitive streak on one side of the embryo, the embryo must have 
established proximal-distal and anterior-postelior axis plior to gastrulation (reviewed 
by Lu et af. , 2001). The processes that establish these asymmetries are now 
understood well enough for a gene network of the interactions involved to be fonned 
(Ang and Constam, 2004, Tam and Loebel , 2007) and are reviewed below. 
1.3.2.1 Nodal establishes the proximal-distal axis 
NODAL signa lling from the epibl ast are responsible for the establishment of the 
proximal-di stal ax is (Brennan e/ a I. , 200 1). Noda l is expressed throughout the 
ep ibl ast and visceral endodenTI at earl y post-implantation tages (Varlet e{ (fl., 1997) . 
Nodar - cmbryos arrcst shortl y before gastrulation and fail to cst8blish a primiti\ 'c 
streak (Conlon et ai., 1994). NODAL is first detected in the rCM and primitive 
endoderm at E4.S. Up to ES.S NODAL has a role in maintaining the expression of 
pluripotency markers Pou5f1 and Nanog as well as TdgfJ (previously known as 
Cripto) and Foxd3 in the rCM/Epiblast (Mesnard et ai., 2006). 
At E4.S-S.S NODAL also has as role in patterning the embryonic and the extra-
embryonic visceral endoderm. At E4.S, Furin, a convertase enzyme that cleaves the 
NODAL precursor to form mature NODAL, is also expressed along with NODAL in 
the primitive endoderm. At ES.O, the distal primitive endoderm has become the 
embryonic visceral endoderm and the cleaved mature NODAL induces the up-
regulation of Lhxl, Fgf5, Fgf8, Otx2 and Fox A 2. At ES.S NODAL signals from the 
epiblast maintain the expression of Gata4, Hnf4a, Ttr and in extra-embryonic 
visceral endoderm whilst they and Furin are down-regulated in the embryonic 
visceral endoderm (Mesnard et ai., 2006), see Figure 1-6A. 
NODAL precursor acts in the extra-embryonic ectoderm VIa ACRVIA and 
ACRV2A to activate the transcription of Furin along with an additional convertase 
enzyme, Pcsk6 (Beck et aI., 2002, Ben-Haim et aI., 2006). The extra-embryonic 
ectoderm then secretes these convertase enzymes into the epiblast then which cleave 
the NODAL precursor to form mature NODAL (Beck et aI., 2002). NODAL then 
amplifies the expression of the co-ligand, TDGFI (Yan et aI., 2002, Beck et aI., 
2002). An additional transforming growth factor family member, GDF 1, is also 
expressed in the epiblast and signals through a similar pathway to NODAL (Chen et 
aI., 2006a). The NODAL signalling through SMAD2/SMAD3 also activates an 
autoinductive feedback loop mediated by the transcription co-activator, FOXH 1 
(Dunn et aI., 2004). see Figure 1-6B. 
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At E5.5, a subset of visceral endoderm at the distal tip of the embryo responds to 
NODAL-SMAD2 signalling by expressing a specific repertoire of genes (Mesnard et 
ai., 2006, Brennan et al., 2001) including Hhex (Thomas et ai., 1998) and the 
NODAL antagonists, Leftyl (Perea-Gomez et ai., 1999) and Cerl (Belo et ai., 1997). 
TGFB1/activinINODAL receptors ACRV1B (activin receptor A receptor, type 18) 
and ACRV2A (activin receptor A receptor, type 2A) are essential for egg cylinder 
organisation and Acrvl b-I- or Acrv2a-/- embryos show a developmental arrest before 
gastrulation (Gu et al., 1998, Song et al., 1999) despite the demonstration that activin 
A and activin B are both dispensable for gastrulation and embryos develop to term 
with no gross defects in mesoderm formation or patterning (Matzuk et ai., 1995). 
The combination of a proximally localised source of the NODAL activating Furin 
and Pcsk6 from the extra-embryonic ectoderm (Beck et al., 2002) and expression 
Leftyl and Cerl at the distal/anterior end of the embryo (Perea-Gomez et ai., 2002) 
result in a proximal-distal gradient of NODAL signalling with highest expression at 
the extra-embryonic/epiblast boundary (Lu and Robertson, 2004), see Figure 1-6C. 
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Figure 1-6: Establishment of the proximal-distal gradient by NODAL during ES.O to ES.S 
A) E5.0, NODAL precursor protein activates the transcription of Furin which cleaves the NODAL 
precursor protein to produce the processed form of NODAL. NODAL signals from the epiblast 
repress the expression of genes such as Hnj4a , Gata4, Ttr (transthyretin) and Furin in the extra -
embryonic visceral endoderm (ExVE) . Simultaneously, in the embryonic visceral endoderm (EmYE) 
NODAL signals up-regulate the expression of Lhx l , Fgf5, Fgf8 , Bmp2, Otx2 and FoxA2. 
B) E5 .25 , NODAL precursor protein from the epiblast acts in the extra-embryonic ec todem1 to 
activate the transcription of Furin and Pcsk6, by signalling activin receptors 1 B and 2A (ACRY 1 B 
and ACRV2A). NODAL and GDF3 , working with a co-receptor TDGFl , specifies the di stal viscera l 
endodem1 (DYE). 
C). E5.5, The graded signalling of processed NODAL from the epiblast/ex tra-embryon ic boundary is 
additionally antagonised by LEFTYI and CER 1 from the DYE to create the proximal-distal gradi ent . 
Diagram adapted from Tam et al ., (2007). 
1.3.2.2 BMP4 and inductive signals from the extra-emblyonic ectoderm 
Along with roles in epiblast patteming, NODAL also pattems the extra-embryonic 
ectodenTI through SMAD2 independent pathways (Brennan et a /. , 2001). NODA L 
precursor m aintains BI17p4 expression in extra-embryonic ectodel111 adjacent to th c 
epiblas t (Brennan cl a/. , 200 1, Ben-Haim ct a/., 2006), see Figure 1-7A. 13l11p</--
embryos fail to gastrul ate and have severe defici encies of mesodenl1 (Winnie}" c/ al.. 
1995). Loss of BMPRI and BMPR2 function also results in reduced epiblast 
proliferation and no formation of mesodenn (Mishina et at., 1995, Beppu et aI., 
2000) .. BMP4 signalling induces Wnt3 which amplifies mesodenn expression in the 
epiblast and mediates the induction of mesodenn (Liu et aI., 1999). Wnt3 is 
expressed at the proximal epiblast and the adjacent proximal visceral endodenn at 
ES.O and subsequently becomes restricted to the posterior epiblast and posterior 
visceral endoderm (Liu et at., 1999, Rivera-Perez and Magnuson, 200S). Wnt3-1-
embryos develop a nonnal egg cylinder but do not fonn a primitive streak (Liu et aI., 
1999). Embryos lacking the WNT co-receptors LRPS and LRP6 also fail to establish 
a primitive streak (Kelly et at., 2004). The expression of WNT target genes is 
regulated by nuclear p-catenin that is bound to transcription factors of the LEF /TCF 
family activation of p-catenin (Morkel et aI., 2003). Non-phosphorylated p-catenin is 
expressed in the extra-embryonic visceral endodenn and subsequently the 
anterior/proximal epiblast and primitive streak (Mohamed et aI., 2004). Catnb-I-
(which encodes p-catenin) embryos have a lack of node fonnation, axis truncation 
and diversion of definitive endodenn to mesodennal fate (Lickert et aI., 2002). 
Similar to NODAL, one downstream target of BMP4/WNT/p-catenin is Tdgfl (Beck 
et aI., 2002, Morkel et aI., 2003). This fonns a positive feedback loop as WNT3 is 
necessary to maintain nonnal expression of NODAL (Liu et aI., 1999). 
FGF4 expression is also dependent on NODAL signalling (Ang and Constam, 2004). 
FGF4 is expressed in the epiblast and subsequently the prospective primitive streak 
(Niswander and Martin, 1992). FGF4 acting through FGFR2 and ERK2 sustains the 
proliferation of undifferentiated trophoblast stem cells that express Eames and Bmp4 
(Ang and Constam, 2004). FGF4 also maintains HI?f4a expression in the \isceral 
endode1l11 maintaining its identity (Goldin and Papaioannou, 2003). 
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1.3.2.3 Anterior visceral endoderm and anterior-posterior patterning 
Around ES.S, the distal visceral endodenn (DVE) cells migrate up the anterior 
portion of the embryo to from the AVE (Thomas and Beddington, 1996), see Figure 
1-7B. Recently, Leftyl has been demonstrated to be expressed asymmetrically as 
early as E4.2S. Leftyl expressing cells are located closer to one pole of the long axis 
of the blastocyst and this asymmetric expression pattern is induced by transient 
NODAL signalling and does not rely on any embryo-uterus interaction (Takaoka et 
af., 2006). NODAL signalling is symmetric along the anterior-posterior axis at ES.S 
and ES.7, the latter being the time when DVE cells begin to migrate to the AVE 
(Yamamoto et ai., 2004), therefore the asymmetric expression of Leftyl may be the 
first step towards the anterior-posterior patterning of the embryo (Takaoka et af., 
2007). A role for WNT signalling has also been described in distal visceral endodenn 
(DVE) fonnation and embryos that lack Ctnnbl (as above) or APC (adenomatous 
polyposis coli protein, which modulates canonical WNT signalling) result in 
impaired DVE fonnation owing to defective proximal-distal regionalisation of the 
visceral endodenn (Huelsken et af., 2000, Chazaud and Rossant, 2006). 
A VE precursors cells actively migrate by continuously changing shape and 
projecting filopodial processes in their direction of motion (Srinivas et af., 2004). 
AVE precursors also migrate towards the site of elevated Cerl and Leftyl expression 
and away from the site of ectopic NODAL activity (Mesnard et af., 2006). It is 
proposed that the inhibition of NODAL signals reduce cell proliferation on one side 
of the embryo, leading to an asymmetric accretion of cells that may also provide a 
propulsive force on the DYE population (Yamamoto et af.. 2004). The AYE 
expresses genes such as Gsc (Filosa et af.. 1997), Otx] (Ang et al.. 1994). Hex 
(Thomas et a/., 1998), Lhxl (Perea-Gomez et a/.. 1999), Fox. 12 (Filosa et af.. 1997), 
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Cerl (Belo et al., 1997), Dkkl (Glinka et al., 1998), Nodal and Lefty (Mesnard et aI., 
2006). Otx2 has been demonstrate to have a role in the movement of the DVE to the 
AVE and in Otx2-/- embryos a proliferation of visceral endoderm is not affected but 
the morphogenetic movement of the visceral endoderm and the expression of Lefty 1 
and Dkkl are ablated (Perea-Gomez et aI., 2001). 
Cerl, Leftyl, Dkkl, SrfPl, SrfP2 act to restrict NODAL and WNT signalling to the 
posterior of the embryo (Kimura et aI., 2000, Perea-Gomez et al., 2002, Yamamoto 
et al., 2004, Kemp et al., 2005) and maintain the competence of the anterior epiblast 
to react to neural inducing signals (Rossant et aI., 2003, Tam and Steiner, 1999). 
Formation of the AVE requires Smad2 (Brennan et aI., 2001) or both FoxA2 and 
Lhxl (Perea-Gomez et aI., 1999) in the visceral endoderm. AVE migration is 
abolished in embryos lacking Tdgfl (Lu et al., 2001). 
In addition to signals from within the visceral endoderm, signals from the 
prospective posterior part of the extra-embryonic ectoderm have been shown to be 
responsible restricting the size of the AVE. Removal of the extra-embryonic 
ectoderm results in an expansion of the Cer 1 expression domain which can be 
counteracted by posterior extra-embryonic cells transplanted to the vicinity of the 
A VE precursors (Richardson et aI., 2006). 
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Figure 1-7: BMP4 and FGF signalling in the mouse embryo during E6.0 to E6.5 
A) E6 _0, BMP4 signalling from the extra-embryonic ectodem1 activates a regulatory pathway 
involving WNT3 which activates T expression initially near the epiblast/extra-embryonic ectodenn 
boundary_ 
B) E6_25 , Movement of the Cerl and Lefiy l-ex pressing AVE to the anterior s ide of the embryo 
establishes an anterior/posterior gradient and the primitive streak forms on the posterior side of the 
embryo _ 
C) E6_5 , Expression of Fgf4 and Fgf8 , which is downstream of T and is enhanced by the acti vity o f 
the NODAL precursor protein, maintains the mesoderm and cells move through the primitive streak. 
Diagram adapted from Tam et ar , (2007). 
1.3.2.4 FCF4, FCF8 and epithelial to mesenchymal transition 
At the same time as the DYE moves to the AVE on the anterior side of the embryo, 
on the opposite side, expression of markers such as Nodal and Wnt3 progress down 
the posterior side (Lu et aI. , 2001) see Fi gure 1-7C _ The expression of numero us 
genes is restricted to the posterior epibl ast prior to gastrul ati on in addi tion to Noda l 
and WIl13 including T (W il kinson c{ aI. , 1990), Mi,'dJ (Pearce and Evans, 1999), 
Eomcs (C iruna and Rossant , 1999) and Gsc (B lum c! aI., 1992) . Subsequentl y, genes 
such as £ ,'x / (O ush and Mart in , 1992), f ~ ' ! , / 4 4 (Niswander and Mart in , 1992), and / / ~ ' ! , f 8 8
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(Sun et al., 1999) are expressed in the developing primitive streak. In chimeric 
embryos containing Nodar l - mESCs, the Nodal-deficient cells preferentially populate 
the anterior compartment of the epiblast, suggesting that cell mixing in the epiblast is 
not random and NODAL signalling mediates a cell-sorting process within the 
epiblast before gastrulation (Lu and Robertson, 2004). Clonal analysis shows that 
epiblast cells are not restricted to their lineage potency prior to recruitment and 
ingression (Lawson and Pedersen, 1992). NODAL signalling through 
SMAD2/SMAD3 pattern the middle primitive streak derivatives (Dunn et aI., 2004) 
and selective loss of Smad2 in the epiblast results in a failure to specify the anterior 
mesoderm and endoderm (Vincent et aI., 2003). NODAL can directly up-regulate 
some genes such as Mixll which is strongly responsive through SMAD2/SMAD4 or 
SMAD3/SMAD4 and FOXH 1 (Hart et aI., 2005). The positive feedback loop with 
W N T / ~ - c a t e n i n n also up-regulates targets including T, TdgfJ, Evxl and Fgf8 (Morkel 
et al., 2003). Eomes is required for the expression of T, Fgf8, Wnt3 and other 
proximal-posterior genes (Russ et al., 2000). In addition maintenance of T expression 
in the primitive streak is required for paraxial mesoderm formation and in Wnt3a-l -
embryos T expression is completely absent from the anterior half of the primitive 
streak suggesting expression of WNT3A is required for maintenance of T expression 
(Yamaguchi et aI., 1999, Arnold et aI., 2000). 
FGFs control the specification of and maintenance of mesoderm rather than primary 
mesoderm induction (Burdsal et aI., 1998, Ciruna and Rossant, 2001). Mutational 
analysis of the known Fgf genes have demonstrated that only Fgf4 and Fgf8 are 
required for early embryonic development (Niswander and Martin, 1992, Crossley 
and Martin, 1995, Ciruna and Rossant, 2001). Fgf8- - embryos fail to express Fgf4 in 
the primitive streak and in the albescence of both FGF8 and FGF4 epiblast cells 
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move into the primitive streak and undergo a epithelial to mesenchymal transition 
but then fail to move away from the primitive streak (Sun et a!., 1999) FGFRI is 
expressed throughout the epiblast prior to gastrulation and becomes restricted to the 
posterior/primitive streak as gastrulation proceeds (Yamaguchi et a!., 1992). FGFRI 
has a role in mesoderm cell fate and is required for T and Tbx6, a marker of paraxial 
mesoderm (Chapman et ai., 2003), expression in the primitive streak. FGFRI 
orchestrates the epithelial to mesenchymal transition at the primitive streak by up-
regulating Snail which functions to repress Cdhl. FGFRI also functions indirectly in 
mesoderm/endoderm cell fate specification, since down-regulation of Cdhl (which 
has a potent ability to sequester ~ - c a t e n i n ) ) allows the W N T / ~ - c a t e n i n n pathway to 
positively regulate T and Tbx6 expression (Ciruna and Rossant, 2001). 
1.3.2.5 Mesendodermal cell types 
Mesendoderm (also sometimes referred to as endomesoderm) is a bipotent precursor 
cell of both the mesodermal and definitive endodermal lineages (Rodaway and 
Patient, 2001). Not all mesoderm is derived from the mesendoderm; non-
mesendodermal mesoderm cells are predominantly fated to form somitic tissue/body 
muscle, whilst mesendodermal mesoderm is fated to become lineages such as blood 
and heart (Warga and Nusslein-Volhard, 1999). The presence of mesendoderm in 
zebrafish has been demonstrated lineage tracing (Warga and Nusslein-Volhard, 
1999) and by the co-expression of the zebrafish mesendoderm marker, t, and the 
endoderm marker, gata5 (Rod away et a!., 1999). The presence of mesendodenn in 
Xenopus has similarly been demonstrated lineage tracing (Nieuwkoop, 1997) and by 
the co-expression of the Xcnopus mesodelm marker, t, and the mesendodenn marker. 
mix 1 (Lemaire ct aI., 1998). Characterisation of mesendodenn in the mouse embryo 
is still unclear (Tada c( aI., 2(05) but the close proximity of mesodenn and endodenn 
fonnation in the primitive streak supports the concept established in the other model 
systems that these lineages are generated from a bipotent population (Kimelman and 
Griffin, 2000). 
The presence of mESC-derived mesendodenn has been identified by the production 
of endodennal cell types from T+ cell populations that also display mesodenn 
potential (Kubo et ai., 2004) and, more specifically, by the isolation of a 
GSC+CDH1+PDGFRA+ expressmg population (markers for mesendodenn, 
mesodenn and endodenn respectively) that subsequently diverges to 
GSC+CDH1 +PDGFRA- and GSC+CDH1-PDGFRA + intennediates that eventually 
differentiate to endodenn and mesodenn lineages respectively (Tada et aI., 2005). As 
yet the presence of mesendodenn in humans or from hESCs has not been verified. 
1.3.2.6 Patterning of the primitive streak 
Fate mapping studies demonstrate in the mouse embryo that the order of and the site 
of progenitor cell ingression through the primitive streak will detennine the fate of 
the mesendodennal cell types (Tam and Beddington, 1987, Kinder et aI., 1999). 
Once the primitive steak is fonned over the next 12-24 hr the streak elongates from 
the rim of the cup to its distal tip. Here at the anterior end of the primitive streak 
specialised organiser structures fonn progressively, known as the early gastrula 
organiser (EGO), mid gastrula organiser (MGO) and the node (Kinder et aI., 2001). 
The EGO and the MGO generate the axial mesendodenn, which comprises of the 
mesodenTI which will populate the midline of the embryo (prechordal plate and 
notochord) and the definitive endodenn ~ ~which fonns the gut tube, lungs and organs 
including the liver, pancreas and thyroid). Until the node tonns (and hence the 
definitive gut endodenTI) the embryo is encased in visceral endodenTI. The posterior 
end of the streak givcs rise to the extra-embryonic mcsodenTI (which fonTIs thc yolk 
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sac vasculature and blood), while the lateral plate mesodenn (which fonns the 
circulatory system and the gut wall) and paraxial mesodenn (which fonns the 
somites, the vertebral column and the skeletal muscle) emerge from the intervening 
levels of the streak (Kinder et al., 1999, Beddington and Robertson, 1999, Tam et aI., 
2007). 
The fonnation of different populations of mesodenn and endodenn depends on the 
expression intensity, duration and locations of NODAL and WNT signalling activity 
in the primitive streak (Ben-Haim et aI., 2006). Loss of NODAL signalling leads to 
the absence of anterior primitive streak derivatives such as the axial and paraxial 
mesodenn and the definitive endodenn (Hoodless et aI., 2001, Beck et al., 2002, 
Yamamoto et aI., 2004). Elevation of NODAL signalling (due to the loss of the 
transcription of a co-repressor or expression of a NODAL antagonist) results in the 
over-expression of mesodennal markers (Meno et aI., 1999, Perea-Gomez et aI., 
2002). Whether the gradient of NODAL activity exists in the primitive streak is still 
not known (Tam and Loebel, 2007). 
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1.3.3 Summary 
hESCs, when given the necessary cues, can be induced to differentiate as a 
population towards a specified lineage, although current methods for hESC 
differentiation result in poor yields of the desired lineages. hEB formation is 
currently one of the most successful methods for hEB differentiation and, although 
the process of differentiation is poorly understood in hEBs, it is well understood in 
mEBs. Given that hESCs represent early embryonic cells, the same mechanisms that 
regulate differentiation in the embryo should also regulate differentiation in hESCs. 
Using the mouse and Xenopus embryos as models for human development, factors 
that induce mesoderm formation in vivo may prove useful to improve the 
differentiation of hESCs to mesoderm and therefore provide the greatest population 
of cells capable of differentiating towards terminally differentiated mesodermal cell 
types. 
1.3.4 Thesis aims and objectives 
The specific aims and objectives of this thesis are: 
• To identify methods for mesoderm induction in Xenopus laevis and apply 
them to hESCs. 
• To devise a system to standardise the initiation of differentiation ofhESCs by 
controlling hEB formation suitable for use in a high throughput manner. 
• To develop methods for increasing the proportion of mesodenn lineage cells 
differentiated from hESCs using simple. optimised treatments. 
• To assess the effectiveness of this system in four hESC lines and identify any 
inter-line variation. 
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• To develop a standard spatial and temporal map of hEB differentiation and 
compare to hEBs treated with growth factors. 
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2 IDENTIFYING PUTATATIVE MECHANISMS OF 
MESODERM INDUCTION AND BLOOD DEVELOPMENT IN 
XENOPUS LAEVIS 
2.1 INTRODUCTION 
To improve the efficiency of mesoderm induction and blood development from 
hESCs, by mimicking the in vivo development of these lineages, we must understand 
the network of factors that direct this differentiation. Mesoderm induction and blood 
development have been intensely studied in the African clawed frog Xenopus laevis 
(Kofron et at., 1999). Despite differences in morphology between mammalian and 
non-mammalian species, the major growth factor signalling pathways and 
transcription factor networks in development are largely conserved (reviewed by 
Kimelman, 2006) and therefore a valid cross-species comparison can be made. In 
addition, Xenopus embryos are externally fertilised and comparatively large which 
makes them particularly suited for micromanipulation. That they are also able 
translate synthetic, injected mRNA has considerably facilitated higher throughput 
gene function studies than is possible in mammals (Harland and Misher, 1988). 
2.1.1 Mesoderm induction in Xenopus 
Similar to mesoderm induction in the mouse embryo, families of signalling 
molecules regulate the various stages Xenopus mesoderm induction. The NODAL 
family is involved in mesoderm initiation, FGFs and WNTs are involved in 
maintaining the mesodum state and BMPs are involved in patterning the mesoderm. 
However, numerous experimental models have demonstrated that ectopically 
expressed FGFs, WNTs and BMPs are capable of promoting mesodennal 
di tTcrcntiation (rc\'ic\\'cd by Kimelman, 2006). 
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The Xenopus oocyte is visibly divided into two parts ; a lower lightl y pigmented 
vegetal hemisphere and an upper darkly pigmented animal hemisphere (Figur 
2-1A). 
A Oocyte B Mid-blastula 
Animal hemisphere Animal pole 
Marginal zone 
Vegetal hemisphere Vegetal pole 
Figure 2-1: Xenopus oocyte and mid-blastula embryo 
At fertilisation the T-box transcription factor VEGT (also known as BRAT) diffuses 
upwards from but is restricted to the vegetal hemisphere by the third, equatorial, 
cleavage plane and inherited equally by all vegetal cells (reviewed by Heasman, 
2006). As development proceeds VEGT activates the expression of nodal5 , nodal6 
(previous known as Xnr5 and Xnr6) and gdOa (previously known as deniere) in a 
pathway that requires p-catenin/TCF3 signalling (Rex et aI. , 2002). In turn nodal 1, 
nodal2 and nodal4 (previously known as Xnrl , Xnr2 and Xnr4) are activated 
(Clements et aI. , 1999, Takahashi et a I. , 2000, Onuma et aI., 2002). This NODAL 
signalling from the vegetal blastomeres induces a broad band of cell s in the region 
midway between the animal and vegetal poles (the equatori al marginal zone) to 
adopt a mesodennal fate (reviewed by Kimelman, 2006). 
2. 1.2 Mesoderm induction in the animal cap assay 
After fertilisation eleven rapid cell divi sions fo ll ow that di vide the embryo into a ball 
of 4096 cell s, ca ll ed the mid-bl as tu la. The mid-bl a tul a has a large iluid fill ed cm'it )' 
(the bl as tocoel) in the animal hemi sphere (Fi gure 2- I B) . Mid-blastul a cell s han : 
been sho\V n to be pluripotent. demonstrated b b ' ' the impl antation of labelled ((.:11..., 
~ I I
from vegetal pole into the blastocoel and subsequent contribution to all three germ 
layers (Heasman et aI., 1984). Without additional signalling dissected explants from 
the animal pole (known as the animal cap) form ectodermal derivatives in culture, 
explants from the equatorial region form mesoderm and explants from the vegetal 
pole form endoderm (reviewed by Heasman, 2006). The addition of exogenous 
factors to the pluripotent Xenopus animal cap explants can direct the differentiation 
to each of the three germ layers (reviewed by Okabayashi and Asashima, 2003) , 
making this system an useful, well characterised model for the di fferentiation of 
hESCs. 
As with the mouse embryo, the Xenopus embryos has two mesodermal populations 
that contribute to haematopoiesis: dorsal mesodenn (analogous to the embryonic 
mesoderm in the mouse) that gives rise to the dorsal lateral plate (DLP) mesodelm 
(analogous to the P-Sp/AGM in the mouse) and definitive haematopoiesis ; and the 
ventral mesodenn (analogous to extra-embryonic mesodelm in the mouse) that gives 
rise to the ventral blood island (VBl, analogous to the extra-embryonic blood islands 
in the mouse) and primitive haematopoiesis (Kau and Turpen, 1983, Ciau-Uitz et al., 
2000) as shown in Figure 2-2 . 
Dorsal 
Posterior 
Ventral 
Dorsal lateral plate 
definitive haematopiesis 
Ventral blood island 
primitive haematopoiesis 
Figure 2-2: Axis of the Xenopus embryo and positioning of th e dorsal latera l plate and ventral 
blood island 
Numerous factors have been demonstrated to have the potential to induce Xenopus 
animal caps to differentiate towards mesoderm and mesodermal lineages including: 
BMP4 (Dale et al., 1992); FGF4 (previously known as eFGF, Slack, 1994): and 
activin A (Ariizumi et al., 1991). 
Animal caps from mid-blastula embryos micro-injected with high concentrations of 
bmp4 mRNA at the I-cell stage differentiate to ventral mesoderm, and can express 
globin mRNA suggesting that BMP4 signalling can directly induce pluripotent cells 
to differentiate to mesoderm and subsequently erythrocytes (Dale et a!., 1992). 
Ectopic expression of bmp4 mRNA in the developing Xenopus embryo results in 
ventralisation, that is characterised by a lack of a notochord, decreased muscle 
formation, and increased blood formation (Dale et a!., 1992, Jones et al., 1992). 
Ectopic expression of bmp4 in the embryo is thought not to effect the initial steps of 
mesoderm induction, either dorsal or ventral, but instead causes ventralisation during 
gastrulation to promote ventral mesoderm and attenuate dorsalising signals (Jones et 
a!., 1996). Interference of BMP4 signalling with either a dominant negative BMP 
receptor (mRNA that encodes a truncated BMP receptor that blocks the BMP 
signalling pathway) or using antagonists, such as NOG (noggin) or CHRD (chordin), 
results in dorsalisation of the embryo with decreased blood formation (Maeno et a!., 
1994, Piccolo et a!., 1996). 
fgf4 mRNA is expressed maternally and is known to be present at the stage of 
mesoderm induction (Isaacs et a!., 1992). FGF4 is involved in the establishment and 
maintenance of mesoderm through a positive feed back loop with T (brachyury, 
Isaacs et aI., 1994, Casey et aI., 1998). Inhibition of FGF4 signalling in whole 
embryos by a dominant negative FGF receptor results in disruption of the 
movements of gastrulation (Isaacs ct al.. 1994). In animal caps, ectopic expression of 
fgf4 mRNA results in the formation of ventral mesoderm and FGF4 has been 
demonstrated to be a substantially more potent inducer of mesoderm than FGF2. 
(Isaacs et at., 1994). 
Activin mRNAs and proteins are uniformly distributed throughout the embryo until 
after mesoderm induction (Dohrmann et al., 1993) and, although this uniform 
distribution could be transformed into an activity gradient by positive or negative 
regulators, there is no evidence of such (McDowell and Gurdon, 1999). Therefore 
activin is not thought to induce mesoderm in vivo. However, animals caps cultured in 
the presence of activin been demonstrated to respond in a concentration dependent 
manner with lower concentrations of activin (0.1-1 ng mrl) promoting the 
differentiation to ventral mesoderm and higher concentrations (5+ ng mr!) resulting 
in more dorsal types of mesoderm (reviewed by Okabayashi and Asashima, 2003). 
2.1.3 Transcription factor complexes in haematopoietic development 
One transcription factor known to play an important role in haematopoiesis is T-cell 
acute lymphocytic leukemia 1 (TALI, previously known as SCL). TALI is a basic 
helix-loop-helix transcription factor identified via chromosome translocation of 
chromosome 1 p32 of in T-cell acute lymphoblastic leukaemia (Begley et al., 1989, 
Aplan et al., 1990, Begley et al., 1991, Visvader and Begley, 1991). In Xenopus 
embryos, tall is expressed in the VBI and DLP (Mead et al., 1998, Walmsley et al., 
2002), and gene targeting in the mouse experiments have demonstrated an essential 
role in both primitive and definitive haematopoiesis as well as vasculogenesis 
(Shivdasani et al., 1995, Robb et al., 1995, Porcher et al., 1996, Visvader et al.. 
1998). Tal r -mouse embryos die at E9.5 due to the complete lack of primitive and 
definitive haematopoiesis (Robb et at., 1995, Shivdasani et at., 1995). Tal r -mESCs 
do not contribute to either primitive or definitive haematopoiesis in chimeric mice 
(Porcher et aI., 1996). 
Using a mouse erythroleukaemia cells it has been demonstrated that TALI can form 
complexes with other transcription factors such as LIM-only protein-2 (LM02, 
previously known as RBTN2, Osada et aI., 1995). LM02 is a member of the LIM 
only class of LIM zinc finger proteins and was identified via chromosome 
translocation of chromosome 11p13 of in T-cell acute lymphoblastic leukaemia 
(Boehm et ai., 1991, Royer-Pokora et aI., 1991). In the Xenopus embryo, Im02 is 
expressed in the VBI and DLP (Mead et aI., 2001). As with Tall-I- mouse embryos, 
LmoT1- mouse embryos die at E9.5 due to the complete lack of primitive and 
definitive haematopoiesis and LmoT1- mESCs do not contribute to either primitive or 
definitive haematopoiesis in chimeric mice (Yamada et aI., 1998). 
In mouse erythroleukaemia cells LM02 can form a bridging complex between TALI 
and GATAI (Osada et aI., 1995). The GAT A family all have two zinc finger 
domains and bind the DNA sequence GAT A (Weiss and Orkin, 1995). In Xenopus 
embryos gatal is expressed in the VBI (Kelley et aI., 1994). Gatarl - mouse embryos 
die at E 11.5 due to anaemia caused by the complete lack of mature erythrocytes 
(Weiss et aI., 1994). In chimeric mice Gatarl - mESCs do give rise definitive 
erythroid progenitors but Gatarl - erythroid cells arrest at the proerythroblast stage 
(Pevny et al., 1991, Weiss et al., 1994). 
Along with the LIM binding protein, LDB 1, that binds LM02 (Agulnick et al., 1996. 
Jurata et al., 1990) and the ubiquitously-expressed E protein bHLH transcription 
factors encoded by tcfe2a (Wadman et al., 1997), TALL LM02 and GATA1 can 
fonn the transcription factor complex shown below (Figure 2-3). 
Figure 2-3: TALI , GATAI and LM02 containing transcription factor complex 
Relative locations binding locati ons of the TALI , LM02 and GAT A I transcription factor complex 
constituents. Adapted from Wadman et at. (1997). 
This transcription factor complex recognises the E-box motif (CAGGTG) that lies 9-
12 base pairs upstream of a GAT A site and promotes erythropoiesis (Wadman et aI., 
1997). In mouse erythroleukaemia cells, over-expression Ldb] inhibits E-box-GA T A 
DNA binding activity and inhibits erythroid differentiation (Xu et al., 2003). One 
target of this transcription factor complex is the gene that encodes erythrocyte 
protein band 4.2 (culTently refelTed to as £pb4.2) the protein of which is an 
important component of the red blood cell membrane (Xu et aI., 2003) . 
The transcription factors involved in haematopoiesis can form a variety of different 
complexes with different constituents. As haematopoiesis progresses, these 
transcription factor compl exes change in composition and define differentiation to 
different lineages as shown in Figure 2-4 (reviewed by Sieweke and Graf, 1998, 
Lecuyer and Hoang, 2004). 
Other blood lineages 
/ 
Early haematopoietic progenitor Erythroid/megakaryocytic 
progenitor 
Erythroid cell 
Megakaryocytic cell 
Figure 2-4: Transcription factor complexes during erythroid/megakaryocytic development 
Changes in transcription factor complex constituents during erythroid and megakaryocytic 
differentiation in the mouse. Adapted from Sieweke and Graf (1998) . 
2.1.3.1 Ectopic expression of transcription factor complex constituents 
It has been established that the injection of mRNA encoding the key elements of the 
erythroid transcriptional complex, tall , gatal and Im02 into the one cell X enopus. 
embryo results in increased primitive haematopoiesis (Mead et aI. , 200 1). This was 
demonstrated by an increase in the size of the VBI , detected by the expression of the 
primitive erythroid marker, aT4 globin (Banville and Williams, 1985), cUlTently 
assigned as hypothetical protein MGC64611. This simultaneous ectopic expression 
of tall , gata 1 and Im02 also results in hyperventrali sed embryos with virtuall y no 
dorsal-anterior structures and expression of aT4 globin throughout the body axis 
(Mead et a I. , 200 1). Ectopi c expression of tall and Im02 simultaneously results in a 
ventrali sed and truncated body and an enlarged VBl. However, ectopic expression of 
either tall , gata 1 and Im02 individuall y results in n01111al blood island f01111ation 
(Mead e/ 01. , 200 1). 
Animal cap explants from mid-blastul a Xe llopus embryos co-inj ected with tall, Im02 
and gata I at the I-ce ll stagc cultured the presence of me ademl inducing acti \ 'i 11 or 
FGF2 also rcsultcd in a ma si\'c incrca e in thc proportion of cr)1hroid cell s 
) 
( 
produced (Mead et at., 2001). In the same experiment Mead et at., (2001) analysed 
the effect of injection of these transcription factors individually, which resulted in a 
small increase in the number of erythrocytes, and in pairs, which resulted larger 
increase number of erythrocytes than individually injected transcription factors but 
still substantially less than the three transcription factors injected together. These 
data suggests that tall, Im02 and gata1 synergise in nascent mesoderm to promote 
primitive haematopoiesis, although it was not established if this process involves an 
increase in the population ofhaemangioblasts or HSCs. 
2.1.4 Aims 
The addition of signalling molecules transcription factors has been shown to augment 
erythrocyte differentiation in the Xenopus animal cap assay (Mead et at., 2001), a 
system analogous to hESCs. This chapter aimed to utilise the Xenopus animal cap 
system to further investigate mesoderm and blood inducing factors that could then be 
applied to hESCs. 
The specific aims of this chapter were: 
• To confirm previous observations that the injection of key constituents of the 
blood inducing transcription factor complex, tall, Im02 and gat a 1, in to 
Xenopus zygote animal pole is capable of increasing the proportion of aT4 
globin-expressing erythrocytes. 
• To investigate the time-course over which tall, Im02 and gatal injected into 
the zygote animal pole induce aT4 globin expression. 
• To investigate whether an increased in erythrocyte production by the above 
transcription factors involves the induction ofbmp4 expression. 
• To determine if increased proportions of aT4 globin-expressing erythrocytes 
is due to an increased population ofhaemangioblasts. 
• To determine if all three transcription factors are required for exogenous 
blood induction. 
• To determine whether the mesoderm inducers activin Band FGF4 act 
synergistically with TALI, LM02 and GAT Al in inducing haematopoiesis in 
the Xenopus animal cap explant. 
2.2 METHODS 
2.2.1 Animals 
Animal husbandry was performed by the University of Nottingham Biomedical 
Sciences Unit. Mature female X laevis were purchased from Nasco and males from 
Blades Biological. Offspring of these animals were bred in-house. Maintenance was 
performed on a 12-hour light cycle at 19°C in a slow-flowing water system that 
results in two water changes per hour. X laevis were fed two to three times a week, 
one being of liver and the remainder pellet food. 
2.2.2 Production of mRNA for Xenopus embryo injections 
2.2.2.1 Determination ofnucleic acid concentrations 
DNA and RNA concentrations were assessed using a spectrophotometer (Spectronic 
10, Thermo) to monitor UV absorption at 260 nm. Purity of samples was assessed by 
the ration of absorption at 260 nm:280 nm. 
2.2.2.2 Plasm ids 
Pre-constructed p ~ U T 2 - H A A plasmids were used to generate the following mRNAs: 
• tall (sc!); cloned from Dania rerio, courtesy of M. Gering, (Gering et aI., 
• 
• 
• 
1998). 
gata]; cloned from Dania rerio, courtesy ofM. Gering (Gering et aI., 2003). 
Lmo]; cloned from Mus musculus, courtesy of M. Gering (Gering et al.. 
2003). 
inhbb (fonns activin 8 homodimer): cloned from Xenopus lac\'is, courtesy of 
B. Afouda (unpublished). 
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• fgf4 (efgf); cloned from Xenopus laevis, courtesy of H. Issacs (Isaacs et aL 
1994). 
2.2.2.3 Restriction enzyme digestion 
Plasmids were linearised using EcoRI (Invitrogen) according to the manufacturer"s 
instructions. Confirmation of digestion by running 1 ~ l l of the reaction on an 
agarose/T AE gel and comparison with the undigested plasmid. 
2.2.2.4 Agarose gel electrophoresis 
Agarose gel electrophoresis was performed as described by Sambrook and Russell 
(2001). 1% agarose (Invitrogen) gels were prepared in 0.5 x TAE (50 x TAE: 2 M 
Tris-acetate; 50 mM EDT A). Ethidium bromide (Sigma) was added to the molten 
agarose to a final concentration of 0.5 ~ g g mr!. Samples were supplemented with 2 ~ l l
Gel Loading Buffer (Sigma) run in comparison to 500 ng of Lambda DNA/ EcoRI + 
Hind III Markers (Promega). Gels were run in 0.5 x T AE at 100v for 30 min then 
visualised using a UV transilluminator and photographed using a UVIdoc gel 
documentation system (UVItec). 
2.2.2.5 Purification ofplasmid DNA 
Phenol/chloroform protein removal was performed as described in Sambrook and 
Russell (2001). One volume of phenol:chloroform:isoamylalcohol (25:24: 1) was 
added to each sample and the tubes were vortexed thoroughly before centrifugation 
at 13,000 g for 3 min at RT in a bench top microfuge. The lower organic protein 
containing rhase was then removed along with any interface. Tl-.; upper aqueous 
phase was then re-extracted to remove any phenol with an equal volume of 
chlorofonn:isoamylalcohol (2-+: 1 ) with vortexing and centrifugation as before. 
91 
2.2.2.6 Concentration ofplasmid DNA 
Ethanol precipitation was perfonned as described in Sambrook and Russell (2001). 
Sodium acetate was added to each tube to a final concentration of 0.3 M. 2 volumes 
of 100% ethanol at -20°C were then added and the samples were mixed by pipetting 
and incubated at -20°C for 1 hr. The tubes were then centrifuged at 13,000 g for 20 
min at 4°C. The supernatant was then removed and the pellet was washed with 70% 
ethanol and centrifuged at 13,000 g for 3 min at RT. Pellets were air-dried on the 
bench for 10 min and re-suspended in ddH20. Concentrations were established as in 
2.2.2.1. 
2.2.2.7 In vitro transcription of mRNA for zygote injections 
mRNA for embryo injections was transcribed using mMessage mMachine® 
(Ambion) kit following manufacturers instructions. To remove plasmid DNA 2U of 
DNase 1 (Roche) was added to each sample after transcription and incubated at 37°C 
for 15 min. Samples were then purified (2.2.2.5) and concentrated (2.2.2.6 but 
replacing the 100% ethanol with isopropanol) and analysed on an RNase-free 
agarose/T AE gel by comparison to pre-DNase I treated samples as in 2.2.2.4. mRNA 
concentrations were established (2.2.2.1) and cocktails of the following mRNAs 
were injected: tall (2.5-100 pg); Im02 (2.5-100 pg); gata1 (2.5-100 pg); inhbb 
(activin B, 200 fg); and fgf4 (2 pg). Concentrations of transcription factor mRNA 
used were established by serial dilution down from the concentrations used by Mead 
et al. (2001). Concentrations of growth factor mRNA used were as those previously 
demonstrated to successfully induce mesodenn within the Patient Lab (unpublished). 
Concentrations referred to hereafter in experiments where more than 1 mRNA was 
injected, indicate the concentration of each mRNA used. 
2.2.3 Xenopus embryo production, manipulation and injection 
2.2.3.1 Embryo production and manipulation 
To obtain embryos adult female X laevis were injected in to the dorsal lymph sac 
with 600U of human chorionic gonadotrophin (Chorulon, Intervet) and kept at 190C 
overnight. Testes were removed from male X laevis and maintained at 4 °C in 70% 
Liebowitz medium (Flow) supplemented with penicillin/streptomycin (10 Ilg mrl) 
and kept for up to 1 week. Oocytes were squeezed from the female and fertilised 
immediately with macerated testis in 0.1 x MBS (88 mM NaCl; 1 mM KCL; 2.4 mM 
NaHC03; 15 mM HEPES.NaOH or Tris.HCL (pH 7.6); 0.3 mM CaN03.4H20; 0.41 
mM CaCh.6H20; 0.82 mM MgS04.7H20; 10 Ilg mrl penicillin/streptomycin 
(Invitrogen). After 5 min the sperm was washed off with 0.1 x MBS. After a further 
25 min the zygote's gel coat was then removed using 2% cystene in MBS (pH 8), 
before washing four times in 1 x MBS. 
2.2.3.2 Zygote injection 
Embryos were then transferred to 1 x MBS supplemented with 3% Ficoll (Type 400-
DL, Sigma) and arranged on injection grids. Embryos were injected directly into the 
centre of the animal pole with 4 nl of the relevant mRNA preparation using injection 
apparatus (PLl-100, Medical Systems Corps.) that had first been calibrated by 
adjusting the injection time to produce a bubble of the correct diameter 
corresponding to 4 nl. Control embryos were injected with the same dH20 used for 
mRNA dilution. After 1 hour embryos were transferred into 0.1 x MBS. The rate of 
embryo development was partially controlled by varying temperature between 1--+ 
and 21°C (14 hr at 14°C or 6 hr at 22°C). Embryos were staged according to 
Nieuwkoop and Faber (1967), see Figure 2-5. 
2.2.4 Animal cap dissection 
For each experimental variable approximately 30 embryos were incubated to stage 
8.5 and dissected. The vitelline membrane was removed using steel forceps whi lst 
embryos were in Petri dishes containing a layer of 1 % agarose and 1 x MBS 
supplemented with 1 % Gentamycin (Sigma). Dissected animal caps were then 
cultured in 1 x MBS on 1 % agarose, ~ ~15 animal caps were developed to the 
equivalent of stage 17 and ~ ~15 to stage 30. Staging was assessed in comparison to 
undissected whole embryos as shown in Figure 2-5. 
Stage 1 
1-cell 
mRNA injected into 
animal pole 
• 
Stage 8.5 
animal cap 
dissection 
Figure 2-5: Xenopus embryo stages used 
• 
2.2.5 Whole mount in situ hybridisation 
Stage 17 
2.2.5.1 Preparation for whole mount in situ hybridisation 
Stage 30 
, ~ ~
At stage 17 or 30 embryos were transfened to 1.5 ml Eppendorf tubes (having 
released stage 30 embryos from their vitelline membranes first). Embryos were fixed 
in MEMFA (0. 1 M 3-[N-Morpholino] propanesulfonic acid, pH 7.4; 2 mM EGTA ; 
ImM MgS0 4: 3.7% f01111aldehyde) for one hour at room temperature. MEMFA was 
then repl aced wi th methanol twice and the tubes left to stand at room temperature for 
30 min. Methanol was then replaced with a fresh aliquot and the tubcs were storcd nt 
-20 °C at least ovel1light. 
l)-t 
2.2.5.2 Whole mount in situ hybridisation 
Whole mount in situ hybridisation was perfonned as described by Harland (1991) 
with minor modifications. All steps were carried out using 1 ml volumes in 1.5 ml 
Eppendorf tubes at room temperature unless otherwise stated. 10-20 intact embryos 
stored in methanol were selected and rehydrated with 75%, 50% and 25% methanol 
in PBS/Tween (PBS: 150 mM phosphate buffer, pH 7.2; 0.85% NaCI containing 
0.1 % TWEEN 20 (Sigma)) for 5 minutes each wash, then washed in PBS/Tween for 
5 minutes. PBS/Tween was replaced by bleaching solution (5% deionised fonnamide 
(Sigma); 0.5 x SSC (20 x SSC: 3 M NaCI; 0.3 M sodium citrate, pH 7.0; 10% H202) 
and tubes were placed on a light box for 5-10 minutes or until the pigment could no 
longer be seen. Embryos were then washed three times in 1 ml PBS/Tween for 5 
minutes then acetylated in 0.1 M Triethanolamine for 5 min then 0.1 M 
Triethanolamine with 2.5 JlI acetic anhydride twice. Embryos were then washed in 
PBS/Tween for 5 min twice. The PBS/Tween was then replaced twice with 0.5 ml 
Hybridisation mix (50% deionised fonnamide (Sigma); 5 x SSC; 1 mg mrl tRNA, 
MRE600 (Sigma); 100 Jlg mrl Heparin (Sigma); 1 x Denhardt's; 0.1% Tween 20 
(Sigma); 5 mM EDTA) in 0.5 ml volume, and prehybridised for at least 6 hours at 60 
°C. The hybridisation mix was then removed and replaced with hybridisation mix 
containing 200 ng-1 Jlg mrl DIG labelled probe (2.2.5.3) and hybridised at 60°C 
overnight. 
The hybridisation mix was removed and stored at -20°C (as it can be used three 
times). Embryos were washed for 10 min at 60°C in 50% fonnamide/5xSSC, 25 0 0 
fonnamide/2xSSC, 2.5% fonnamide/2xSSC, 2 X SSC,O.1 % Tween, 0.2 :\ SSC. 
Embryos were then washed in 0.1 % Tween at 60°C for 30 min follo\\ed by 
P B S d \ \ ' i . ~ c l 1 1 at room temp for 5 min three times and in Maleic Acid Buffer (VIAB, 
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100 mM Maleic acid; 150 mM NaCl; pH 7.5) at room temp for 10 min. Following 
this embryos were blocked in MAB + 2% Boehringer Block at room temp for 4-5 hr. 
Antibody staining was performed using 112000 dilution of Anti-Digoxygenin-AP, 
Fab fragments (Roche) conjugated to alkaline phosphatase in MAB + 2% Boehringer 
Block at room temp with gentle rocking overnight. 
Excess antibody was then washed away with 5 x 1 hr washes in MAB. Embryos 
were then equilibrated with a 10 min wash in AP buffer (0.1 M Tris, pH 9.0, 50 mM 
MgCh, 0.1 M NaCl, 0.1 % Tween) with gentle rocking then colour development was 
performed by incubating embryos at room temperature in AP buffer:BM Purple AP 
Substrate, precipitating (Roche) (3: 1) at room temp in the dark until the colour had 
developed (this was moved to 4°C if overnight) as observed under a light 
microscope. Once the colour reaction had developed sufficiently, embryos were 
washed twice in PBS/Tween for 5 min at room temperature and fixed in MEMF A for 
1 hr then washed for 5 min 3 times in methanol before storage at -20°C. Embryos 
were then photographed under bright field optics on a blue background. 
2.2.5.3 In vitro transcription of whole-mount in situ hybridisation probes 
DIG labelled probes for whole-mount in situ hybridisation were prepared as 
described by Harland (1991). Digestion was performed using stated restriction 
enzymes (Table 2-1) according to the manufacturer's instructions. Samples were then 
purified (2.2.2.5) concentrated (2.2.2.6) and analysed on an agarose/T AE gel by 
compmison to undigested samples as in 2.2.2.4. Concentrations were established as 
in 2.2.2.1. Transcription was perfonned using SP6, T3 or T7 kits (Promega) and DIG 
UTP mix (Roche) for 2 hr at 37°C. Template was then removed \\ith D1'\ascI 
(Roche) and the reaction stopped with EDTA to a tinal concentration of 2 m\1. The 
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probe was then concentrated (2.2.2.6) and pellets were re-suspended in hybridi ation 
mix. A portion of the sample was analysed on an agarose/T AE gel by comparison to 
pre-DNase I samples as in 2.2.2.4. 
Table 2-1 : Digestion enzymes and transcrip tion kits used in the construct ill situ hybridisation 
probes 
Probe Linearisation Tra nscri pti on Reference 
aT4 globin EcoRI (Promega) SP6 (Walmsley et aL, 1994) 
f1i 1 Sma I (NEB) T3 (Meyer et aL , 1995) 
runx1 SaIl (Invitrogen) T7 (Traceyet aL, 1998) 
bmp4 EcoRI (Promega) SP6 M. Jones, unpublished 
2.2.6 Real-time pe R 
2.2.6.1 RNA extraction 
For each sample ~ ~15 animal caps (at either stage 17 or 30) or whole embryos were 
snap frozen in dry ice for 15 min, before storage at -80°C. Samples were then 
suspended in embryo homogenisation buffer (50 mM NaCI; 50 mM Tris, ph 7.5; 5 
mM EDTA, pH 8.0; 0.5% SDS; III 00 volume Proteinase K). For caps, embryo 
homogenisation buffer was supplemented with 10 Ilg glycogen. Embryos/caps were 
disaggregated using a pipette tip, vortexed and incubated for 1 hr at 37°C with 
occasional inversion. Samples were then pU1;fied (2.2 .2.5) , concentrated (2.2 .2.6) 
and pell ets were re-suspended in RNase free water. Concentrations were establi hed 
as in 2.2.2. 1. 
2.2.6.2 Reverse tral1scriptiol1 
Reverse transcription was perfollned usmg M-ML V Rever e Tran cripta ' C Kit 
( Invitrogen) and random primers (1 Omer, Sigma) at L r r o c c for 90 111111 . Optical 
den sities were e tablished u ing a pcctrophotometcr. 
2.2.6.3 Real-Time peR 
Semi-quantitative Real-Time PCR was perfo rmed usmg an Applied Biosystems 
Prism 7700 Sequence Detector (Applied Biosystems) using Taqman probes. qPCR 
Mastermi x Plus (Eurogentec) was used according to the manufacturer' s instructions 
in a 25 ~ l l volume containing 1 ~ l l of cDNA, 5 pmol of forward and reverse primers 
and 5 pmol of probe. Primer and probe sequences (designed within the Patient Lab) 
are included in Table 2-2. All samples were run in tIi plicate and normali sed to 
ornithine decarboxylase (odc) expression, known to remain constant in Xenopus 
development (Isaacs et at. , 1992), using the comparative CT method . Assay 
conditions were as follows : 50 °C for 2 min; 95 °C for 10 min; 40 cycles of 95 °C for 
15 sec and 60 °C for 1 min. 
Table 2-2: Primer s and probes used for Rea l-Time pe R 
Primer/probe Sequence 
oT4 globin (forward primer) TCTGAATCTGCTACTTGCTG 
oT4 globin (reverse primer) TCTCCGATCGTCATTCTGCC 
oT4 globin (probe) CACACAGGCTGCTTGGGACAAATTCCT 
fli1 (forward primer) CTGCAGCCTCGACATTCAATGGATTC 
fli1 (reverse primer) CTGGCTTGTCCCGATCTGAA 
fli1 (probe) TGTCCCTTCACACCCATCCTCTATGCC 
runx1 (forward primer) TGTTGCTGTCTCCCAGTCCT 
runx1 (reverse primer) AAAAGTCTCAAAGTTCTCCT 
runx1 (probe) CAAATCCCATGCCCAACCCACG 
odc (forward primer) AGATCGGCAGCCTTTCACAGAAA 
odc (reverse primer) ACACCGTGTCATCAGAAAAGGGC 
odc (probe) CTGCAGCCTCGACATTCAATGGATTC 
All primer pairs and probes were validated by compari ng the reacti on efficiency with 
that of odc when using a serial dilu tion of cD A. A log of the erial dilutio n of 
cD A was plotted aga in t the difference in thre hold cycle val ue (L1Ct) between the 
two primer/probe sets. A gradient value <0.1 and a correlation coefficient of 0.95-1 
were deemed suitable validation of reaction and detection efficiency. 
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2.3 RESULTS 
2.3.1 Effect of transcription factor injection into the animal pole on embryo 
development and blood marker expression 
In order to ascertain the effect of various combinations of tall , Im02, and gata 1 
mRNAs on blood development, mRNAs were injected as a cocktail into the animal 
pole of a I-cell Xenopus embryo and embryos were developed to between stages 17 
and 30 (Figure 2-6). Whole embryos were then in situ hybridi sed using probes for: 
aT4 globin, a primitive erythrocyte marker (Banville and Williams, 1985); bmp4, a 
growth factor involved in mesoderm patterning (Dale et a!., 1992), fli 1, an early 
endothelial marker (Meyer et a!., 1995); and runx 1, an early blood marker (Tracey et 
a!., 1998). All pictures show the typical result for each experiment represented by at 
least 75% of embryos. 
mRNA injected into 
animal pole 
Stage 1 
1-cell 
fli1 and runx1 
expression 
Stage 17 
exT4 globin 
expression 
Stage 30 
Figure 2-6: Transcription factor mRNA co-injection and effect measurement time-points 
2.3.1.1 Effect of co- injecting of a combination of tall, gata1 and Im02 on oT4 
globin expression 
To confinTI the effect of the additi on of bl ood development related transcription 
factors on primiti ve haematopoies is in the whole embryo as seen by Mead (!( 01., 
(2001) , equal amounts of tall , gata 1 and 1m02 mRNA were co-injected a ab(wc and 
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in situ hybridisation was performed using an aT4 globin probe. To m1l11mlSe the 
ventrali sed phenotype seen by Mead et al., (2001) with co-injection of 1 ng of each 
of tall , gata 1 and Im02, a dilution gradient was established. Embryos co-injected 
with 10, 20, 40, and 80 pg of tall , gat a 1 and Im02 mRNA were developed to stage 24 
as these doses were judged to be embryonic lethal beyond thi s stage (Figure 2-7). 
Embryos co-injected with 2.5 , 5, 10, and 15 pg of tall , gata I and Im02 mRNA were 
developed to stage 30. 
In general a dose/response relationship was observed between the levels of aT4 
globin expression and increasing doses of tall , gata 1 and Im02 mRNA. In embryos 
exposed to higher concentrations of tall , Im02 and gat a I mRNA (2: I ° pg), aT4 
globin expression was no longer restricted to the ventral surface of the embryo but 
was extended laterally up the side of the embryo. These embryos were 
hyperventrali sed and the body axes were severely truncated. 
In embryos exposed to 2.5 and 5 pg of tall , gatal and Im02 mRNA the VBI was 
expanded without overt ventralisation and the doses were used in all subsequent 
experiments . 
Figure 2-7: Expression of aT4 globin at stages 24 and 30 after the co-injection of tall. gata 1 and 
Im02 mRNA at va r ying concentrations 
Embryos were co- injected ell the I-ce ll stage with between 2.5 pg and RO pg or tall. gata I and lnw2 
Il1RNA and cxprcss ion 0 1' aT..J. globi n at stage 2..J. or .30\\·os detected by II/ ,illl hybriohatil1n 
I () I 
2.3.1.2 Time-course of the effect of the co-injection of tall, gata1 and Im02 
mRNA on aT4 globin expression 
To assess if the introduction of these exogenous blood development transcription 
factors to the zygote animal cap was having an effect on the timing of blood 
induction a time-course was performed, developing embryos to stages 17, 19, 21, 24, 
and 30 (Figure 2-8) . In sham-injected, Control embryos aT4 globin expression was 
first detected at stage 24. The of area of expression of aT4 globin was observed 
visually to be increased relative to the Control embryos at stages 24 and 30 in 
embryos co-injected with 2.5 pg of tall , gata 1 and Im02 mRNA and even earli er at 
stages 19 and 21 in embryos injected with 5 pg of tall , gata 1 and Im02 mRNA. 
Slight ventralisation was also noted in embryos co-inj ected with 5 pg of tall , gat a 1 
and Im02 mRNA at both stage 24 and 30. 
Figure 2-8: Expression of a T4 globin betwee n stages 17 and 30 after the co-injection tall, gatal 
and Im02 mRNA 
Embryos were co- injected at the I-ce ll stage with 2. 5 pg and 5 pg of tall . gata I and 111102 I11RNA and 
express ion o f aT4 globin at stages 17. 19,2 1.24.30 was detec ted by ill Sill! hybridisation. 
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2.3.1.3 Effect of co-injection of tall , gatal and Im 02mRNA on bl1lp4 expression 
Since the ventralised phenotype observed after injection of high concentrations of the 
tall , lm02 and gata 1 mRNA cocktail was reminiscent of the phenotype previous 
reported when injecting bmp4 mRNA into the animal pole (Jones ef aI. , 1996) . 
Embryos co-injected with tall , lm02 and gata 1 were in situ hybridised using a bmp4 
probe to assess if these three transcliption factors induce bmp4 expression (Figure 
2-9). Expression of bmp4 was similar to the Control in embryos co-inj ected with 2.5 
pg of tall , Im02 and gata 1 mRNA. In embryos co-injected with 5 pg, elevated bmp4 
expression was detected at stages 17-24, with a particularly enlarged area of bmp4 
expression on the ventral side of the embryo at stage 19 (indicated by arrow) . 
Figure 2-9: Expression of bmp4 between stages 17 and 30 after the co-injection ta ll , ga ta 1 and 
Imo2 mRNA 
Embryos were co- injected at the I-ce ll stage with 2.5 pg or 5 pg of ta ll , gata I and 111102 mRNA and 
express ion of bmp4 at stages 17, 19,2 1, 24 , 30 was detec ted by in situ hybridisa ti on. 
2.3.1.4 Effect of co-injection of tall , gata I and Im 02 mRNA on fli I and I'llllxl 
expressIOn 
Thc cffect of co-injcctio n of tall , gata I and Im02 111 to the animal pole on early' 
l ' F' _'- I ()) :] 11d e" I-I\' t)I/)')c:l (I-un.x I. Fi .!!urc 2-1 I) marker cndothelial (t II ; IgurC ~ ~ u _ \, \, _-
10) 
expreSSIOn at stages 17 and 28 was examined. An increase in the area of marker 
expression was observed for both markers relati ve to the Controls. At stage 17 the 
areas of both fli 1 and runx 1 expression was increased on the prospective ventral side 
of the embryo in a dose/response manner (indicated with arrows on runx 1 images, 
Figure 2-11). At stage 28 wider fli 1 expression was detected in the DLP and anterior 
VBI (Figure 2-11) and wider runx 1 expression was detected in the VBI in embryos 
exposed to 2.5 pg of tall , lm02 and gata 1 and which was expanded laterally in 
embryos exposed to 5 pg (Figure 2-11). 
Figure 2-10: Expression of fli1 at stages 17 and 28 after the co-injection tall , ga ta l and Imo2 
mRNA 
Embryos were co-inj ected at the l-ce \1 stage w ith 2.5 pg or 5 pg of tall , ga ta I and Im02 mR A and 
express ion of fli 1 at stages 17 and 28 was detected by in Sil l! hybridisation. 
10-+ 
Figure 2-11: Expression of runxl at stages 17 and 28 after the co-injection tall , gatat and Im02 
mRNA 
Embryos were co-injected at the I-cell stage with 2.5 pg or 5 pg of tall , gata l and Im02 mRNA and 
expression of runx 1 at stages 17 and 28 was detected by in situ hybridi sa tion . 
2.3.1.5 Effect of individual injection of tall, Im02 or gata1 mRNA 011 aT4 globin 
expression at stage 17 
In order to asceliain whether individual injection of the three haematopoietic 
inducing transcription complex members could result 111 increased erythrocyte 
induction, stage 17 embryos injected with 5, 25 or 100 pg of each were examined for 
aT4 globin expression. Higher quantities of the individual mRNAs were used as 
expeliments in Dania reria have demonstrated that substantially higher quantiti es of 
transcription factors (100 pg) are required to induce globin expression when inj ected 
indi viduall y (Gering et aI. , 2003). At stage 17 no expression of aT4 globin wa 
detected after inj ection with either tall , Im02 or gata I mRNA at concentration of 5. 
25 or 100 pg. (Figure 2-1 2). 
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Figure 2-12: Expression of aT4 globin at stage 17 after the injection tall , Imo2 or gatal 
individ ually 
Embryos were injec ted at the I-cell stage with 2.5 pg, 5 pg or 100 pg of either ta ll , gata I or Im02 
mRN A and the expression of aT4 globin at stage 17 was detected by in silu hybrid isation. 
2.3.1.6 Effect of individual injection of tall, Im02 or gatal mRNA on aT4 globin 
expression at stage 30 
Expression of aT4 globin at stage 30 after inj ection of individual mRNAs was also 
examined (Figure 2-1 3). In embryos injected with 25 pg of tall , Im02 or gata 1 
mRNA the VBI was slightly enlarged compared to Contro l embryos whereas in 
embryos inj ected with 5 pg of mRNA there was no detectabl e effect. In embryos 
inj ected with 100 pg of tail or Im02 mRNA the VBI was of simi lar size to those 
inj ected with 25 pg. For em bryos injected with 100 pg of gata 1 mRNA the VBI was 
substanti all y increased in si ze and the embryos were distinctl y ventrali sed. 
Figure 2-13: Expression of aT4 globin at stage 30 after the injection of tall , lmo2 or gatal 
individually 
Embryos were injected at the I-cell sta ge with 2.5 pg and 5 pg of ei ther tall , gata I or Im02 mRNA 
and expression of aT4 globin at stage 30 was detected by in situ hybridisation. 
2.3.1.7 Effect o.finjection of tall, Im02 and gata1 mRNA in pairs on aT4 globin 
expression at stage 17 
Transcription factor mRNA was also inj ected in pair combinations: tall and Im02 ; 
tall and gata 1; gata 1 and Im02 (Figure 2-14). In embryos allowed to develop to stage 
17, aT4 globin expression was detected in all embryos inj ected wi th 5 pg of the pairs 
of mRNAs, whereas none was detected in the Control embryos. In particular the 
combination of tal I & gata 1 induced the largest and most scattered area aT4 globin 
expression. In embryos injected wi th 25 pg of the pairs of mRNAs the combinati ons 
of tall & gata I and gat a I & Im02 produ ced similar enl arged and cattered 
populations of aT4 globin positi ve cell s whereas tall & Im02 induced a popul ati on 
of similar s ize to that induced by 5 pg of tall & Im02 . In the embryo inj ected with 
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100 pg of both mRNAs the aT4 globin expreSSIon showed a marked decrease 
compared to the 5 pg and 25 pg injected embryos. 
Figure 2-14: Expression of aT4 globin at stage 17 after the injection tall , Imo2 and gatal mRNA 
in pairs 
Embryos were inj ected at the I -cell stage with 2. 5 pg, 5 pg or 100 pg of either: tall & Im02, tall & 
gata I , or gata I & Im02 mRNA and the expression aT4 globin at stage 17 was detected by in situ 
hybridisation. 
2.3.1.8 Effect o.finjection of tall, lm02 and gata1 in pairs on aT4 globin 
expression at stage 30 
As above transcription factors were injected in embryos pair combinations and the 
embryos were allowed to develop to stage 30 (F igure 2-1 5). Inj ecting 5 pg of mR JA 
for each of the combinations resulted in a no or very little increase in the area of aT4 
glob in expression. Inj ection of 25 pg of gata 1 & Im02 mR A resulted in a more 
substanti al increase in the area aT4 globin express ion. In embryos inj ected with 25 
pg of tall & Im01 or tall & gata 1 mRNA, an en larged VB I \Va ob er\'ed. although 
ta ll & gata I inj ected embryos were paJiially ventrali ed . [n cmbryo injccted \\ ith 25 
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pg of gatal & Imo2 mRNA a very large area of aT4 globin expression was detected 
along with substantial ventralisation . Injection of I OO pg of tal l & Imo2 mR lA 
resulted in a further enlarged VBI although with slight ventralisation. 100 pg of tall 
& gata I mRNA resulted in more extreme ventrali sation without any further increase 
in the size of the VBI. Embryos injected with IOO pg of gatal and Imo2 were full y 
ventralised and truncated with little expression of aT4 globin detectable. 
Figure 2-15: Expression of uT4 globin at stage 30 after the injection tall , Imo2 and ga ta l in 
pairs 
Embryos were inj ected at the I-cell stage with 2 .5 pg and 5 pg of either: ta ll and Im02, tal l and ga ta 1 
o r ga ta I and Im02 mRNA and the expression of aT4 globi n at stage 30 was detec ted by i l1 sit/l 
hybridisat ion. 
2.3.2 Effect of co-injecting activin B or fgf4 with tall , Im02 and gata l mRN A 
into zygote animal poles on haemangioblast and pri mitive erythrocyte 
gene express ion in the an imal cap explant 
Once it was establi shed that co-inj ecti on of ta ll . gata I and IIl102 Il1R A into the 
animal pole of the zygo te can induce an incrca c in the hacm angiobl as t and 
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erythrocyte populations in the whole embryo , the animal cap explant as ay was used 
to quantitate how thi s system performs in an in vitro setting. mRNA encoding a 
mesoderm inducer (either activin B or fgf4 , see 2.1.2) was also included to direct the 
pluripotent animal cap to mesoderm whereupon tall , gata 1 and Im02 can direct 
differentiation to haemangioblasts and primitive erythrocytes. Similar experiments 
by Mead et al., (2001) , using Ing of tall , Im02 and gata1 mRNA and cultUling 
animal caps in the presence of 100 pM activin resulted in a - 1200 fo ld increase in 
the number of erythroid cells. 
Real time peR was used to quantify changes in gene expression associated with 
exogenous mRNA co-injection into the animal pole. Embryos were co-injected at the 
I-cell stage with a cocktail of 2. 5 pg or 5 pg of tall , lm02 and gata 1 mRNA along 
with either activin B (200 fg) or fgf4 (2 pg) mRNA. Other embryos were injected 
only with activin B or fgf4 mRNA. The animal cap of each embryo (30 per sample) 
was then removed at stage 8.5 and half were cultured to the equi valent of stage 17 
(by comparative staging to a whole embryo) and the remaining cul tured to the 
equivalent of stage 30 (Figure 2-1 6). Taqman real time pe R was then perfonned on 
both stages for markers of haemangioblast (fli 1 and runx 1) and primi tive erythro id 
cell gene expression (aT4 globin). 
mRNA injected into 
animal pole 
r; C a--, 
I /animal cap removal , 
.... 
• 
Stage 17 
Stage 8.5 
Figure 2- 16: mRNA injectio n and a nima l pole ex pl a nt procedure 
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2.3.2.1 Expression offlil and runx1 in animal caps cultured to stage 17 after co-
injection of tall, Im02, gata1 and activin B or fgf4 
Expression of both fli1 and runx1 in stage 17 animal caps co-injected with tall, Imo2 
and gata1 mRNA without a mesoderm inducer was similar or lower that that of the 
sham-injected Control (Figure 2-17). 
Where activin B mRNA was used as the mesoderm inducer, no increase in fli 1 
expression was detected when activin B mRNA was injected alone or with the 
addition of tall, Imo2 and gata1 mRNA. A 2.2 fold increase in runx 1 expression was 
induced by injection of activin B mRNA alone which was further augmented by 2.5 
pg (4.5 fold increase) and 5 pg (10.8 fold increase) of tall , Imo2 and gatal mRNA. 
When using injection of fgf4 mRNA as the mesoderm inducer only in combination 
with 5 pg tall, lmo2 and gatal was an increase in fli1 expression detected (9.0 fold). 
A small increase runx1 expression was induced by injection of fgf4 mRNA alone 
(1.5 fold) which was augmented by 2.5 pg (6.6 fold increase) and 5 pg (20.9 fold 
increase) of tall , Imo2 and gata1 mRNA. 
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2.3.2.2 Expression of flU and runxl in animal caps cultured to stage 30 after co-
injection of tall, Im02, gatal and activin B or fgf4 
Expression of both flil and runxI in stage 30 animal caps co-injected with tall, lmo2 
and gatal mRNA without a mesoderm inducer was lower that that of the sham-
injected Control (Figure 2-18). 
Where activin B mRNA was used as the mesoderm inducer, a small increase in fli 1 
expression (1.3 fold) was detected when activin B mRNA was injected alone. This 
effect was abrogated by co-injection of tall, Imo2 and gatal along with activin B 
mRNA. Expression of runx 1 was not increased by injection of activin 8 alone but a 
small increase in expression was detected after co-injection of activin Band 2.5 pg 
(1.7 fold increase) and 5 pg (2.0 fold increase) of tall , Imo2 and gatal mRNA. 
When using injection of fgf4 mRNA as the mesoderm inducer a decrease in fli 1 
expression was detected either with or without tall, Imo2 and gata 1 co-injection. A 
similar decrease in runx 1 expression was detected in animal caps injected with only 
fgf4 mRNA. Conversely co-injection of fgf4 plus 2.5 or 5 pg of tall, lmo2 and gat a 1 
mRNA resulted in a substantial increase in runxl expression (7.6 and 4.7 fold 
respecti vel y). 
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Fig ure 2-18: Expressio n of nil a nd run xl in stage 30 animal caps de tected by rea l time pe R 
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2.3.2.3 Expression of aT 4 globin in animal caps cultured to stage 30 after co-
injection of tall, Imo2, gatal and activin B or fgf4 
Expression of aT4 globin was detected in stage 30 animals co-injected with tall, 
Im02 and gatal with and without activin B mRNA. This experiment was repeated 
twice (two real time peR experiments performed on the same animal cap cDNA 
samples) due to unexpected negative effect of a combination of activin B and tall, 
Im02 and gatal on aT4 expression (see below). In both replicates (Globin 1, blue 
bars and Globin 2, red bars; Figure 2-19) injection of tall, Im02 and gatal mRNA 
without a mesoderm inducer did not induced aT4 globin expression. 
In replicate 1 (Globin 1) injection of activin B mRNA alone was sufficient to induce 
an 1130 fold increase in aT4 globin expression. This effect was reduced when 2.5 pg 
of tall, Im02 and gatal mRNA was added to the activin mRNA (111 fold increase) 
and no increase in aT4 globin expression was detected when 5 pg of tall, Im02 and 
gata1 mRNA along with activin B mRNA was co-injected. This result was not seen 
in replicate 2 (Globin 2). 
In both replicate 1 and 2, injection of fgf4 alone induced an increase in aT4 globin 
expression (1425 and 317 fold respectively) which was augmented by in the addition 
of 2.5 pg of tall, gata1 and Im02 mRNA (1825 and 357 fold respectively) and even 
further augmented by the addition of 5 pg of tall, gata1 and Im02 mRNA (2215 and 
633 fold respectively). 
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2.4 DISCUSSION 
The objective of this study was to evaluate whether factors known in Xenopus 
development to be mesoderm (activin Band FGF4) and blood inducers (TALI, 
LM02, GATAl) could successfully increase globin expression in Xenopus animal 
caps and assess if this improvement occurs through the normal process of 
haematopoiesis. 
2.4.1 Increased and earlier expression of aT4 globin is induced by co-injection 
of tall, gatal and Imo2 into the zygote animal pole 
Previous experiments using Xenopus embryos have demonstrated that the expression 
of aT4 globin can be increased by co-injecting a combination of tall , Im02 and gatal 
(1 ng of each) although acute ventralisation of the embryo was also seen (Mead et 
al., 2001). By titrating down the concentrations of the combination of tall, Im02 and 
gata 1 co-injected into the embryos it was possible establish a level which induced 
increased aT4 globin expression without overtly ventralising/posteriorising the 
embryo (Figure 2-7), as previously demonstrated in zebrafish (Gering et al., 2003). 
Co-injection of 2.5 pg of tall, Im02 and gatal increased the size of the aT4 globin 
expressing area at stages 24 and 30 in comparison to the sham-injected Control 
embryos (Figure 2-8), whereas in embryos co-injected with 5 pg of tall, Im02 and 
gata 1, aT 4 globin expression could be detected earlier (at stage 19 and 21) along the 
future ventral side of the embryo. In addition, at stages 24 and 30 the area of 
expression of aT4 globin was larger in these 5 pg injected embryos relative to 2.5 pg 
injected embryos; although slight ventralisation was detectable. Interestingly, high 
concentrations of the mRNA cocktail (above 20 pg of each transcription factor) were 
embryonic lethal beyond stage 28, although it was not established if this lethality was 
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due to hyperventralisation of the embryo or mRNA toxicity. One method of testing 
mRNA toxicity would be to inject a scrambled mRNA sequence at the same 
concentration as the transcription factor mRNAs. Scrambled mRNA sequence would 
also provide a more appropriate Control for Xenopus embryo injection experiments 
than injecting water. 
Together these results demonstrate that ectopic expression of tall, lm02 and gata1 
are capable of increasing erythropoiesis and may provide a useful method for control 
of haematopoiesis in hESCs, although careful attention will need to be paid to 
transcription factor dose. 
2.4.2 Pairs of transcription factors, but not individual transcription factors, 
are sufficient to induce on aT 4 globin expression 
When injected alone neither tall, gata1 or lm02 induced aT4 globin expression at 
stage 17 (Figure 2-12). At stage 30, a small increase aT4 globin expression was 
observed in embryos injected with higher concentrations of individual transcription 
factors. In particular, injection of gata1 appeared to ventralise the embryo and induce 
a larger population of aT4 expressing cells at a concentration of 100 pg than either 
tall or lm02 (Figure 2-13). These results are consistent with those from both whole 
embryo and animal cap experiments performed by Mead et ai., (2001), who 
demonstrated a small increase in the number of erythroid cells when injecting single 
transcription factor mRNA into the zygote animal pole, but much less than the three 
transcription factors together. When pairs of transcription factors were co-injected all 
combinations were capable of inducing aT4 globin expression in the presumptive 
ventral region of the embryo at stage 17 although this effect seemed to lessen as 
doses were increased (Figure 2-14). At stage 30 all combinations of pairs of 
transcription factors induced an increase (iT -+ globin expression in a dose-dependent 
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manner over 5-25 pg (Figure 2-15). Of interest, when gata1 was injected either on its 
own at 100 pg, or with taIlor Im02 at either 25 or 100 pg, the embryos became 
ventralised. This suggests than gata1 or gatal-containing complexes may have a 
more prominent role in the induction of factors that increase ventralisation, and may 
be responsible for the hyperventralisation seen in embryos injected with high doses 
of the three transcription factors together. The lower increase in erythropoiesis in 
embryos injected with single transcription factors and lack of induction at stage 17 
suggests that, although single transcription factors are able to up-regulate other 
transcription factor complex constituents (e.g. Im02 up-regulation of tall, Mead et 
al., 2001), this is not substantial enough to induce increased aT 4 globin expression. 
In addition of 25 pg and 100 pg of tall and Im02 induced the largest area of aT4 
globin expression with the lowest level of ventralisation when compared to 
combinations of tall and gatal or gatal and Im02. This combination of tall and Im02 
has been demonstrated to be sufficient to induce haemangioblasts in non-axial 
mesoderm in zebrafish embryos although, without the addition of gatal, these 
haemangioblasts differentiate to endothelial cells (Gering et aI., 2003). This suggests 
that although a combination of tall and Im02 may have the least effects on additional 
pathways (i.e. those involved in ventralisation), the combination of tall, Im02 and 
gata 1 will be most suitable for future experimentation in the hESC system. 
2.4.3 tall, gatal and Imo2 co-injection induce bmp4 expression 
The similarities of the ventralisation phenotype of tall, gata 1 and Im02 co-injected 
embryos (Mead et aI., 2001) with the phenotype of bmp4-injected embryos (Jones et 
at., 1996), lead Mead et at., (2001) to postulate that the combination of tal L gata 1 
and Im02 may be able to induce bmp4 expression. Ectopic bmp4 alone is able to 
induce erythropoiesis in animal cap explants after injection into the zygote animal 
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pole (Dale et al., 1992). Thus, the current study was aimed to test whether co-
injection of tall, Im02 and gata1 directly induced erythrocyte differentiation or 
whether these transcription factors induced bmp4 expression which then 
subsequently induced erythrocyte differentiation. No substantial increase in bmp4 
expression over the Control embryos was detected in embryos injected with 2.5 pg of 
tall, Im02 and gata1 (Figure 2-9), although this dose did expanded the area of aT4 
globin (Figure 2-8). However, co-injection of 5 pg of tall, lm02 and gata1 had a 
more dramatic result with ectopic expression of bmp4 with at stages 17-24, 
particularly at stage 19. Once induced, this ectopic bmp4 may be able to form a 
positive feedback loop with tall, lm02 and gata1 as bmp4 is known to induce the 
expression of these three transcription factors (Zhang and Evans, 1996, Mead et aI., 
1998, Mead et al., 2001, Sanada et aI., 2003). The bmp4 promoter contains multiple 
E-box and GAT A binding sites (Kim et aI., 1998) and therefore can be induced by 
the transcription factor complex that includes tall, lm02 and gatal. In addition bmp4 
can also form a self-inducing auto-activational loop and increase its own expression 
(Metz et al., 1998). Therefore, although increased erythropoiesis is can be induced 
without ectopic bmp4 expression, as in the case of 2.5 pg injected embryos, this 
positive feedback loop may be responsible for the further increased erythropoiesis 
detected in 5 pg injected embryos. This result is substantially different to that seen in 
zebrafish embryos where the injection of 25 pg of each of tall, lm02 and gata 1 
mRNA neither activated ectopic bmp4 expression nor ventralised the embryo yet was 
sufficient to cause anterior erythropoiesis (Gering et aI., 2003). Injection of 100 pg of 
each mRNA did result in increased bmp4 expression in half of the embryos although 
these embryos were not ventralised/posteriorised (Gering et aI., 2003). To establish if 
this is a true inter-species difference these Xenopus expeliments could be furthered 
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by the use of a dominant-negative BMP receptor which would clarify if tall, gata1 
and Im02 are able to induce erythropoiesis without the assistance ofbmp4. In hESCs, 
induction of this positive feedback loop between bmp4 and tall, Im02 and gat a 1 may 
be beneficial for the production of erythrocytes but could also limit the production of 
definitive haematopoietic lineages. 
2.4.4 Increased aT 4 globin expression occurs through the normal route of 
haematopoiesis 
To assess if the increased, premature aT4 globin expression was a result of the 
normal route of haematopoiesis in vivo, i.e. through mesoderm to haemangioblast to 
HSC to erythrocyte, a potential increase in the haemangioblast population (Walmsley 
et at., 2002) was investigated using the haemangioblast/endothelial marker, fli 1 
(Ciau-Uitz et aI., 2000) and the haemangioblastihaematopoietic progenitor marker 
runx1 (Tracey et at., 1998). At stage 17, the co-injection of tall, gata1 and Im02 
induced an increase in area of both fli 1 and runx 1 expression, in comparison to the 
Control embryos, on the prospective ventral side of the embryo (Figure 2-10 and 
Figure 2-11). At stage 28 the area of fli 1 expression was increased in both the DLP 
and VBI in comparison to the Control embryos (Figure 2-10). The area of runx 1 
expression was increased in the VBI (Figure 2-11) in a similar pattern to that seen for 
the expression of aT4 globin (Figure 2-8), with the area of expression increased 
laterally in embryos co-injected with 5 pg of tall, Im02 and gata1. Taken together 
these results suggest that the increase in aT4 globin expression is preceded and 
accompanied by an increase in the haemangioblast population and therefore tall. 
Im02 and gata1 co-injection induces aT4 globin expression by the normal route of 
haematopoiesis as reported in the zebrafish (Gering et al.. 2003). This result is 
particularly relevant to hESCs as it demonstrates that these three transcription factors 
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promote the increased differentiation of mesoderm to haemangioblasts, rather than 
merely encouraging differentiation ofHSCs to erythrocytes. 
2.4.5 Induction of haemangioblast marker and aT 4 globin expression in 
animal cap explants 
The induction of substantial number of erythroid cells from animal caps by the co-
injection of tall, Im02 and gatal mRNA into the animal pole of the zygote, and 
culture in the presence of either activin or fgf2 has been demonstrated by Mead et al., 
(2001). To further the understanding of this process and to assess if, as in the whole 
embryo, aT4 globin expression is preceded by and increase in the expression of 
haemangioblast markers, real time PCR was performed on animal caps at stage 17 
and 30. In animal cap experiments a mesoderm inducer is required to direct the 
animal cap cells to mesoderm and without a mesoderm inducer animal cap cells will 
form atypical epidermis (Okabayashi and Asashima, 2003). In these experiments 
activin Band fgf4 were chosen as the mesoderm inducers. Activin B has been 
reinstated as a mesoderm inducer in the whole embryo (Piepenburg et aI., 2004) and 
FGF4 is known to be a more potent inducer of mesoderm than FGF2 (Isaacs et aI., 
1994). FGFs synergise with many haematopoietic cytokines to stimulate the 
proliferation of haematopoietic progenitors (Huber et al., 1998, Miyanaga et aI., 
1999) although FGF4 has also been demonstrated to inhibit BMP4-induced 
erythropoiesis (Xu et al., 1999). 
A key difference between experiments performed here and those performed by Mead 
et al., (2001) is that in these experiments mRNA encoding the mesoderm inducers, 
was co-injected into the animal pole of the zygote (stage 1) along with tall. Im02 and 
gata 1 mRNA rather than culturing the animal caps (stage 8.5) in soluble growth 
factor protein. 
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At stage 30 the co-injection of fgf4, tall, Im02 and gatal mRNA induced a massive 
increase in the expression of aT4 globin (Figure 2-19). A less dramatic increase in 
aT4 globin expression was also detected with the use of fgf4 alone. This suggests 
that although cells induced to form mesoderm (using just fgf4) can form 
erythrocytes; this process is greatly improved when cells are also further directed to 
the blood lineage using the haematopoietic transcription factors. Also no increase in 
aT4 globin expression was detected when using the combination of transcription 
factors alone without either of the mesoderm inducers therefore directed 
differentiation to mesoderm is an obligatory step required for haematopoiesis. 
Although globin expression is a well established marker of erythrocytes, these 
experiments could have been further enhanced by isolating cells from the stage 30 
animal cap samples, adhering them to a slide and performing Wright-Giemsa stain to 
allow the visual identification of primitive erythrocytes. 
At stage 17 high levels of both fill and runx 1 expression were detected in animal 
caps from embryos co-injected with fgf4, tall, Im02 and gata1 (Figure 2-17). Co-
injection ofactivin B, tall, Im02 and gata1 had a lesser effect on runx1 expression 
and no effect on fli 1 expression. In animal caps embryos from embryos co-injected 
with fgf4, tall, Im02 and gata1 and developed to stage 30, runx1 expression was 
substantially lower than that detected at stage 17 and little fli 1 expression was 
detected (Figure 2-18). Together these results suggest that, as with the whole 
embryo, tall, Im02 and gata I-induced erythropoiesis occurs through the normal route 
of haematopoiesis. 
Taken together this work demonstrates that tall, Im02 and gata I do act 
synergistically in a multi-protein complex to promote primitiyc erythrocyte 
fonnation. At higher concentrations this combination of transcription factors also 
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induces bmp4. bmp4 may then fonn a positive feedback loop by fonning and auto-
inductional loop with itself whilst also increasing the expression of the transcription 
factor complex constituents which in tum increase bmp4 expression. At lower 
concentrations tall, lm02 and gatal induce an increase in aT4 globin expression 
without ventralisation or ectopic expression of bmp4. Also demonstrated is that this 
increase in aT4 globin expression is preceded by an increase in haemangioblast 
markers which indicates that tall, lm02 and gatal act to increase the haemangioblast 
population rather than simply specifying erythrocyte differentiation. 
2.4.6 Potential for use of this system in hESCs 
A key difference between the animal cap assay and hESCs is that although animal 
cap cells are pluripotent, when allowed to differentiate without the addition of 
growth factors they fonn atypical epidennis whereas hESCs will fonn cells of the 
three genn layers suggesting that animal cap cells are from a later stage of 
development. In addition injection of mRNAs in the animal pole of the single cell 
zygote and removal of the animal cap at stage 8.S in Xenopus does not have an 
analogous human system as injection would have to be made into the human zygote 
and a hESC line derived from the blastocyst. Therefore to adapt this mRNA injection 
system to hESCs a different delivery route will be required such as transfection 
although as yet, the introduction three separate genes into human cells, as would be 
required for tall, lm02 and gatal, has not been demonstrated. This work does 
provide proof of principle of a system that can successfully induce erythropoiesis 
through the nonnal route of haematopoiesis and therefore provide the first step 
towards creating a similar system in hESCs. 
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3 OPTIMISING AN EMBRYOID BODY SYSTEM FOR 
EVALUATING DIFFERENTIATION STRATEGIES IN 
HUMAN EMBRYONIC STEM CELLS 
3.1 INTRODUCTION 
Methods for differentiation of hESCs to the mesodermal lineage from are still in their 
infancy and optimised differentiation protocols that are efficient and work across a 
range of hESC lines have yet to be established. One of the most frequently used 
methods for controlling haematopoietic and cardiac differentiation is via hEBs. hEB 
lineage induction relies on the innate propensity of hESCs to randomly differentiate 
to the three germ layers when cultured as three dimensional aggregates, usually in 
the presence of undefined FBS and the absence of pluripotency-maintaining growth 
factors. Once formed, to direct differentiation to a particular cell type, hEBs are 
treated with lineage-specific growth factors, then enriched by selected according to 
relevant blood and cardiac surface/intracellular markers. The common 'mass culture' 
method for hEB formation results in highly heterogeneous hEBs with potential 
contamination with MEFs. This heterogeneity results in a population of hEBs that 
that differentiates asynchronously, complicating the identification of factors that 
direct differentiation towards a particular lineage. 
This chapter details the establishment of a forced aggregation system to promote 
hESC differentiation in a more homogeneous and therefore reproducible manner. 
This system was then used to identify and evaluate differentiation in CDM, with and 
without the addition of growth factors, to assess hEB formation in a serum free 
environment. This system will allow clearer future insight into the factors that etTect 
hFSC differentiation and aims to provide a platfonn for tirst 
. . 
mcreasmg 
differentiation to mesodenn in a controlled manner and thus producing a progenitor 
greater population that is capable ofhaematopoietic and cardiac differentiation. Inter-
line variability of differentiation in this system across four hESC lines has also been 
examined to establish the generic applicability of the technique. 
3.1.1 Methods of mouse embryoid body formation 
3.1.1.1 Mass culture 
Numerous methods have been devised for the fonnation of mEBs (reviewed by 
Desbaillets et al., 2000, Dang et al., 2002). Static suspension in mass culture is the 
most widely used for fonning mEBs and involves partial disaggregation of the 
colonies from the MEF feeder layer before either seeding onto culture gelatine-
coated bacteriological Petri dishes for 1-4 days in culture medium with or without the 
addition of LIF (Williams et al., 1988) then/or transferring to untreated dishes 
allowed to fonn aggregates in a medium containing 15-20% FBS without LIF 
(Doetschman et al., 1985). Spinner flasks have also been demonstrate for successful 
mEB cultivation (Wobus et al., 1991). 
3.1.1.2 Induced aggregation 
The "hanging drop' methods is commonly used for mEB fonnation and involves the 
suspensIOn of 400-1000 mESCs from the lid of a Petri dish, after 2 days of 
incubation mEBs are harvested and subsequently cultivated in suspensIOn 
(Wartenberg et aI., 1998). It has also been established that there is a optimum 
number of mESC cells fonned in hanging drop mEBs that gives rise to the highest 
number of cardiomyocytes (Bader et aI., 2001), therefore mEB size may han? a 
crucial role in directing ditTerentiation towards a particular lineage. Although the 
hanging drop method has been used to fotm hEBs from clumps of hESCs (Yoon cf 
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aI., 2006, Baharvand et at., 2006c) it has not yet been demonstrated that fully 
disaggregated hESCs will form hEBs in this manner (Reubinoff et aI., 2000). 
More recent methods for mEB formation have involved using 96-well U bottom 
plates coated with the polymer 2-methacryloyloxyethyl phosphory1choline to reduce 
the adhesion of cells and successfully form mEBs without the need for centrifugation 
with mEB size correlating to seeding cell number (Konno et at., 2005). Also an 
attempt has been made to 'engineer' mEBs by aggregating mESCs using 
biotinylation and avidin cross-linking which proved successful for improving bone 
nodule formation (De Bank et at., 2007). 
3.1.1.3 Semi-solid methylcellulose 
Suspension of single cells in semi-solid methy1cellulose and subsequent growth 
allows the formation of clonal mEBs (Keller et aI., 1993). It is suggested that mEB 
size may be self-regulated, perhaps resulting from the lack of some developmental 
cue( s), demonstrated by experiments demonstrating that mEBs whether generated 
from 1 cell or 1000 cells are equivalent by d 12 (Dang et aI., 2002). hEBs have yet to 
be demonstrated initiate from single cells (Daley, 2003) therefore formation in semi-
solid methylcellulose medium is unlikely possibly due to hESCs poor survivability at 
clonal levels (Amit et at., 2000). 
3.1.2 Methods of human embryoid body formation 
The three main methods for successful hEB formation: static suspension culture; 
bioreactors, spinner flasks and stirred culture vessels; and forced aggregation are 
reviewed below. 
3.1.2.1.1 Static suspe11sio11 i11 mass cliiture 
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The standard method for hEB formation involves culture of hESCs on MEFs 
followed by dissociation from the feeder layer in to small clumps of cells. These 
clumps can be formed by either manual dissection into approximately 200 ~ m m pieces 
(Khoo et af., 2005), or a combination of dissection/scraping, pipette tip dissociation 
and enzymatic treatment (Gerecht-Nir et af., 2005). For enzymatic dissociation, 
clumps of different cells numbers have proven optimum for hEB formation: 3-20 
cells with collagenase IV (Kehat et ai., 2001); -100 or more cells with collagenase 
IV (Mummery et ai., 2002); 500 to 800 cells with dispase (He et af., 2003). Partial 
disaggregation with trypsin has also been used although yields a hEBs of 
heterogeneous sizes (Sottile et ai., 2003). Clumps are then suspended in a medium 
containing 20% FBS without FGF2 in non-treated Petri dishes for 4 to 10 days 
(Kehat et af., 2001, Cui et af., 2007, Mummery et ai., 2002) 
3.1.2.1.2 Bioreactors, spinner flasks and stirred culture vessels 
The use of bioreactors or spinner flasks, horizontally rotating fluid-filled culture 
vessels, is particularly amenable to scale-up of the process to produce clinically 
significant numbers of cells (Cameron et ai., 2006) although one problem might be 
the expense of defined media on a large scale. Bioreactors have been demonstrated to 
enhance the efficiency of hEB formation (Gerecht-Nir et ai., 2004a) and stirred 
culture vessels have improved hEB proliferation (Cameron et ai., 2006). 
Agglomeration between two mEBs has been demonstrated as the major process 
limiting cell proliferation and differentiation, a process which is accelerated in stirred 
culture (Dang et aI., 2002) although it is suggested that this can be avoided by using 
bulb-shaped impellers rather than paddle-type impellers (Schroeder et af.. 2005). The 
encapsulation of mESCs in size-specific support matrices combined with culture in 
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stirred suspension bioreactors have proved successful for producing large quantities 
ofhaematopoietic progenitor cells (Dang et aI., 2004). 
3.1.2.1.3 Forced aggregation 
To improve the heterogeneity ofhEB size a forced aggregation has been used (Ng et 
al., 2005b). This system involves depositing a know number of hESCs grown on 
MEFs in round-bottom ultra low attachment 96-well plates then aggregating the cell 
into hEBs by centrifugation After 8-12 days, these hEBs were transferred to tissue-
culture treated plates to differentiate further and demonstrated superior 
haematopoietic precursor frequencies than have previously been reported in serum-
free cultures (Tian et al., 2004). Also noted was the effect of initial numbers of 
hESCs on propensity to differentiate to the haematopoietic lineage with 3000 cells 
per well producing the highest percentage ofhEBs forming blood. 
Of all of the methods for hEB formation forced aggregation provides the greatest 
control over hEB size and cell-cell interaction. 
3.1.2.2 Embryoid body adhesion 
Once hEBs have formed and developed they become adherent. mEB formation 
followed by plating of cells on gelatine (reviewed by Conley et aI., 2004b) or 
fibronectin coated plates (Carpenter et al., 2001) is frequently used to continue 
differentiation. Typically hEBs have been cultured in suspension for 4 or more days 
before plating on specific matrix components for further differentiation (reviewed by 
Carpenter et aI., 2003). Dang et al. (2002) noted no difference in the kinetics or 
frequency of haematopoietic development between suspension culture, semi-solid 
methylcellulose medium or hanging drop techniques although, importantly, they 
demonstrated that attachment prior to d4 impairs haematopoietic development of 
mEBs as the mEBs quickly fl atten out and loose 3-D structure. Collagen 3D 
scaffolds have been demonstrated to be useful in the differentiation of hepatocytes 
from hEBs, and this strategy is suggested to more closely resemble in \'i \ 'o 
environment than standard hEB culture (Gerecht-Nir et a!. , 2004b, Baharvand et aI. , 
2006b). 
An overvIew of the variables in steps that can be used In hEB formation and 
development is shown in Table 3-1 . 
Table 3-1: Summar y of strategies used for hEB formation and differentiation 
Summary of the strategies used for hEB formation, including methods of standard culture, methods 
for culture just prior to hEB formation (Preparation), enzymatic and non-enzymatic dissoc iation 
methods, methods for hEB aggregation, hEB growth/development and finall y surfaces used for hEB 
adhesion. TC, tissue culture; COM, chemically defined medium; FBS, foetal bovine serum. 
Culture Preparation Dissociation Aggregation Development Adhesion 
MEFs Dispase Suspension Conditioned Gelatin-coated 
culture medium TC dish 
MEFs 
Low density Collagenase 96-well fo rced 15-20% FBS MEFs aggregation 
TC dish 
Collagen TC Tryps in Sti rred vessel Growth factors Flasks 
Matrigel 
96-well flat Matrige l Scraping Bioractor CDM bottom 
3.1.3 Factor s affecting hEB formation and development 
The patte111 and efficiency of differenti ation are affected by parameters li ke hESC 
cell density, media components and amino acids, growth factors and extra-cellul ar 
matri x proteins, pH and osmolarity and the pat1icular batch of FBS (Weitzer, 2006). 
3.1.3.1 Chemically defin ed media 
The use of COM removes numerous vari ables facilitates greater understanding ot the 
fac tors invo lved in differenti ation. CDM has been successfull y u ed for neuronal 
, . , t' l ESC (ZI / 1 ')00 1 LI' n / al 700') 'lSO I1kl' 11 alld Koli aco,' , di fferentiatIOn 0 1 S 1ang (! a" - , L " - -, u 
2006) and fo r haematopo ieti c differe ntia tion , albeit \\'ith the addition or a number or 
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growth factors (Ng et at., 2005b). The most commonly used CDM is that first used 
for mEB differentiation by Johansson and Wiles (1995), although the same authors 
also suggest that mesodermal differentiation is inhibited in strictly serum-free 
conditions (Wiles and Johansson, 1999). 
3.1.3.2 Effects of growth factors on differentiation 
Controlling the growth factor environment that hESCs are exposed to allows us to 
study how these factors influence cellular differentiation. As detailed in Chapter 1 
(1.3) and Chapter 2 (2.1.1), mouse and Xenopus studies have implicated the T G F ~ , ,
FGF and WNT families in mesoderm induction. 
Activin A has been demonstrated to increase the expression of markers of mesoderm 
in d4 and d5 mEBs such as T, Mixll and Gsc, (Ng et aI., 2005a, Johansson and 
Wiles, 1995, Tada et at., 2005). Activin A has been demonstrated to restrict 
differentiation of hEBs to the mesodermal lineage (Schuldiner et at., 2000). The 
addition of activin A to hESCs has also been shown to induce differentiation to 
endodermal rather than mesodermal lineages (Levenberg et at., 2003, D'Amour et 
at., 2005). This was suggested to only occur when PI3K signalling through 
insulinlIGF is suppressed (McLean et at., 2007). This apparent paradox in activin A 
effect is likely explained by the a dose effect, as seen in Xenopus animal caps, where 
lower concentrations promote mesodermal lineage and higher concentrations 
promoting endodermallineages (Okabayashi and Asashima, 2003). 
NODAL has been demonstrated to maintain pluripotency whilst reducing 
differentiation to the neuroectodermal linage (Vallier et at., 2004a) Inhibition of 
NODAL decreases the expression of LEFTYl and LEFT'{2 as well as T and 
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increases expression of ectodermal markers, suggesting that NODAL has a role in 
promoting differentiation to the mesodermal lineage (Dvash et ai., 2007). 
BMP4 has been suggested to be a more potent mesoderm inducer than activin A 
(Johansson and Wiles, 1995, Ng et al., 2005a) but induces it mesoderm markers 
(such as n only transiently, suggesting that that BMP4 induces extra-embryonic 
mesoderm and primitive haematopoiesis (Wilkinson et al., 1990, Johansson and 
Wiles, 1995) rather than embryonic mesoderm which produces cardiomyocytes and 
definitive haematopoiesis. 
FGF2 has a well established role in maintaining hESC pluripotency (see 
Introduction, 1.1.7) however treatment of hEBs from dO onwards with the FGF 
receptor inhibitor SU5402 demonstrated a significant reduction of expansion by d4 
and <1 % cell survival by d8 (Joannides et aI., 2006). In mEBs, a dominant negative 
FGFR2 abrogated the formation of the primitive ectoderm layer, by affecting 
basement membrane formation and mEBs became necrotic after 6-8 days (Li et al., 
2001a). These results suggest that FGF2 signalling is essential for hEB growth and 
development. FGF2 has also been demonstrated to alter the fate of mouse epiblast 
cells to mesoderm in vitro (Burdsal et al., 1998) and be essential for mEB 
differentiation via signalling through PI3K (Chen et al., 2000). In Xenopus, FGF4 
has been demonstrated to have a role in mesoderm induction (Isaacs et al.. 1994). but 
in the mouse and in mESCs, FGF4 has been suggested to have a role in maintaining 
trophectodenn (Feldman et ai., 1995, Goldin and Papaioannou, 2003. Guzman-Ayala 
et al., 2004) 
Growth factors that have been used to direct hESC differentiation are rc\'ic\\cd in 
Table 3-2. 
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3.1.4 Low molecular weight differentiating agents 
It is possible that small molecules can drive differentiation by driving up- or down-
regulation of transcription factors. Steroids are likely candidates given that they can 
directly activate nuclear receptors (Pouton and Haynes, 2005). 
All-trans retinoic acid (RA), is essential for mouse normal embryonic development 
and plays key roles in cell differentiation, proliferation and apoptosis in a 
concentration dependant manner (reviewed by Ross et ai., 2000). Undifferentiated 
hESCs express retinoid receptors (Huang et al., 2006). In hESCs high concentrations 
of RA have been shown to induce smooth muscle (Huang et ai., 2006) and neurons 
(Carpenter et al., 2001, Li et ai., 2005) but not to be inductive for cardiomyocytes 
(Xu et al., 2002a). DMSO has also failed to induce hESCs to cardiomyocytes (Kehat 
et ai., 2001, Xu et al., 2002a). 5-aza-2'-deoxycytidine, a demethylating agent, has 
been demonstrated to successfully improve the differentiation hEBs to 
cardiomyocytes (Mummery et ai., 2002, Xu et al., 2002a, Y oon et al., 2006, Cui et 
al., 2007), as has ascorbic acid (Passier et ai., 2006). A combination of 
dexamethasone, ascorbic acid-2-phosphate and ~ - g l y c e r o l p h o s p h a t e e has been 
demonstrated to promote both mesenchymal stem cell and osetogenic differentiation 
(Olivier et ai., 2006, Sottile et al., 2003, Bielby et ai., 2004). 
Low molecular weight differentiating agents that have been used to direct hESCs 
differentiation are reviewed in Table 3-2. 
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Table 3-2: Directed differentiation of hESCs using growth factors and low molecular weight differentiating agents 
Table of growth fa ctors and low molecular weight differentiating agents that have been used to direct hESC differentiation. Adapted from Trounson (2006). 
- ---
"-:>"'"r' l ineage Primary inducers Tissue type - . . . , ~ ~ ~ ~
Trophectoderm FGF2 , BMP4 Trophectoderm (Xu et al., 2002b) 
Extraembryon ic endoderm BMP2 Yolk sac (Pera et al., 2004) 
EGF, FGF2, PDGF-AA, IGF1 Neurons (Carpenter et aI. , 2001) 
RA, NGFB Neurons (Schuldiner et al. , 2001) 
NOG Neural progenitors (Pera et al. , 2004) 
FGF2, RA, BDNF, TGF-a Dopaminergic neurons (Park et aI. , 2004a) 
NOG Neural progenitors (Gerrard et al., 2005) Ectoderm FGF2 , FGF8, SHH Forebrain and midbrain TH+ neurons (Yan et al., 2005) 
FGF2 Transplantable neural progenitors (Zhang et al., 2001) 
FGF2, EGF, RA, DMSO Oligodendrocytes (Nistor et al., 2005) 
FGF2, RA, SHH , BDNF, GDNF, IGF1 Motor neurons (Li et al., 2005) 
NOG, DKK1 , IGF1 Retinal progenitor cells (Lamba et al., 2006) 
WNT3A, END3, SCF, Melanocytes (Fang et al., 2006) 
Dexamethasone, ascorbic acid-2-phosphate, 13- Mesenchymal stem cells (Olivier et al., 2006) glycerol phosphate 
Dexamethasone, ascorbic acid-2-phosphate, 13- Osteogenic cells (Sottile et al., 2003) glycerol phosphate 
BMP2 Chondrogenic cells (Toh et al., 2007) 
Mesoderm 5-aza-2 ' -deoxycytid ine Cardiomyocytes (Mummery et al., 2002) 
BMP2 Cardiomyocytes (Mandalet al. ,2006) 
BMP4, SCF, FL T3L, IL3, IL6, GCSF Blood (Murdoch et aI. , 2002) 
SCF, TPO, FL T3L Blood (Tian et al., 2004) 
VEGF, BMP4 Blood (Cerdan et aI. , 2004) 
SCF, FL T3L, TPO , IL3, IL6, GCSF Blood (Zhan et al., 2004) 
BMP4, VEGF, SCF, FL T3L, IL6, IGF2 Blood (Ng et al., 2005b) 
Sod iu m butyrate, DMSO Hepatocytes (Rambhatla et al., 2003) 
Endoderm FGF2, nicotinam ide Pancreatic and Beta-cells (Segev et al., 2004) 
activi n A and low FBS Definitive Endoderm (D'Amour et al., 2005) 
activin A and PI3K suppression Definitive Endoderm (McLean et al., 2007) 
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3.1.5 Aims 
Substantial heterogeneity exists m hEBs formed from usmg the mass culture 
technique. This heterogeneity hinders the analysis of conditions that improve 
directed lineage differentiation. Using a forced aggregation methodology along with 
CDM and growth factors that maintain cell viability and promote mesoderm 
induction, it will be possible to devise a system optimised for mesodermal lineage 
differentiation. This system will also be tested in multiple hESCs lines to confirm 
transferability. 
The specific aims of this chapter are: 
• To assess mass culture heterogeneity. 
• To devise a system for controlled hEB formation that improves hEB 
homogeneity and allows robust differentiation towards the mesodermal 
lineage. 
• To analyse the effect of the system on multiple hESCs lines to confirm 
transferability and assess inter-line variation. 
• To quantify improvements of differentiation to mesoderm derivatives. 
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3.2 METHODS 
3.2.1 hESC culture 
The following manually passaged hESC cell lines were used: HUES-7 (pi I ), kindly 
gifted by Harvard University (Cowan et aI., 2004); BGOI (p24) purchased from 
BresaGen (Mitalipova et al., 2003) and NOTTI (p22) and NOTT2 (pI8) derived at 
The University of Nottingham (Burridge et aI., 2007). After progression from 
manual passage on MEFs, continued culture was maintained by enzymatic trypsin 
passaging on MEFs (CDI strain, E13.5) and feeder-free culture with trypsin 
passaging on Matrigel. Briefly, for co-culture MEF feeders were first maintained in 
75 cm2 tissue culture flasks (Falcon, BD Biosciences) with MEF medium which 
consists of DMEM high glucose (Invitrogen) supplemented with 10% foetal bovine 
serum (FBS; EU Approved, Invitrogen), 2 mM Glutamine (Sigma) and 1 % Non-
Essential Amino Acids (Sigma) and passaged by exposure to a minimal volume of 
0.05% Trypsin-EDTA (Invitrogen) for I min at 37°C, followed by tapping of the 
flasks to liberate single cells. At p2 MEFs were mitotically inactivated for 2.5 hours 
with 10 J.!g mrl mitomycin C, trypsin passaged and seeded at 6 x 104 cm-2 onto 35, 
65 or 90 mm tissue culture dishes or 8-well chamber slides (NUNC) and used 24-48 
hours later. For creation of conditioned medium for hESC feeder-free culture 
mitomycin C treated p2 MEFs were plated into T75 flasks as before. Standard 
culture medium, referred to as BGK in Denning et al., (2006), which consists of 
DMEM-F 12 (Invitrogen) supplemented with 15% Knockout serum replacement 
(Invitrogen), 2 mM Glutamine (Sigma) and 1 % Non-Essential Amino Acids, 100 J.!M 
2-Mercaptoethanol (Sigma) and 4 ng mrl FGF2 (Peprotech) was conditioned for 22-
26 hours on mitomycin C treated MEFs, pooled and supplemented \\'ith an additional 
-+ ng mrl FGF2 (referred to as conditioned medium). Medium was conditioned fIX =' 
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consecutive days and unused aliquots were frozen for use at a later date. Feeder-free 
hESC cultures were maintained on 25-75 cm2 tissue culture flasks (Falcon, BD 
Biosciences) coated with Matrigel (Matrix Growth Factor Reduced, BD Biosciences) 
in conditioned medium and passaged with trypsin (Denning et aI., 2006, Xu et aI., 
2001). All culture was carried out at 37°C in a humidified atmosphere containing 
5% CO2 . Medium was changed daily for hESC culture. All lines were shown to be 
karyotypically normal before use and expressed high levels of the stem cell markers 
SSEA4, TRA-I-60 and TRA-I-81 and were negative for SSEAl expression. 
3.2.2 hEB formation and size assessment 
hEBs were formed by either of two methods referred to as mass culture or forced 
aggregation. The mass culture method, described previously (Denning et aI., 2006), 
involved culture of hESCs on MEFs to confluence in a 90 mm dish, as detailed 
above, followed by treatment with Collagenase IV (Sigma) for 15 min at 37°C then 
scraping with a cell scraper (Orange Scientific). The clumps formed by this process 
were then suspended in conditioned medium, further disaggregated by vigorously 
pipetting with a 10 ml pipette and centrifuged at 100 g for 4 min before transfer into 
fresh conditioned medium and a 90 mm bacteriological Petri dish. The forced 
aggregation method is based a protocol devised by Ng et aI., (2005b) with 
improvements to allow the use of hESCs cultured on Matrigel, (see Figure 3-1). 
Briefly, hESCs were grown in 25 cm2 flasks to standard confluence (1.8 x 105 cells 
cm-2) on Matrigel in conditioned medium, trypsin passaged as above and re-
suspended at either 1 x 104 cells mr!, 3x 104 cells mr! or ] xl 05 cells mr! in either: 
conditioned medium; differentiation medium, which consists of DMEM high glucose 
(Invitrogen) supplemented with 20% fetal bovine serum (FBS; EU Approved. 
Im'itrogcn), :2 mM Glutamine (Sigma) and I °0 Non-Essential Amino Acids and 100 
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~ M M 2-Mercaptoethanol (Sigma); or CDM with BSA (Vallier et aI., 2005) which 
consists of 50% F-12 Nutrient Mixture (Ham's, Invitrogen), 50% Iscove's Modified 
Dulbecco's Medium (Invitrogen), 5 mg mr! bovine serum albumin fraction V (BSA), 
1 x Chemically Defined Lipid Concentrate (Invitrogen), 450 ~ M M 1-Thioglycerol 
(Sigma), transferrin (Sigma) and insulin (Roche). Differentiation medium was also 
tested with 10% serum instead of 20% and CDM was tested replacing BSA with 1 
mg mr! polyvinyl alcohol (PV A, Sigma). A summary of mediums used in this study 
is included in Table 3-3. Cells were then pipetted into U-bottom (U-96), V-bottom 
(V-96), or U-bottom ultra low attachment (ULA U-96) 96-well plates and 
centrifuged at 950 g for 5 min. hEBs were kept in suspension by pipetting every 
other day. Samples were collected every 2 days between days 2-12 and the medium 
was changed every 3 days. hEB sizes were assessed both in the wells and after 
transfer to dishes to remove optical distortion created by U and V bottom plates 
using a Nikon TE2000 microscope. 
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A B C D 
BGK CM hEB test medium D·FBS20 D·FBS20 
Media and plate testing <dO dO-d12 
dO-d2 d2·d8 d8-d24 
Cardiomyocytes <dO 
== 
dO-d4 - - --------- d4·d10 d10-d24 
dO-d6 --------- ---- d6-d12 d12-d24 
Blood <dO dO-d4 d4-d16 
Figure 3- 1: Schematic of the 96-well forced aggregation procedure 
!\) All hESC lines we re cultured on Matri ge l in conditioned medium (BGK CM) with trypsin passaging. B) On dO hEB formation was initiated by seeding into 96-we ll plates 
and centrifug in g at 950 g for 5 min at room temperature. For media and plate combination testing hEBs were matained at this stage upto d12 . C) For cardiomyocyte and blood 
diffe renti a ti on hEBs ce ll s were maintained in V-96 plates (step B) for 2, 4 or 6 days before transferr into untreated 90 mm Petri dishes containing D-FBS20 for 6 days 
(cardi omyocytes) or 12 days (b lood). D) For the final stage of cardiomyocyte differentiation hEBs were individually re-plated into untrea ted U-bottomed 96-well plates and 
maintai ned upto d24. 
Tab le 3-3: L ist of media assessed for hEB formation and maintenance efficiency 
I Jighligh ted media are th ose a lso used for maintaining hESC pi uri potency. 
Media Acronym Base Serum Growth factors Additional ingredients 
Standard Culture Medium BGK DMEM:F12 15% KSR 4 ng mr l FGF2 glutamine, NEAA, 2-mercaptoethanol 
Conditioned Medium BGKCM DMEM:F12 15% KSR 4 ng mr 1 FGF2 glutamine, NEAA, 2-mercaptoethanol. 24 h on MEFs, 
refreshed 4 ng mr 1 FGF2 
Differenti ation Medium with 20% FBS D-FBS20 DMEM 20% FBS None glutamine, NEAA, 2-mercaptoethanol 
Differentiation Medium wi th 10% FBS D-FBS10 DMEM 10% FBS None glutamine , NEAA, 2-mercaptoethanol 
Chemically Defined Medium with BSA CDM-BSA IMDM:F1 2 None None BSA, lipid concentrate , Hhioglycerol , transferrin and insulin 
(Va llier et al., 2004) 
Chemically Defined Medium with PVA CDM- PVA IMDM:F12 None None PVA, lipid concentrate, 1-thioglycerol, transferrin and insulin 
Chemica lly Defined Medium with PVA CDM-PVA+ IMDM:F12 None 12 ng mr 1 FGF2, PVA, lipid concentrate , Hhioglycerol , transferrin and insulin 
supplemented wi th FGF2 and activin A 10 ng mr 1 activin A 
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3.2.3 Tissue processing and haematoxylin-eosin staining 
hEBs were washed in twice in D-PBS (Invitrogen), fixed in 4% parafonnaldehyde 
(PFA, Sigma) in D-PBS for 15 min then washed twice in D-PBS again. hEBs were 
then set into 1 % agarose (Invitrogen) in distilled H20 and processed over-night using 
Shandon Excelsior tissue processor (Thenno). Processed agarose blocks were then 
embedded in paraffin wax (Tissue-Tek) using a Tissue-Tek III thennal / dispensing / 
cryo-consol and sectioned using a microtome at 5 ~ m m and affixed to SuperFrost Plus 
slides (Menzel-Glaser). Slides/sections were dewaxed using xylene (VWR), 
rehydrated through a Ethanol/H20 gradient, stained with Harris' Haematoxylin 
(VWR) and Eosin Yellowish (VWR) then dehydrated and mounted using DePeX 
mounting medium (VWR) before visualisation using a Leica DMRB upright 
microscope and Improvision OpenLab 4.0.2 and Velocity 4 software. 
3.2.4 Cardiomyocyte formation assay 
To assess cardiomyocyte fonnation hEBs were fonned from 1000, 3000 or 10000 
HUES-7, BG01, NOTTI or NOTT2 hESCs in V-96 plates in either BGK-CM, 
CDM-PVA or CDM-PVA supplemented with 12 ng mr! activin A and 10 ng mr! 
FGF2 (CDM-PVA+). After either 2, 4 or 6 days hEBs were transferred into 90 mm 
Petri dishes containing D-FBS20 for 6 days. hEBs were kept in suspension by 
pipetting every other day. hEBs were then transferred into U-96 well plates (1 hEB 
per well) containing D-FBS20 and cultured upto day 24. At each stage medium was 
changed every 3 days. At d24 the number of wells per plate with beating areas was 
assessed using a Nikon TE2000 microscope. 
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3.2.5 Haematopoietic colony-forming assay 
To assess haematopoietic potential hEBs were cultured as above (3.2.4) but 
maintained until d16 in the 90 mm Petri dishes in D-FBS20. At d16 the hEBs were 
disaggregated with trypsin and cells were counted and suspended in MethoCult 
growth factor enriched methylcellulose (HF4434, Stem Cell Technologies) which 
contains BSA, FBS, Stem Cell Factor (KITLG), GM-CSF (CSF2), IL3 and 
Erythropoietin (EPO). Cell suspensions were then transferred to 35 mm dishes and 
cultured for up to 30 days. Colonies of haematopoietic appearance were isolated; 
cytospun onto SuperFrost Plus slides (Menzel-Glaser), fixed in methanol and stained 
with Wright-Giemsa (BDH) before visualisation using a Leica DMRB upright 
microscope and Improvision OpenLab 4.0.2 and Velocity 4 software. 
3.2.6 Non-author contributions to results 
The modification and adaptation of forced aggregation of hEBs from defined 
numbers ofhESCs in ultra low-attachment U-bottom plates as described by Ng et aI., 
(2005b) to V-bottom plates was done jointly by P. Burridge and C. Denning. The use 
of V -96 plates was suggested by C. Denning, while selection of conditioned medium 
and chemically defined medium for hEB formation was jointly discussed and 
formulated by P. Burridge and C. Denning. The additional media types used were 
selected by P. Burridge, who also developed and optimised all Bond-max histology 
protocols. Haematopoietic differentiation protocols were jointly developed by P. 
Burridge and H. Priddle. The experiments to assess inter-line variability were 
devised by C. Denning and L. Young and performed jointly by C. Denning, P. 
Bun-idge, D. Anderson and H. Priddle. 
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3.3 RESULTS 
3.3.1 Size variability in mass culture hEBs 
To assess traditional methods of hEBs formation, HUES-7 and BGO 1 hESCs 
cultured on MEFs or Matrigel were harvested by treatment with either collagenase 
IV or trypsin. Cells were place in suspension in mass culture in conditioned medium 
(BGK CM) to allow hEBs to form for 6 days at which in time hEB size was assessed. 
BGK CM was used for hEB formation as previous experiments within our lab had 
demonstrated that when directly transferring dis aggregated hESCs produced via the 
scraping method to a differentiation medium (D-FBS20) hEB formation was 
unsuccessful (Denning et aI., 2006). Measurements were taken in two directions, at 
90° to each other (See Table 3-4). These results demonstrated a substantial 
heterogeneity in the size of hEBs produced, particularly with the commonly used 
collagenase IV treatment of hESCs on MEFs with hEB diameters ranging from 100-
850 )lm and 175-1100 )lm for HUES-7 and BGO 1 respectively. Treatment of HUES-
7 cells grown on Matrigel with trypsin produced the most homogenous hEBs with 
diameters ranging from 137-288 )lm although the number of hEBs was poor. No 
hEBs formed when using these conditions with BG01 cells. Figure 3-2 contains 
example images of the heterogeneity of hEBs formed by traditional mass culture 
method. Incubation of hanging drop cultures seeded with between 300 and 10000 
HUES-7 or BGO 1 cells for up to 6 days in BGK CM failed to produce hEBs 
(Burridge et aI., 2007) as noted by others (Reubinoff et aI., 2000). 
Table 3-4: Formation of hEBs from HUES-7 and BCO l by mass culture 
hESC lines HUES-7 and BGO I were cultured using one of three methods and induced to form hESs . 
Coli IV, collagenase IV; SE, standard error. Data courtesy ofC. Denning (B urridge el aI. , 2007) . 
hESC Passage Matrix Enzyme line 
HUES-7 p25 MEFs Coil IV 
HUES-7 p28 Matrigel Coil IV 
HUES-7 p28 Matrigel Trypsin 
BG01 p51 MEFs Coil IV 
BG01 p52 Matrigel Coli IV 
BG01 p52 Matrigel Trypsin 
hEB# Ave. Diameter Diameter SE range (!-1m) 
40 
40 
40 
40 
40 
40 
166 26 100-850 
211 12 75-400 
187 6 137-288 
333 27 175-1100 
178 9 100-450 
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Figure 3-2: Image of hEBs formed by suspension culture 
Representative image of d6 hEBs formed in BGK CM in suspension culture by co ll agenase IV 
treatment and scraping of HU ES-7 cells grown on MEF feeders. Sca le bar= 500 11m (images courtesy 
of O. Anderson (Surridge ef a i ., 2007)). 
3.3.2 Comparison of 96-well plate formats and cell seeding density on forced 
aggregation hEBs 
These observations (3 .3. 1) prompted the evaluation of methods to generate hEBs 
directl y from trypsin passaged hESCs cultured on Matrigel. The forced aggregation 
system devised by get al., (2005b) was evaluated and potenti al improvements were 
tested. The combi nat ion of thi system with hESCs maintai ned feeder-free condition 
would enab le the formation of hEBs from a defined number of cell s and therefore 
po tenti all y reduce va riabi lity in hEB size. Ultra- low attachment plates (UL U-96) 
I-U 
plates used by Ng et al., (2005b) were prohibitively expenSIve for large scale 
experiments so comparisons were made using standard uncoated U-bottom and V-
bottom plates alongside ULA plates. Trypsin dissociated HUES-7 hESCs were re-
suspended in BGK CM at plated in 1 00 ~ l l volumes into 96-well plates at 1000, 3000 
and 10000 cells per well and centrifuged. Medium was changed in the wells every 
three days up to day 12. Comparisons were made between the number of hEBs per 
well (Figure 3-4) and the number of single or multiple hEBs per well (Figure 3-5). 
hEB formation was also visually assessed. If hEBs were present ~ 5 5 hEBs from each 
seeding density and plate type were removed from the 96-well plate to a 35mm flat 
bottomed tissue culture dish to remove any effect the shape of the well may have on 
perceived hEB size and remove any free floating hESCs that obscured the hEB. 
Pictures were taken every 2 days of representative wells from each cell number/plate 
combination and hEBs discarded (Figure 3-6). 
Centrifugation of HUES-7 cells in untreated U-bottom plates resulted in erratic 
and/or poor hEB formation (Figure 3-5). In contrast V-bottom plates produced hEBs 
at a similar efficiency to ULA U-96 plates of >90% hEB formation per well. The 
presence of a single hEB or a number of hEBs in each well was also observed 
(Figure 3-5) and demonstrated that wells seeded with 3000 cells produced a higher 
proportion or multiple hEBs per well. hEBs formed in ULA U -96 plates showed 
higher levels of agglomeration than those formed in V -96 plates. When using these 
conditions without centrifugation no hEB formation was observed (observation C. 
Denning (Burridge et aI., 2007)). 
Visual analysis of hEB formation and development was also observed with HUES-7 
hESCs (Figure 3-6). In U-bottom plates hESCs fonned no hESs with 1000 or 3000 
cells and numerous small hESs in each \\'ell from 10000 cells. ULA U-96 plates 
14-l 
fonned no hEBs with 1000 cells, small hEBs with 3000 cell s and hEBs comparable 
to those made in V -bottom plates with 10000 cells. V -bottom wells provided a single 
consistent hEBs in each well at all cell numbers. 
Together these experiments demonstrated that hEBs can be efficiently fonned from 
either 3000 or 10000 HUES-7 hESCs and uncoated V -bottom plates to be most 
advantageous for producing single hEBs per well. A visual comparison between 
hEBs produced by mass culture and the optimised forced aggregation system is 
provided in Figure 3-3 and demonstrates the proportional increase in hEB fOlmation 
and homogeneity provided by this system. 
Figure 3-3: Visual comparison of hEBs produced by the mass culture and forced aggregation 
systems 
Representative image of d6 hEBs A) fom1ed in BGK CM in suspension culture by co llagenase IV 
treatment and scraping of HUES-7 cells grown on MEF feeders and B) hEBs formed in BGK CM 
from 10000 HUES-7 ce lls per well grown on Matrigel. Scale bar= 500 11m (images courtesy of D. 
Anderson) . 
1-+5 
100 r--- r- r--- r- .--- .--- r- r=---r- 0-
90 f-- f-- I-- I-- I-- I-
Cl 
c: 80 r-- b-- I-- I-- I-- I--
E 
... 
0 
-f/) 
CD 70 I-- I-- I-- I-- I-- t-- I-- I-- f=---
I--
UJ 
~ ~
~ ~
-
60 . ~ ~ I-- - I--- I-- I-- - t-- r- I-- f-- I--
f/) 
Qi 
~ ~ 50 I-- - r-- I-- I--- - I-- ~ ~ I-- I-- r-
-0 
(1) 
OJ 
"' 
40 
-
I-- - I--- I--- I-- - I-- '-- I-- I-- r-
c: 
(1) 
u 
... 
(1) 30 Co - I-- - I--- I--- I--- - I-- r- I-- I-- r-
(1) 
OJ 
"' 
... 
(1) 20 > i--- I-- - r-- I-- I-- - I-- - - I-- I--
« 
10 f------- I-- - - I-- I-- I-- - I-- - r- I-- I--
0 - '- '- - - - '-r- '- - --r- '- '- ..- - '-r- - - '-r- '- '-
I I I I I d2 d4 d6 d8 d10 d12 d2 d4 d6 d8 d10 d12 d2 d12 
1000 cel ls 3000 ce ll s 
Number of cells seeded/Day of different iation 
~ ~ U L A A U-96 0 U-96 ! 
Figure 3-4: Effect of cell seeding density a nd 96-well plate format on the number of hEBs for med per well 
II U ES-7 hEBs were formed in BGK eM from 1000 (left) , 3000 (centre) or 10000 (right) cells per well in either uncoated V-bottom (V -96, blue bar); ultra low attac hment coa ted U-
bOllom (U L;\ U-96, red bar) or uncoa ted U-bottom 96-we ll plates (U-96, yellow bar) . hEBs were maintained in the wells and medium was changed every 3 days. Numbers of we lls 
\vil h 1 o r more hEBs present were recorded every 2 days over 12 days of differentiation. Each data point represents the average percentage of well s (±SEM) of 2 independen t 
npcr imc nts (192 wel ls in lota l). In to ta l 3456 we ll s were counted in these experiments. 
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Figure 3-5: Effect of cell seeding density and 96-well plate format on the number of single or multiple hEBs formed per well 
lIULS-7 hEBs were COllned in BGK eM from 1000 (left) , 3000 (centre) or 10000 (right) cells per well in either uncoa ted V-bottom (V-96) ; ultra low attachment coated U-bo tlo Jl1 
(U I J\ U-96) o r uncoa ted U-bo ttom 96-we ll pl a tes (U-96). hEBs were maintained in the wells and medium was changed every 3 days. Numbers o f well s with I hEB (b lue bar) or 
1llore I hEB (red bar) prese nt we re reco rded every 2 days over 12 days of differentiation. Each data point represents the percentage of wells one experimenta l rep lica te (96 we ll s in 
total). In to tal 1725 we ll s were co unted in thi s experiment. 
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Fi gure 3-6: Visua l analysis of the effect of 96-well plate formats and cell seeding density on forced aggregation HUES-7 h EB formation and maintenance 
V-96 
/ / U L L - 7 7 hU3s we re fo rm ed in BGI( eM from 1000 (left) , 3000 (centre) or 10000 (right) cells per well in either uncoated U-bottom 96-well (U-96) , ultra low attachm ent coa led U-
bo tt o l1l (U LJ\ -9o) o r uncoated V-bo ltom (V -96) plates. hEBs were maintained in the wells and medium was changed every 3 days. hEBs were removed fj-om plates every 2 days a nd 
p/w tng raphcd . Data co ll ec ted fro m two ex pe rimenta l rep li cates. Scale bar = 100 Ill. 
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3.3.3 Visual analysis of the effect of media and cell number on forced 
aggregation hEB formation and maintenance 
A variety of media were tested to determine capacity for supporting hEB formation. 
The media tested were unconditioned medium (BGK), differentiation medium with 
10% serum (D-FBSI0), differentiation medium with 20% serum (D-FBS20), and 
conditioned medium (BGK CM) to be used as a control. A semi-chemically defined 
medium (CDM-BSA, Johansson and Wiles, 1995, Vallier et aI., 2005) was also 
trialled along with a fully chemically defined medium as CDM-BSA but replacing 
BSA with the chemically defined PYA (CDM-PVA, personal communication 
Ludovic Vallier, University of Cambridge). In addition CDM-PVA supplemented 
with 10 ng mrl activin A and 12 ng mrl FGF2 was also trailed (CDM-PVA+). 
Activin A is a well established mesoderm inducer allowing for an increase in the 
population of mesodermal cells before further differentiation, FGF2 was included to 
maintain cell proliferation in, what is, a limiting medium. Trypsin dissociated HUES-
7 hESCs were re-suspended in the 7 different media at plated in 100 III volumes into 
96-well V -bottom plates either 3000 or 10000 cells per well and centrifuged (Figure 
3-7). hEBs were removed from the well to photograph as above. Medium was 
changed in the wells every three days up to day 12. Analysis of percentage hEB 
formation in different media is provided in Figure 3-8. Consistent with the above, 
data high efficiency of formation and maintenance (100%) up to d 12 was noted with 
BGK CM. High efficiency was also observed in CDM-PV A and CDM-PV A+. hEB 
formation in less efficient CDM-BSA (77-90%), unconditioned medium (BGK, 66-
82%) and standard differentiation mediums (D-FBS 1 0 or D-FBS20, 0%). Therefore 
subsequent ditTerentiation experiments focussed on f0l111ation, growth and 
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differentiation from hEBs formed in V-96 plates using BGK CM, CDM-PVA and 
CDM-PVA+. 
150 
CDM-PVA CDM-PVA+ 
d2 
d4 
d6 
d8 
d10 
d1 2 
CDM-PVA 
d2 
d4 
d6 
d8 
d10 
d1 2 
Figure 3-7 : Effect of different media on HUES-7 hEB formation and development using hEBs 
formed from 3000 and 10000 cells 
II UES-7 hEBs were form d from 3000 (top) and 10000 (botto m) ce ll s per well in uncoa ted V-b(lttom 
plates in CDM-P VA, CDM-PVA+, BGK C 1, CDM-BSA. BGK. D-FBS IO. D-FB 20. hEBs \\ere 
maintained in the well s and media were changed e\ 'ery 3 days . hEBs \\ 'ere remowd from plate'S and 
photographed c\'ery 2 days . Data co llected from (\\ '0 experimental replicates . Wh itt' scale bar 100 
pm. 
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Fig ure 3-8: Ana lysis of H UES-7 h EB fo rma tion in differen t media 
I I U U ~ - 7 7 ce ll s we re pl ated o ut at 10000 ce ll s per we ll in uncoa ted V-bottom (V-96) plates in CDM-PVA, C DM-PVA+ , BGK CM , C DM-BSA, BG K, D-FBS IO or D-FBS20. hESs 
\\ ne l1lain ta ined in th e we ll s a nd media were changed every 3 days. N umbers of we ll s with 1 or more hEBs present were recorded every 2 days over 12 days of d iffere nt iat ion. Eac h 
d;lta poin t represents the ave ra ge pe rce ntage of we ll s (±SEM) of2 independent experiments (192 well s in total). In to tal 69 12 well s were co un ted in these ex perime nts. 
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3.3.4 Histology of hEBs 
To assess the effects of hEBs fonnation method on the development and internal 
structure fonnation, hEBs were sectioned and stained with haematoxylin and eosin 
(H&E) which highlight nuclei and cytoplasm respectively. HUES-7 hEBs were 
fonned either by mass suspension culture of cells cultured on MEFs and harvested 
with collagenase IV and scraping (Figure 3-9) or by forced aggregation of trypsin-
passages cells cultured on Matrigel. For the forced aggregation, V-96 well plates 
were seeded with 1000, 3000 and 10000 HUES-7 hESCs in BGK CM (Figure 3-9) or 
CDM-PV A (Figure 3-10). Medium was changed on d3 and hEBs were collected on 
d2, d4 and d6. 
Forced aggregation hEBs cultured in BGK CM appeared more dense and unifonn 
that mass culture hEBs between d2-d4 and the cells fonning mass culture hEBs 
appeared to have larger cytoplasms. Similar results were seen for hEBs fonned from 
either 1000, 3000 or 10000 cells. Distinct change in both forced aggregation and 
mass culture hEBs was detected at d6 with large internal cavities fonning. In mass 
culture hEBs a single large central cavity fonned whereas in forced aggregation 
hEBs numerous cavities fonned throughout the hEBs. Forced aggregation hEBs 
fonned in CDM-PVA appeared similar to those fonned in BGK CM between d2-d4 
but at d6 the CDM-PVA hEBs were substantially less cavitated and no hEBs fonned 
from 1000 cells remained. 
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Figure 3-9: Haematoxylin and eosin staining of H UES-7 hEBs form ed by for ced aggrega ti on 
and mass culture in BGK eM 
Images ofrcprescntati\ 'e hEBs f0Il11ed in BGK e M Crom 1000,3000 and 10000 ce lls and mass culturL' 
and stained with Il &F at d2 , d4 and do. Bl ack sca le ba r 100 pm. 
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Figure 3-10 : Haematoxylin a nd eosin sta ining of HUES-7 hEBs formed by forced aggregation in 
CDM-PYA 
Images o f representati ve hEBs formed in COM-PYA fro m 1000, 3000 and 10000 cell s stained with 
H&E at d2, d4 and d6. B lack sca le bar = I 00 ~ ~ . .
3.3.5 Inter-line comparison of hEB development using BGK eM and the 
forced aggregation system 
To further study the fo rced aggregati on system using V -96 plates, the kineti c of 
hEB growth in relati on to input cell number, days of di ffe rentiat ion and med ia were 
in vesti gated. hEBs were formed fro m 1000, 3000 and 10000 HUE -7. BGO I. 
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NOTT1 and NOTT2 hESCs by forced aggregation in BGK CM. Cell s were seeded in 
triplicate and one plate at each density was cultured until d2 , d4 or d6, at which time 
40 hEBs were removed and average hEB size was calculated (see Figure 3-11). 
Analysis of hEB size indicated a high degree of reproducibility between experiments 
and both increasing input cell number and day of differentiation contributed to 
increasing size (Figure 3-11). Similar overall growth profiles were observed between 
lines. However, significant differences in growth profiles were observed during the 
first 6 days of differentiation (p = 0.437 to 0.001 ; one-way analysis of variance 
(ANOVA)). 
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Cell number Day 2 Day 4 D ~ 6 6
1000 0.364 0.002 0.062 
3000 0.325 0.001 0.437 
10000 0.429 0.001 0.042 
Figure 3-11: Size of hESs produced from 4 hESCs in SCK CM 
h - Bs were formed in BGK CM from the hESC lines HUES-7 , BGO I. OTT I and NOTT1 from 1000 
(+), 3000 (_ ) or 10000 ( . ) ce ll s in V-bottom plat s and assessed for size ewry 1 days. Eac h data 
point represent s ave rage (±SEM) o f between 2 and -l independent ex periments . Table represents inter-
line compari sons by one-way A OV . numbers in bold indica te significant dillerences bet\\ ecn 
lines . Data produced in co llabo ration ",ilh C. Denning and D. ndcrs(ln. 
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3.3.6 Inter-line comparison of hEB development using CDM-PVA and CDM-
PV A + and the forced aggregation system 
To study the effect of CDM-PV A and CDM-PV A+ on the kinetics of hEB growth in 
relation to input number hEBs were formed from 1000, 3000 and 10000 HUES-7, 
BG01 or NOTT1 hESCs in either CDM-PVA or CDM-PVA+ (Figure 3-12). For 
hEBs formed in both CDM-PVA and CDM-PVA+, hEBs initiated from 10000 cells 
increased in size from d2 to d6 of differentiation. However, the size of hEBs formed 
from 3000 cells remained static or declined and those formed from 1000 cells 
declined suggesting this medium is less efficient that CM for hEB growth. Similar 
overall growth profiles were observed between lines. However, significant 
differences in growth profiles were observed during the first 6 days of differentiation 
(p = 0.880 to 0.007; one-way ANOV A). 
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Figure 3-12: Size of hEBs produced from 3 hESC lines in CDM-PYA and CDM-PYA+ 
hEBs were formed in COM-PYA and COM-PYA supplemented with ac ti vin A and FGF2 (COM-
PY A+ ) from the hESC li nes HUES-7, BGO I , NOTTl and from 1000 (. ), 3000 (_ ) or 10000 ( . ) cell s 
in V -bottom plates and assessed for size every 2 days . Each data point represents average (±SEM) o f 
betwee n 2 and 4 independent ex periments. Table represents inter- line compari sons by o ne-way 
ANOV A, numbers in bo ld indica te s ignifi cant d ifferences between lines Data produced in 
co llaborati on with C. Dennin g and O . Anderson, 
3.3.7 Cardiomyocytc d iffere ntiation 
The reproducibi li ty of the V-96 forced aggregat ion system and thc abi lity to di ctate 
hEB Size by altering input cell number providcd an opportuni ty to CatTY out (1 
systcmat ic comparL on of mc, odcI111 al di ffcrcntiat ion ctliciencv bet\\'een the i'oLlr 
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hESCs. Cardiomyocytes were used as an indication of successful mesodenn 
induction due to the speed, simplicity and low cost of their differentiation in 
comparison to haematopoietic lineages and the ability to accurately score successful 
differentiation by simply counting the number of beating wells which has been 
demonstrated as proportional to aMHC gene expression (Burridge et al., 2007). 
hEBs were formed form 1000,3000 or 10000 HUES-7, BG01, NOTT1 or NOTT2 
hESCs in BGK CM (Figure 3-13) or CDM-PVA and CDM-PVA+ (Figure 3-14) and 
cultured until d2, d4 or d6 of differentiation. hEBs were then switched to D-FBS20 
in uncoated 90 mm dishes for 6 days before transfer to uncoated U-96 plates and 
maintained until d24 of differentiation (Figure 3-1) when the number of wells with 
beating areas were counted. 
For all four hESC lines, formation in BGK CM and transfer to D-FBS20 on d2 
yielded limited number of beating hEBs. Similarly, cardiomyocyte differentiation 
was consistently poor using 1000 cells with transfer on d2, d4 or d6. There were 
significant inter-line differences in absolute efficiency of the most successful 
conditions for cardiomyocyte production: HUES-7 (3000 cell, d4), 9.5±0.9%; BGOI 
(10000 cells, d6) 1.6±1.0%; NOTT1 (10000 cells d6), 5.3±3.1%; NOTT2 (1000 cells 
d6), 6.6±2.4%; P = 0.008, one-way ANOV A. 
HUES-7 hEBs formed in CDM-PVA from 10000 cells and switched to D-FBS20 at 
d2 of differentiation produced 4.2±2.9% beating areas at d24. This was increased 
significantly to 23.6±3.6% by fonnation in CDM-PVA+ (p = 0.01, T-test). 
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3.3.8 Haematopoietic differentiation 
Although large scale anal ysis of the effect of hESC input number, days in culture, 
day of transfer and media used were prohibi tively expensive, a small sca le analysi 
of forced aggregation hEB propensity to fonn blood was perfOlmed. Y -96 forced 
aggregation hEBs were fonn ed fonn 10000 cell s in CDM-PY A+ (Figure 3-13) and 
cultured until d4 of differentiation. hEBs were then switched to O-FBS20 in 
uncoated 90 mm di shes for 12 days before transfer to MethoCult growth factor 
enriched methylcellulose and cultured for 30 days before staining with Wright-
Giemsa. A small number of cobblestone areas, endothelial-like outgrowths and 
colonies with red colouration were noted during growth in methylcellulose. Using 
Wright-Giemsa staining cells from these colonies were identifi ed as erythrocytes and 
macrophages . 
Fig u re 3- 15: Il ae m atopo ietic colonies and Wrig ht-G ie lll sa sta in ed ce ll s 
I t l l C H ! ! l ' ~ ~ o r c c l o n n c ~ ~ alkr 30 d ( 1 \ , ~ ~ ~ l l ~ P t ' I 1 1 i o l 1 1 in t'-kthoCult (t op) and \\ 'right-C;icllhil 'tail1l'J l'cll, 
~ ~ . 
(bot tom) . 
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3.4 DISCUSSION 
The object of this study was to develop a system for the controlled formation of 
hEBs to improve the size of the mesodermal population and provide a standardised 
platform for the analysis of inter-line variability. 
3.4.1 Analysis of traditional mass culture hEB formation 
Traditional protocols for hEB formation initiate suspension by harvesting colonies 
directly from MEFs using manual dissection, scraping, enzymatic digestion or a 
combination of techniques. Consistent with previous reports (Ng et al., 2005b, Yo on 
et aI., 2006) this strategy resulted in a high degree in heterogeneity in hEB size in 
hEBs formed from either HUES-7 or BGOI hESCs grown on MEFs with 
Collagenase IV passage or grown on Matrigel with Collagenase IV or trypsin 
passage (Table 3-4 and Figure 3-2). Previous experiments in our lab have 
demonstrated high variability in haematopoietic differentiation, likely a consequence 
of the variability in cell numbers that form each hEB. This experiment also 
demonstrated that hEBs were able to form from the aggregation single cell trypsin 
dissociated HUES-7 grown on Matrigel without MEF contamination. 
3.4.2 Establishing a forced aggregation system 
Ng et al. (2005b) published data demonstrating successful hEB formation from a 
known number of HES-2, HES-3 or HES-4 hESCs using forced aggregation. This 
system involves centrifugation at 500 g for 4 minutes at 4°C using 96-well plates 
with an ultra low attachment (ULA U-96) coating along with a semi-chemically 
defined medium supplemented with growth factors. After 8-12 days hEBs were then 
transferred to flat bottom plates and with the introduction of blood inducing growth 
t ~ l C t o r s . . high levels of blood difterentiation could be achieved. Although hEB size 
1 6 ~ ~
data was not reported, efficient haematopoietic development required a minimum of 
500 cells per well and input number was critical for directing cells to the 
haematopoietic lineage with 3000 cells most successful. 
While this strategy proved useful as a proof of concept, there were several potential 
limitations. Firstly, ULA U-96 plates were prohibitively expensive for large scale 
experiments. Secondly, differentiation studies were performed using hESCs derived 
from a single institute therefore the performance of this study in independently-
derived hESCs was not established. Thirdly, this system involved the addition of a 
large number haematopoietic inducing growth factors without insight into the 
individual effect of the growth factors. Finally, this system involved the use of 
hESCs cultured on MEFs, albeit at a lower density, and a mixed population of the 
two cell types were used in the aggregation experiments. It has been suggested that 
contaminating MEFs may have the potential to interfere with differentiation by 
competing with cell-cell interaction and insulating communication between mESCs 
(Weitzer, 2006). 
Comparisons were made using standard uncoated U-bottom and V-bottom plates 
alongside ULA plates. HUES-7 cells grown on Matrigel and force aggregated in 
ULA plates produced >90% hEB formation, consistent with observations using HES-
3 cells grown MEFs (Ng et at., 2005a). Centrifugation of HUES-7 cells in untreated 
U-bottom plates resulted in erratic and/or poor hEB formation (Figure 3-4 and Figure 
3-6). In contrast V -bottom plates produced hEBs at a similar efficiency to ULA U-96 
plates of hEB fonnation per well. The differences detected in hEB formation 
efticiency between V-96 and U-96 plates, along with the success of ULA U-96 
plates, suggests that the force exerted upon the cells has a prominent effect on hEB 
fonnation. The success of hEB fonnation in V -bottom plates maybe attributed an 
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increase in the compression of the hESCs during the forced aggregati on caused by 
the angle and more defined point of the V -bottom well. The differences in hEB 
formation efficiency seen between the U-96 and ULA-96 plates, which have 
identical dimensions, suggests that the reduction in friction on the plate surface due 
to the ultra-low attachment coating also aids hEB formati on (see Figure 3-1 6) . 
U-96 
\ 
I 
l 
Size mm) 
Dimension U .. 96 V .. 96 
G1 7.0 6.8 
G2 6.3 6.4 
L 10.3 9.8 
M 4.1 4.6 
Figure 3-16: Comparison of U-96 and V-96 well dimensions 
V-96 
G1 
1- - [ 
G2 
............. 
...J 
Diagram demonstrating the differences in well dimensions between U-96 and V-96 plates. Diagrams 
adapted from http://www.nuncbrand .com 
The presence of a single hEB or a number of hEBs in each well was al so observed 
(Figure 3-5) and demonstrated that well s seeded with 3000 cells produced a higher 
propOliion on multiple hEBs per well. hEBs fOim ed in U LA U-96 plates showed 
higher levels of agglomeration than those f0 1111ed in V -96 plates which has been 
demonstrated as the major process limiting cell proliferati on and differenti ati on 
(Dang e/ a/. , 2002 ). 
Visual analys is of h EB fo rmati on and developm cnt \Va also ob cr\'ed with H ES-7 
hE C (Fi gurc 3-6). In U- bOttOlll pl [l tcc h ESCs fonn cd no hES s \\ 'ith 1000 or ~ ( ) O ( ) )
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cells and numerous small hEBs in each well from 10000 cells. ULA U-96 plates 
formed no hEBs with 1000 cells, small hEBs with 3000 cells and hEBs comparable 
to those made in V-bottom plates with 10000 cells, this is in contrast to Ng et al., 
(2005a) who suggested that the most successful hEB formation came from 1000 
cells/well. After 12 days maintenance in the plates with conditioned medium these 
hEBs started to form more complex structures suggesting that even in the presence of 
a medium that is used as standard for maintaining pluripotency differentiation can be 
induced by forcing the cells into a 3D formation. 
3.4.3 Effect of media on hEB formation in the forced aggregation system 
A variety of media were tested to determine capacity for supporting hEB formation 
(Figure 3-7 and Figure 3-8). Of the 7 media tested BGK CM, CDM-PV A and CDM-
PV A+ produced the highest efficiency of hEBs formation with efficiency decreasing 
in BGK, CDM-BSA, D-FBS 1 0 and D-FBS20. BGK CM, CDM-PV A and CDM-
PVA+ all yielded hEBs that were maintained through to d12. The underlying 
mechanisms responsible for the differences observed between hEB formation in 
different media are unknown but expression levels of key adhesion factors, such as 
CDH1 (discussed in Chapter 4), are likely targets for further studies. It has been 
demonstrated that over 60 cell-adhesion related genes are up-regulated in 
undifferentiated HS237 hESCs upon transfer from an FBS containing medium to a 
medium containing Knockout™ Serum Replacement (Skottman et al., 2005). 
3.4.4 Size of hEBs in conditioned medium and chemically defined medium 
The kinetics of hEB growth in relation to input cells number and days of 
differentiation was assessed in four hESC lines HUES-7, BG01, NOTTI and 
NOTT2. For hESs fanned at all seeding densities. both increasing cell input number 
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and day of differentiation contributed to increasing size. This study was extended to 
include the hESC lines BG01, NOTT1 and NOTT2 and similar growth profiles were 
observed (Figure 3-11). 
Similar experiments to those above were performed using HUES-7, BG01 and 
NOTT1 hEBs formed in CDM-PVA and CDM-PVA+ (Figure 3-12). Overall hEBs 
formed in CDM-PVA and CDM-PVA+ were similar but only increased in size when 
seeded from 10000 cells suggesting that only this density is able to overcome the 
absence of factors present in BGK CM. 
3.4.5 Histology of hEBs 
HUES-7 hEBs were formed in BGK CM and CDM-PV A using forced aggregation 
and compared to hEBs formed using suspension mass culture. Samples were 
embedded, sectioned and haematoxylin and eosin stained to show nuclei and 
cytoplasm as well as levels of development and the formation of internal structures. 
Results correlated well with hEB size results (Figure 3-11 and Figure 3-12). At d6 
BGK CM mass suspension culture hEBs appeared to consist of an outer epithelial 
layer with a central cavity (Figure 3-9), similar to that seen in mEBs (Weitzer, 2006). 
Cavitation of hEBs has been demonstrated (Itskovitz-Eldor et aI., 2000, Conley et 
aI., 2004a, Khoo et aI., 2005) but it is not currently known how well this correlates 
with mEB cavitation. Forced aggregation BGK CM and CDM-PVA hEBs appeared 
more dense than mass culture hEBs at d2-d4, likely a result of the forced aggregation 
procedure (Figure 3-12). At d6, in both BGK CM hEBs numerous random cavities 
were seen, which were smaller in CDM-PV A hEBs (Figure 3-9). The random nature 
of this cavities, rather than one large central cavity. and the lack of any identifiable 
epithelial layer suggests that forced aggregation hEBs do not differentiate in the 
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same manner to mass culture hEBs although the cell lineages present could only be 
identified using immunohistochemistry. 
3.4.6 Production of terminailineages 
The ability of hEBs formed by forced aggregation to form cardiomyocytes was 
assessed. FBS was included in the extended differentiation period because the 
absence of serum is reported to be detrimental to the maintenance of primary 
cardiomyocytes (Heng et aI., 2004). Each of the hESC lines yielded only a limited 
number beating hEBs, particularly poor were hEBs formed from 1000 cells (Figure 
3-13). Most successful was HUES-7 hEBs formed from 3000 cells at d4 with 
9.5±0.9% of hEB beating. Interestingly, HUES-7 formed the largest number of 
cardiomyocytes from 3000 cells at d4 whereas the other three lines produced the 
most cardiomyocytes from 10000 cells at d4 or d6. Similar experiments were also 
performed using HUES-7 with hEB formation in CDM-PV A and CDM-PV A+ 
(Figure 3-14) and demonstrated that CDM-PVA hEBs formed from 10000 cells 
resulted in 4.2±2.9% of beating hEBs at d24 whereas supplementation with activin A 
and FGF2 induced 23.6±3.6% beating hEBs (Figure 3-14). This suggests that the 
combination of CDM-PVA supplemented with activin A and FGF2 is a successful 
combination to induce cells of the mesodermal lineage. This percentage compares 
favourably to other groups who have formed cardiomyocytes by mass culture who 
achieved between 0-25% beating hEB efficiency when using mass culture 
mechanicalldispase dissociation and 18-22% when usmg hanging drop hEB 
fonnation (see Table 3-5). 
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Table 3-5: Reported efficiencies of beating hEB production from different laboratory groups, 
hESC lines and differentiation method 
The tope section of the table contains methods that involve rna s culture, whil st the bottom sec ti on 
contains altemative methods such as hanging drop and co-culture . 
.. / . ~ . . hESC Diffarentiati Beating hEB r..;da:Jtn, gJlJWth passage method on culture Reference 
media efficiency 
HES-1,2 MEFs/FBS mechanicall dispase 20% FBS none (Reubinoff et al., 2000) 
H9.2 MEFs/FBS mechanicall dispase 20% FBS 8.10% (Keha t et al., 2001) 
H1 , H7, H9, Matrigell Coli IV 20% FBS upto -70% H9.1, H9.2 KSR-CM (Xu et aI. , 2002a ) 
H1.7,9 ,14 MEFs/KSR mechanicall dispase 15% FBS 10-25% (He et al., 2003) 
Royan H1 MEFs/FBS mechanicall dispase 20% FBS 10% (Baharvand et al., 2004) 
H1 MEFs/FBS mechanicall dispase 20% FBS -13% (Xue et al., 2005 ) 
H9.2 MEFs/KSR mechanica ll dispase 20% FBS 21 .50% (Segev et al., 2005) 
SA002 MEFsl mechanica l 20% FBS -30% (Norstrom et al., VitroHES 2006) 
Miz-hES2, MEFs/KSR mechanica l 20% FBS 5-8% (Yoon et al., 2006 ) HSF-6 
H1 MEFs/KSR mechanical 20% FBS 3-15% (Bettiol et al., 2007 ) 
BG01V, MEFs mecha nical 5% FBS + 7-9% (Pal and Khanna , ReliCell-hES 1 BMP2 2007) 
BG01 , HUES- Matrigell trypsin 20% FBS -2% (Denning et al., 7 KSR-CM 2006) 
Miz-hES2, MEFs/KSR mechanicall hanging 20% FBS 18-22% (Yoon et al., 2006) HSF-6 drop 
HES2 MEFs/FBS mechanicall dispase 20% FBS 15-20% (Mummery et al., 
onto END2 co-cu lture 2002) 
HES2, HES3, MEFs/FBS mechanicall dispase 20% FBS 35±10% (Mummery et aI. , HES4 onto END2 co-culture 2003) 
H7 Matrigell Coil IVI monolayer activin A and >30% of cells (Laflamm e et al., KSR-CM based BMP4 ca rdiomyocytes 2007) 
Differences in developmental potential between hESC lines has been prevIOus 
desclibed (Mikkola et a/. , 2006), including differences in preferenti al tenllinal 
differenti ation , despite no difference in hEB f0n11ation, between two lines (Miz-
hES4 and Miz-hES6) deli ved under the same conditions (Kim et a /. , 2007b). The 
di fferences in developmental competence between hESC lines may be the result of 
the conditions and developmental stage under whi ch the hESC lines were deri ved. 
male-female di fferences or geneti c va ri ati on. Si ngle nucleotide po lymorp hi Ill S arc 
ugges ted to contribute to the unique genetic protile of individual hE Clines 
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(Abeyta et al., 2004). Epigenetic differences and X-inactivation status may also 
affect gene expression patterns (Allegrucci and Young, 2007, Hoffman et ai., 2005). 
Once a suitable system was established for mesodennal lineage differentiation was 
established, the system was tested for haematopoietic lineage production. Successful 
differentiation, albeit very low numbers, of haematopoietic cells of the erythrocyte 
and macrophage lineage was obtained from HUES-7 hEBs. The number of 
haematopoietic cells fonned was too low and variable to identify a pattern or most 
successful conditions that favour haematopoietic differentiation suggesting that 
additional factors that further induce haematopoiesis may be required such as those 
used by Ng et al. (2005b). 
This study combines the use of a standardised method for culturing multiple hESC 
lines without feeders with a forced aggregation procedure to provide a system that 
produces highly homogenous hEBs which is optimised for mesodennal lineage 
differentiation. This system allows for accurate comparison between the 
differentiation capacities of different hESC lines and provides a platfonn for the 
further study of the effects of media, growth factors and plating on the process of 
di fferentiation. 
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4 SPATIAL AND TEMPORAL ASSOCIATION BETWEEN 
LOSS OF PLURIPOTENCY AND GERM LAYER 
FORMATION DURING HUMAN EMBRYOID BODY 
DIFFERENTIATION 
4.1 INTRODUCTION 
The reproducibility of the forced aggregation system detailed in Chapter 3 allows for 
production of large numbers of standardised hEBs. In tum this provides a platform 
for the analysis of the spatial and temporal association between the loss of 
pluripotency and germ layer induction during hEB differentiation. This chapter 
details the spatial relationships of cells expressing markers for POU5F1, NANOG 
(pluripotency), T (mesoderm), SOX17 (endoderm) and SOX} (ectoderm) during the 
initial stages of differentiation (16 days). The inter-line variability in early 
differentiation in hEBs formed from 4 hESC lines is also examined. In addition the 
effect of CDM supplemented with activin A and FGF2 on the molecular induction of 
differentiation is also analysed to determine whether the mesoderm component can 
be enhanced by these additives. 
The early stages of hESC commitment and differentiation in early hEBs and the 
relationships between cell types are largely uncharted (Laslett et aI., 2007). Currently 
in addition to data extrapolated from work on EBs derived from rhesus monkey 
ESCs, common marmoset ESCs and human embryonal carcinoma (F9) cells, most 
clues are derived from mEBs. This data is usually interpreted using information from 
mouse embryonic development \\'hich provides a clue to the expected timing and cell 
type relationships dUling hEB ditTerentiation (rc\'ic\\'cd by Tam and Locbe!, 2007). 
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4.1.1 Markers of pluripotency and germ layer induction in mouse embryos 
Although attempts have been made to standardise marker genes for the detection of 
differentiation in ESCs (Willems et af., 2006), often the selected genes appear too 
late in development to be of use for the identification of germ layer induction. To 
examine the ontogeny of germ layer formation, the effect of culture conditions and 
how this differentiation correlates to previously published studies of early post-
implantation development from both mouse and human, within this chapter the 
following panel of molecular marker genes were selected: POU5Fl and NANOG for 
pluripotency; T, MIXLl, GSC, SOXl7 and FOXA2 for mesendoderm; and SOXI 
and SOX3 for ectoderm. 
For simplicity, the mouse embryo stage terms used refer to the following stages of 
development: E6.25, pre-streak; E6.5-6.75, early streak; E7.0-7.5, mid-streak; E7.25-
7.75, late streak; E7.5-8.0 neural plate; E7.75-8.0, headfold; E8.0+, somites. Derived 
from Downs and Davies (1993) and the Edinburgh Mouse Atlas staging criteria 
(http://genex.hgu.mrc. ac. uk/Databases/ Anatom y/MAstaging.shtml). 
4.1.1.1 Pluripotellcy markers 
4.1.1.1.1 PlJlJ5J<1 
POU5Fl (POU domain, class 5, transcription factor I, also known as OCT4) is a 
nuclear transcription factor (reviewed by Pan et af., 2002). POU5FI was discovered 
in mice (Scholer et aI., 1 990b) as a POU (Pit-Oct-Unc) domain-containing 
transcription factor that binds the octamer sequence, ATGCAAAT (Herr and Cleary. 
1995). Pre-implantation expression of P O l l ~ f l , , is first detected at the four- to cight-
cell stage (Yeom el af., 1996. Palmieri el al.. 1994). P 0 1 L ~ f l l expression is unifonn at 
the morula stage. however as the outer cells ditTcrentiate to trophectodenn. P 0 1 L ~ f 7 7 is 
1 7 . ~ ~
down-regulated and becomes restricted to the ICM of the blastocyst (Rosner et a!.. 
1990, Scholer et ai., 1990a). As development continues Pou5/l expression becomes 
restricted to the epiblast and subsequent primitive ectoderm (Rosner et a!., 1990, 
Scholer et ai., 1990a) and by E8.S is only maintained in PGCs (Yeom et a!.. 1996, 
Yo shimizu et ai., 1999). POUSFI has been demonstrated to be required for PGC cell 
survival in mice (Kehler et ai., 2004). In the mouse embryo POUSFI is essential to 
establish pluripotency and in Pou5j1-I- embryos, cells from the ICM in the blastocyst 
do not fully mature and are restricted to the extra-embryonic trophoblast lineage 
(Nichols et ai., 1998). Human POUSFI has two isoforms, both containing identical 
POU DNA binding domains and C-terminal domains, but differ in their amino-
terminal domains (Lee et ai., 2006). POUSFI also has six proposed pseudogenes 
(Pain et ai., 200S). 
4.1.1.1.2 lV£tlVlJ(J 
NANOG is a homeobox family transcription factor originally identified in mESCs 
(Chambers et ai., 2003, Mitsui et ai., 2003). In the mouse embryo Nanog is first 
detected in the compacted morula then restricted to the ICM of the blastocyst. At 
ES.S, Nanog is expressed asymmetrically in the proximal epiblast at the 
embryonic/extra-embryonic junction. At E6.0, Nanog expression extends distally in 
the epiblast at the site of the presumptive primitive streak. At E6.S, Nanog is 
localised to the epiblast of the emerging primitive streak but is not detected in the 
embryonic visceral endoderm. At E7.0, Nanog is detected anteriorly within the 
epihlast as the streak forms and elongates along the embryonic anterior-posterior axis 
between E7-7.S. with maximal expression in epiblast cells flanking the primiti\c 
streak. Expression is lost in cells as the enter they primitiYc streak and .\'(/llog is 
undetectable by E9.S, except for the genital ridges at Ell.5, containing PGCs 
1 -, .., I .' 
(Chambers et ai., 2003, Hart et ai., 2004). In humans NANOG has ten proposed 
processed pseudogenes and one tandem duplicate (Booth and Holland, 2004). 
4.1.1.2 Primitive streak markers 
4.1.1.2.1 T 
T (brachyury) is a transcription factor that is commonly used as a panmesodermal 
marker (Herrmann et ai., 1990). However T has been detected in definitive endoderm 
(Kispert and Herrmann, 1994) and it is possible that expression of some primitive 
streak genes is maintained for a short period after differentiation to definitive 
endoderm (Yasunaga et ai., 200S). Like all T-box family members, T binds to the 
DNA consensus sequence, TCACACCT, at the T-box region in its N-terminus 
(reviewed by Wilson and Conlon, 2002). In the mouse embryo, T expression is first 
detected at ES.S at the extra-embryonic ectoderm/proximal epiblast boundary 
(Thomas and Beddington, 1996, Perea-Gomez et aI., 2004, Rivera-Perez and 
Magnuson, 200S). T then localises to the nascent primitive streak by E6.S (Thomas 
et aI., 1998, Inman and Downs, 2006). Between E6.7S and 7.0, T is detected along 
the length of the primitive streak and in the nascent mesoderm (Inman and Downs, 
2006). At E7.S T expression is detected in the notochordal plate and extra-embryonic 
mesoderm (Kispert and Herrmann, 1994). At later stages T expression is seen in the 
node, notochord and tail bud of neural plate and somite stage embryos (Wilkinson et 
aI., 1990, Wilson et aI., 1993). T has also been noted to be maintained in migrating 
PGCs (Saitou et at., 2002). T - embryos die at around E 1 0 due to defective anterior 
mesodenn tonnation, ma1tc)lmed anterior so mites and absent posterior somites 
(Kispeli and H elTIll ann, 1994). Recently T has been demonstrated to be expressed in 
the mouse blastocyst in a ICM specific manner along \\'ith P01l5f/ and Nallog 
17-l 
(Yoshikawa et al., 2006). The human homologue of T (Edwards et at.. 1996) has 
been associated with spina bifida (Morrison et a!., 1996). 
4.1.1.2.2 } k f ~ 1 1
MIXL1 (mesoderm induced homeobox-like 1) is the only identified human member 
of the Xenopus Mix/Bix family of hom eo box proteins (Robb et al., 2000, Sahr et at.. 
2002, Guo et al., 2002). In the mouse, Mixll is essential in for axial mesendoderm 
morphogenesis, as well as endoderm differentiation (Robb et a!., 2000). Mixl is first 
expressed in posterior visceral endoderm and posterior epiblast at ES.S-6 before 
localising to the primitive streak and nascent mesoderm at E6.S-7.S (Pearce and 
Evans, 1999). Mixl] then localises to the mesoderm of the developing midgut and 
hindgut (but not the definitive endoderm), and finally in the tailbud before switching 
off after E9.S (Pearce and Evans, 1999, Robb et al., 2000, Mohn et a!., 2003, 
Mossman et a!., 2005). 
4.1.1.2.3 GSC 
GSC (goosecoid) is a homeodomain protein (Blum et al., 1992) commonly used as a 
marker for mesendoderm (Tada et al., 2005). However, Gsc is not entirely specific to 
the mesendoderm as it is also expressed in the anterior visceral endoderm during 
early development (Perea-Gomez et al., 2002). Gsc is expressed in the anterior end 
of the primitive streak at E7.0-E7.S followed by expression in the anterior end of the 
embryo at ES.O (Filosa et aI., 1997). At ES.S, Gsc is expressed in all three germ 
layers (ventral neuroepithelium of the forebrain, prechordal mesoderm and foregut 
endodenn), followed expression in the ventral diencephalon of the brain and oral 
epithelium at E9.S (Blum et al.. 1992, Filosa et aI., 1997). At E 1 0.5, GSC expression 
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becomes restricted to portions of the facial process, branchial arches, limbs and body 
wall (Gaunt et aI., 1993). 
4.1.1.2.4 ~ ( J ~ ~ ~ ~
EOMES (eomesodermin, also known as TBR2) is aT-box nuclear transcription 
factor related to T (Hancock et aI., 1999). EOMES is expressed in mouse oocytes 
and in both the ICM and trophectoderm of the E3.S blastocyst stage embryo 
(McConnell et af., 200S). Eames has then been shown to localise to the 
trophectoderm then the extra-embryonic ectoderm between ES.O and 6.S and the 
posterior epiblast and primitive streak and nascent mesoderm between ES.7S and 7.S 
(Russ et af., 2000). Eames is then detected in the developing forebrain and olfactory 
lobes at EI2.S-14.S (Russ et aI., 2000) and the hippocampus from EI8.S (Kimura et 
af., 1999). 
4.1.1.2.5 ~ ( J X 1 7 7
SOX17 (SRY (sex determining region Y)-box 17) is a transcription factor originally 
identified as a stage-specific transcription factor during spermatogenesis (Kanai et 
af., 1996). Sox17 is commonly used as a marker of definitive and visceral endoderm 
although it is not expressed in the anterior visceral endoderm (Kanai-Azuma et aI., 
2002). Sox 17 can form two splice variants that are both translated into proteins, with 
the shorter form displaying no apparent DNA-binding activity (Kanai et aI., 1996). 
SOX-type transcription factors share a conserved high mobility group (HMG)-box, 
minor grove DNA-binding domain (Pevny and Lovell-Badge, 1997). SOX proteins 
bind to specific DNA sequences by a core consensus sequence ATTGTT. although 
nanking sequences and accessory factors are often involved (reviewed by Wilson 
and Koopman, 2002. Kamachi ef al.. 2000, Pevny and Lovell-Badge. 1997). Sox 17 is 
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first detected in the visceral endodenn nearest the epiplacental cone at E6.0 (Kanai-
Azuma et af., 2002). It is then expressed across the entire extra-embryonic visceral 
endodenn at E6.5, but is undetectable in the embryonic visceral endodenn (Kanai-
Azuma et af., 2002). At E7.0, Sox17 is expressed in the endodenn subjacent to the 
anterior end of the primitive streak, and in the endodenn underlying the neural plate 
by E7.5 (Kanai-Azuma et af., 2002). At E8.5, Sox17 is expressed in the middle and 
posterior gut endodenn (Tam et af., 2004). Sox1 T/- embryos are deficient in gut 
endodenn (Kanai-Azuma et af., 2002). 
4.1.1.2.6 FOXA2 
FOXA2 (fork head box A2, previously known as H N F 3 ~ ) ) is a transcription factor 
that also interacts with chromatin. At the pre-streak stage, FoxA2 is expressed in the 
visceral endodenn (Ang et af., 1993). In the early streak stage, FoxA2 expression is 
localised to the anterior portion of the primitive streak, and by mid-streak a large 
group of cells within the anterior third of the streak express FoxA2 before becoming 
restricted to the node, to anteriorly migrating mesodenn and to endodenn cells of the 
head process (Filosa et af., 1997). At the headfold stage FoxA2 is expressed in all 
three genn layers; in the notochord, neural plate, and underlying midline endodenn 
and the medial and lateral regions of the foregut and prechordal mesodenn (Ang et 
al., 1993, Monaghan et aI., 1993, Ruiz i Altaba et aI., 1993, Sasaki and Hogan, 1993, 
Hart ct af., 2002, Filosa et aI., 1997). At EI6.5, FoxA2 is expressed in predominantly 
in the liver but is also detected in the lung, pancreas, intestine and stomach (Ang et 
aI., 1993). Gene targeting of FoxA2 in visceral endodenn has distinguished an 
essential role in primitive streak morphogenesis (Dufort et al.. 1998). 
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4.1.1.3 Ectodermal markers 
4.1.1.3.1 SOX1 
SOX1 (SRY (sex determining region Y)-box 1) is a transcription factor, first cloned 
in humans (Malas et al., 1997). It is one of the earliest transcription factors to be 
expressed in definitive ectoderm (Pevny et al., 1998). In mouse embryos, Sox} is 
first detected in the columnar ectoderm cells in the anterior half of late-streak 
embryos and is maintained in all neuroepithelial cells along the entire 
antereoposterior axis as the neural plate bends at E8.0-8.5 and fuses to form the 
neural tube at E9.0-9.5 (Pesce et al., 1998). As development proceeds, Sox} is down-
regulated in along the dorsoventral axis of the neural tube. By E13.5, Sox} is 
restricted to a thin ventral zone in the central nervous system (Pevny et al., 1998, 
Wood and Episkopou, 1999). soxr/- mice do not exhibit any obvious abnormalities 
except for reduction in the size of the lens of the eye and cataract (Nishiguchi et al., 
1998). 
4.1.1.3.2 SOX3 
SOX3 (SRY (sex determining regIOn Y)-box 3) is a transcription factor first 
identified in humans (Stevanovic et al., 1993). In mouse embryos, Sox3 is expressed 
at E6.5 in a band of extra-embryonic ectoderm at the embryonic/extra-embryonic 
boundary (Wood and Episkopou, 1999). At E7.0 Sox3 expression becomes restricted 
to the anterior ectoderm whilst extra-embryonic expression becomes restricted to the 
chorion. At E7.5 Sox3 expression spreads from the anterior to the posterior epiblast 
in cells that contribute to the paraxial mesoderm. At E8.0 Sox3 is expressed in an 
anterior-posterior gradient up-regulated in the postelior ectodenn during latc streak 
and neural plate stages and is concomitantly down-regulatcd in the chorion. From 
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ES.O onwards Sox3 is expressed in the neuroectodenn (Wood and Episkopou, 1999). 
At E9.5-10.5 Sox3 maintained in the full length of the developing central nervous 
system including brain and spinal cord. At E 11.5 Sox3 expression is maintained 
throughout the foetal brain and by E 13.5 expression has become limited to the 
ependymal layer where undifferentiated neural progenitor cells are still actively 
dividing (Collignon et aI., 1996). 
Table 4.1 summarises the sites of expression of markers selected for use in this 
study. 
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Table 4-1: S ummary of expression of pluripotency and germ layer markers during gastrulation 
Summery of the ex press ion patterns of markers used to detect pluripotency and germ layer induction. IeM: inner cell mass, ESC: embryonic stem cell , PS : primitive streak, D. Endo: 
defin iti ve endoderm , Pro Endo: primiti ve endodern1, VE: visceral endoderm, PE: parietal endodern1, TE; trophectoderm. 
Gene name Symbol ICMI PS Ectoderm Mesoderm D. Endo Pr.Endl TE Refs ESC VE/PE 
POU domain , class 5, transcription factor 1 POU5F1 * * Scholer et al., 1990 
Nanog homeobox NANOG * Chambers et al., 2003 
T, brachyury homolog (mouse) T * * Hermann et al., 1990, Inman and Downs, 2006 
Mix1 homolog-like 1 MIXL 1 * * * Pearce and Evans , 1999, Ng et aI. , 2005a 
goosecoid GSC * * * * Blum et aI. , 1992, Tada et al., 2005 
eomesodermin homolog (Xenopus laevis ) EOMES * * * Ciruna and Rossant , 1999 
SRY (sex determining region Y)-box 17 SOX17 * * Katoh et aI. , 2002, Matsuura et al., 2006 
forkhead box A2 FOXA2 * * * * Levinson-Dushnik and Benvenisty , 1997 
SRY (sex determining region Y)-box 1 SOX1 * Malas et al., 1997, Wood and Episkopou, 1999 
SRY (sex determining region Y)-box 3 SOX3 * Stevanovic et al., 1993 
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4.1.2 Ontogeny of pluripotency and germ layer marker gene expression during 
mEB differentiation 
There is surprisingly little data available on the spatial expression of germ layer 
markers in mEBs. In part, this is due to the requirement for mEB to adhere to 
facilitate the later stages of mesendodenn differentiation (Bader et ai., 2001) that 
makes visualisation by sectioning difficult. 
Leahy et ai., (1999) used RNA in situ hybridisation to in mEBs to examine P o u ~ f J , ,
T, and Gata4 (expressed in primitive and definitive endoderm). This group found 
Pou5fl strongly expressed a dl-4 throughout the mEBs before becoming patchy at 
d5 and down-regulated between d7 and 10. T expression was first seen at d3, 
markedly increased at d4 in a patchy fonnation localising one side or point of 
elongation before becoming more restricted to areas at the edge of the mEBs at d5-6 
and declined after d7, with traces of expression found through to diO. By whole 
mount in-situ hybridisation T has been shown to be expressed in a "clustered (patch 
like) fonnation" in mEBs at d5, d6 and d7, making up an estimated 3-8% of the total 
mEB cell number (Yamada et ai., 1994). In addition this study demonstrated that the 
proportion of T expressing cells could be increased by the addition of activin A (150 
ng mrl) or FGF2 (300 ng mrl), although no statistical analysis was performed 
(Yamada et ai., 1994). MIXL1 was expressed throughout mEBs at d4 (Ng et al.. 
2005a). 
SOX 17 and FOXA2 were detected by immunohistochemistry, in points of elongation 
at the periphery of the mEBs, in gut-like epithelial structures after 6 days culture as 
hanging drops without LIF. Expression intensity decreased after an additional 7 days 
on gelatine coated dishes and disappeared after 20 days total culture (Matsuura c/ al.. 
.2006 ). 
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These results suggest there is a definable order to differentiation within mEBs but no 
conclusion can be drawn to the germ layer spatial relationships from the available 
data. 
In mouse, the transcriptional profiling of pluripotency and germ layer marker 
expression has involved harvesting mEB samples every day over the first 6 days, 
with analysis of early markers via RT-PCR, real-time RT-PCR or microarrays (Ng et 
ai., 2005a, Mossman et aI., 2005, Willey et aI., 2006, Hirst et aI., 2006). These 
studies demonstrate that the expression level of pluripotency genes such as Pou5f1, 
Nanog, Sox2 and Zpf42 (Rexl) are reduced over the first 5-6 days of differentiation, 
that epiblast markers such as Cdhl and Fgf5 are expressed until d4-6 (with highest 
levels at d3) and markers of the primitive streak such as T, Mixll, Gsc and Wnt3a are 
expressed from d2 to d5 (with highest levels at d3-d4). Markers of endoderm such as 
Gata6, Piat, Lambl, Ker19 and Nr2fl are expressed in undifferentiated mESCs and 
up-regulated at d6. Overall, whilst these studies have demonstrated that genes for 
epiblast, primitive streak, mesoderm, and endoderm markers are sequentially 
expressed, there is a caveat that mRNA expression may not faithfully recapitulate 
mature protein expression. 
4.1.3 Ontogeny of pluripotency and germ layer marker gene expression during 
hEB differentiation 
The spatial and temporal expression of pluripotency and germ layer markers is even 
less well studied in hEBs. In hEBs formed by mass culture, POU5Fl is expressed 
across H9 and HI3 hEBs at d2 (Dvash et al., 2006), in small areas towards the 
periphery of some FES20 hESs at d7 and ubiquitously in FES30 hESs at d7 
(Mikkola et at., 2006). POU5Fl has also been detected predominantly at the 
periphery of HES2 hESs at d3 whereas it is more rcstticted to discrete regions of the 
1 ~ 2 2
periphery at d5 and broadly undetectable at d7 (Conley et aI., 2007). Interestingly 
POU5Fl expression was detected in the core of mass culture d3-d5 rhesus monkey 
EBs (Mitalipov et al., 2002). 
T is expressed towards the centre of in a small proportion of larger d7 hEBs formed 
from FES22 hESCs, although no expression was seen in FES30 hEBs under the same 
conditions (Mikkola et al., 2006), highlighting the potential for inter-line variability. 
Expression of later markers for mesoderm (PECAM 1), endoderm (AFP) and 
ectoderm (NEFH) was detected by confocal immunofluorescence on sections of d7 
HES-2 hEBs (Conley et al., 2004a). Although this study described the expression of 
markers of each of the germ layers in clusters of cells within the hEBs, and reported 
that PECAM 1 expression was also localised to a point of elongation at the periphery 
of the hEBs, no details their co-expression of was provided (Conley et a!., 2004a). 
In contrast to immunohistochemistry and immunofluorescence data, differences in 
pluripotency and germ layer marker expression between undifferentiated hESCs and 
differentiating hEBs have been well studied using RT-PCR and microarrays. Using 
RT-PCR the expression of pluripotency markers such as POU5Fl, NANOG and 
ZPF42 was detected from dO to d2I of HI and H9 hEB differentiation with 
mesoderm markers T and TBX5 and endoderm marker SOX17 detected between d7 
and d2I (Barberi et a!., 2007). In force aggregated hES2, hES3 and hES4 hEBs 
(cultured in CDM supplemented with haematopoietic inducing growth factors), 
POU5F 1 was expressed from dO to d26 whilst T and MIXLI were detected from d4 
to d8 (Ng et at., 2005b). In HI and HES2 hEBs (cultured in an aggregation medium 
supplemented with FGF2, BMP4 and VEGF), POU5F 1 was expressed from dO and 
reduced towards d8, T was expressed at low levels from d I-d6, peaking at d 2 - d ~ ~ and 
FOX.':: was expressed from d I-d8 (Kennedy ef at., 2007). Serum-free neural 
induction medium suspension of HS346 hESCs resulted in expression of POU5Fl 
from dO-d24, NANOG from dO-dI4, SOXl from d14-d42 and no detection of Tor 
AFP (Nat et aI., 2007). When using a 'neuralising medium" on H9 and HUES-7 
hEBs, expression of POU5Fl and NANOG was detected up to d8. Expression of T 
was detected in undifferentiated cells and hEBs up to dl2 and expression of FOXA2 
was also detected in undifferentiated cells and hEBs up to d8 and SOXl was detected 
at d8-d16 (Joannides et ai., 2006). In H9 hEBs cultured in CDM POU5Fl was 
detected at dO-d8, SOX17 was detected at dl2 and dl6 and NEURODl, a marker for 
neuroectoderm, was detected at d8-d16 (Vallier et aI., 2005). 
Using microarrays, hEBs created using the suspension culture method and harvested 
at d12-d14 of differentiation (Miura et aI., 2004, Brandenberger et ai., 2004b, 
Bhattacharya et ai., 2005, Li et ai., 2006a, Cai et aI., 2005, Liu et aI., 2006a) or on 
d2, dlO and d30 (Dvash et aI., 2004) have been analysed and identify numerous new 
genes that are >3 fold up-regulated after differentiation. Unfortunately these studies 
do not cover intermediate time-points and therefore do not allow us insight into the 
process of pluripotency down-regulation and germ layer induction. Others that have 
included time-points every 2 days have concentrated on a small number of genes, 
such as those associated with pluripotency (Calhoun et ai., 2004, Noaksson et at., 
2005). 
4.1.4 Aims 
The initial stages of mEB differentiation have been well studied and appear to 
successfully recapitulate in vivo mouse embryo development, but equivalent stages in 
hEBs have been poorly characterised. Using a carefully selected panel of 
pluripotency and early gastrulation markers, this chapter aims to elucidate the spatial 
and temporal relationship between pluripotency/germ layer markers within hEBs. In 
order to determine whether mesoderm component can be enhanced, the effect of 
FGF2 and activin A on germ layer induction will also be evaluated. 
The specific aims of this chapter were: 
• To optimise immunohistochemistry methods for pluripotency and early germ 
layer marker detection in differentiating hEBs. 
• To compare the effects of different methods of hEB formation on marker 
expreSSIOn. 
• To investigate the spatial and temporal association between loss of 
pluripotency and germ layer formation. 
• To investigate inter-line variability in hEBs from 4 hESC lines. 
4.2 METHODS 
hESC lines HUES-7, NOTTI, NOTT2 and BGOI were cultured in identical 
conditions using Matrigel and MEF CM, derived from the same MEF batch and , 
passaged with trypsin. hEBs were aggregated by forced aggregation as described in 
Chapter 3 (3.2.2) using 10000 cells. hEBs were maintained the in V -bottom plates in 
MEF CM for 4 days before transfer to Petri dishes containing differentiation medium 
consisting of 20% FBS. FBS with the same batch number was used for producing 
MEF CM and differentiation medium. All lines formed consistent high proportions 
of hEBs (>95%) as detailed in 3.3.2. HUES-7 hEBs were also formed in CDM 
supplemented with activin A and FGF2 as previous described (3.2.2) and are referred 
to as HUES-7 CDM hEBs. Mass culture hEBs were also formed as previously 
described (3.2.2). The hESC line HI (Thomson et at., 1998) was also used after 
transfer to the same feeder-free culture conditions as used for the other 4 hESC lines. 
4.2.1 RT -peR 
4.2.1.1 Sample collection and RNA isolation 
hEB and undifferentiated hESC samples were washed twice in D-PBS (Invitrogen), 
centrifuged at 500 g for 4 min and flash frozen in liquid nitrogen then stored at -80 
°C. RNA was isolated using RNeasy Mini columns (QIAGEN), including steps for 
DNase DNA digestion (QIAGEN) following manufacturers instructions. Optical 
densities were established using a ND-IOOO spectrophotometer (NanoDrop 
Technologies). Samples used in 4.3.9 were as follows: BG01 p49 cultured on 
Matrigel in CM and passaged with trypsin; HUES-1 p3 L HUES-7 p26. HUES-8 p37 
and HUES-9 p30 all culture on MEFs and passaged with trypsin kindly gifted by 
Chad Cowan and Doug Melton, Uniycrsity of Wisconsin. lISA: hES-,\L-1 p22 and 
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HES-2 p56 cultured on MEFs and passaged with collagenase kindly gifted by 
Christine Mummery, University of Utrecht, The Netherlands. Control samples were 
also assessed: week 6 foetal brain (Virogen) and week 20 foetal testis (BioChain): 
week 10 foetal heart and foetal liver RNA were kindly gifted by Dr. Rhodri Jones, 
with The University of Nottingham and NHS Trust ethical approval. 
4.2.1.2 Reverse transcription 
cDNA was synthesised from RNA samples isolated above or from commercial RNA 
using the First-Strand cDNA Synthesis Kit (GE Healthcare) with pd(N)6 random 
hexamers following manufacturer's instructions using 200 ng of RNA from each 
sample. 
4.2.1.3 peR 
Primers were designed using sequence data from the NCB! Entrez Gene database 
(http://www .ncbi.nlm.nih.gov / entrez/ query. fcgi? db=gene) using online Primer3 
software (http://frodo.wi.mit.edu/primer3/input.htm).Primer sequences are shown in 
Table 4-2. PCR was performed using HotStarTaq PCR kit (QIAGEN) in a 25 Jll 
volume using ~ ~ of the manufacturers recommended constituents; 200 JlM each 
dNTP (Invitrogen), 0.4 JlM each primer (Sigma-Genosys), 0.5 Jll of cDNA and 1.5-
3.5 mM MgCb and/or Q solution as required. PCR tubes were placed in Flexigene or 
TC-512 thermal cycler (Techne) with the following program: initial activation, 95°C 
15 min; 35 3-step cycles of 95°C 1 min, 50-68°C 1 min (5°C below Tm, typically 
57°C), 72 °C 1 min; final extension, 72°C 10 min. Primers were optimised first for 
Mg2+ concentration using Tm -5°C then temperature and finally cycle number. 
Optimised conditions for each primer set are shown in Table 4-2. 
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Table 4-2: peR primers used for detection of pluripotency a nd germ layer marker gen e exp ression 
Abbreviati ons: Tm , melting temperature; Ta , annealing temperature; Mg2+, magnesium concentration; C#, cycle number. 
I Positive Tm mRNA gDNA Ta Mg2+ Reference and accession Name Detects 
control Primers (0C) (bp) (bp) (0C) (mM) C# number 
used 
POU5F15' gaaggtattcagccaaac 64 .2 Courtesy of Helen Priddle 
Pluripotent cells hESC 644 1192 57 3.5 26 
POU5F1 3' cttaatccaaaaaccctgg 63 .9 NM 0027Q1 
NANOG 5' aggcaaacaacccacttctg 59.1 Courtesy of Helen Priddle 
Pluripotent cells hESC 263 1507 59 3.5 28 
NANOG 3' tcttcggccagttgtttttc 59.6 NM 024865 
T5' agagcclgcagtaccgagtg 64 .5 
Mesoderm hESC 546 1826 59 1.5 36 
T 3' tgaactgggtctcagggaag 64 .2 !":jM 003181 
MIXL 1 5' ggtaccccgacatccacttg 66.2 (Guo et aI. , 2002) 
Mesoderm hESC 341 1772 59 1.5 32 
MIXL 1 3' ctcccatgagtccagctttg 64.1 N M ~ ~ j 9 4 4 4
GSC5' gctctcgagaacctcttcca 63.6 Courtesy of Helen Priddle 
Mesoderm hESC 257 563 59 2 .5 34 
GSC3' tcagctgtccgagtccaaat 64.8 Nrvl 173849 
EOMES 5' Mesoderm! gtcctcaggggtcggagc 57 .9 (Kimura et aI. , 1999) 
Trophectoderm hESC 870 3200 59 0+2.5 40 EOMES3' aataacggtgttttggtagg 67.4 NM 005442 
SOX175' Fetal ctttcatggtgtgggctaagg 65.4 Endoderm liver 193 805 59 2.5 34 SOX173' cggtacttgtagttggggtggt 65 .7 NM 022454 
FOXA25' Fetal gacaagtgagagagcaagtg 57 .6 (Ginis et al., 2004) Endoderm liver 234 234 53 1.5 34 FOXA23' acagtagtggaaaccggag 59 .1 NrvL021784 
SOX15' Fetal caatgcggggaggagaagtc 64 (Li et al., 2005) Ectoderm/Neural brai n 464 464 59 1.5 30 SOX13' ctctggaccaaactgtggcg 64.1 NM_ OO5986 
SOX35' Fetal catgggctcggtagtgaagt 64 Courtesy of Virginie Sottile Ectoderm/Neural brain 213 213 59 1.5 36 SOX33' cgttccgttgactgcagtc 64 .6 t-.JrvL005634 
1853' All ce lls rRNA Propri etary na 324 324 61 3.5 14 X03205 
- -
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4.2.1.4 Agarose gel electrophoresis 
1.5% agarose (Invitrogen) gels were prepared in 0.5 x TBE (VWR). Whilst molten, 
ethidium bromide (Sigma) was added to a final concentration of 20 ng mrl. Samples 
were supplemented with Gel Loading Buffer (Sigma) run in comparison to 100 Base-
Pair Ladder (GE Healthcare). Gels were run in 0.5 x TBE supplemented with 20 ng 
mrl ethidium bromide at 100 V for l.5 hr then visualised using a UV 
transilluminator and photographed using a Raytek cooled CCD camera system 
incorporating a FujiFilm LAS-I 000 CCD camera and AIDA software. 
4.2.2 Fluorescence activated cell sorting 
For each of the three cell lines HUES-7, NOTTI and NOTT2, a single cell 
suspension was made using 0.05% trypsin (Invitrogen) from ~ ~15 million cells 
cultured on Matrigel in MEF conditioned medium. Cells were washed in D-PBS 
(Invitrogen), blocked in 20% FBS and incubated in SSEA3 or SSEA4 primary 
antibody (1 in 200, Chemicon) for 30 min and FITC conjugated Rabbit anti-Mouse 
(Jackson ImmunoResearch) secondary antibody for 30 min. Cells were passed 
through a Beckman Coulter F ACS and the top 20% most fluorescent were collected. 
~ 5 x l 0 6 6 cells were recovered from each sample and RT-PCR was performed to 
analyse the expression of pluripotency and germ layer markers. A proportion of each 
sample was attached to a Superfrost Plus slide (Menzel-Glaser) using a Shandon 
Cytospin (Thermo) at 1000 rpm for 4 min and allowed to dry overnight before the 
addition of 1 drop of Vector Shield with DAPI (Vector Laboratories) and a coverslip. 
Images were captured using a Leica DMRB upright fluorescent microscope. 
Hammatsu camera and Improvision OpenLab 4.0.2 and Volocity 4.0.1 software. 
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FACS figures were assembled usmg Weasel \'2.3 
(http://www.biotechcentre.net.au!cytometry/index.html ). 
4.2.3 Embedding and sectioning of mouse embryos and hEBs 
For mouse E6.5 and E7.5 embryos, pregnant MFI mice were killed by cervical 
dislocation according to home office schedule 1 at midday either 6 or 7 days after 
plugs were discovered. For E6.5 embryos whole decidua were removed from the 
uterus and fixed in 4% PFA (Sigma) in D-PBS for 1 hour. For E7.5 embryos, 
deciduas were dissected and embryos isolated and fixed in 4% PFA in D-PBS for 15 
min. All embryos were embedded and sectioned in the same manner as hEBs as 
detailed in 3.2.3. 
4.2.4 Immunofluorescence on whole mouse embryos and intact hEBs 
Whole E6.5 and E7.5 mouse CDI embryos were obtained as in 0, dissected from the 
decidua and Reichert's membranes were removed. hEBs were produced as described 
in 3.2.2. Both embryos and hEBs were fixed in 4% PFA for 15 min. EmbryoslhEBs 
were washed three times in 0.1 % Tween 20 (Sigma)/D-PBS then permeablised in 
0.5% Triton X-IOO (Sigma)/PBS for 30 min (10 min for hEBs). EmbryoslhEBs were 
blocked overnight at 4 °C in 0.1 % Tween 20, 1 % Rabbit Serum/PBS. EmbryoslhEBs 
were incubated for I h at room temperature with primary antibodies in 0.1 % Tween 
20, 1 % Rabbit Serum/PBS. EmbryoslhEBs were washed three times for 20 min with 
0.1 % Tween 20/PBS. EmbryoslhEBs were incubated for 1 h at room temperature 
with a rabbit anti-goat or rabbit anti-rat FITC conjugated antibody (Jackson 
ImmunoResearch) in 0.1 % Tween 20/PBS. Images were captured using a Leica 
DMIRE SP2 laser confocal microscope and Leica software. 
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4.2.5 Immunohistochemistry of sections 
Slides were processed using a Vision Biosystems Bond-max immunohistochemistry 
(IHC) robot. Bond-max is fully automated and allows for simultaneous staining of 30 
slides including dewaxing and epitope retrieval. The system was used in conjunction 
with Vision Bioystems proprietary Bond Refine Detection System, a biotin-free kit 
which provides peroxide block, secondary antibody, compact polymer reagent, DAB 
chromatin system and haematoxylin counterstain. The compact shape of the polymer 
reagent allows multiple conjugates to bind in close proximity and access to antigen 
sites inaccessible with convention long chain polymers. This results in high signal 
amplification for the detection of antigens at low concentrations and allows increased 
primary antibody dilutions for increased sensitivity. The Bond Refine Detection 
System is designed to work with Vision Biosystems proprietary primary antibodies 
raised in mouse or rabbit, to circumnavigate this issue a custom program was 
developed replacing preparatory primary antibody with those listed in Table 4-3. For 
primary antibodies raised in goat or rat the secondary antibody from Bond Refine 
Detection System was also replaced with either an unconjugated rabbit anti-goat 
antibody (Jackson ImmunoResearch) or an unconjugated mouse-absorbed rabbit 
anti-rat antibody (Vector Labs) respectively. The following parameters were used: 
Peroxidase Block 5 min; Primary antibody 30 min, Secondary antibody 15 min, 
Polymer 15 min, Mixed DAB 0 min, Mixed DAB 10 min, Haematoxylin 5 min. 
Slides were then processed through 100% ethanol and xylene before affixing a cover 
slide with DePeX mounting medium (VWR). Images were captured using a Leica 
DMRB (embryos) or DM4000B (hEBs) upright mIcroscope, Qimaging 
Micropublisher camera and lmprovision OpenLab 4.0.2 or 5.0.2 and Volocitv -+ 
software. 
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4.2.6 Immunohistochemistry on slides of undifferentiated hESCs 
All lines were cultured on Matrigel with MEF conditioned medium before transfer to 
Matrigel coated 4 well slides and growth for 48 hI. HUES-7 p2 1, NOTT 1 p27. 
NOTT2 p33 , BGOI p52 and HIp 19+ 11 Hoffman Objective images were taken after 
PFA fixation to minimise fixation related artefacts. Slides were processed thro ugh 
the Bond-max in the same manner as sections except excluding the dewax step. 
Table 4-3: Antibodies used with Vision Biosystems Bond-max 
Protein Raised Antibody Manufacturer Reference in 
POU5F1 Mouse monoclonal Oct-3/4, detects Santa Cruz ( S c h u ~ l l et al . 2004) both POU5F1 isoforrns 
NANOG Goat polyclonal Anti-human NANOG R&D Systems (Cai et ai , 2005b) 
T Goat poly clonal Anti-human Brachyury R&D Systems (Ca i et ai , 2005b) 
MIXL 1 Rat monoclonal MIXL 1, clone 6G2 Courtesy of Andrew Elefanty and Anna Mossman, (Mossman et al ., 2005) Monash University . Melbourne, Australia 
SOX17 Goat poly clonal Anti-human SOX 17 R&D Systems (Cai et al ., 20OSb) 
SOX1 Goat polyclonal Anti-human SOX1 R&D Systems (Cai et ai , 2005b) 
192 
4.3 RESULTS 
4.3.1 Validation of primitive streak markers in whole gastrulating mouse 
embryos using immunofluorescence 
Before immunofluorescence was used to determine the spatial expression of markers 
of the primitive streak (mesendoderm) and early mesoderm in whole hEBs, the 
specificity of these markers was first examined on whole CD 1 mouse embryos at 
E7.S. Expression ofT was clearly detected along the strip of primitive streak cells on 
the posterior side of the embryo and lower expression was detected in the allantoic 
bud (extra-embryonic mesoderm), MIXL 1 was detected in individual cells on the 
posterior side of the embryo but was less clearly localised to the primitive streak. 
Images of embryos stained with anti-T and anti-MIXLI antibodies and respective 
negative controls with primary antibodies omitted are shown in Figure 4-1. 
1 9 ~ ~
T 
MIXL1 
Figure 4-1: Expression ofT and MIXL1 in the primitive streak of gastru lating mouse embryos 
Whole E7 .5 mouse embryos were stained with anti-T (A and B) or anti -MIXLl (0 and E) antibodies 
fo llowed by secondary antibodies conjuga ted to FITC to revea l T or MIXL 1 express ing ce ll s in the 
primitive streak. Representati ve FITC filter images observed using a confoca l microscope are shown 
on the left and phase images on the ri ght. Enlarged and merged images are shown in B and E. Arrows 
indicate T or MIXL I ex pressing cell s in the posterior region o f the embryo. PS , primiti ve strea k; AB , 
allanto ic bud . Representative images of embryos stained in the same manner as embryos in A and C 
with the primary antibody omitted (control) are shown in Band 0 respecti ve ly. Mouse embryo 
ex periments were repea ted independently twice . Data above is recorded from the seco nd repli ca te. 
Approx imate ly 6 embryos for each of the 4 conditi ons were observed under a confocal mi croscope. 
Sca le bar = 250 ~ t t . .
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4.3.2 Detection of primitive streak markers in hEBs using 
immunofluorescence 
In order to detennine whether T and MIXLI expression could be detected in hEBs, 
d8-12 HUES-7 hEBs were fonned by the forced aggregation method detailed in 
Chapter 3 (3.2.2). Immunofluorescence was perfonned, using 30 hEBs for each 
sample, to detect the expression of T and MIXL 1 using an identical protocol to that 
used for mouse embryos in 4.3.1. d8-d12 hEBs were selected for examination on the 
basis of previous RT-PCR detection of T and MIXLl at these stages by Ng et al. 
(2005a). hEBs were fonned every two days over six days allowing d8-d 12 samples 
to be collected on the same day to standardise exposure to PF A fixation. 
Representative results are shown in Figure 4-2. Both markers were detected in d8-
d 12 hEBs. T was expressed at a higher level than MIXL 1 and was localised mostly 
to the outside. MIXL 1 expression demonstrated a more punctate and rather more 
dispersed pattern of expression throughout the hEBs. 
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Figure 4-2: Expression ofT and MIXLI in d8-d12 HUES-7 hEBs 
Whole HUES-7 hEBs formed by forced aggregation of 10000 ce ll s at d8, d 1 0 and d 12 were stained 
with anti -T (A, E, I) or anti-MI XLI (C, G, K) antibodies fo ll owed by secondary antibodies conjugated 
to FITC to revea l T or M IXL 1 expressing ce ll s. Representati\ 'e FITC filter images obse r\'ed Llsing a 
confocal microscope ar shown on the left and phase images on the right. Images of hESs stained in 
the sa me manner as hESs in A, E, I and C. G. K with the primary antibody omitted are sho\\1l in B. F . 
.1 ;lI1d D, H, L respec tivel y. 
ca le bar = 250 pm. 
4.3.3 Validation of pluripotency and germ layer markers in mouse embryos 
using immunohistochemistry 
Since, in whole mount hEBs, immunofluorescence revealed only peripheral staining 
of T and MIXL 1, sections were then examined to investigate whether improved 
detail could be resolved. The use of sections also allowed the prevention of issues 
associated with lack of antibody penetration. The availability of a Vision Biosystems 
Bond-max ™ automated immunohistochemistry system, which allows for high 
throughput analysis and provides high levels of inter-run comparability, lead to this 
system being chosen over manual immunofluorescence staining. In addition to 
investigating the expression of primitive streaklmesendoderm markers the high-
throughput system allowed for simultaneous analysis of pluripotency and germ layer 
markers to better define the relationship between remaining pluripotent cells and 
cells that have begun germ layer specification. Serial sections of the hEBs (5 )lm) 
allowed comparative staining of multiple markers in the same region of an individual 
hEB. Five markers were chosen; POU5Fl and NANOG to detect pluripotent cells, 
SOXI to detect ectoderm/early neuroectoderm, SOX17 for endoderm and T for 
mesendoderm (and, in later development, mesoderm). The anti-T antibody was used 
rather than anti-MIXLI due to the more restricted expression pattern of T observed 
within the primitive streak during gastrulation in section 4.3.1 and also conflicting 
evidence of Mixll expression in the visceral endoderm (Pearce and Evans, 1999, 
Robb et al., 2000, Molm et al., 2003). 
To validate the specificity of these markers within the hEB system. 
immunohistochemistry was perfOlmed on sections of early primiti\'e streak (E6.5) 
and gastrulating (E7.5) MFI mouse embryos. Each of the fi\'c markers wcrc 
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previously shown to be expressed in a restricted location (See 4.1.1.1-4.1.1.3 and 
Table 4-1) 
In the E6.S embryo POUSFI expression was restricted to the forming early primiti\'e 
ectoderm, with nuclear staining in both epiblast and epithelial primitive ectoderm 
cells (Figure 4-3A). More loosely packed cells with larger cytoplasm formed a strip 
of POUSFI expressing cells along the posterior/distal portion of the embryo. Low 
level expression ofPOUSFI was also noted in a small number of cells of the forming 
embryonic visceral endoderm at the distal tip of the embryo and cells of the extra-
embryonic visceral endoderm. Some staining, potentially due to antibody trapping, 
was also seen in the location of Reichert's membrane on the anterior and posterior 
sides of the extra-embryonic portion of the embryo. 
In the E7.S embryo POUSFI was strongly detected throughout the primitive 
ectoderm, which by this stage had formed a distinctive epithelial morphology, with 
some nuclear and cytoplasmic locations staining (Figure 4-38). POUSFI was also 
detected throughout the extra-embryonic visceral endoderm and in the recently 
formed primitive streak and scattered cells of the embryonic visceral endoderm. 
NANOG expression was substantially different to POUSFI expression (Figure 4-4A) 
and with only low levels detected in scattered cells within the epiblast/primitive 
ectoderm of the E6.S embryo. In the E7.S embryo (Figure 4-48), very low NANOG 
expression was seen in both the nucleus and cytoplasm of a few scattered cells of the 
columnar primitive ectoderm and the primitive endoderm towards the distal end of 
the embryo. 
T expression was seen in two distinct areas in the E6.5 embryo (Figure -+-5A). T \\as 
strongly expressed in the nucleus of cells in a tightly packed single cell-thickness 
area assumed to be the anterior mesendoderm. This layer of cells exists outside of the 
epiblast/primitive ectoderm, immediately anterior to the distal tip of the embryo at 
the location of the presumptive headfold/node. T was also expressed in the region of 
the forming primitive streak. This area extended up to the nascent allantoic bud. 
At E7.5, T was strongly expressed in an embryonic region between the visceral 
endoderm and the epithelial primitive ectoderm (Figure 4-5B). The epithelial 
primitive ectoderm of this area also expressed T, albeit at a lower level. Distally to 
this region, T was expressed throughout the posterior side of the embryo including 
the visceral endoderm in an area of cells showing little epithelial organisation. Below 
this area was a cluster of cells not expressing T surrounding the area of the T-
expressing node. As in E6.5 towards the anterior portion of the distal tip of the 
embryo at the location of the presumptive headfold/node, a single cell layer of cells 
was seen to strongly express T. On the anterior side of the embryo, T was detected 
between the primitive ectoderm and the anterior visceral endoderm. T was also 
observed in the extra-embryonic regions of inside of the both the anterior and 
posterior extra-embryonic visceral endoderm and within cells of the amniotic and 
chorionic mesoderm. 
SOX 17 was expressed m similar regions of in both the E6.5 and E7.5 embryo. 
Expression was detected in the nucleus of cells in the single cell-thickness visceral 
endodermal layer around the outside of the whole embryo. At E6.5 SOX 17 
expression was also seen at very low levels in the epiblast/primitive ectodenn, with 
more dominant expression in the nucleus (Figure 4-6A). In the E7.5 embryo 
expression was most obvious in the visceral endodenn but was also present in the 
cytoplasm of the epithelial primitiYe ectodenn (Figure 4-6B), Of note. no e x . p r e ~ ~ i o n n
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of SOX17 was observed in the nascent primitive streak areas of either the E6.5 or 
E7.5 embryos. 
Nuclear SOX 1 expression was observed throughout the E6.5 embryonic and extra-
embryonic epiblast/primitive ectoderm, in particular in the non-epithelial cells 
towards the anterior side of the E6.5 embryo (Figure 4-7 A). In the E7.5 embryo 
SOXI expression in the embryonic and extra-embryonic primitive ectoderm 
appeared confined to the cytoplasm (Figure 4-7B). 
Negative controls with the primary antibody omitted are included in Figure 7-1. 
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Figure 4-3: Expression of POU5Fl in early streak and gastrulating mouse embryos 
Sections of E6. 5 (A) and E.75 (8 ) mouse embryos after immunohistochemi try for detecti on of the 
expression of POU 5F I . Images of fu ll embryo on the left (A using l O x obj ec ti ve and Busing 5 x 
objecti ve) and magnified area of interest of the right (20 x objective). A) Showing expression 
thl-ougholll the epiblast/primitive ectoderm. B) howing expression in the now full y epitheli al 
prim i ti ve ec todeIl11 and lower leve l expression in the viscera I ndodeml . E7 . 5 experimen ts \\ en.' 
repea ted tw ice independe ntl y and 6.5 once. ExVE: extra-embryonic \'isceral endodelll1 : FPI-ctlY 
ep ithelial primitive ec toderm: Epi: Ep iblast: VE : \ 'isceral endodenl1 : P : primitiw st reak . 
ca le ba r = 50 pm
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Figure 4-4: Expression of NANOG in early streak and gastrulati ng mouse embryos 
Sec ti ons of E6.5 (A) and E.7 5 (8) mouse embryos after immunohi stochemistry for detection of the 
express ion of NANOG. Images of full embryo on the left (A using l Ox obj ecti ve and Busing 5 x 
objecti ve) and magnified area of interest of the right (20 x objective). A) Showing ex press ion in few 
sca ttered ce lls o f the epiblas t/primitive ec todel111 (arrow). B) Showing expression in the cytoplasm or 
ce ll s within the primiti ve ec todel111 (arrow). EPEcto: epithelial primitive ectodel11L Epi: epiblast: VE : 
visceral endodel111 . 
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Figure 4-5 : Expression of T in early streak and gastrulating mouse embryos 
Sections of E6.5 (A) and E.75 (B) mouse embryos after immunohi stochemi stry for detec ti on of the 
express ion of T. Images of full embryo on the left (A using lO x objective and Busi ng 5 x objective) 
and magnifi ed area of interest of the ri ght (20 obj ect ive). A) Showing expression towards the 
allantoic bud , forming primitive streak area (anow) and anterior mesendodel11l. B) hawing 
express ion in the primiti ve strea k. the posterior primiti ve ec tode1111 and the node. AB. alla nt oic bud: 
AME. anteri or mesendode1111: PS. primitive streak: VE : \'isceral endode1111: C 1. chorionic mesodcnn : 
AM, amni oti c l11 csoden11 . EPEc to: ep ithelia l primitiw ectodenn. 
Sca le bar = 50 11111 . 
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Figure 4-6: Expression of SOX 17 in early streak and gastrulating mOll se embryos 
Sections of E6. 5 (A) and E.75 (B) mouse embryos after immunohi stochemi stry for detecti on of the 
express ion of SOX 17. Images of fu ll embryo on the left (A using lO x objec ti ve and Busing 5 x 
objec ti ve) and magnifi ed area of interest of the right (20 x obj ec ti ve). A) Showing express ion in the 
single ce ll -thickness visceral endodeml around the periphery o f the embryo stronges t at the 111 0: t 
di stal point of the embryo and in the epib last/primiti ve ec todenn. B) howing expression in the 
visceral endodeml which has no thi ckened to - 2 ce ll s th ick and C)10plasl11i ca ll) \\ 'ithin the epithel ial 
primiti ve ec toderm . Ep i. ep ibl ast: VE: visceral endodenn : P . primiti w streak: ' 1\1 : I ~ P h : l l l : :
ep ithe li al primitive ectoderm. 
ca ll' bar 50 pm. 
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Figure 4-7: E xpression of SOXl in early streak and gastrulating mouse embryos 
Sections of E6.5 (A) and E.75 (B) mouse embryos after immunohistochemistry for detection of the 
expression of SOX I. Images of full embryo on the left (A using lOx objective and 8 using 5 x 
objec ti ve) and magnified area of interest of the right (20 x objective). A) Showi ng expression in the 
extra-embryo nic and embryonic epiblas t/primitive ectodenn, particularly in the non-epithelial ce lls 
(an ow). 8) Showing expression in the cytoplasm of cell s of the extra-embryonic and embryoni c 
primiti ve ec todeml . ExPEc to, extra-embryonic primitive ec todeml , EP Ec to: ep ithe lial prim iti ve 
ectodeml ; Ep i: epiblas t; VE : viscera l endodeml . 
Sca le bar = 50 \1 m. 
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4.3.4 Comparison of pluripotency and germ layer marker expression in d2 
HUES-7 hEBs formed using mass culture or forced aggregation 
hEBs were analysed using the immunohistochemistry protocols validated on mouse 
embryos (4.3.3). First compared was the effect of the method of hEB formation on 
marker expression. Previous experiments using haematoxylin and eosin staining 
(3.3.4) had identified substantial differences in the structure of the hEBs produced by 
the two methods, even immediately after formation. Figure 4-8 shows the expression 
ofPOU5Fl, NANOG, T, SOXl7 and SOXl in serial sections of d2 mass culture and 
forced aggregation HUES-7 hEBs. 
Mass culture hEBs (Figure 4-8A) displayed substantial variation in pluripotency 
marker expression with nuclear POU5Fl expression only detected in some hEBs of a 
small size «200 11m, denoted by circle) and isolated small clusters within the larger 
hEBs (> 1000 11m, denoted by square). Low level nuclear POU 5F 1 expression was 
also detected in scattered cells throughout the mass culture hEBs (arrows). NANOG 
was more ubiquitously expressed than POU5FI. In larger mass culture hEBs, regions 
of both nuclear and cytoplasmic expression were detected (arrows). Highest nuclear 
expression was detected in regions of high POU5Fl expression (square) and at the 
periphery of some hEBs. NANOG was also highly expressed in the smaller hEBs 
that expressed POU5Fl (circle). Uniform nuclear POU5FI expression was detected 
throughout all forced aggregation hEBs (Figure 4-8B). Nuclear NANOG expression 
was also detected in the majority of cells of the forced aggregation hEBs, albeit at 
lower levels than POU5FI and at higher levels at the periphery. 
In the mass culture hEBs nuclear T, SOXl7 and SOXl expression was detected in 
many cells. In the larger mass culture hEBs T was expressed in scattered, isolated 
cells at the centre of the hEBs (arrows) whereas cells expressing SOX 17 appeared 
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localised together (arrows) and SOXI appeared more ubiquitously and 
cytoplasmically expressed (arrows). In the some of the smaller hEBs that expressed 
high levels of POU5Fl and NANOa, high levels of nuclear T, SOXl7 and SOXl 
expression were also detected (circle). In the forced aggregation hEBs, only very low 
levels of (nuclear) T, SOXl7 and SOXI expression were evident throughout the 
hEBs, with slightly more intense staining towards the periphery. 
These results reinforce the more, reproducible differentiation observed using the 
forced aggregation system in comparison the traditional mass culture system, as 
observed in Chapter 3 (3.3.1-3.3.2). Pluripotency/germ layer maker expression 
patterns in mass culture hEBs are highly variable, with an apparent relationship to 
hEB size detected. In contrast, expression patterns in forced aggregation hEBs 
exhibit almost no variation between hEBs. 
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Figure 4-8: Expression of POU5FI, NANOG, T, SOX1 7 and SOXl and in mass culture and forced aggregation hEBs 
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4.3.5 Ontogeny of pluripotency and germ layer marker expression in mass 
culture and forced aggregation HUES-7 hEBs throughout differentiation 
To map pluripotency and genn layer marker expression in mass culture HUES-7 
hEBs, samples were collected for analysis every two days over 16 days of 
differentiation. 30-40 hEBs from each time-point were embedded and serial sections 
were assessed using immunohistochemistry for the pluripotency and genn layer 
markers POU5Fl, NANOG, T, SOXl7 and SOXl. cDNA was prepared from 10-15 
hEBs of the same samples and used for R T -PCR with an extended panel of 
pluripotency and genn layer markers: pluripotency, POU5Fl and NANOG; 
mesendodenn, T, MIXLl and GSC; endodenn, SOXl7 and FOXA2; ectodenn, SOXl 
andSOX3. 
4.3.5.1 Timing of expression ofpluripotency and germ layer markers in mass 
culture HUES-7 hEBs detected by RT-PCR 
RT-PCR (Figure 4-9) demonstrated that the pluripotency markers POU5Fl and 
NANOG were both highly expressed in undifferentiated cells (dO). Both were 
substantially down-regulated at d2, before further reducing in expression gradually to 
d 14, with no or very low expression detectable at d 16. Immunohistochemistry results 
were consistent with this data, showing that POU5F1 and NANOG gradually 
reduced in expression during hEB differentiation, but that both were still detectable 
in a very small number of cells at d 16 (Figure 4-10). 
Of the three mesendodennal markers, T was expressed at relatively low levels in 
undifferentiated cells compared to MIXLl and GSC. mRNA expression of all three 
mesendodennal markers peaked at d2-d6 before gradually reducing towards d 16 
(Figure 4-9). T protein was also detected in undifferentiated cells (Figure 4-18) and. 
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during differentiation, it was expressed at highest levels from d2-d 10 (although it 
was still evident at d 16), see Figure 4-10. 
Expression of the endodennal markers, SOX] 7 and FOXA2, was seen at low levels in 
the undifferentiated cells and both makers were consistently expressed through d2-
d 16 (Figure 4-9). SOX 17 protein was expressed in undifferentiated cells (Figure 
4-18) and throughout differentiation with highest expression at d 14-d 16 (Figure 
4-10). 
Of the two ectodennal markers, SOX] was expressed at very low levels in 
undifferentiated cells, and SOX3 was not detected. SOX] and SOX3 expression 
gradually increased, peaking at d8-d 10 before gradually reducing to d 16 (Figure 
4-9). SOX1 protein was detected in undifferentiated cells (Figure 4-18) and 
cytoplasmic expression was seen throughout differentiation and weak nuclear 
expression could be detected from d8-d 16 (Figure 4-10). 
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Figure 4-9: Expression of pluripotency and germ layer markers in HUES-7 hEBs formed by 
mass culture and forced aggregation detected by RT-PCR 
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4.3.5.2 Spatial expression of POU5F1, NANOG, T, SOX17 and SOX1 in mass 
culture HUES-7 hEBs detected by immunohistochemistry 
Overall, sections of mass culture hEBs demonstrated highly variable morphology in 
hEBs at d2 (Figure 4-10). Numerous hEBs of > 1000 !lm in diameter (4 visible in 
images) were produced along with smaller hEBs of ~ 2 0 0 0 !lm (11 visible in images). 
Internal cavities were present at this time-point but appeared to be formed by the 
aggregation process rather than by cavitation, since no characteristic epithelial cell 
layer or basement membrane was visible. Over d4-d8, hEBs became more uniform in 
size with diameters ranging from 300-600 !lm and one or more internal cavities 
present in the majority of hEBs from d6. hEB size was constant from d8 onwards 
despite an increase in the number and size of cavities and the formation of internal 
structures. 
4.3.5.2.1 Mass culture day 2 
At d2, the first time-point examined after hEBs were induced to form, approximately 
50% of the smaller «200 Jlm) mass culture hEBs demonstrated nuclear co-
expression all of the five markers (Figure 4-10, denoted by circles). POU SF 1. 
NANOG, T and SOXI were co-expressed in some small regions of the larger hEBs 
(> 1000 !lm, denoted by circles). NANOG was additionally expressed 
cytoplasmically in the some of the larger hEBs (denoted by arrows, example in 
inset). T and SOXI were expressed both cytoplasmic and scattered nuclear locations 
towards the centre of the larger hEBs (arrows). Nuclear SOX 17 expression. whereas 
not clearly co-expressed with the other markers in larger hEBs. was detected in 
substantial areas across the larger hEBs ( arrows) . 
./.3.5.2.2 Mass culture day ./ 
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The pattern of co-expression seen at d2 was maintained at d4 with all five markers 
co-expressed in some of the smaller hEBs «300 ~ m , , circles) along with some areas 
of the intermediate sized hEBs (300-600 ~ m , , circles). In one hEB POU5Fl, T and 
SOX17 were independently expressed in spatially separate areas (denoted by red 
square). Larger hEBs (600-1000 ~ m ) ) and a small number of intermediate sized hESs 
demonstrated no expression of POU5F1 or NANOG but both clusters of low level 
nuclear and cytoplasmic expression ofT, SOX17 and SOX1 (arrows). 
4.3.5.2.3 Mass culture day 6 
At d6, hEBs had become more uniform in size and internal cavities surrounded by an 
epithelial layer were visible. Nuclear co-expression of POU5Fl, NANOG, T and 
SOX17 was detected in distinct clusters of cells in approximately 60% (9/14) larger 
sized hEBs (example inset and circles). Cytoplasmic expression of NANOG, T, 
SOX17 and SOX1 was detected in patches particularly in hEBs in which clusters of 
nuclear expression were not detected (arrows). 
4.3.5.2.4 Mass culture day 8 
At d8, pluripotency marker expression was reduced in comparison to d6 and was, in 
some hEBs, spatially separate from mesoderm/endoderm marker expression. 
POU5Fl expression was only detected in approximately 25% of hEBs (7127). 
Spatially, POU5F1 was observed throughout some smaller hEBs, at the periphery of 
immediate sized hEBs and surrounding some cavities or in loose cells in the centre of 
larger hEBs (circles). NANOG was expressed cytoplasmically in all larger hESs 
(arrows) in addition to nuclear locations expressing POU5Fl (circles) and a fe\\ 
additional locations (squares). Nuclear T and SOX17 expression was detected in 
some locations similar to POU5Fl and NANOG (circles). Nuclear cytoplasmic T 
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expression also partially co-localised with high levels of SOXl7 expression in larger 
hEBs (squares). For the first time, SOXl7 was also expressed in areas lacking T 
expression, in some intermediate size hEBs (squares). SOXl was expressed 
cytoplasmically in areas exhibiting nuclear expression of both T and SOX 17 
(arrows). 
4.3.5.2.5 Mass culture day 10 
At dlO, mesoderm and endoderm markers were expressed in additional locations in 
comparison to the pluripotency markers. Nuclear expression of POU5Fl was 
detected in small areas of -25% (4116, circles) of the larger hEBs. NANOG was 
expressed cytoplasmically in all d 1 ° hEBs, with nuclear expression in similar areas 
to POU5Fl (albeit in a larger area of cells). Nuclear expression of T was seen in 
large clusters centred on areas of POU 5F I expression as well as in areas not 
expressing POU5Fl (squares). T was also expressed cytoplasmically in all hEBs. 
Strong nuclear and cytoplasmic expression of SOXl7 was seen in all hEBs with 
strongest nuclear expression in areas of expressing T (squares). Weak nuclear and 
cytoplasmic expression of SOX I was seen in similar areas to those expressing T and 
SOXl7 (squares). 
4.3.5.2.6 Mass culture day 12 
Although only a few hEBs were analysed at dl2 (n=4), no expression of POU5Fl, 
and only weak cytoplasmic staining of NANOG and T was detected (arrows). 
Nuclear expression of SOXl7 in a tight cluster of cells was detected along with some 
cytoplasmic staining (squares). Nuclear SOX 1 expression was seen in some isolated 
cells at the periphery of one of one hEB . 
./.3.5.2.7 Mass clIltlire day 14 
At d14, little pluripotency marker expression remained, although substantial genn 
layer marker expression was obviously detected. Clusters of approximately 5 cells 
expressing POU5Fl were seen at the periphery of approximately 33% (6/18) ofhEBs 
(circles). Cytoplasmic NANOa expression was seen in all hEBs along with strong 
nuclear expression in areas also expressing POU5Fl (circles). T was expressed 
cytoplasmically throughout some intermediate sized hEBs and at the centre of others 
whilst at the periphery of larger hEBs (squares). SOX17 was expressed 
cytoplasmically in similar locations to T but also with strong nuclear staining at the 
centre of intermediate sized hEBs and at the periphery of larger hEBs. SOXI 
expression was similar to SOX17 although nuclear expression was weaker. 
4.3.5.2.8 Mass culture day 16 
At d 16 substantial nuclear expression was only visible for SOX 17. Almost no 
POU5Fl expression was visible except a few cells in two hEBs (circles). Nuclear 
expression of NANOa and T were similar to POU5Fl (circles) with additional 
cytoplasmic expression present in all hEBs. SOXl7 was cytoplasmically expressed 
in all hEBs and with strong nuclear expression at the centre of the majority (15123) 
ofhEBs (squares). Low level nuclear expression of SOXl was detected surrounding 
surround cavities of some of the larger hEBs (squares). 
4.3.5.2.9 Comparison of marker expression between mass culture and forced 
aggregation HUES-7 hERs 
Along with the substantial difference in size and cardiomyocyte potential (Chapter 3) 
a number of differences in developmental programming/ontogeny were noted 
between mass culture and forced aggregation hEBs. Most ob\"ious was the spatial 
disparity between POU5Fl and NANOG expression at d2 between the two 
techniques, as described in 4.3.4. Expression of POU5F1 was maintained at high 
levels in forced aggregation hEBs throughout d2-d6 as shown by both 
immunohistochemistry (Figure 4-12) and RT-PCR (Figure 4-9). In contrast, in mass 
culture hEBs, only some smaller hEBs and small areas larger hEBs expressed 
POU 5F 1 at d2. These low levels POU 5F 1 expression were maintained until d 16. 
In mass culture hEBs (Figure 4-10), NANOG expression was similar to POU5F] 
expression by RT-PCR despite higher levels of cytoplasmic expression throughout 
differentiation. In comparison, in forced aggregation hEBs, NANOG expression was 
more quickly down-regulated than POU5F1 expression detected by both RT-PCR 
and immunohistochemistry assays. 
By RT-PCR both mesendodenn and endodenn markers appeared most highly 
expressed at d2-d4 in mass culture hEBs compared to maximal expression at d 10-
d12 in forced aggregation hEBs (Figure 4-9). Notably, by immunohistochemistry, 
SOX17 expression was seen to spatially diverge from POU5F1INANOG/T 
expression in mass culture hEBs at d8, despite the constant level of expression 
detected by from d2-d16 by RT-PCR (Figure 4-9), whereas, in forced aggregation 
hEBs, this separation occurred later at d 12. 
mRNA expression for the ectodennal markers, SOX1 and SOX3. peaked at d 12-d 14 
in forced aggregation hEBs, concordant with a similar a peak in SOX 1 protein 
expression. In comparison, in mass culture hEBs, no peak in either SOX] or SOX3 
expression any of the time-points or substantial nuclear of SOX 1 expressIOn was 
detected. 
OveralL gene and protein expression in mass culture hEBs was characterised by a 
slow down-regulation of the markers from d2 to d 16. In comparison torced 
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aggregation hEBs appeared to have a more distinct pattern of pluripotency marker 
down-regulation and subsequent germ layer marker up-regulation. 
Figure 4-10: (pages 217 to 220) Expression of POU5Fl, NANOG, T, SOX17 and SOXI in d2-d16 
HUES-7 hEBs formed by mass culture 
Sections of mass culture HUES-7 hEBs at d2-d 16 after immunohistochemistry for the detection of 
POU5F1, NANOG, T, SOX17 and SOXl. Upper images were taken using a 5 x objective and lower 
images with a 20 x objective. 
Images demonstrate the timing and co-localisation of marker expression with: 
Circles highlighting areas of conserved expression between pluripotency and germ layer markers. 
Squares highlighting areas of contrasting expression between pluripotency and germ layer markers 
Arrows highlight areas of cytoplasmic and/or scattered nuclear expression. 
Scale bar = 500 ~ m . .
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4.3.6 Ontogeny and spatial organisation of pluripotency and germ laver 
marker expression in forced aggregation hEBs formed from HUES-7, 
NOTTl, NOTT2 and BGOI hESCs 
In order to examine any variation the patterns and timing forced aggregation hEB 
induced differentiation between hESC lines, HUES-7, BG01, NOTTI and NOTT2 
hEBs were formed as described in Chapter 3 (3.2.2) and assessed using 
immunohistochemistry and RT-PCR. hEBs were selected for photography (Figure 
4-12 to Figure 4-15) based on being most representative of the expression pattern of 
hEBs on a given slide. Serial sections of each hEB were stained for POU5Fl, 
NANOG, T, SOX17 and SOXI. 
4.3.6.1 Forced aggregation day 2 
In HUES-7 (Figure 4-12), NOTTI (Figure 4-13), NOTT2 (Figure 4-14), and BOOl 
(Figure 4-15) hEBs at d2, numerous small cavities were visible. Strong nuclear 
POU5Fl expression was detected ubiquitously and NANOG was expressed in 
scattered cells across the hEBs from all 4 lines, albeit at a lower level that POU5Fl 
(concordant with RT-PCR data for POU5Fl and NANOG expression; Figure 4-11). 
Low levels of nuclear SOX17 expression were also detected ubiquitously throughout 
the hEBs. Both T and SOXI were detected cytoplasmically at very low levels. 
4.3.6.2 Forced aggregation day 4 
At d4, cavities had increased in size and high levels of nuclear POU5Fl expression 
were maintained throughout the hEBs from all lines. NANOO was expressed morc 
highly than at d2, with slightly lower expression at the centre of the hEBs. This 
higher lc\'cl of expression at d4 was also detected by RT-PCR. Relati\c to d2, higher 
Ic\'cls of cytoplasmic T expression, particularly towards the periphery (in a similar 
221 
manner to NANOG) were detected, mirroring the increase in T mRNA detected by 
RT-PCR. In BGOl, but not in the other 3 lines, hEBs exhibited additional nuclear 
expression of T in localised patches of cells at the edge of the hEBs (Figure 4-15. 
denoted by square), in areas still expressing POU5FI and NANOG. Ubiquitous 
nuclear SOXl7 expression was detected at similar or slightly higher levels relatiye to 
d2, corresponding to a small increase in SOX]7 detected by RT-PCR in all lines. 
4.3. 6.3 Forced aggregation day 6 
By d6, cavities had increased in size in all lines and POU5FI was typically down-
regulated towards the centre of the hEBs. NANOG was down-regulated more 
POU5FI and expressed only towards the periphery of NOTTI, NOTT2 and BGOI 
hEBs. However HUES-7 hEBs expressed NANOG in a few cells scattered across the 
hEBs. RT-PCR results mirrored the faster down-regulation of NANOG than 
POU5Fl. Low levels of cytoplasmic T expression were generally maintained, with 
some clusters of nuclear expression evident towards the periphery of BGO 1 hEBs. 
Both nuclear and cytoplasmic expression of SOX 1 7 was detected throughout all 
hEBs with slight increases in expression in the areas of nuclear T expression in 
BGOl hEBs (square). Low levels of cytoplasmic SOXl expression were generally 
and these were localised more towards the periphery of BGOl hEBs (arrow) than for 
the other lines. 
4.3.6.4 Forced aggregation day 8 
At d8, POU5Fl continued to down-regulate down-regulated and was restricted to a 
fcw clusters of cells at the periphery of the hEBs for all lines. NAl\'OG c x p n : ~ ~ i o n n
was detected in a subset of these clusters (circles). For the first time, strong nuclear 
expression of T was detected and. notably, this \\'as co-expressed \\ith POU:,Fl 
(circles). RT -peR detected a general increase in expression of all three 
mesendoderm markers T, MIXLI and GSC in hEBs for the different lines. Nuclear 
SOXl7 expression was detected across the hEB sections, with strongest areas of 
expression co-Iocalising with POU5Fl/T expression (circles). In NOTT2, these areas 
of SOXl7 expression that corresponded to areas of T expression demonstrated a 
distinctly different, less compact morphology than the other lines (circle). In NOTT2 
and BGOI, low levels of nuclear and cytoplasmic SOXl expression were detected in 
different areas to those expressing POU5FI/T/SOXl7 (squares). 
4.3.6.5 Forced aggregation day 10 
At dlO, there were no obvious interline differences from most hEBs. Cavities had 
lost their circular shape and single cell-layers were often left between some of the 
cavities. Nuclear POU5Fl and NANOG expression were generally maintained 
around the periphery of the hEBs and in vicinity of some cavities. As with previous 
time-points, NANOG expression existed only in a subset of POU5Fl expressing 
areas (circles). Nuclear T and SOXl7 expression was detected in the vicinity of 
cavities, in the same locations expressing POU5FIINANOG (circles). SOX17 was 
also expressed at low levels throughout the hEB (arrows). SOXI expression was 
nuclear and was always spatially distinct from the other four markers (squares). 
4.3.6.6 Forced aggregation day 12 
At d 12, more interline variation was discemable. In HUES-7 hEBs three separate 
areas of nuclear marker expression were discemable. POU5Fl and NANOG were 
co-expressed at the periphery of the hEBs and in areas surrounding portions of Sl)Il1L' 
cavities. T and SOX 17 were, for the first time, expressed in distinctly spatial1: 
POl:,FI separate regions, with T expression more closely matching areas ot 
expression (circles). Nuclear expression of SOXl7 was particularly strong in the 
regions of single cell-thickness that separated the cavities (squares). Some 
cytoplasmic expression of SOXl7 (arrows) correlated to areas cytoplasmic and 
nuclear SOXI expression (squares). 
In NOTTl hEBs POU5Fl and NANOG were tightly co-expressed in regIOns 
adjacent to the cavities (circles). T and SOXl7 were co-expressed in regions of 
scattered cells within larger cavities (circles) that also expressed low levels of 
POU5Fl and NANOG (arrow). SOXl was expressed in large areas across the hEBs 
that did not express any of the other four markers (circle), and well formed SOXl-
expressing neural rosettes were visible (arrows). 
NOTT2 hEBs had lost the round morphology seen at earlier stages and become more 
adhesive. Marker expression was substantially reduced and only nuclear T and 
POU5Fl co-expression was detected. 
BGOl hEBs also lost their round morphology and were more adhesive by d12. In 
these hEBs, nuclear co-expression of POU5Fl and NANOG was detected in small, 
scattered clusters of cells (circles), low levels of nuclear T expression were detected 
in small or scattered areas of cells (square) and nuclear expression of SOX17 was 
detected in small clusters of cells (arrow). In the hEB shown in Figure 4-15, SOXI 
was expressed on the interior surface of a neural rosette-like cluster of cells that 
exhibited an epithelial-like morphology (arrow and square). 
4.3.6.7 Forced aggregation day 14 
At d14 very little POU5Fl or NANOG expression could be detected in hEBs from 
any of the hESC lines. Nuclear T expression was detected in a few small clusters. (0-
localising with POU5Fl in NOTTI and NOTT2 hEBs (circles). SOX17 \\as 
expressed with T in HUES-7 hEBs (squares) whereas it was expressed in an entirely 
separate location in hEBs formed from NOTTl, NOTT2 and BGOl (outlined and 
squares). SOXl expression was detected in HUES-7, NOTTl and NOTT2 hEBs in 
areas separate from any of the other markers. 
4.3.6. 8 Forced aggregation day 16 
The hEBs from all 4 lines became substantially more adherent at d 16 and no longer 
retained their rounded morphology. In HEUS-7, NOTTI and NOTT2 hEBs (as with 
d14) very little POU5Fl and NANOG expression remained (arrows and circles). 
Low levels of both nuclear and cytoplasmic T expression were detected in small 
clusters of HUES-7 and NOTT2 hEBs (squares) which were in spatially distinct 
areas from SOXl7. Nuclear and SOXI expression was detected at low levels 
throughout the hEBs from both of these lines. 
In NOTTI hEBs, cytoplasmic SOX17 expression was detected in an area of 
elongated cells that also expressed SOX17 in the cytoplasm (square). One BGOI hEB 
exhibited a very distinctive morphology at d 16 (complex morphology was also seen 
in two other examples, data not shown). In the hEB shown, nuclear POU5Fl 
expression was detected in a compact layer at the periphery of the hEB (arrow) and 
two clusters just inside this layer (circles). T was co-expressed with POU 5F 1 in the 
inner layer, but was also in a central region not expressing POU5Fl (square). SOXl7 
was expressed in a layer surrounding a cavity inside of the T expressing layer and 
also in numerous other, more central locations. SOXI was expressed in two neural 
rosettes towards the centre of this hEB. 
~ ~ ~ ~:: _. 
100 bp ladder f 'til II I, ~ ~ 11\1 1' .11 , I PII:I 100 bp ladder Q. (JQ c: etI ""I 0 (t> undiffere nt iated I I • undifferentiated 
0 ... 
-
, 
-
d2 I I II I ' I :. . ;1 . I I I ( II I I I d2 
::r 
-tr:l .. 
etI trj d4 I I -II I t I I IMI I I I I I II I I I d4 
'" 
><! 
~ ~ "0 
""I d6 1 I I I I I I I d6 '" (t> Q. 
'" 
• 0 Il'i I II ' ~ : : I IJI I (t> '" I I :1 I I I l , I I z c .... o· d8 0 d8 (t> :: m r'l I I ,. I -i (j) ...... 0 d1 0 I: I 'I i I I, I -i d10 (t> , c. .... : ' N ---..,J 
r::r "0 rl I • . I t r 1 d12 i d12 '< C- ' . :::0 :l. d14 I 111 11 -11 I!II I II 11 :11 I I I d14 
..., "0 
, 0 
""= 
.... 
(t> d16 I II III I I _ I 1 II I I I d16 ('j :: 
:::0 ~ ~
water control I I I I I I water control 
~ ~
:: 
100 bp ladder 111 111 I' 11111111 c. I U 1111 100 bp ladder 
Iv (JQ ~ ~ ~ ~ ~ ~ ~ ~ 0 ~ ~ t ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 0 ~ ~ t ~ ~Iv (t> 
""I ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ X ~ ~ z C 0- S ~ ~ 0 0 ~ ~ ~ ~ ~ ~ X ~ ~ z c ~ ~ x x ~ ~ 0 r 0 ~ ~ ~ ~ ~ ~ 0 r 0 ~ ~
-
w ~ ~ ~ ~ ~ ~ Q ~ ~ w ~ ~ ~ ~ ~ ~ 0 ~ ~
~ ~
'< 
100bPladderl' !l1  'I , I ~ ~ ~ ~ I , , I , , I" U I I ~ ~ u n 1 d ~ : : : ; ~ i : ~ : ~ ~(t> ""I S 
~ ~ undifferentiated 
""I I I II I f 11 lU I I II I I I I 1.1 I :;.;- d2 
(t> d2 
""I 
'" I I II I il l l ,.1; I • II II I I III I d4 
:: d4 
::I: I I 111 'il l:1 . 11 III II I I 1II 1 d6 d6 C I I H( II I: 1;1 d8 I I I I f. Ifll I z ~ ~ OJ \fJ d8 G) 0 , r t II I' I I d 1 0 I 'II l . oil' il J -i -J 0 I -i d10 -'- -'-
'Z 
" 
I ; I • I • 11 I I d12 0 
....J d12 
....J I I 1,11.1 •• :1 III III I I I 1' 1 d14 
-
d14 
~ ~
'2 1I,Iili IIIi'll II I II I ; 1 d16 
0 d16 
....J I I I I I I I I wa te r control 
.., wa te r co ntrol 
N 111111 II I n II r I II II . r ~ ~ 100 bp ladder 100 bp ladde r 
d2 
d4 
d6 
dB 
d10 
d12 
d14 
POU5F1 
O ' - · ~ ~~ - · · - - a a
~ ~ . 
~ . " " ¥ : : .' : . ~ ' t t .' . '. ,. ' C)., . 
• }'i/ < ~ ~ ~ ~ , 
':,:.,::. @',.' 
...... ~ . . . . . . , , ~ , ,I • . ' ,, ',-~ ~... : .. .. ... • ' . ~ ~ J • . . 
(.< ' ' ' : ~ ~ ~ . 
\ .. . ' . : .... . 
. " - ~ . - ' , . .
.. .. _ • ' ,. '. flo, '"'ZO\ 
t • .: '-
; ; . ~ ~ :"f_ ~ : : :.,' 
.. ... 4 ~ ~ .'.. • . ... r.. 
' • • ! . ,.. .. . _. ' ., .... 
.' f J J ~ ~ " ~ : : . , , . .
" .. ..... 
_-r 
NANOG 
.. ' , , " "'. 
... .. . , 
.., -" . 
• ,.:.. . . ~ ~ < 
Cf!".,: .. .J ) , C ". \ .! ~ ~ ~ , . "' 0 ~ ~ , ,' I : ' ' ' ' ~ \ - - ' ' ' ' . . .., \ ~ , , J." r. ~ - I . . -! 
.. ) .' ... f 
.• ' , .. :', ~ : i i i
~ , , . ., ' ~ ) i i
T 
. " 
' 0 
I 
o 
SOX17 
o t '0(' ' . . 
C) 
, . 
.'([) 
, .. 
, , . 
• ' J ';"': 
"": ...... 
, -,l 
::.: : t 
'1 ,,' 
", 
," -.. 
., 
· · .. v 
' 0 . . " , • 1 
SOX1 
, ",' 
" 
Figure 4 ~ ~12: Co-expression of p luripotency and germ layer ma rkers in II C ES-7 h EB 
Cir les hi ghl ight areas of conseryed expression b c t \ \ ' \ ~ e n n pluripotenc), and genn !a\l'r 111'lrk\.'r 
quares h i g h l i ~ h t t areas or contras ting expression betwccn pIUrIP l1 ICIK: and gerl11 1.1\ \.'I' Ill,Hk\.'r--
rrows highl ight areas orcytop lasmic and or sca ttered nLIcit-'lr \.'''prc''''ll1n. " calc bar 1 ()() pill 
POU5F1 NANOG T SOX17 SOX1 
d2 
d4 
d6 
d8 
d10 
d12 '. 
" ~ ; ; j 
--? 
d14 
. ~ \ . . ~ ' ' ~ . . " , , ' '
' .. ~ ' ' : " , 
... • \.... .. C-
. .. ....... 
~ ~ . 
d16 , j ' ' ' ' ". ~ ~.. 
"" '. 
, t,;" 
'. : . 
Fioure 4-1 3: Co-expression of pluripotency and germ layer ma rkers in :\OTT I h EBs 
irc les hi ghlight areas o t' consel\ 'ed expression between pluripotenc: <l nd gl'nn !a\l'r 1ll.H\..cr" 
quares hi u. hlight areas or cont ras ting expression bctween pluripotcl1C Y <l nd gl'1'1ll la\ l'!" 1ll:11 \..cr" 
!TOWS highlight areas or cytop las mic and or scattered nucil'ar c'\prl's' ll1 n, ' l'ail' hdr I (ll ) pill 
d2 
d4 
d10 
d12 
d14 
d16 
POU5F1 
~ ~ ~
• 
' .. : ' 
. 
. I 
t.. . _ . ', 
" , ~ ' . 1 1
; 
NANOG 
" "' ' \ 
. \ 
G 
T 
:' 
.' 
...... ... . 
. j 
'.. .. .. 
..... 
.. . 
.. -: .... 
'. -
0 .. ·· . .\;' .;.:'- . 
... 
., 
SOX17 
, .'. ': .. ' 
, " 
" 
. ' 
.' ,. 
.. ~ . .
. . . ~ ~
= .:....'-+-, .AI 
;, 
. 
" 
SOX1 
.. ' 
, ', 
", 
' ... 
., 
. 
, . 
" 
" .. :( 
. ' . 
'0 .! 
" 
.. ,' .. 
. ' " ~ ~ .: 
Figure 4-14: Co-exp ress ion of pluripotency and germ layer markers in :\'OTT2 hEB 
Circles hi ghlight areas o f conserved expression between pluripotency and germ layer lllarkL' r'o 
quares hi ghlight areas o f contras ting expression between pluripotell cy and germ la\ er m,lrkL'r, 
ITO WS hi ghli l!. ht areas ol'cytop las mic and or scattered nuclear l',\pn,:-;sl l) tl Scak bar I (l() ~ I I III 
229 
POU5F1 
d2 
d4 
d6 
dB 
d1 0 
, 
G ' e;) , .
d12 ' -
® 
-" 
. 
, , 
",;." 
, , 
~ ~ 0' d14 ., 
< , 
I ~ ~
.' 
d16 
, . 
NANOG 
o I 
.' 
I, .: 
... J ~ ~.• 
' . . ; ~ ~
.; : : ,,, 1 
..... ,. 
:.'" 
- , ' 
, .. 
" 
" , 
T 
• w' \ 
I ;, ""', 
~ ~ ~ ~ , ,
t :- . " 
,,' " VI 1 ~ ~ '.,/ 
" . , * 
, , 
SOX17 
( ~ ~ .. -. -t , .. · .' I ~ ~ . ::' ',,'j 
, , ,> 
\' ' ", ';1 
'." 
... 
, 
.. : . .. :.', ~ ~ oJ, 
, , 
Q o" ~ " Q Q" : :
,.' .' p O 
... ',. • • .. t· 
. \. - ,. .. 
" , 
EJ ' 
. -, ,," 
1 ' ~ ~
,,' 
r 
. -- . " 
'-. ( ," 
'," ,-
SOX1 
~ ~l : , 
-' ~ ~
, .-
, ",' 
", . 
, : 
' 1 • 
r , , 
, , 
r 
-'" .. , 
of 
- .. 
, I • 
, . 
Figure 4- 15: Co-expression of pluripotency a nd germ layer markers in BGO I h EBs 
,', 
t' 
..... 
ircles hi ghlight ar as o f conserwd express ion between pluripotency and gerlll ll1\l'r Ilwrkcr" 
quares hi ghli ght areas of contras ting expression between pluri potcl1 c} and gl'rlll 1l1\ l' r I l l ~ l r r l ' ' " "
ITOWS hi ghli v. ht areas or c top las mic and or sca tt ered nucJc ar L L \ . . r e e " I I ) I I . . ~ c a k k bdr I ()() Pill, 
4.3.7 Effect of CDM, activin A and FGF2 on co-expression of pluripotency and 
germ layer markers in forced aggregation HUES-7 hEBs 
The effect of HUES-7 hEB formation in chemically defined medium with PYA and 
supplemented with activin A and FGF2 (referred to simply as CDM) was also 
assessed, and referred to as HUES-7 CDM hEBs. HUES-7 hESCs were chosen for 
demonstrating the effect of CDM as experiments in Chapter 3 had demonstrated 
these conditions to provide the highest proportion of beating cardiomyocytes. 
4.3.7.1 POU5F1 
In HUES-7 CDM hEBs at d2, POU5Fl was expressed in scattered cells at a lower 
level than HUES-7 hEBs (Figure 4-17). A lower level of POU5F 1 expression in 
HUES-7 CDM hEBs than HUES-7 hEBs was also detected by RT-PCR (Figure 
4-16). In d4 HUES-7 CDM hEBs, nuclear POU5Fl expression was detected 
relatively lower levels than HUES-7 hEBs. POU5Fl mRNA was also reduced in 
HUES-7 CDM hEBs from d2 to d4 and was substantially lower than expression in 
HUES-7 hEBs. POU5Fl expression was almost undetectable by RT-PCR at d6 in 
HUES-7 CDM hEBs and completely undetectable at d8 whereas expression was still 
detected at d 16 in HUES-7 hEBs. 
4.3.7.2 NANOG 
In the HUES-7 CDM hEBs at d2, nuclear NANOG expression was comparable to 
HUES-7 hEBs, only detectable in few scattered cells throughout the hEBs with 
higher expression towards the periphery. NANOG mRNA was also expressed at 
similar levels in each of the hEB types. At d4, NANOG expression \\"as higher 
relative to d2 in both HUES-7 CDM hEBs and HUES-7 hEBs, although an increase 
was not detected by RT-PCR. By d6, NANOG expression was restricted to the 
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periphery of both hEB types. NANOG expression at d6 was detected in HUES-7 
CDM hEBs by RT-PCR at a very low level but not thereafter. From d8 onwards 
NANOG was expressed cytoplasmically in HUES-7 CDM hEBs at a low level 
whereas nuclear NANOG expression remained detectable in HUES-7 hEBs up to 
dI4. By RT-PCR, NANOG levels in HUES-7 hEBs diminished from d8-d16. 
4.3.7.3 T, GSC and MIXLI 
A low level of cytoplasmic T expression was detected in both HUES-7 CDM hEBs 
and HUES-7 hEBs at d2. T and MIXLl mRNA were expressed at similar levels in 
each of the hEB types. At d4, a high level of nuclear expression of T expression was 
detected in HUES-7 CDM hEBs whereas only cytoplasmic expression was detected 
in HUES-7 hEBs. A concordant high level of T, MIXLl and GSC expression was 
detected by RT-PCR. These high levels of expression were quickly down-regulated 
and by d6 only low levels of nuclear T expression were detected in HUES-7 CDM 
hEBs. Correspondingly, low levels of each of the three mesendodermal marker 
mRNAs were detected at d6. At d8, only low levels of cytoplasmic T expression 
were detected in HUES-7 CDM hEBs in HUES-7 hEBs T was detectable at high 
levels. After d8, low levels of cytoplasmic T expression were detectable in HUES-7 
CDM hEBs until dI6, GSC was undetectable from dIO onwards and the already low 
levels T and MIXLl expression further reduced but were still detectable at d 14/d 16 
by RT-PCR. In comparison nuclear T expression was detected in HUES-7 hEBs until 
d 14. All three mesendodermal markers peaked in expression from d8-d 12 and were 
still detectable at d 16 by R T -PCR. 
4.3.7.4 SOXl7 and FOXA2 
SOX17 was more highly expressed in HUES-7 CDM hEBs at d2 than in HUES-7 
hEBs although, in both hEB types, expression was detected in scattered cells. SOX 17 
and FOXA2 mRNA was detected at similar levels. At d4 and d6 SOX 17 was 
expressed at substantially higher levels in HUES-7 CDM hEBs than in HUES-7 
hEBs, a result recapitulated by RT-PCR which detected a peak of SOX1; and 
FOXA2 expression at d6. In contrast, SOX17 and FOXA2 expression in HUES-7 
hEBs peaked at d 1 O-d 14. From d8 onwards, low levels of both nuclear and 
cytoplasmic SOX17 expression could be detected in HUES-7 CDM hEBs, along 
with a steady down-regulation of both SOX17 and FOXA2 towards d16. 
4.3.7.5 SOXl and SOX3 
Although cytoplasmic expression of SOX 1 was detected at d4-d6 and nuclear 
expression was detected at d10-d16, only low level cytoplasmic expression through 
d4-d16 was detected in HUES-7 CDM hEBs. Very low expression of SOX1 was 
detected at d 12 in HUES-7 CDM hEBs coinciding with a peak in HUES-7 hEB 
SOX1 expression. SOX3 expression was detected decreasing from d2-d 14 whereas 
expression in HUES-7 hEBs peaked at d 12-d 14. 
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4.3.8 Comparison of the expression of pluripotency and germ layer markers in 
five undifferentiated hESC lines 
The automated immunohistochemistry system established above was used to detect 
the expression of T, SOXI7, SOXl, POU5Fl and NANOG in the undifferentiated 
cells of five hESCs lines grown on Matrigel for at least five passages in identical 
conditions (Figure 4-18). 
For each of the markers both nuclear and cytoplasmic expression was detected. All 
five lines expressed high levels ofPOU5Fl and NANOG. T expression was detected 
at low levels in all cells with some individual cells expressing T at higher levels 
particularly in the HI hESCs. SOX17 and SOXl appeared to be expressed 
ubiquitously at very low levels in HUES-7, NOTTl, NOTT2 and BGOI. In the HI 
hESCs, SOX17 and SOXl were additionally expressed at higher levels in some 
individual cells. 
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4.3.9 Expression of mesendodermal markers in seven undifferentiated hESC 
lines maintained under different conditions 
Once it was established that mesendodennal genes were expressed in each of the 
undifferentiated hESC lines analysed above (Figure 4-11 and Figure 4-18), and with 
the overall aim to improve mesodennal lineage specification, seven different hESC 
lines were analysed for mesendodennal marker expression. Six of the lines were 
maintained in other laboratories using different culture conditions. All seven lines 
were analysed for the expression of an increased panel of mesendodermal genes 
(EOMES, T, GSC and MIXL1) to establish if the detected gene expression above was 
due to the culture conditions used. 
RT-PCR was perfonned on cDNA produced from cell pellets obtained from different 
undifferentiated hESC lines cultured in three separate laboratories (Figure 4-19): 
BGOI from our own laboratory, HUES-I, HUES-7, HUES-8 and HUES-9 from the 
University of Wisconsin and hES-NL-l & HES-2 from the Interuniversity 
Cardiology Institute of the Netherlands. All but BGOI were cultured on MEFs in 
FBS-containing medium. Week 6 human foetal brain, week lO foetal heart, week 10 
foetal liver and week 20 foetal testis samples are also obtained and analysed to 
establish the timing of maintenance of mesendodermal gene expression in humans. 
Expression of EOMES, T, GSC and MIXLl was detected at similar levels in HUES-I. 
HUES-7 HUES-8 HUES-9 hES-NL-l and HES-2. BGOl hEBs expressed esc and , , , 
MIXLI at similar levels to the other lines, but T expression was substantially lower 
and EOMES was almost undetectable. MIXLI and esc were found to be expressed 
in each of the 4 human foetal samples, EOMES was expressed in foetal brain and 
heart and T was expressed only in foetal testis. 
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Figure 4-19: Expression of mesendodermal genes in seven hESC lines and human foetal organs 
determined by RT-PCR 
RT-PCR assessment of the expression of EOMES, T, esc and MIXLl in seven hESC li nes cultured in 
different laboratories and comparison to human foetal organ control samples. 
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4.3.10 Expression of pluripotency and germ layer markers in SSEA3+ and 
SSEA4+ FACS-sorted undifferentiated hESCs 
To establish if germ layer marker expression detected in undifferentiated cells was 
due to a ubiquitous low level of expression or to the presence of a 'differentiated' 
subpopulation, undifferentiated cells from the hESC lines NOTTL NOTT2 and 
HUES-7 were labelled with SSEA3 and SSEA4 antibodies and sorted using F ACS. 
Samples incubated without primary antibody (i.e. secondary only) were used to 
establish the baseline fluorescence background for flow cytometry analysis. 
Figure 4-20 shows that both HUES-7 and NOTT1 cells maintained a substantial 
(98.1 % and 88.2% respectively) SSEA4 positive population, with lower (but still 
substantial) SSEA3 positive populations (79.4% and 81.1 %). A much smaller SSEA3 
positive fraction (65.10/0) was detected in NOTT2 cells. In the NOTT2 SSEA4 
positive population two distinct levels of intensity were seen, with 20% of cells in the 
higher intensity peak and 40% in the lower intensity peak. From each sample SSEA3 
and SSEA4 high and low fractions were isolated by sorting the 20% highest or 
lowest fluorescent intensity cells for SSEA3 and SSEA4 respectively. 
For visual confirmation of antibody specificity, approximately 10% of the volume 
each sample was removed placed onto slides and treated with Vectashield with 
DAP!. Slides were visualised with a fluorescent microscope with DAPl and FlTC 
filters. Merged DAPIIFITC images show that the expression of either SSEA4 or 
SSEA3 is visually higher in the FACS high populations than the F ACS low 
populations (Figure 4-21). The remainder of the sample was analysed using RT-PCR 
for a panel of pluripotency and germ layer markers. Although ditTerenecs in 
mesendodenn and endodenn marker expression were detected in each of the l i n e ~ ~
after F ACS separation, no apparent con'elation bct\\"l'cn the lc\"CI of mcscndndcnn 
and endodenn marker expression and the level of SSEA3 or SSEA4 expre Ion \\'a 
detennined (Figure 4-22). 
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Figure 4-21: Expression of SSEA3 and SSEA4 in undifferentiated HUES-7, NOTTI and NOTT2 
cells after F ACS separation 
Merged DAPIIFITC images of SSEA4 and SSEA3 hi gh or low sorted undi fferentiated HUES-7 , 
NOTTI and NOTT2 cells. 
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Figure 4-22: Expression of pluripotency and germ layer markers in SSEA3 and SSEA-t sor ted 
hESCs 
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4.4 DISCUSSION 
The objective of this study was to identify the spatial and temporal interaction of 
cells expressing makers of pluripotency and the three germ layers during hEB 
differentiation. Traditional methods of hEB formation lead to heterogeneity in hES 
size and contamination with feeder cells, whereas forced aggregation of a defined 
number of hESCs grown in feeder-free conditions allows the reliable production of 
homogeneous hEBs and improves inter-hEB comparability as described in Chapter 3. 
4.4.1 Immunofluorescence of T and MIXL 1 in mouse embryos and hEBs and 
antibody validation in the immunohistochemistry system 
At E7.5 in the mouse embryo, the primitive streak, from which mesoderm and 
definitive endoderm will form, has arisen along the anterior side of the embryo 
(Keller, 2005). Using immunofluorescence, a high level of T expression was detected 
in the area of the primitive streak and a lower level expression was detected in the 
allantoic bud (Figure 4-1), similar the expression pattern seen by others using in situ 
hybridisation (Perea-Gomez et ai., 1999). Although MIXL partially localised to the 
primitive streak area, as previously reported using immunofluorescence (Mossman et 
ai., 2005), it was also evident at low levels in non-primitive streak areas suggesting 
that MIXL1 is not as restricted as T. In hEBs both T and MIXL localised to the 
periphery at d8, d 10 and d 12 of differentiation (Figure 4-2) suggesting that 
mesendodermal differentiation had occurred on the outside of these hEBs. Although 
informative, these experiments demonstrated that more precise and detailed methods 
were required to visualise differentiation in hEBs. Therefore subsequent experiments 
were perfonned using sections of hEBs to allow visualisation of the interior of the 
hESs. Additionally, an automated immunohistochemistry system was used to allow 
high throughput analysis. To validate the automated immunohistochemistry system. 
E6.5 and E7.5 mouse embryos were analysed for expression of POU5Fl (Figure 
4-3), NANOG (Figure 4-4), T (Figure 4-5), SOXl7 (Figure 4-6), and SOXl (Figure 
4-7). Each marker exhibited the pattern of expression previously reported in the 
EMAGE database (http://genex.hgu.mrc.ac.uklEmage/database/emagelntro.htrnl) 
validating this system for use on sections of hEBs. The expression of SOX 1 was 
particularly low in the E7.5 embryos and the interpretation of this result would ha\'e 
been further enhanced by the inclusion of a positive control such as a mouse 
embryonic brain section. Negative controls produced by omitting the primary 
antibody (Figure 7-1) demonstrated very low levels of background staining although 
these experiments would have been further enhanced by using isotype or pre-immune 
serum controls to estimate the non-specific binding of target primary antibodies to 
cell surface antigens. 
4.4.2 Comparison of pluripotency and germ layer marker expression in mass 
culture HUES-7 hEBs 
To establish a baseline with which to compare the differentiation of hEBs produced 
by forced aggregation, cultures of HUES-7 hESCs grown on MEF were collagenase 
treated, scraped and suspended in mass culture. Comparing mass culture and forced 
aggregation hEBs at d2 demonstrated substantial differences in expression pattern 
(Figure 4-8). Whilst forced aggregation hEBs demonstrated a high level of 
homogeneity of marker expression between different hEBs, mass culture hEBs were 
highly variable in size and shape and expression of the tive markers \'aried 
substantially between hEBs. This suggests that mass culture hEBs, even at d2, ha\'C 
already begun to ditTerentiate in a non-synchronous manner. 
During subsequent differentiation of mass culture hEBs. co-localisation w a ~ ~ noted 
bet\\ eCI1 T. POU =' Fl. NANOG and SOX 17 (Figure 4-10). This co-localisation oj 
2-+5 
POU5Fl, NANOG, T and SOX17 may represent cells progressing from primiti\e 
ectoderm to mesendoderm and endoderm, indeed the co-expression of POU5Fl and 
the primitive streak marker MIXLI in hESCs has been previously reported 
(Mossman et aI., 2005). Although these four markers co-localised within the hESs 
, 
and in some cases they were expressed at the centre of the hEBs (Figure 4-10, d6), 
overall there appeared to be no correlation between where the markers were 
expressed between different hEBs, reiterating the chaotic differentiation that occurs 
in mass culture hEBs. SOXI was expressed cytoplasmically at low levels throughout 
differentiation suggesting that the mass culture method for hEB formation does not 
promote high levels of differentiation towards definitive ectoderm. In addition, a 
large proportion of cells within mass culture hEBs expressed none of the markers for 
pluripotency or the three germ layers, even at d2, suggesting that these cells are 
either at an intermediate stage between pluripotency and germ layer (possibly a non-
SOXl expressing definitive ectoderm), are of extra-embryonic lineages such as 
trophectoderm (Xu et al., 2002b) and may express markers such as CDX2 (Strumpf 
et al., 2005), or have already progressed past the early germ layer stages. 
In mass culture hEBs, an immediate down-regulation of pluripotency markers was 
detected at d2 by RT-PCR (Figure 4-9), and this low level of expression was 
maintained until dl4. Mesendodermal markers were highest at d2-d4 and slowly 
declined towards d 16 whereas the expression of endoderm markers was sustained 
throughout differentiation. An increase of ectodermal marker expression was 
detected from d8 onwards. In comparison, in forced aggregation hESs a clear pattem 
of pluripotency down-regulation was followed by up-regulation of mesendodennal 
endodennal and ectodennal markers similar to a previously report in the H FS2 line 
(Ng ct af.. 2005b). This extended maintenance of plutipotency and genn layer 
marker expreSSIOn IS m mass culture hEBs most likely due h h to t e ighly 
heterogeneous population of hEBs and demonstrates that there are substantial 
differences in the timing of differentiation between mass culture and forced 
aggregation hEBs, at least in the HUES-7 and HES2 (Adjaye et at., 2005) lines 
studied 
Overall, therefore in mass culture HUES-7 hEBs, no standard pattern of 
differentiation could be detected. Interestingly, very few mass culture hEBs appeared 
to follow the standard cystic EB pattern of differentiation typical of mEBs as 
described by Weitzer (2006). Additionally, very little spatial separation of marker 
expression was seen in mass culture hEBs. In mEBs the production of visceral 
endoderm as a layer around the periphery of mEBs is responsible for the production 
of the basement membrane, which induces epithelial primitive ectoderm formation 
and, in tum, allows cystic mEB formation (Li et at., 200Ia). No visceral endodenn 
layer (which would be marked by SOXI7, as demonstrated by mouse embryo 
immunohistochemistry) was detected in mass culture hEBs and a lack of this cell 
type may be responsible for the lack of cystic structure in these hEBs. As noted in the 
Introduction (1.2.6.5), the basement membrane is also required for mEB attachment 
and the subsequent formation of parietal endoderm. Since the latter lineage facilitates 
the induction of mesoderm, the lack of this inducer which may, along with the 
heterogeneous and non-synchronous differentiation, be the cause of poor formation 
of terminal mesodermal lineages such as blood and cardiomyocytes previously 
observed from mass culture hEBs (Denning et aL 2006). 
4.4.3 Expression of germ layer and pluripotency markers in forced 
aggregation hEBs 
Improvements in terminal mesodermal lineage differentiation noted in Chapter 3 
from hEBs produced by forced aggregation raised the question of what physical 
factors are responsible for this improvement and how future improvements could be 
made. To establish a spatial and temporal map of differentiation in this system and 
detennine whether this methodology standardises differentiation across lines, hEBs 
fonned from four hESC lines were examined for the expression of POU 5F 1, 
NANOG, T, SOXl7 and SOXl by immunohistochemistry. 
Differences between the spatial pattern of differentiation in hEBs from separate 
hESC lines has been reported (Mikkola et at., 2006). This work demonstrated that, in 
hEBs formed from two hESC lines (FES22 and FES30) by mass culture, there were 
substantial differences between the expression of POU5Fl and T at d7 of 
differentiation. FES22 hEBs expressed small amounts of POU5Fl towards the 
periphery of the hEBs and T towards the centre. In contrast, FES30 hEBs expressed 
high levels of POU5Fl throughout the majority of hEBs and at the periphery of a 
small number ofhEBs, whereas no T expression was detected. 
4.4.3.1 Limited cavitation in forced aggregation hEBs 
The phenotype ofhEBs formed by forced aggregation was broadly similar between .f 
hESC lines but substantially different from that seen in conventional mEB 
development (Weitzer, 2006) and no obvious central cavities were noted (Figure 
4-12 to Figure 4-15). As with mass culture hEBs, no SOX 17 expression at the 
periphery was detected during early differentiation, as would be expected with the 
f0l111ation of a layer of visceral endodenl1. In hEBs trom each of the hESC lines there 
did appear to be a single cell thickness layer of cells around the outside of the hEB 
although this layer expressed POU5F1 which is not expressed in primitive endoderm 
(Palmieri et al., 1994, Rossant et al., 2003). Therefore this further suggests that 
primitive endoderm is not formed and therefore the traditional cystic model of 
differentiation is not occurring. Forced aggregation hEBs did possess numerous, 
randomly located, small cavities at d2 which were increased in size at d4 and further 
increased at d6 in hEBs from each of the hESC lines analysed (Figure 4-12 to Figure 
4-15). In later differentiation, the expression of T and SOX17 was either associated 
with these cavities, frequently in chains of single cells within the cavities, or at the 
points of extension/elongation of the hEBs. This suggests that cell movement may 
have a role in mesendoderm formation in hEBs. 
4.4.3.2 Co-expression ofpluripotency and mesendodermal (but not ectodermal) 
markers in forced aggregation hEBs 
Markers of pluripotency were down-regulated from the centre of hEBs from d6 
onwards, opposite to what has been found in mEBs (Weitzer, 2006). POU5Fl has 
been previously demonstrated to be restricted to the outside of the hEBs (Joannides 
et al., 2006, Dvash et al., 2006, Mikkola et al., 2006) suggesting there are some 
substantial differences between mEB and hEB differentiation. Figure 4-23 presents a 
diagrammatic summary of the immunohistochemistry and RT-PCR results obtained 
in this chapter to demonstrate the spatial and temporal relationship betwecn the 
vatious markers in hEBs from all four of the hESC lines analysed. Pluripotency 
markers are mostly down-regulated from d6-d 1 O. At d8, mesendodenn markers are 
expressed in the same cells that are still expressing markers of p1urip()t(J1cy. 
indicating cells that are progressing from a pluripotent state to mesendodcnn. :\t 
d 1 O-d 12 SOX 1 is expressed in non p l u r i p o t e n c y m c ~ c n d o d c n n n c . \ p r c ~ ~ i n g g arca..;. 
indicating that ectoderm is derived from a separate population. At d 1 0-14 
pluripotency and mesendoderm markers become expressed in separate populations. 
Mesendoderm subsequently diverges to form mesoderm and endoderm between d 12-
14, when markers of pluripotency are down-regulated and the expression of the three 
germ layer markers becomes spatially separate. Almost no overlap between POU5F1 
and SOX 1 expression was detected in hEBs from any line. This might suggest that 
despite that in the mouse embryo, primitive columnar ectoderm differentiates to 
neuroectoderm with little cell movement, and that columnar ectoderm cells in the 
anterior half of late-streak mouse embryos express SOX 1 (Pevny et al., 1998), this 
marker may be to late to detect a POU5FlISOXI co-expressing population in hESCs. 
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4.4.4 Enhancement of mesendoderm with activin A and FGF2 
When fonning HUES-7 hEBs in a chemically defined medium supplemented \\'ith 
activin A and FGF2 (CDM), improvements were seen in the percentage 
cardiomyocytes produced at the end of differentiation (see Chapter 3). To assess the 
effect of this medium on hEB fonnation and differentiation, immunohistochemistry 
and RT-PCR was perfonned on a time course of samples as before (Figure 4-16 and 
Figure 4-17). HUES-7 CDM hEBs appeared as homogeneous in marker expression 
as the HUES-7 hEBs. Treatment with CDM leads to precocious and increased 
expression of mesodermal and endodermal markers at d4-6 in comparison to HUES-
7 hEBs (diagrammatic representation, Figure 4-24). Pluripotency marker expression 
was down-regulated after d4. Ectoderm marker expression was also detected earlier 
from d8-10. This expression pattern in hEBs formed in CDM appeared to offer 
further improvement in the synchronicity of mesoderm induction, creating a larger 
population of cells at the same point in differentiation. 
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4.4.5 Maintenance of POU5FI expression in hEBs and potential for 
tumourigenesis 
The maintenance of POU SFl expression up to d 16 of hEB di fferenti ation as seen in 
these expeliments has been demonstrated by other groups ( g e{ aI. , 2005a, 
Joannides et aI. , 2006, Barbeli et aI. , 2007, Nat et aI. , 2007) despite the conventi onal 
view that pluripotency is qui ckly down-regulated in differentiating ESC (J ohn 0 11 Cf 
a/., 2006). Undifferenti ated hESCs are tumoUligenic (Itskovitz-Eldor cf 01.. 2000) 
therefore any maintenance of pluripotency is impoliant con idcratioll for clinical 
appli cati ons. It is uncl ear if the expression of POU5F 1 and T\' lOG so late 111 
di fferenti ati on in these h Bs is due to the mai ntenance of a populatil)n or 
undifferentiated cells or alternatively to the spontaneous generation of PGCs. In mice 
POU5Fl is expressed in PGCs during migration and maintained in male PGCs 
throughout foetal development and in the adult proliferating gonocytes, pro-
spermatogonia and later in undifferentiated spermatogonia (Pesce et aI., 1998). 
NANOG is also expressed during PGC migration and becomes undetectable in 
females at EI3.5-EI4.5 and in males at EI4.5-EI6.5 (Yamaguchi et al., 2005). 
Therefore both markers may potentially be expressed in PGCs derived from hESCs. 
4.4.5.1 Transient up-regulation of NANOG expression in d4 hEBs 
It was noted that hEBs formed from each of the 4 hESC lines examined to express 
higher levels of NANOG at d4 than d2, whereas POU5Fl was constant (Figure 4-12 
to Figure 4-15). This result was recapitulated RT-PCR data from NOTTI and BGO! 
but not HUES-7 or NOTT2 (Figure 4-11). Biphasic peaks of NANOG expression at 
dO and d3 has been observed using microarray transcriptional profiling (Hirst et aI., 
2006). This was suggested to be an in vitro recapitulation of the NANOG expression 
first seen in the ICM of the preimplantation mouse blastocyst and then later in the 
epiblast adjacent to the elongating primitive streak (Hart et aI., 2004). This may 
demonstrate the ability of the hEB system to mimic human development. 
4.4.6 Mesendodermal marker expression in undifferentiated hESCs 
This study detected markers of mesendoderm in undifferentiated (dO) hESCs by RT-
PCR. To assess this was restricted to the culture conditions employed in our 
laboratory, cell pellets were obtained from 3 independent labs (including our own) 
using a variety of culture and passage methods. The R T -PCR results demonstrated at 
. ., 11 l' ed The usc of least some mesendodennal gene expressIOn IS 111 a Illes assess. . 
independently cultured lines shows that this result is not restricted to a particular 
passage method or culture technique. Expression of T as well as FOXA2 has 
previously been detected in undifferentiated H9 hESCs (Joannides et al.. 2006). 
Since the RT-PCR was performed at 35 cycles it is possible that only 'leaky" gene 
expression was detected, to assess if germ layer marker expression in 
undifferentiated hESCs was detectable at the protein level immunohistochemistry of 
T, SOX17, SOXl, POU5Fl and NANOG was performed in undifferentiated cells 
from five hESC lines cultured under the same feeder-free conditions. It was 
demonstrated that all three germ layer markers were expressed at low levels in most 
undifferentiated cells. These results also demonstrated that simultaneous expression 
of germ layer and pluripotency markers occurs in a subset of cells expressing the 
markers at a higher level. The mouse ICM has been identified as a heterogeneous 
population of unpredictable potential (Lake et al., 2000) and T expression has been 
detected in all cells by ISH (Y oshikawa et aI., 2006). The co-expression of 
pluripotency and germ layer markers noted may represent either the readiness to 
differentiate or the cycling of cells from a state expressing high levels pluripotency 
markers and very low level of mesendoderm markers to a state still expressing high 
levels of pluripotency markers but also slightly elevated germ layer markers and 
back again by dedifferentiation, an ability suggested in mESCs by Niwa et al., 
(2000) and Suzuki et aI., (2006). In addition it is possible that differentiated cells 
may have a role in the maintenance of the undifferentiated state (Bendall et aI., 
2007). 
4.4.7 Gene expression in pluripotency-sorted cells 
The above result raised the question of whether undifferentiated hESCs maintain a 
population of differentiated cells within the unditTerentiated population or if the e e l l ~ ~
. 'I 'I ,t 'ntainino their high arc able to possess higher genn layer marker expressIOn \\ 11 S mal ~ ~ ~ ~
pluripotency marker expression. To answer this question, two cell surface markers 
demonstrated as the most descriptive for pluripotency (Henderson et a!., 2002), 
SSEA3 and SSE4 were used. Both of these markers are expressed on the cell surface 
of hESCs and are down-regulated as these cells differentiate (Thomson et a!., 1998, 
Reubinoff et al., 2000). It has recently been demonstrated that hESCs can remain 
pluripotent after the depletion of SSEA3 and SSE4 (Brimble et al., 2007) suggesting 
that these two markers are merely indicators rather than having a direct role in 
pluripotency. Cells were F ACS sorted and the highest and lowest SSEA3 and SSEA4 
expressing cells were isolated. RT-PCR was performed for the expression of markers 
of pluripotency and the three germ layers. Results showed that F ACS sorting had no 
effect on germ layer marker expression suggesting that 'undifferentiated' hESCs are 
capable of expressing markers of the three germ layers without loosing expression of 
pluripotency markers. 
The combination of immunohistochemistry and RT-PCR data in the present study 
provides a spatial and temporal map of hEB loss of pluripotency and germ layer 
formation. The forced aggregation system that has been shown to substantially 
improve cardiomyocyte formation is demonstrated to form hEBs which differentiate 
more synchronously that mass culture hEBs. A consistent pattern of differentiation is 
seen in hEBs from independently-derived hESC. Treatment with CDM supplemented 
with activin A and FGF2 is shown to induce precocious expression of 
mesendodennal markers at d2. The combination of forced aggregation and 
automated immunohistochemistry provides a platform to identify and quantity 
potential improvements in the differentiation of hESC -delived hESs and a novel tool 
for studying early human development. 
256 
5 GENERAL DISCUSSION 
To realise the full scientific and clinical potential of hESCs, strategies to overcome 
the high degree of heterogeneity of differentiated populations are required. The 
results presented here demonstrate the development of a forced aggregation system 
for the formation of hEBs from a defined number of hESCs. This system removes 
numerous variables in hEB formation and allowed the study of the temporal and 
spatial expression of markers of pluripotency and the three germ layers in hEBs. 
Also demonstrated is the formation of hEBs in CDM supplemented with activin A 
and FGF2, which resulted in an increase in mesendodermal marker expression at d2 
of differentiation and the production of beating cardiomyocyte areas at d24 of 
differentiation in 23.6% ofhEBs. Additionally, a successful method for the improved 
differentiation of pluripotent Xenopus animal cap cells to mesoderm, 
haemangioblasts and erythrocytes has been established. 
5.1.1 A standardised system for hEB differentiation 
The forced aggregation system developed in Chapter 3 provides a number of 
enhancements to the system demonstrated by Ng et ai., (2005b). Particularly 
significant is the formation of hEBs from a defined number of cells cultured on 
Matrigel. This allows the formation of hEBs of a reproducible size and removes any 
possible contamination on hEBs with MEFs. The use of a fully chemically defined 
medium, that replaces BSA used in previous experiments (Vallier ct al., 2004a, 1\g cl 
aI., 2005a), with PV A, is an important step for use in future clinical applications as 
well as for reducing the number of non-defined variables for differentiation studies. 
Together, these optimisations represent a significant enhancement to the hEB 
, . . f'th f' th·s f'orced au gre1!.ation s\ stem fOlmatlOn protocol. The demonstratton 0 e use 0 1 b -- -
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in four hESC lines cultured using the same method (Denning et c.I )006) , 1 ., _ an \\ er 
important questions regarding the transferability of technique as frequently 
differentiation methods are only tested on lines derived from one laboratory 
(Allegrucci and Young, 2007). 
5.1.2 Spatial map of germ layer interaction during hEB differentiation 
This is the first report of the spatial relationship between pluripotency and genl1 layer 
markers in hEBs. The pattern of differentiation observed in each of the hESC li nes 
was broadly similar allowing the formation of a composite of the spati al relationshi p 
between pluripotency and germ layer marker expression in hEBs (Figure 5-1 ). 
POU5F1 
SOX1 
T 
SOX1 
-
Pluripotency 
dB 
-
Endoderm 
d10 d1 2 d16 
- -
Mesoderm Ectoderm 
Figure 5-1: Composite of the spatial and temporal relationship between pluripo tenc y and ger m 
layer markers in hEBs 
Lighter areas of the bars represent lower levels of expression. Adjoi ning bars represent areas of co-
ex press ion. Co loured bars which are adj acent to one-another represent co- loca li sa tion of l 1 1 a r k e r ~ ~ at 
that time-point. Co loured bars that are not adj acent to one-another represen t no co- loca lisation 
between markers. 
The timing of the expression of pluripotency and meSOdel111 and endodeI1l1 marker 
ex pression closely cO lTelates to a composite of data previously publi hed ( 1!2, ('I (/1 .. 
2005a, Valli er et a I. , 2005 , Kennedy et aI., 2007, Joannides c( al .. 2007) . The co-
expression of ANOG, POU5F I, SOX 17 and T seen at d6-d 8 closely mimic.; the 
e pre ion pattelll seen ill " f,'o in the mouse embryo as the posterior portinn l)j" the 
pib last/plim iti ve eetodenll becomes the primiti\'C strcal-.. althoug.h c l ) n l < ' ) r l l l ~ l t l l ) n n ll\ 
this co-expression would require fluorescent double-labelling. The co-expression of 
POU5Fl and the mesoderm/endoderm marker, MIXL1, has been previously 
described in hESCs (Mossman et aI., 2005). The co-expression of T and SOX 17 at 
d 10 before spatially separate expression at d 12 tentatively suggests that these cells 
progress to mesoderm and endoderm from a bipotent cell type, mesendodenn. 
Mesendoderm has been suggested to exist in both vertebrate and non-vertebrate 
species (Rodaway and Patient, 2001), but has not been previously described in 
humans. The presence of mesendoderm could be further analysed by co-staining for 
T and SOX17 and subsequent FACS analysis as used by Mossman et al., (2005) for 
POU5Fl and MIXLI. The expression of SOXI did not overlap with any of the other 
four markers at any time point in hEBs from any of the 4 hESC lines examined. 
Together with the known co-expression of POU5FIINANOG/T/SOX17, this 
suggests that the SOXI population arises from a distinct subset of cells that down-
regulate POU5FIINANOG early in differentiation. POU5Fl is expressed in 
primitive ectoderm until E7.5 of mouse development and SOX 1 is detected from 
ES.O onwards, which may explain why a POU5FlISOXl co-expressing population 
was not detected. 
5.1.3 Germ layer marker expression in undifferentiated hESCs 
T, SOX17 and SOXl proteins were all detected in undifferentiated hESCs, both at 
low levels in all cells and at higher levels in scattered individual cells. The 
expression of germ layer marker mRNA in undifferentiated hESCs has been reported 
previously, albeit at low levels (Joannides et aI., 2006). Studies of indiddual cells in 
early gastrula Xenopus embryos have shown that 'rogue' cells exist that e x p r e ~ ~ ~
markers of one or more different genn layers than those predicted by the fate map 
(Wardle and Smith, 2006). This phenomenon is potentially a consequence of the 
stochastic nature of gene expression (reviewed by Fiering et aI., 2000), which 
suggests that a gene is expressed in the absence of an enhancer and merely increased 
when an enhancer is linked to the gene. The exposure of hESCs to low levels of 
multiple signals (including signalling factors and their inhibitors) from the CM and 
the Matrigel; therefore may also enhance this stochastic gene expression. Low level 
expression of germ layer markers in hESCs may not represent irreversible 
commitment to a specific fate but may merely reflect establishment of the of the 
machinery permissive for differentiation should further external influences present 
themselves. 
5.1.4 Inter-line variation in spatial and temporal marker expression and 
cardiomyocyte differentiation 
Inter-line variation in mesoderm fonnation has been previously noted in hESCs 
(Mikkola et ai., 2006). Even after hEB cell number optimisation, BG01 hEBs 
consistently produced substantially fewer beating cardiomyocyte areas (1.6± 1.0%) in 
comparison to HUES-7 (9.S±0.9%), NOTTI (S.3±3.1 %) and NOTT2 (6.6.±2.4%) as 
shown in Figure 3-13. BG01 hEBs also had a substantially different spatial and 
temporal profile of pluripotency down-regulation and genn layer (Figure 4-23). It is 
suggested that the complex conditions under which ESC lines have been derived has 
an effect on EB development (Weitzer, 2006). As these cells are grown under the 
same conditions and demonstrate similar pluripotency marker expression there may 
be an additional underlying cause of this difference in differentiation capacity. ESC 
isolation maybe prone to epigenetic events or other stochastic processes that 
predispose the differentiation process of an ESC line (Weitzer, 1006). It has been 
demonstrated that epigenetic changes can be induced by culture conditions and that 
these changes are inherited by ditlerentiated cells (Allegrucci ct al.. 1007). The 
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BGOI cells used in this study were also of a substantially later passage (p48-55) than 
any of the other three hESC lines (p20-31) and, although BG01 cells were 
karyotypically normal, this extended culture may have introduced epigenetic 
instability (Burridge et al., 2007). 
5.1.5 The synergistic role of tall, Imo2 and gatal in Xenopus haematopoiesis 
and potential for transfer to the hESC system 
The co-injection of activin B or fgf4 mRNA along with tall, gata1 and Im02 mRNA 
into the Xenopus animal pole, and subsequent culture of animal cap explants 
demonstrated a highly successful system for the induction of mesoderm, 
haemangioblasts and primitive erythrocytes. Additionally, it was demonstrated that 
all three of tall, gata I and Im02 mRNA are required for maximal differentiation to 
erythrocytes. Cells of the Xenopus animal cap are analogous to hESCs in that they 
are described as pluripotent (Heasman et al., 1984). They also differ substantially 
from hESCs in that they survive in a simple saline medium, will differentiate to 
atypical epidermis without the addition of factors to direct differentiation and already 
have some three dimensional structure due to their origin from the blastocoel roof 
(Okabayashi and Asashima, 2003). Therefore, directed differentiation in Xenopus 
animal caps offers a substantially simplified version of the process required for 
directed differentiation in hESCs. In order to direct differentiation using transcription 
factors in hESCs a non-viral, transient delivery is desirable for clinical applications. 
Transient transfection has been reported in hESCs with over 50% efficiency 
(Anderson et aI., 2007), although either using three transcription factors in one 
plasmid or co-transfecting three plasmids has not been demonstrated and remains a 
technical challenge. Electroporation of ill l'itro transclibed mRNA has been 
demonstrated in hESCs with 80-90% eHiciency (Van Driessche et aI., 2 0 0 ~ ) ) and. 
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although has not yet been demonstrated for the introduction of more than one 
mRNA, may prove a useful route for transcription factor-mediated directed 
differentiation. 
5.1.6 Future prospects 
The CDM-PVA+ medium for used for differentiation in this thesis was identical to 
that used by Vallier et ai. (2005) for maintenance of hESCs in the undifferentiated 
state with the exception of replacing BSA with PV A. Use of defined media for both 
undifferentiated cell culture (without the use of feeders or serum) and differentiation 
(using a controlled number of cells and standard size of hEBs) would allow the fine 
tuning of conditions that promote lineage induction with minimised influence of 
other factors. Such a controlled system will leave just two main variables of hESC 
differentiation, i.e. the number of days of hEB culture and the growth factors the 
hEBs are treated with. 
5.1.7 The advantages and drawbacks of hEBs 
The main advantage of hEB formation is the generation of three-dimensional 
interactions that cannot be imitated in monolayer culture (Vallier and Pedersen, 
2005). However, the three dimensional structure of hEBs also represents their major 
drawback, by reflecting that the extra-cellular environment inside of hEBs cannot be 
defined or controlled. As a consequence, the generation of pure populations of single 
cell types through hEB differentiation may not be possible. The potential for 
monolayer differentiation ofhESCs has been described (Yao et ai., 2006) and further 
improvements in this type of system would present a signifIcant step towards a 
simplified, scalable, clinically valuable system for hESC differentiation. Monolayer 
differentiation will necessitate improvements in our knowledge of factors that control 
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differentiation, potentially to mImIC some of the environmental cues that are 
experienced in hEBs, and the possibility that three dimensional cell-cell contact may 
be required for differentiation represents a significant challenge. 
5.1.8 Sequential treatment with growth factors: mimicking in vivo ontology 
The involvement of growth factors in mESC and hESC cardiogenesis and 
haematopoiesis have been evaluated in several studies (see Table 3-2). As yet, the 
effect of individual factors added at different time-points and in different 
combinations has not been attempted. Therefore, after the establishment of this 
improved system for homogeneous hEB formation and high level mesodenn 
induction, the next step will be to trial factors known to promote the different steps 
of terminal lineage differentiation, potentially mimicking the sequence of events 
experienced in vivo. 
5.1.9 Potential culture systems for differentiation along the mesodermal 
lineage 
The hEB formation and differentiation system developed within this thesis could 
potentially be improved in different ways. Since this work was completed, further 
progress has been made by using a transgenic approach to positively select for 
cardiomyocytes expressing a bicistronic reporter (GFP and puromycin resistance) 
from the alpha myosin heavy chain that resulted in 91.5±4.3% cardiomyocytes 
(Anderson et al., 2007). To further attempt to improve the yield of tenninal lineage 
cells, one important step to be attempted would be to remove the mass culture stage 
after the initial hEB formation, by directly transferring hEBs to 96-well U bottom 
plates at d2-d4. This would remove factors associated with inter-hEB 
communication. This could be followed by a transgenic enrichment procedure or h ~ ~
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FACS to enrich for the desired lineage (Figure 5-2C). Removal of this mass culture 
step was attempted (results not shown) but resulted in a reduced cardiomyocyte 
production despite proving successful for blood formation (Ng et ai., 2005a). To 
further improve differentiation in the forced aggregation system, the use of hESCs 
grown in CDM, followed by introduction of either cardiomyocyte inducing 
transcription factors or haematopoiesis inducing transcription factors (such as tall, 
Im02 and gata2) either through transient transfection or mRNA electroporation 
followed could be used followed by sequential additional haematopoietic or 
cardiogenic inducing growth factors (Figure 5-2D). Careful attention to using the 
right combinations of transcription factors at the right time point will need to be 
made by referring to transcription factor networks (Loose and Patient, 2004, Swiers 
et at., 2006). Finally, use of the above system of CDM along with transcription and 
growth factor induced directed differentiation could be used in combination with 
monolayer differentiation (Figure 5-2E). Without hEB formation this system could 
potentially provide an entire population of hESCs differentiated to mesoderm and 
subsequently to terminal mesodermal lineages. This high-yield differentiation, if 
used a hESC line derived under good manufacturing practice conditions could 
provide cells suitable for clinical use and allow simple scale up to clinically relevant 
levels. 
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In conclusion, this work demonstrates that formation of forced aggregation hEBs 
enhances terminal lineage differentiation. However, forced aggregation hEBs do not 
differentiate according to the standard model of differentiation established in mEBs, 
but show a lack of a visceral endoderm layer and pluripotency down-regulation from 
the centre of the hEBs. Formation ofhEBs in CDM supplemented with activin A and 
FGF2 further altered hEB formation, substantially increasing T expression at d2 of 
differentiation, whilst reducing the expression of markers of pluripotency, ectoderm 
and endoderm. This treatment prevented the formation of internal structures seen in 
hEBs formed in CM, but also further improved terminal lineage differentiation. 
Together these developments suggest that perhaps the future of hESC differentiation 
lies not in mimicking human development, but understanding it and perturbing hESC 
differentiation in a manner that directs to one cell type, without the normal 
interaction of other cell types. 
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7 APPENDIX 
7.1 BOND-MAX NEGATIVE CONTROLS 
Figure 7-1: Supplementary images of negative controls for immunohistochemistry staining 
Sections of whole E7.5 mouse embryos after immunohistochemistry for detection of the expression of 
T, SOX17 and MIXLI and their respective negative Controls (with primary antibody omitted). Images 
of full embryos on are shown in A (using 10 x objective) and magnified areas of interest in Band C 
(20 x objective). Scale bar = 50 !lm. 
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ABSTRACT 
Although all human ESC (hESC) lines have similar mor-
phology, express key pluripotency markers. and can ditTer-
entiate toward primitin' germ layers in \itro, the Iineage-
specific dcvelopmcntal potential may vary betwecn 
individual lines. In the current study, four hESC lines were 
cultured in the same feedcr-free conditions to pro\ide a 
standardized platform for interline analysis. A high-
throughput, forced-aggregation system involYing centrifu-
gation of defined numbers of hESCs ill V -% plates (V -96F A) 
was developed to examine formation, growth, and subse-
quent cardiomyocyte ditTerentiation from> 22,000 EBs. Ho-
mogeneity of EBs formed b ~ ~ V -96FA in mouse e m b r ~ o o
tibroblast-conditioned medium was significantly improved 
compared with formation in mass culture (p < .02; Lcvene's 
test). V -96F:\ EB formation was successful in all four lines, 
although significant differences in EB grO\\1h were obscrved 
during the first 6 days of differcntiation (p = .044 to .001; 
one-way a n H I ~ s i s s of \'llriance IA:\()\AI). C u r d i o l l 1 ~ o l , ~ t l ' '
differentiation potential abo 'l'uried: 9.5( ± 0.9(<. n.(,e, ± 
2 . - t t ; ~ . . 5.2t;( ± 3.F", and 1.6« ± l.IV( healing Ell, \\ere 
identified for HUES-7. ~ ( ) T T 2 , , ~ ( ) T T 1 , , and 8GII1. respec-
th'ely (p = .OOR; o n e - w a ~ ' \ I \ O \ \ \). Formation of IIl'ES-7 
V-96F,\ EBs in defined mcdium containing actiyin .\ and 
hasic fibroblast growth factor resulted in 1-'.0[, ± , ~ , o ( (
heating EHs, repl'csenting u \3.I-fold increase relative to 
mass culture (l.Rr-le ± 0.7('(), consistent with an Oh'HHd 
14.8-fold increase in :lIYH6 (al\lHC) expression h ~ ~ real-time 
p o l ~ ' m e r a s e e chain reaction. In contrast. no bellting a n'a, 
were derhed from :\()'n'I-EBs and 8<;01-EII, formed in 
defined medium. Thus, the \' -96F, \ ~ y s t e l l l l highlighted in-
terline v a r i a b i l i t ~ ~ in EB gro\\ th llnd c a r d i o m ~ ~ o c ~ ' t e e differ-
entiation but, under the test conditions dl>scrihcd. identitied 
Hl'FS-7 as a line that can respond to cardiomyogenic stim-
ulation. 5TH,,\ C l L L ~ ~ :!lIo7;25:<J2<.J-<J38 
Disclosure of potential conflict, of intert',! is found at the end of this article. 
INTRODUCTION 
Numerous differentiated lineages haw now been derived from 
hES(', [1]. supporting the notion that the,e cel " hold promise as 
luoh for ~ c i e n ! i f i c c re't'arch and as cell-ba<;ed ther::lpelltic, It h;" 
::Ilso been ,1Iggt'sted that approximately 150 hESC line, will be 
required lO match the majority of HLA i ~ o t ) ) pc, in the l' .K. 
population for transplantatil)n [21, However. considerabl) more 
hESC lint" will be required if differentiation toward ~ p e c i f i c c
lineages i., favored or r e , ~ t r i c t e d d by the inherent or culture-
induced properties of indhidual lines. It II ill therefore he im-
portant to evaluate linc::Igc-speci lic c1illerentiation potential h) 
direct interline comparbon. prekrahl y under paralld, standard-
iled conditions. 
C o m p a r i ~ l l n n \11 hESC lines has hegun through 't'Yeral orgn-
n i l a t i o n ~ , , includinQ the lntemational Stem Cell Initiative. the 
NIH Stem Cell l' nlL and lhe American T) pt' Culture Collection 
131. Tlll"l' initiati\T' arl' il1\estigating variabilil) in parameters 
such :.I'> expression of smfact' markers and relative K:\A lew)., 
in undifferentiated hES(, or at carl) '>!agl" of difkrentiation. 
Other interline comparisons indicate that there are diftcrences in 
population doubling timc, [3). transcriptome [3]. hematopoietic 
clifferentiation [-n and teratoma formation [5, 0]. Hl\\\,'ver. the 
wide range of feeder cel"- culture m e d l ~ 1 . . additi\c,. anll ra",I12e 
methods u'>ed between lines confound, interpretation of true 
interline difference, Consequentl). it i, challenging to draw 
conclu,iuil' as to whether variabilit) i, due 10 inherent genetll' 
vari::ltion or el1\·irunmental interference 
In nn effort to limit the influence of culture-induced 
differences in intcrline compari,un. we recentl) l I e w l o ~ d d
,unclardized condition, fpr culture and cardiomyol') te dif-
ferentiation of twp independentl) deriled hESC line'>, 
HU:S-7 and BG()1 [7], T h e ~ e e condition' halt' 11\)\\ ht'ell 
e\tencled til :\()TTI and :\OTT2, which we recclltly derived, 
Ilu,,·ewr. the differentiatil)n ,>tratt:gl we llriginally u,ell [7] 
in\ olved formation of t'mhr) oid hodie, (I As) froml'iump, of 
hFSC colonic, han c'ted lhing collagena,e treatment. and 
5 n M CE US ~ ( ) 0 7 7 : ~ ) : 9 ~ l ) - 9 J ~ ~ \\\\'\\,StemCelb,coll1 
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this resulted in a high degree of heterogeneity in EB size, 
morphology, and formation efficiency within each experi-
ment. This confounds the ability to meaningfully test the 
efficacy of new factors/protocols on differentiation. 
In this report, we have adapted an approach proposed by Ng 
et al. [8] to develop a high-throughput. forced-aggregation sys-
tem that involves centrifugation of defined cell numbers in 
V-bottom 96-well plates (termed V-96FA). More than 22,000 
EBs were generated either from l,OOO, 3,000, or lO,OOO trypsin-
passaged HUES-7, BGO 1, NOTT I, and NOTT2 hESCs, which 
were routinely maintained in the same feeder-free conditions on 
Matrigel. V-96FA resulted in significantly greater reproducibil-
ity in EB size and gross morphology during early differentiation 
and, in some cases, in more beating areas at late stages of 
differentiation. Interestingly, significant interline variability was 
observed in EB size and cardiomyocyte differentiation. More-
over. although V-96FA formation of HUES-7 EBs in defined 
medium supplemented with activin A and basic fibroblast 
growth factor (bFGF) could dramatically enhance cardiomyo-
genesis, these conditions failed to produce beating outgrowths in 
the other lines tested. These data suggest that derivation of 
hESC lines with redundancy in HLA coverage will likely be 
required to ensure delivery of the full spectrum of clinically 
relevant lineages suitable for transplantation. 
MATERIALS AND METHODS 
Materials and General Culture 
Culture reagents were purchased from Invitrogen (Paisley. U.K.. 
http://www.invitrogen.com). and chemicals were from Sigma-Al-
drich (Poole. U.K.. http://www.sigmaaldrich.com) unless otherwise 
spedfied. Culture was canied out 'It :'7'C in a humidified atmo-
sphere containing 5% CO2 , Medium \\as changed daily for hESC 
cultures and every 3-4 days during differentiation. 
hESC Culture 
HUES-7p II cells w e n ~ ~ kindly donated hy Harvard University [91 
and expanded llsing trypsin passaging on mouse emhryo tlhrohlast 
(MEF) feeders for cryopreservation at p 17, as recommended by the 
supplier. Aliquots of HUES-7 were thawed to Matrigel-coated 
tlasks and cultured using trypsin passaging in feeder-free conditions 
in conditioned medium (CM): under these conditions. HUES-7 cells 
were routinely passaged by incubating with 0.05tK trypsin for < I 
minute at :'T'C and then tapping the t1asks to liberate single cells or 
preferahly small clumps of cells. To prepare CM, MEF, (strain 
CDI. 1.1.5 days post coitum) were mitotically inacti\'ated wit2 
mitomycin C (MMC) (\0 /Lg/ml. 2.5 hours) and seeded at 6 x 10 
cells per cm2 . The next day. inacti\ated MEFs in a T75 tlask were 
incuhated with 25 ml of Dulhecco's modified Eagle's medium-
Ham's F-12 medium (DMEM-FI2) supplemented with 15lK 
KnockOut Serum Replacement, 100 /LM l3-mercaptoethanol (13-
ME), I'k nonessential amino acids (NEAA). 2 mM GlutaMAX, and 
~ ~ ng/ml bFGF for 24 hours. at which time CM was harvested and 
made ready for use hy supplementing with an additional.4. ng/ml 
bFGP. Each tlask of inactivated MEFs was used to condItIon the 
medium for 7 consecutive d a y ~ ~ [7. 10l 
BGOI p24 cells were purchased from BresaGen (Athens. GA. 
htlp:llwww.bresagen.com) [II] and expanded using manual p a s ~ a g g
iog on MEF feeders to p3 7. as recommended hy the supplier. BGO I 
cells were transferred to feeder-free conditions in CM at p ~ U U and 
cultured as for HUES-7. NOTTI and NOTT2 were derived at the 
University of Nottingham with informed patient consent and in 
accordance with Human Fertilisation and Emhryoillgy Authority 
license ROI41-2-a. Fresh IVF emhryos (grade 213) were cultured for 
5-6 day,,- to the blasto9st stage in Vitrolife GIll sequential me-
dium. as spccified b) the manufacturer. The LOna pellucida was 
removed by treatment with acid T y r o d e · ~ . . and the e l 1 l h r ~ o o w a ~ ~
plated to MMC-inactivated MEFs (7.5 X 104 cells per 1.'111-). Cul-
Variable Cardiomyocyte Differentiation in hESC5 
tures were maintained in 80ck KnockOut DMEM. 2lYk ES S l " f e e n ~ d d
Hyc\.one fetal bovine serum (Perbio. Tattenhall. U.K .• http://www. 
perblO.com), I X GlulaMAX. I ~ ~ NEAA. IOU /LM ~ - M E . . ~ ~ nc/ml 
b ~ G F F•. and 10 ng/ml human recombinant leukemia inhihitory f ~ c t n r r
(Chemlcon. Temecula. CA. hnp:llwww.chemicon.coml. After :; 
days. hESC outgrowths were isolated and expanded using manual 
passaging on MEF feeders. NOTIlpl5 and NOTI2plll were t r a n ~ ~
fen'ed to feeder-free trypsinlMatrigel culture in CM and cultured as 
for HUES-7. Both NOTT lines expressed OCT -4. S S £ A - ~ . . TR A-
1-60. and TRA-I-81 but were negative for SSEA-I (data not 
shown). 
Karyotype Assessment 
Exponentially growing cultures of at kast I X 105 cells were treated 
with 100 ng/ml co\cemid (Karyomax) for ~ 5 5 minutes and han ested 
with O.05tK trypsin-EDTA. Pdleted cells (200g for ~ ~ minutes) \\ere 
resuspended in 0.6% sodium citrate and incuhated at .H-C for 20 
minutes. Cells were then centrifuged (300g for ~ ~ minutes) and fixed 
by resuspension in 16.7% glacial acetic acid in methanol before 
washing with two additional changes of fixative. Chromo"ome 
spreads were prepared hy dropping cells onto glass slides, which 
were air-dried and heated to 70°C overnight. Chromosomes were G 
banded with trypsin and stained with Leishman' s. For each culture. 
30 metaphase spreads were examined; full analysis involving hand-
hy-hand comparison hetween chromosome homologues was per-
formed on three spn:ads. and the prcsence of gross a b n l l r n l a l i t i c ~ ~
was visually examined in 27 spreads, in accordance with the Inter-
national System for Human Cytogenetic Nomenclature international 
guidelines [12], 
Feeder-free, trypsin-passaged cultures of HUES-7 were main-
tained from pl8to p37. Nonnal karyotype (46.xy) was ohserved at 
pl8 and p3 \. However, hy p37, only 22 (7 _ ~ r / , , ) cells of the :'0 celb 
analyzed per culture (duplicate cultures) were ~ 6 , X Y . . up to seven 
(2:. ck) cells were ~ 7 . x Y . + + 12. and the remaining spreads showed 
nonclonal random gain or loss of chromosomes. Therefore. differ-
entiation of HUES-7 was initiated from p20 to p2ll cultures. Feeder-
free, trypsin-passaged cultures of BGO I were maintained from p40 
to p55 (46.xy at p40 and p52). NOTTI from pl5 to p33 ( ~ 6 . X X X at 
p23 and p33). and NOTT2 from pl8 to p2ll H6.XY at p26). 
Differentiation and Cardiomyocyte Analysis 
Mass cultures of HUES-7 E B ~ ~ and BGO I EBs were prepared as 
descrihed previously [7]. Forced aggregation of EBs in untreated 
V-96-wel\ plates (Nunc. Roche,ter. NY. htlp:llwww.nunchrand. 
com), termed V-96FA. and subsequent cvalualion of EB sile and 
efficiency of canliomyocyte differentiation i ~ ~ d e ~ e r i h e d d in Figure 
I A. V -96FA EBs were initiated from feeder-free. Iryrsin-p_"sagetl 
cultures of HUES-7 p20-28. BGOI p48-55. NOTII p26-31. and 
NOTT2 p24-28. The media tested for their ahility to support 
V-96FA EB formation and growth were a:-- follow,: (a) ("\1. (h) 
unconditioned medium (UeM) was prepared as for CM hut without 
MEF conditioning, (c) DMEM supplemented \\ith 20',; klal b.l\inc 
~ e r u m m [FBS]. 100 /LM I3-ME. Pi, NEAA. amI 2 mM GlutaMAX 
(D-FBS). (d) defined medium supplemented with tll" inc serum 
alhumin (CDM-BSA). and (e) defined medium supplemented wilh 
polyvinyl alcohol (CDM-PVA) (ooth CDM-BSA and CD\1-P\ ,\ as 
dcscrihed hr Vallier et al. [I:'] [L. Vallier. \\. AIe"ander. and RA 
Pedersen. rcrsonal communication]) and containing 1: I mix of 
I s c o v e ' ~ ~ modified Dulhecco's medium (F12 supplemented \\ith I x 
lipid. 450 ,..,M monothiogl:.cerol. 7 ,..,g/ml insulin [Rl,,:he D i a g n l l ~ ~
tics. Basel. Switzerland. hltp:l/w\\\\ . r o c h e - a p p h e l l - s C l e n n : . ~ ~... )mJ. 
and 15 /Lg/ml transferrin [Roche] plu, 5 mgJml hovine ,erl.lm 
albumin fraction V [CDM-BSAJ or I mglml pol)' '10) I akoholl. 
CDM-PV A was used either with or withllllt 10 ng/ml aetivin A and 
12 ng/ml bFGF (hoth frllm P c p f l l t e ~ · h . . London. http://'\\\\\, 
peprotech.coml. ..' , . . 
Numhers of \'iahlc c'dh present wtthm HUI:S· 7 ·dert\ctl EH, "t 
d2, -L and 6 of differentiation \\ ere mea,ured lhing an \f1' Cell· 
Titre 96 ll11nradil)adi\'e cdl proliferatilln a " . I ~ ~ (Promc'g.!. 
Southampton. U .K .. hllp://\\ w\\ .prl.lmega.com) slOce Illh ",tem 
has lx'en pre\'iousl\ U.'-l'd III define ,'ell numlxp, 111 mOll,e EB, II ~ ~ I 
HUES-7 EB, were Iransferred in 100 ,..,1 ot meJlumt" a n.ll·ho{!"f1l 
lJ6-well plate on the aprrllpri.llc· day. anti 15 P.l'l! \ITI dye Splllll,1fl 
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F!gu re I. . rkvcl<lp ing l l ~ e e V ~ 9 6 F A A ,),lc ill . (A): S S ~ ~ e l l l a l l C C 01 Ihe V-96FA proceJure. ( I ): A ll hUlllan E. C (hESe ) Illle\ IILTl' cullured U ' " I ~ ~ III " Ill 
P<I.,,:)g lllg .'.') t ~ l l d ~ I - , I . l t ' t ' ' U)lld IIIOIl ' O l ~ ~ M :lln gt' l III C IV!. ( III : Oil d:l) 0 (lH)) " i' dii'krl? llli :1 liPI1 , L13 101'ln:H101l 'I<L' 11111t;Hl'd b) ' l ' l ' d l l l ~ ~ UIHIl'.I;l'J ' \ \ - I I f I I
pldl c:,' 1:1 t l l ~ ~ . ~ ~ l : : I ~ ~ lu th enhel 1,000, .l ,OOO, (I I 10,000 n: lI , per II ell III dlffert' nt 1t'\l Il1 t'di:1 and ct' lllrirug ing il l ' ) 5 0 ~ ~ I 2,X()O rl'llli 1.'1 'i 11I1I1Ulc' ,It 
:,OU Il1 k l l ~ ~ l l . t t t ~ ~ . . :o.lI luw EB,}" gr oll, V -96 p l a a e ~ ~ Ile rl' IIlClIh;lled lor eithcr 2, 4, 01 6J (i ndil':l1L'd h ~ ~ dOlled ;11'1'11\',) ( 111 ) ()nlhc ' pecil lcd d.I) , 
e-1\)\\ lh \1:1' a\\t"c ci b) II .l lb!ell l l1g .)11 EB, I lll lll :) \ -96 pl :l l l' 10 :1 llulllre,lI<,d 1)0-111111 dl , 1I ill D-FI3':> :llld l a a u u a l l l l ~ ~ Ihe dl.lI11ell· 1 \11 21l r;1I1L"'II111 
,,'k ded EB, per cx pL' nnl\;n l b) aVl'I':lgillg IhL' ' lll ;tlk,' 1 ; lIld I:trge' t CI'<"'-,,'( l ill ll;II cillllCI1 , illn " I' l', !l'h blldl I EB, I I L ' ' ' e e Illl', I, "rl' " In l)()- 11I1l1 " h hl'; 
a, lIptl l':t 1 LiI , lllrl IOll llCc ur, ill V -L)6 pl:lIL" ,) EB, wt' rL' Illai ll ta ined ill , u'pt' ll , ioll fur ClJ III :1 11 \,\1 tUrlht'1 d i t l t ' ' ~ I I l t : I I I I I I l , , II II l'l't '\\;1 1'1 , EB , II l' rl' d'I"L'llt" i 
1 1 ~ 1 1 1 1 Iht'. l 'u ltllre ""II h) gt' lll le pi l' e' ttill .£! IiI )' U h lI'e rt' II il lb ren t'd III L':tc h 1It'1I 11" I,' I 'H I't' l II t' li I \1 1 .111 1Illll e:lled l U !('- lIt'li 1'1:lIL' II I I)- I 'IIS 011 
l L4 <I I d III.nL'fll l:t tlu ll , 1111' l'ercc ll l" ge (I I hC:l l lng EB , II ;" t'; ,J l ' II I" ll'd rel;11 i ,,' III 9(' (1 .1' .. I he Ilulllhe' 1 ti l V _1)6 II ell , 1 1 r r ~ ~ III,,J" ,el' l lt'd II II" hF .., , I ('1\ I 
(H) or d ~ I : I I I t t d d Illc'c1 l l1lll , ' l I p p l t ' I l l ~ I I I t t J J \I ill! pll lyl iny l :Ik<l lln i (e) \I -L)6I ,,.\ II l l L.:S -7 E13, II t'l L' f\lIlll L'd 1', \ 1111 I ,O()O'l dl,l l;l \l lld ,1. .1, lltX) ('LlU.ll t',I , <'I 
I O . f f ( ( ~ ) ) ( I J ' ' ~ l l l g k : " " CI: II " ;lIld ' I ll' \I", c:,J l' ul:t ll'd \111 d 2 . 4. o r (, o r diriL'rellliali l' Il , A hhrl'\ i.II I(III' . ('1\ 1 L'Olldl li,"h:d llleJ,UIlI. d. d.II , D-Flh , J)u lhL'l 'CII ' , 
Illoti lh t!d E[lgie , nw ci lllill " tlppit-Illell le'd lI' i l h 2(1 1'; fel:l l h(l' i l l ~ ~ ,(' rull) , 
\ V a ~ ~ adlic'd , pl ;lI eo; \\c rc illL'Llh;l te: LI for.2 hOI II', at .n C hd\IIT a d d i l l ~ ~
I on /-l l \11' ' Illp su luliun and so lu hi l i7i llg lll'emighl al . ~ 7 7 'c. A h " " I ~ ~
b;lI1 ce w a ~ ~ dt' lerm ined :11 ) 70 nm u s i i ~ ~ ~ ~ rc iL'rellL't' \ \ a a e l t t n ~ ~ h h u t 
650 11 m i l l a /-lQU.tllt pl are rt'ader ( 1 3 i ~ ~ T e J , ,.. \\' in()("ki . V T , IHlI' :// 
w\lw.hi\'Ie: k .com) . Cd l number, r c r EB lI,crL' l,:tl c li lakd fru lll a 
~ ( " I l d d r d d curve Ih ill g a "11('\\' 11 tHllllf1er (I I c c I I : : [I II read ing' laken 
\\cn: in lh e: l i ncar rangl' of thL' ;""'y . 
Real - t ime T ;lq1V\ ;l n p() ly mer;" .: c l! ;lill ICdC li o ll I PC R I 1\'" , 1I ,t'd 
tl) d t' l t' rtn int' re lalil't: e.\ pre" i(l n \1 1 m)Il' in he,)I) l ' haill (1I M) 'H (l. 
t' IlClxlt's nM IIC) . Rl'I't' I'St' trJIl , cripti\, " 1-1';1., ca lTied o ul u, in ", Su-
p e r ~ c r i J l I I " ( I n l ' itl'\ 'gcn ) 1\ itll .. HlO nt! 01 RN ,\ [lccll rding tn Iht' 
IlI Cl IlIlt';)CIUrel< ill <;[ruC l i(l II ' . The r r , u l t i i ~ ~ d)N /'\ \\ :h d iluleJ (II a 
rin :tI vl) lullle II I I Of) l,tI . T ;ILJl\ bn PCR (If ';lml'lL', \\';1' l 'arr ied I)U( 
lhill t! A I'PI ic:d Bioo;y, te: Ill ' " " ) lin D l'm ;llId (FO'lL' r Cit) , CA, 
http://1I \\ \\ .:11'1'1 it'dhi l") , [t' Ill ,.(,(11ll1 I'rimer,/ rruht' se l , tn ,\/l'H6 
(p"rI numlw r H ,O()-I II (!Oi\_ ITII ) and HPRT ( inlnnal n'llll'I , l : 
H ,L)l)L)L)L)\)09_1ll 1) ill conjullc li l .n \\ itll T :ILJ fan Lin i lt: r,al PCR 
1\'I.t o; l er ;'I I i ,\ . NI I AmI'Er"s<: lIN(; (A ppl ied Bi \),1 ' tl'lll' I ;lIld ~ ~ /-l l Il l' 
eON in ~ ~ l\ ,l a l r<::ldilln I 'p l lllll <: \1 1 .20 J..ll. Cyck L'(lllciiti u ll ' lIel t' 
n llL' L)'l'k n r ()) 'c rur ) Inillute, rll l kllll'd h j 50 LycIL:, \. i' L)5 Crill 
In ' t'(lI nt " , (10 'C IIII' I Illinutc , T \\n indept' lldl' nt PC R" e.ll 'h in 
trip l il 'al e, IICI'C rU11. ;l ll d rel .lli lL' qU;tllli l i l ' ;lli \1 1I \\,1' pn furlll ,'d u ' i l l ~ ~
til t: ;\pp l icd l:lio,),It'm , 7)Oll F;1\ t Real - tl llle PCR S)'tl'm alld 
'lIn \\ ;In: . 
Tl' cOllfirm (il c pre"e' lice (If c lrdi l' lll )l'l'y 1<" ill h l l ' l i l l ~ ~ ;HC.I' 
dt'l'i I L' d I rum H L' I:S-7 ER, ill dd int'd Illc'dillm 'UPI'IL:mt' llt ed II ith 
poll I illl I alL'II l1ol. 10 I H.:1i 11 I ;)c,til ill ,\ , alld I ~ ~ II !.! / I 11 I h l {jl-' I C I) 1-
PV :-\ + A f ), 1ll' llqU:llltit: lli lt' RT-PCR dl1d inll;HllI l hl.linin", IIcrt' 
1I ,c:d . (DN \ II ,Is I' l cP;lrC" ;1\ .lhnl t' . PCR L)cle par,lllll' lt'r, II ere .1' 
fo ll ,.\\, : \)II t' L)l' le (If 1)-1 (' Ili l ) Illilllill" : 1)--10 l')l k, \,1 l)-1 C 1'\)1 
.I ll ,'CCll lld " )l! C r(l l ,0 't'l'l llld" ,llld ( , ~ ~ (' 1(11 I IllillUll" .IIKI \) lI t' 
c)ck " I 6l'i (' 1111 I tll1lilllliL" lI,ill ", H i ~ i l l h l ic'lill 1'('1{ r-,1 ,,, tlT :-- 11\ 
( RLlc he) , Seq llL'lll' l" \\l' IL' ,1\ 1'" 11 ,,,,, . I-II'/{I'I 1'111'\\ ,lid (1-- 1. 5 '- I- r -
(I f\ (" f\CT CC C:\ .. \ \ ,\ CA t\ T C ~ ~ ,\G:\ - I ', ,Ind 11'1 CI"L' I R I, ) '-
r C,C;CC; ,\T(,TC ,\ :\ 1 \ (iC, \ CTC C \( j \ , ', C'l'nl' II) - , ~ ~ 1 1
1'(J( '5/'1 r , ::; '-C \ \ CiC;T\TIC \ \ ~ n n \ ,\ '\ '-J ' ,I lid R , ) -CT-
T /\ ,\ TC('.\ \ ,\ ,\ ,\CCC T C;(; ,\ ', ( ;l' ll l' I f) "4 hO, (; I I I .J 1-, ) 
.\ ,\\C; \ C(;C;C, \ TCCA\ ,\ (T -\C \\\ -\ -,', ,Ill" R, " '-C\-
G .'\TCCT C(; GT GCT Ae; ;\:\ '\ c. \ C. \ - ,' , (I ,' ll l' II) 262h, ,\ ;"::C 5 
I ', ,'i'-AC,C;.-\CeCTAC, C;Cce;A.-\ '\ , c; -, ', .Il1d R, ~ ' ' C , , ­
C(j :\ ,\ (jTTC /\ CCi ,\ , \CiTIC;T-.", C,CIll' II) I - - l ' ' ~ : : T H,\ 5 I", .'i ' 
n 'TC'C iCT.\r\ :\ 'l TCCACCj ,\ -.\ ' . • llld R, ,'i'- 'II Cn,C; ,\ .. \C;C, 
AG ,\('(;AGCTC -.\'. C CIlL' II) 6l)IO: I/} 'If() F,:; \TG ,\CCC; \TC ; 
CCCt\Ci t\TC;(;C TC; ,\ -.\', dlld R, 5 '-TC \CTC 'CTCT TC' I (;C 
(,CCGG T :\ -3 ' , GellL' 10 4 ( , ~ ~ : : ,1/) '11 7 I" ." ,\C; TC;(,C(C \ 
( j ( ' ( ; G G T ( ) C N ~ ~ (; -.", ;1I11i R, Y -CTCeXI C'TTC TCC ;e;('("1 (C \ 
GeT -,I ', Gl' lI L' ID -1(2) : ,11l 'L! r , ." '-CC:-\ \CT c. \ ,\ CGTCT 
T e r Ce /-\TC;T- .\', Jlld R, 5' -CXI C' , ,,\ '11 J'C rJ'C ,\ 11- 1 n c 
,\ ('(,TTC,, -.1', (;t'lll' If) -I ().\_', \LC'i.\1 I', ) '-C( TIl nc( 1 
T Cr\C,:\TTC ;C;.-\ C;ACC-,I ', .lIld R. ) ' -'1'(,(,,1 (" I I e(,"1 C IT I eel -
Gel' ('.\C;T-3', (,L'IlC I D 6)-1(, :.\ EH 1-' , ) ' , \ Tej \'1"( ;,\ .\ T( ,\ ( (, I 
C;CTC;C;CT ,\ ,\ ,\ -J', "Ild R, ,- ' -T(; \ CTTT( TI (TCiCj( ; \ \TC ( 
TIl,(i -3 ' , Ci t' ll t' 10 -1711 ,' 
Pnl'r Il' I m m l l l l l l I " I I l I I l l , , hl" lllll", .Ire", lIere d",I!:!",I L'g, llt'd " 
dc'C"ribed prl' l llll"l) [I) 16 J. Bli c fi l , b C . l I l l l ~ ~ .lI e';I' II ,'rc tn ,Illll.illl 
di"t'I'IeLl , 1I,1,Ilt'd ill I'h'''l'h"le- hlllfl'l L'd " illn L' I PfI" l ,III" Ilwll 
illcuh.ll t'd tl lt' ,'II tnIIlUl t" .11 " 'l'tn lCI11PCI .ltUIL' III hulkl I ( 12t1IlI \l 
N ;ICI , . ~ . - I I l I ' \ 1 1 KCI. 5 111;>"1 ;'II ",SO ,. 'i 111\1 \(.dIUIIl I') IU I,I IL" 21 1 III \I 
I ~ u r i l l t ' , , If) tn:-- I H EI'E) , ~ I J J tn I ",I lIL'\"l', I' ll (, L) I. 1<11 -1.- 1l1i1lUIl', .1 1 
:'7 C ill bullLT 2 I I ~ O O 111;'11 ~ : t ( 1 1 "-1 tn \l K( I ~ ~ 111 \1 \ I", "() , 'i 
111:-- 1 ",,-liUI11 pI nll .llL'. 211 III 1\ I 1.ILlJ'lIlL', III 111 \1 IIl!' I " [I, 111 \1 
(':tCI ., 20 Illr-, I !.!llIU"l', I 1ll"/ llil L,. I1" ,,:cll,hl' B, pH "lIl .mel 1<11 I 
IHILII ~ H H ,, "' Ill 1 l ' ~ I J J C r r I I U I L ' ' IIl 'hulkl ' I ~ ~ ~ ~ 111 \1 " ( I 'III I \ \ ~ ' > ( ( , ,
~ ~ Illr-- I 'I" lilltn p)rU I.t (l', 2tl 111 \ 1 1,IUIIIl,' I III I 1(,1 \ 'i 111 \1 
crL'.tlinl' .. ,0111\ 1 " : " !'(), , ~ 1 1 1 1 1 \ 1 1 ",ltl""l' I Ill :': 1111 .1 \". I' l l 
~ I I fln ,IIII , cl'lI l ' llhlL'r' lI<.:r,' dl"\'<I, lll'd b, I 1"',IIt'L1 " I J ' t l t l l l ~ ~
thl \, u",11 ,I lil(HIO til' oIlld Ihl' Ilbl'l .l l l'J "II, I;cr,' "'l'd't! 1\' ~ I I " "
l '\'Il'r, III" 111 U I B'> h,II ,'"III": .ltl .ILhlll,'Il\. "II, liLT,' II,'" \Lllh 
-I ', 1',) 1 all'l lll.II"ch)lk I l'i IllIIHIll" .II ""'Ill It'Illl','1 IIiii' 'I I"" II, 
,Ibill/cd II 1111 1/111 '11 \ 11111 111 I '" " 11I11I1I1," ,II 1""111 1,1111',1,11111, I 
,llld Ih cll IIlLlIb,ltl''' IIl lh Ih.: Ilh l lhl' III"n,.,I,III,II ,11111" 1.1 1111 I 
~ I I O I I \'1 ,1 1I11 -11\II'l'III,,"11i I I -II, ("1 I 1I"1I1 ,II 1 < ~ ' 1 1 1 1 Icll!"I .IIIII, 
11l,1Ib.ltll l ll \lilll Ilt ,' 'l',lIlld,III ,llIltI",dll" (I \ ",',II 11/11 IIH'U" 1_(, 
( I 2'i(l I, ,111" Ilu\'rl"l,' 11 1 l "l{hl<" \, III"ll ":" II ,I'ili llil'll ,1.:<, 11M 
h\111I L,d,'"1l 111I11I1I1II'1':'l',II,1I l ,d"'llh'lit' \\,' I (,1\'" I' \ 
hili" 111111 I,ll ",,'nlllllllllll\' ,"'111 \\,1' l'lll,'"I,,1 I, I t I 
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Figure 1, HI IES-7- EB f" rll1 ;) li " ll b) 111:1" culture or forced agg rega ri lln , R < < p r t " " I l l : I I i l t ' ' Image , ;1 rt' , 1)(I\\n I'll I' 111;1" ,'ullilre El:h 1'1 '1';11l'" , , ~ ~
coll 'lgc n;)'l' tre;1 II11C111 + , cr'lping of HI IES-7 n: lb ,1n mOlh': em hr\'o tibrnbla, t kC'lkr' :111" tilell culluring 111 , u' pc' n, ion III Cr-- I 111)111 dn " I 
di l't'erenliatioll (A) ,Inl! V-L)(,FA E13 , prcp:lr,'d rrOlll IO,tH)il k eder- free HLIES-7 ce ll , l'ultllrl'd ill cl ll k r,' Il I lllL'lli:1 11 11111 d2, -I , '" (, ot dill,'felll l,111 "n 
( n ) , Media tc, led lIe fe a, f o l l , , \ \ \ ~ : : (' (\1, I I(,M , D-FBS, (,DM -BSA, : lIlel C' Di\ I-PVA Pefl" ' lltage, >l L'I'c' ' \ Ik'u l.lkJ II'<lmlhe nUlllher 01 \l ell , II) l', lLil 
\ '-')6 pl:i te that cOll winecl [ 8 " ( :!: SEM : 11\1l ex pcrilliellh l. Sc:dc h:11' = 100 /-l-nl. A ilhrcI iatlon" CDi\ I- r\ <;r\ , d" li n" d Illed lllil l ,ul' l, kmcllied \I Ilh 
bOl' illc , erUlll aibulll in : CDI'vI-PVA , Jef ined lllediUIll ' Upl' ie lllell tc'd " ith I'll I)' I i ll) I alL-ulw l: ('(\ 1. (unditi l lned mc,hulIl : J, d,)) : D-rl3 <; , nu l"",'(,,', 
ll10J ified Eag.It! ' , lll e,diUI)) , uppielllcnk d wil li 20', fd<1 1 bLII illt' ,e fUIll I 'c<:' (\1., Ic'r iJI, alld (\ lellllld'l : l 'C:t 1. UIIU'lldll lll llCd Ilied lUll1 
roOIll temperature, S a l l l p l l ~ ~ \ve rt' Ilw ul1ted in Vectur,;hield K l l d ~ c c 1 1
cOll ta inin g ~ , 6 6 d i : : 1 1 1 1 1 d d l l u - 2 - p l l e l l y l i i l l n l e e (VeL'l ll r L L a h o r a t l l r i e ~ , , Pe-
terboruugh, U,K .. h r r p : / / / \ ~ ~ , \ ' c c d u r l a h " . . ( ) f l l ) ) alld vi, ual i7eJ on a 
Leica SP2 conf(1ca l Illicro,cope ( I k erhrug:; , S\\ i t7er lalld , hrlp :!/ 
INWW ,it.: ica,co l1l ), 
H&E Staining 
EBs \\e re w a ~ h e d d in I \ \ i c e e in PB S, fi xt'd in ~ ~ k k paralu rnl aldeh:-dt' 
in PB S for l :'i I l l l n l l l t ' ' , , and Ihen \\ 'a, hed tw i"e in PBS , EB , we' re 
SC I in lo I r;, a ~ a a o ~ , ' ' in dnubk c1 i , t i li ed H ,0 ~ l l l c i i p r o o ' L ' ~ ~ ~ c l l
o\'t' rni i! ll I u ~ i n ; ; a Shandun E,\L'ehinr l l ~ ~ u e e 1 ~ 1 ' < 1 c e ~ ~ l l r r I Therl11 Ll 
Sc ient ific, Ru; co rn , L' ,K .. hllp :// \\ \1 ' 1,1 ,th c' rill LJ.,'Llill ), P r r 1 C e ~ , t ' d d
ag:l rnse h luc k" we re emhedded in p:ll-atli li \\'ax ( T i , , u t t - T e " " II 
eillhedd ili g II' J\ , 7 : o e h ~ J ' \ \ ' u u d t ' , , The N e e h e r l : l i i d ~ , , http:// \\\\II , 
l i ~ ~ l l e - l e k k CO Il1 ) il sing a Ti ss ue-T ek III l l l e e i l l a l / d i ~ p p ' n ~ i i : : / c r ~ ' n n
con,,, !. St'c ti ll lled u, i ni! :1 III ic ru tPl11 e' at :' }.-lIl1. :ll ll l arri \ed tll 
S u u c r F I ' l l ~ t t Pl us , l i tl e, t M cnle l-(; liI,c r , Rr:lun'c'hll c ig , (; crl11 :ln ), 
hll p:/h \\\\' ,lll l' II Lc l ,de ), PCl r :l ll in ~ ~ c c i o n ~ ~ \\ CrC dc\\a\l'L1 Lhing 
XI kne, rehvdraled 111I'Llll 2h ;1 11 elha no l/ I-! ,0 gr:IJi t' 111 and ;;ta int'd 
~ ~ ; i l h h H a r r r ~ ' ' He' matosl lin ( V WR , \\.'c<1 (,he,le l-, P,\ , hllp :// 
W\\'I\ , \'I\'I' ,l 'Uill ) and h,; in Ye ll llll i ~ h h I\I \\ ' I{ ), h<'fore deli ) dr:lting 
and 1II II un lil i O l l ~ i i i ! ! DePeX 11I (lUli t i ll i! lIl ed iu lll I \ ' \ \'R ), S:lnlple, 
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Table 1. Formation of EBs from HUES-7 and BGO] by mass culture 0 ~ ~ d . , , r orce aggregatIOn 
Defined input ceO number (cells per ha . dr ngmg op or cells per weill 
Undefined input cell number l'ntreated 
( m a s . ~ ~ culture): collagenase Hanging drop ULA (t.:-961 (U-961 Untreated ,Y_96,b 
from MID's (0.3-10,000)" 3,000 10.000 3.000 10,000 3.000 10.000 
HUES-7 
% EB formation" NA 0 82::!: 18 100::!: 0 0 56::!:·B 93::!: 6 loo::!: 0 
Average EB diameter (mm) 318::!: 27 NA 389::!: 23 445::!: 15 NA NO 377::': 16 ~ 7 6 : : ! : : 15 
(100-1,200)<1 (250-45lf) (400 ... 575.1) 
BGOI 
o/e· EB tormation NA 0 91 ::!: 2 100::!: 0 0 0 9O::!: 4 100::±: 0 
Average EB dhlmeter (mm) 333 ::!: 28 NA 257::!: 16 401 ::!: 27 NA :>IA 2H5::±: II 387::': 9 
( 175-1150<1) 
. (:!50 J25tl l ( 3 2 5 ~ 5 I j d ) )
All EB size measurements were taken after incubation fOf 6 da' . CM ; x p e r i ~ n e n t s , , with 20 E B ~ ~ measured per experiment. ) s In and represent averages (::±: SE\11 from at least two independent 
b H ~ g l n g g ~ r o p p.. c u l t u ~ e s s (30 J-tl) .were seeded with 300. 1.000, 3,000. or 10.000 celb. 
c W IthO\l\ ~ e n t r . l r u g a \ l o n . . fonnallon efficiency was poor (data not shown). 
d% EB fOll:nal1on was calculated as the number of wells containin EBs on da 6 of d" .. N l I ~ b e r s s 111 parentheses indicate the range of EB sizes (l11inil11u'; to I ~ ' " " ,y . I f t e r e n ~ l a ~ l O n . . . 
equality of variance indicated si
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niticant ditlerences between HUES 7 E ~ ~ , ~ u m ) ) ~ b ~ e r v e d d wuhlll the expenl11ent.11 groups: L e v e n e ' ~ ~ test for 
.001) or 10.000 (p < 001) cells"'or BGOI EBs f o r ~ ' d d b I' - " ~ ~ onne y lila" culture EBs and by Y-96FA from 3.000 (p < 
. ' e y mass cu lUre an by Y-1}6FA from' 000 (p 001 0 
AbbreVIatIOns: CM. conditioned medium; MEF, mouse embryo fibroblast. NA "t r. hI ~ N O O < ." ) ?f I .000 (I' = .02) cells. bottomed 96-we\l plates. ' . ,no app Ica e, . not done: l LA, ultralow-attachment U-
diverse range of Sizes observed between EBs formed in mass 
culture w a ~ ~ s i g n ~ f i c a n t l y y reduced by V-96FA (Table I: supple-
me?tal onltne Fig. I; P < .02, Levene's test for equality of 
vanances). 
Evaluating the Effect of Media, Cell Number, and 
Day of Differentiation on V -96F A EBs 
Successful formation of EBs in CM via the V -96FA system 
allowed the etfectiveness of different media to be tested. As an 
initial screen, percentage EB formation was compared on d2, 4. 
or 6 after V-96FA with 10,000 HUES-7 cells in CM, UCM, or 
D-FBS. which contains 20% serum (Fig. 2B). CDM-BSA and 
COM-PYA were also tested, since these semidelined and de-
fined media, respecLi vely. were recently repOtted to suppOtt 
undifferentiated proliferation of the hESC lines H9 and HSF-6 
113] (L. Vallier, M. Alexander, and R.A. Pedersen, personal 
communication). Consistent with our observations above. high 
efficiency formation (I00Iff) in CM was onserved on d2. 4. and 
6 of differentiation (Fig. 2B). Efficiency was the same in COM-
PYA but lower in UCM (66%-82'7i), CDM-BSA (77%-90l7c). 
and D-FBS (0%). Therefore, subsequent experiments focused 
on formation, growth. and cardiomyocyte differentiation from EBs 
produced by V -96FA in CM and the detined medium, CDM-PV A. 
The utility of the V-96FA system was developed further by 
investigating the kinetics of H U ES-7 EB growtll in relation to 
input cell number, days of differentiation, and medium formu-
lation. Plates were seeded in triplicate with 1.000. 3,000, or 
10.000 HUES-7 cells in CM or CDM-PY A. After centrifuga-
tion, one plate at each densHy was cultured until d2. 4. or 6 of 
ditferentiation, at which time average EB size was calculated 
(Fig. IA). Analysis of EB size i;dicated a high degree of 
reproducibility between independent experimenL" ~ u s i n g g ~ ~CM or 
CDM-PV A (Fig. I B. I C), which was confirmed by evaluating 
viable cell numbers per EB (supplemental online Fig. 2A. 2B). 
These observations were also consistent with histological exam-
inalion using H&E staining. which showed greater h ~ m o g e n e i l y y
in sile and tissue morphology of V -96FA EBs formed in either 
medium than their mass culture counterparts formed in CM {Fig. 
3). For EBs formed in eM from all cell seeding densities. both 
increasing input cell number and day of differentiation contrib-
uted to increa,ing sil\: (Fig. 1R). Similarly. EBs initiated from 
10,000 cells in COM-PV A increased in size from d2 to d6 of 
differentiation (Fig. IC). However. the size of CDM-PVA EBs 
formed from 3,000 cells remained SIalic. whereas those from 
1,000 cells declined. with no EBs detectao\e by d6 of differen-
tiation (Figs. I C. 3). These observations indicated that V -96FA 
provided a reproducible platfOim with which to evaluate the 
effect of different media on EB formation and growth. thus 
enabling comparison belween different hESC lines. 
Formation of V-96FA EBs in eM was efficient from 
HUES-7, BGOI. NOTI\, and NOTT2. WiUl similar overall 
growth profiles observed between lines (Fig. ~ ) . . demonstrating 
that the system has the potential to be applied generically" 
However. ~ t a t i s t i c a l l analysis indicated several interline differ-
ences in EB size (supplemental online Table I). For example, on 
d4 of differentiation, the size of EBs seeded from 1.000 hESC, 
varied between the lines (p = .002; one-way analysis of vari-
ance [ANOV Aj), as did those from 3,000/d4 (p = ,()()\) and 
10,000/d4 (p = .(01) or 10.000/d6 (p = J}.t2). Similar otN:r-
vations were made for CDM-PVA EBs from the three line ... 
examined (HUES-7. BGO!, and NOTII; compare Fig. IC with 
supplemental online Fig. 3A. 3B). with significant differences in 
size observed from \O,000/d2 (p = .03 \). 3 . 0 0 0 / d ~ ~ (f' = .038 I. 
and 1O.000/d6 (p = .007; supplemental online Table I). Thus. clear 
differences in EB growth kinetics were observed between the lines. 
Variable Cardiomyocyte Differentiation Between 
hESC Lines 
The reproducibility of the V-96FA system and the a h i l i l ~ ~ III 
dictate EB size by altering input cell number and/or time in 
culture prmided an opportunity (0 C ~ l I T ) ) out s ~ ~ stemalil: compar-
ison of cardiomyocyte differentiation cfticienc) tx:t\\ een the 
four hESC lines. As before. V-96FA EBs were formed frolll 
1.000. 3.000, or 10,000 cells in eM and cultured until d2 . .t. or 
6 of ditlerentiarion. EBs were then \\\ itehed (0 and maintaint'd 
in D-FBS until d24 of differentiation (Fig. 1 A). FRS \\ J' in-
cluded during the C\lemkd differentiation period b e ~ ' : I l 1 , e e ab-
sence or serum i ~ ~ reported to he detrimental III m a i l l t ~ n J I I l ' e e lit 
primary cardiomyocytes 1171 
For all fOllr hFSC lines. t r a n ~ l e r r llt the Y -%L \ •. H ... prn-
duced frol11 1.000, 3.()()O. or mOOO hESC, til D·FRS on d! I II 
differentiation yidded onh limited number- or h c . 1 I 1 1 1 ~ ~ ER, 
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le' l1ll ), r oor w ; i i ~ ~ I ,{)()O ilES(" s\\ ilL'ilt'U III D -FBS 011 J .f Ill' 0 
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disaggregated with collagenase to single cells or small clumps 
of cells. After replating, the cultures contained cells that con-
tinued to spontaneously contract and were immunoreactive to 
antibodies against a-actinin and tropomyosin (Fig. 6D). Anal-
ysis of the cultures by RT -PCR indicated the presence of tran-
scripts for cardiac transcription factors (GATA-4, TBX-5, and 
NKX2.5) and structw-allregulatory elements (MYH6, MYH7, 
SLC8AJ, and MYL2) but not for NEB, which encodes the skel-
etal muscle protein nebulin (Fig. 6D) [18,21]. Analysis by size 
category indicated that CDM-PVA+AF HUES-7 EBs of 250-
3S0 I-I-m at time of transfer to D-FBS produced the highest 
percentages ( 19.6% ± 4.5%) of beating EBs, a pattern similar to 
that seen for HUES-7 EBs formed in CM (Fig. 6E). 
Formation of HUES-7 EBs in mass culture resulted in 
beating outgrowths arising from 1.8% ± O.7<k of total EBs 
analyzed on d24 of differentiation. This percentage increased to 
9.S% ± 0.9% using V-96FA from 3,000 cells in CM with 
transfer to D-FBS on d4 and to 23.6(Yl' ± 3.6% using 10.000 
cells in CDM-PV A + AF/d2. These data associated well with 
relative quantification by real-time PCR of MYH6 transcripts 
(Fig. 6F), indicating that forced aggregation of HUES-7 in 
defined medium with addition of activin A and bFGF increased 
cardiomyogenesis by greater than 13-fold compared with mass 
culture in CM. Thus, the abiliLy to form EBs in defined media 
makes the V-96FA system amenahle to evaluating growth factor 
induction of cardiomyocyte differentiation. 
DISCUSSION 
Although formation of cell lineages representing the three germ 
layers via in vitro differentiation and expression of various 
pluripotency markers, such as SSEA-4, TRA-I-60, OCT4. or 
NANOG, forms a useful umbrella under which to group the 300 
or so hESC lines derived to date, the phenotype of each line is 
likely influenced by both inherent genetics and environmental 
parameters [31. Indeed. the culture environment can have a 
profound effect on the molecular signature of hESCs; changing 
the serum component of the culture medium to KnockOut 
Serum Replacement altered the expression protile of I A 17 
genes in the hESC line HS237 [22]. Therefore, we used stan-
dardized conditions to provide a common platform to initiate 
differentiation of indepenclently-derived hESC lines to test ge-
neric applicahility of differentiation protocols., .. . 
Most differentiation protocols for human EB formation 1111-
tiate sllspension cultures by harvesting hESC colonies directly 
from feeders using manual dissection or collagenase. However. 
consistent with otller repOtts [8, 23], we found that this strategy 
resulted in a high degree of heterogeneity in EB size and limited 
cardiomyocyte differentiation in all lines tested. likely a ~ o n s e e
quence of the variability in cell numbers that seed each EB. In 
mouse ESCs. this issue has been solved by seeding hanging drop 
cultures with a defined number of trypsin-passaged cells (typi-
cally 300-700). This results in reproducible productio.n. of 
mouse EBs that are 100-200 I-I-m in diameter by d3 of dIffer-
entiation and has enabled a reliable system that recapitulates the 
early stages of dcvelopment [24J. Moreover. after e.xtended 
differentiation, many of the murine EBs develop beating out-
growths [19]. Formation of human EBs in hanging d r o p ~ ~ has 
been reported from manually dissected hESC colony p l l ~ c e s s
[23]. However, the size of starting material remain, heteroge-
neous. and the labor-intensive nature of the system is not ame-
nable to high-throughput development. Our attempts to form_ 
EBs in hanging L1rops seeded with defined n u m t x ' r ~ ~ ot 
trypsinized in HUES-7 and BGOI cdls were unsuccessful. _con-
sistent with a previous report using HES-I and HES-2 [ 2 ~ ] . .
Variable Cardiomyocyte Differentiation in hESCs 
As a ~ ~ alternative approach, Ng et a\. [8] developed a forced 
aggregation system to form EBs from defined numbers of 
HES-2, -3, and -4 by centrifuging at 500g for of minutes at .rT 
in ultralow-attachment U-96-wdl plates. Although data rdatino 
to E ~ ~ .size w e r ~ ~ not reported. efficient blood formation required 
a mmlmum of SOO cells per well. and input cell number was 
critical for directing efficient L1ifterentiation to specific hemato-
poietic lineages [8]. Although this strategy provided valuable 
proof of concept that forced aggregation was a viable technique. 
there are several potential limitations with the study. First lilA 
U-96 plates are difficult to obtain and prohibitively expensive 
(--$20 USD per plate) for high-throughput de\ e\opmenl. Sec-
ond, the three lines used were all derived at the same institution. 
and so the generic utility of the strategy between independently 
derived hESC lines was unknown. Finally, hESCs were cultured 
on MEFs, and mixed populations of the two cell types were used 
in the aggregation experiments; however. it has ht'Cn suggested 
that contaminating MEFs have the potential to interfere with 
differentiation by both competing for cell-cell interactions and 
insulating communication between the ESCs [24]. 
We observed >90ck EB formation using defined numbers of 
trypsin-passaged HUES-7 and BGOI cells maintained in fecder-
free conditions in ULA U-96 plates, consistent with observa-
tions using HES-3 [8]. Importantly for high throughout devel-
opment. aggregation was also efficient in untreated V -96 plates 
(-$1 USD per plate), and this method proved to be transferable 
to NOTTI and NOTT2. In our laboratory, V-96FA has since 
been successful using defined numbers of trypsin-harvesteLi HI 
(routinely passaged with trypsin) and HUES-7 (routinely pas-
saged with collagenase), both cultured in feeder-free conditions 
(unpublished observations). 
Certain parameters influenced efficiency and reproducihility 
of EB formation. Rather than containing one discrete EB per 
well. multiple EBs were identified in a minority of \\elh whcn 
V -96 plates were centrifuged at SOOg for 5 minutes. Thi, issue 
was virtually eliminated \\ hen plates were subjected to 950g. 
Interestingly. EB formation occurred from HUES-7 anLi BGOI 
irrespective of the undifferentiated hESC culture density, 
whereas formation from NOTr I (and HI) became erratic when 
density exceeded 2 x 105 cells per cm1 . The medium also 
int1uenced EB formation, with highest efficiencies occurring in 
CM and CDM-PVA, efficiency decreasing in UCM or CDM-
BSA. and no fOlmation in D-FBS. The underlying mcchanbm, 
responsible for the differences observed in EB formation be-
tween hESC lines or media are not known, but altercLi expres-
sion levct- of key adhesion factors seems a Ii\...ely target for 
future studies. Indeed. it has been demonstrated that over 60 cell 
adhesion-related genes were upregulated in the hESC line 
HS237 Lw ,witching the serum component of the medium to 
KnockOt{t Serum Replacement [22] It is also notabk that 
pre\'ious microarray studies have h i g ~ l i g h t e d d poten.tial d i f f e r ~ ~
ences in expression profile of integnn ~ u b c \ a s s e s s \11 H I and 
BGOI [10.261, However, from our data and that ot Skottman el 
al. [22], it is plausible that differences in ccll den\ity o ~ ~ (ul!ure 
medium at time of cell harve'ting could abo account tor ,nme 
of the documented variability between hFSC line,. and thc 
potential inl1uence of these f a c t o ~ ~ will need to be l"1I1l'ldered 
when deSigning arm;.' ,tudies to make future interline l"l1l1lpan'lllh 
Since the standarLlized culture anLi \' -96FA ' t r a l e ~ ~ ~ de· 
, · .... "d here functioned between all thc l i n e ~ ~ inve,tigated. \\e scntl" .. T 
"ere able to make parallel. interline compari'1lI1' Slgnlll";l111 
variabilit) in EB formation. gflm tho a n L i c a r d i o l l 1 ~ ~ oqlc' dltlcr-
entiation' \\as ohserved bet\\een indepcndently dCfl\cd hFS< 
line" but. notal1l;.. not he!w een 'OTT I and ,orc. \\ hlL'h ~ L ' I L ' '
hoth derived in our labllrJtory. Other ,tuLlle,. tn\C\tlg;ltlng ~ c n t ' '
exprcssion. have alq) ol1,cf\ed greater ' I m l l a f l t ~ ~ between line' 
isolated within the ,amI.' laborJtnr;.. i m p l t c a ! l n ~ ~ thc dem alton 
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and culture history of each line as a source of variability. For 
example, four lines from Finland (FES21, FES22. FES29. and 
FES30) were more similar to each other than to the three from 
Sweden (HS181, HS235, and HS237) [27], HSFI and HSF6 
were more similar to each other than to H9 [28], and BGOI/ 
BGOI-MEDII were more similar to each other than to HI [29]. 
N e v ~ 1 t h e l e s s , , the greatest percentage of' beating areas were 
obtal11ed from NOTTl by seeding EBs with 10,000 cells and 
culturing in V -96 plates until d4 before transfer to D-FBS. 
w h e ~ e a s s IO,OOO/d6. was most effective for NOIT2, suggesting 
that 1nherent genetic and/or epigenetic differences are also im-
portant. This is consistent with observations of Yoon et al. [23]. 
who observed spontaneous beating in 0% of EBs derived from 
Miz-hES-l, -4. and -6 but ~ 2 2 1 7 ( ( in Miz-hES2. 
The variability in EB size and in cardiomyocyte differentiation 
observed b e t w ~ e n n the hESC lines may also relate to passage 
number of the hnes at time of differentiation. HUES-7 cells were 
provided at pl2 by Harvard University [9], and we derived 
NOITII2. Consequently, differentiation could be carried out at 
p20-30. Conversely, only higher passage BGOI cells could be 
purcha'ied from BresaGen [11], and p45-55 cells were used for the 
differentiation studies. Although the cells lhal were used for dir-
ferentiation were assessed as karyotypica.lly normal by G-banding 
analysis. there is mounting evidence to suggest that extended cul-
t u r ~ ~ is a'isociated with more subtle changes. such a<; gene amplifi-
cation (c.g., the proto-oncogene MYC) and differential methylation 
[30]. Because this argues for using the lowest passage hESCs 
possible. we did not attempt to culture HUES-7. NOITI. and 
NOIT2 to ~ p 5 0 0 for comparison with the passage BGOI cells and 
cannot lUle out the possibility that high passage number has a 
negative effect on cardiomyocyte differentiation. However. it is 
notable that i n c r e a ~ i n g g passage number of H9.2 hESCs has been 
associated with increasing cardiomyogenic potential [31]. 
Cardiomyocyte differentiation of tl1e four lines examined 
here appeared to be most efficient when EBs of 250-350 /-Lm 
were transferred to D-FBS. This is consistent with several other 
studies thai indicate EB size or input cell numbers arc important 
for influencing lineage specilicalion. Erythroid or myeloid lin-
eages were formed most effectively from forced aggregation of 
1,000 cells or 1,000-5.000 HES-3 hESC's. respectively. More-
over. a study investigating cardiomyocyte differentiation in 
hanging drops seeded with between 32 and 2,mO mouse AB2.2 
ESCs found that EBs formed from 565 cells produced the 
highest percentage of beating areas [321. In this c a ~ e , , primitive 
endoderm within the mouse EBs influenced the onset of car-
diomyogenesis in a concentration-dependent manner [32]. In 
line with these observations. cardiomyocyte differentiation of 
mouse P 19 embryonal carcinoma cells and human ESCs 
(HES-2. -3. and A) has been induced by coculture with END-2. 
which has characteristics of \isceral endoderm [33-35]. In ad-
dition. microarray studies monitoring cardiomyogenesis in 
HES-2 have shown that induction of genes of the plimary 
mesoderm and endodermal lineages is followed hy expression 
of those in cardiomyocyte progenitor cells and fetal cardiomy-
ocytes [36]. Thus. detailed time course analysiS of mesodermal-
and endodermal-rclated proteins within dcveloping human EBs 
may yield clues of how to promote cardiomyogenesis. which 
could be evaluated using V-96FA in dd'ined media. 
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The V-96FA system also provides a much improved. homo-
geneous platform with which to test the effect of different media 
and/or factors on EB fonnation. growth. and differentiation 
b e t ~ e e n n l i ~ e s . . Activin A and bFGF support proliferation of 
U I ~ d l f f e r ~ n t l a t e d d H9 and HSF6 hESCs [13] and have been im-
plIcated 1n c ~ d i o g e ~ e s i s s from mouse and human ESCs [19. 20]. 
Our observatIons WIth HUES-7 indicate that EB formation in 
~ e f i n e d d .CDM-PV A medium supplemented with both growth 
tactors 1nstigates up to a 2.5-fold innease in beatine areas 
compared with forced aggregation in CM and a 13. I-fold in-
crease compared with mass culture in CM. It will now not only 
be necessary to identify whether activin A. WGF. or a combi-
na.tion of both factors has the greatest effect on cardiomyogen-
eSIS, but also to determine the most effective concentrations. 
Intel:estingly, formation in defined conditions did not produce 
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In conclusion. we have coupled standardized culture with a 
high-throughput. V -96FA procedure to facilitate accurate com-
parison of cardiomyocyte differentiation potential between in-
dependently derived hESC lines. Since this strategy will also he 
amenable for derivation of otl1er differentiated lineages, it 
should provide a useful platform to rapidly identify whether 
particular lineages are favored by specific hESC lines. Relating 
sllch information to both the original derivation conditions of 
each line and the data emerging from organilalions such a ~ ~ the 
International Stem Cell Initiative should expedite production of 
a new generation of hESC l i n e ~ ~ thal are derived and cultured 
using universally agreed-upon conditions. 
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7.3 LIST OF MANUFACTURERS 
Table 7-1: List of manufacturers referred to in text 
Reference in FuJI company name and 
text location Website 
Ambion , Austin, TX, USA 
Ambion (Supplied by Applied httQ:llwww.ambion .coml 
Biosystems) 
Applied Applied Biosystems, Warrington , h t t Q : l l w w w . a Q Q l l e d b i o s ~ s t e m m . c o o l lBiosystems UK 
Beckman Coulter Beckman Coulter (U .K.) Limited , httQ:llwww.beckmancoulter.coml High Wycombe, UK 
BO Biosciences BO Biosciences, Oxford , UK httQ:llwww.bdbiosciences .com (Supplied by SLS) 
BioChain BioChain, Hayward , CA, USA httQ:llwww.biochain .coml 
Blades Blades Biological Ltd . 
Biologicals Edenbridge, Kent, UK httQ:llwww.blades-bio.co.ukl 
Chemicon Chemicon Europe, Ltd ., httQ:llwww.chemicon .coml Chadlers Ford , Hampshire, UK 
Eurogentec Eurogentec Ltd ., Southampton, httQ:llwww.eurogentec.coml Hampshire, UK 
Fisher Scientific UK Ltd ., 
Fisher Loughborough , Leicestersh ire , httQ:llwww.fisher .co .ukl 
UK 
GE Healthcare GE Healthcare, Chalfont St httQ:llwww.gehealthcare.coml Giles , Buckinghamshire, UK 
Hyclone 
Hyclone UK Ltd ., Cramlington , h t t t : : / w w w . h ~ c l o n n . c o m m
Northumberland , UK 
Improvision Improvision , Coventry, UK httQ://www.imQrovision.coml 
Intervet 
Intervet UK Ltd ., Milton Keynes , httQ:llwww.intervet.co .ukl 
UK 
Invitrogen Invitrogen Ltd ., Paisley, UK httQ :/lwww.invitrogen .coml 
Jackson Jackson ImmunoResearch httQ://www.jireuroQe .coml 
ImmunoResearch Europe Ltd ., Newmarket, UK 
Labtech Labtech International Ltd., httQ:/ /www.labtech .co.uk 
International Ringmer, UK 
Leica 
Leica Microsystems (UK) Ltd ., h t t Q : / / w w w . l e i i a - m i c r o s ~ s t e m m . c c m l l
Milton Keyes , UK 
Medical Systems Medical Systems Corps , Miami , h t t Q : / / w w w . m e e i c c l s ~ s t e m m . c c m l l
Corps FL, USA 
Gerhard Menzel, 
Menzel-Glaser 
Glasbearbeitungswerk GmbH & httQ://www.menzel.del I Co. KG , Braunschweig , Germany (supplied by SLS) 
NanoDrop 
NanoDrop Technologies Inc., 
httQ://www.nanodroQ.coml Wilmington, DE, USA (supplied 
Technologies by Labtech Internationa l) 
:'-2 7 
Nasco NASCa, Fort Atkinson , WI , USA httQ ://vvww.enasco.com/ 
NEB New England Biolabs (UK) Ltd ., httQ://vvww. neb. uk .com/ Hitchen , Hertfordshire, UK 
Nikon Nikon UK Limited , Kingston httQ://vvww.nikon .co .ukl upon Thames, Surrey, UK 
NUNC Nunc AlS , Roskilde, Denmark httQ:/ /vvww . nuncbrand .com/ (supplied by Fisher/VWR) 
Orange Scientific n.v./s .a . 
Orange Scientific Braine-I'Alleud, Belgium httQ:/ /vvww . ora ngesci . com/ 
(supplied by Fisher) 
Promega Promega, Southampton , UK httQ://vvww.Qromega.com/uki 
PeproTech PeproTech EC Ltd ., London , UK httQ://vvww.QeQrotechec.com/ 
OIAGEN OIAGEN Ltd, Crawley, UK httQ://vvww.giagen .com/ 
R&D Systems R&D Systems Europe Ltd ., httQ://www.rndsy:stems .com/ Abingdon, UK 
Raytek Raytek Scientific Ltd ., Sheffield , httQ:/ /vvww . ra vtek . co . u kI UK 
Roche 
Roche Diagnostics Ltd ., Burgess httQs ://www.roche-aQQlied-
Hill , UK science.com/ 
Santa Cruz 
Santa Cruz Biotechnology Inc., httQ://www.scbt.com/ 
Heidelberg, Germany 
Sakura 
Sakura Finetek Europe B.V., httQ://www.sakuraeu .com/ 
Zoeterwoulde, The Netherlands 
Sigma 
Sigma-Aldrich Company Ltd. , httQ://www.sigmaaldrich .com/ 
Gillingham , Dorset, UK 
SLS 
Scientific Laboratory Supplies httQ:I/www.scientific-labs .neti 
Ltd ., Nottingham, UK 
Sigma-Genosys Sigma-Genosys, Cambridge, UK httQ://www.sigmaaldrich .com/ 
Barloworld Scientific Ltd., Stone, httQ://www.techne .com/ 
Techne UK 
Thermo Fisher Scientific httQ://www.thermo .com/ 
Thermo (supplied by Fi sher) 
UVltec UVltec Ltd., Cambridge, UK 
httQ://www.uvitec.co .ukl 
Vector Vector Laboratories Ltd., httQ://www.vectorlabs .com/uk 
Laboratori es Peterborough, UK 
ViroGen Corporation , httQ://www.virogen .com 
ViroGen Watertown , MA, USA 
Vi sion Vision BioSystems (Europe) httQ ://www.vision-bio .com 
Ltd. , Newcastle , UK ~ ~Biosystems 
VWR International Ltd. , httQ ://uk. vwr .com 
VWR Lutterworth , UK 
